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The functional characteristics and control mechanisms 
of the hypothalamic- pituitary -testicular axis were 
explored by examining the patterns of pituitary and 
testicular hormone secretion in pubertal subjects and in 
adults with impaired spermatogenesis. The overnight 
hormone profile and the pituitary response to repeated 
GnRH stimulation were studied on 1 -4 occasions in 16 
patients (mean age 16.3 ± 2.7 years) with delayed sexual 
development while their clinical progress was followed 
for a mean duration of 22.4 ± 8.5 months. Changes in 
testis and genital size were confirmed to be the two 
physical markers which correlated best with the hormonal 
patterns. The earliest detectable evidence of pubertal 
onset was an increase in frequency and amplitude of 
pulsatile LH secretion during nocturnal sleep. Further 
progress in puberty was characterized by quantitative and 
qualitative changes in the pattern of LH secretion 
resulting from the combined effects of changing frequency 
of hypothalamic GnRH pulses, of gonadal feedback and 
possibly other ill- defined central mechanisms. Heightened 
pituitary responsiveness to GnRH could account for the 
pubertal rise in LH. Since the estimated amplitude of GnRH 
pulsatile secretion remained constant, the increase in GnRH 
pulse frequency was considered to be the prime mover in the 
activation of pituitary- testicular functions at the onset 
of puberty. Thus the hypothalamic GnRH frequency 
modulation of the pituitary provides the basic mechanism 
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for the neuroendocrine control of sexual maturation. The 
pituitary response to GnRH may be helpful in the endocrine 
assessment of patients with delayed puberty. In response 
to a single 10 pg bolus of GnRH, an LH rise of 5 u/1 or 
more was associated with well- defined nocturnal pulsatile 
LH secretion in subjects who subsequently progressed 
through puberty spontaneously. However, in those where 
the GnRH- induced LH rise was under 5 u /1, it was not 
possible to differentiate between constitutional delayed 
puberty and hypogonadotrophic hypogonadism. The pubertal 
development of testicular functions was more closely 
related to the progressive increase in amplitude rather 
than frequency of pulsatile LH secretion. The roles of 
FSH and prolactin were less obvious. Exogenous GnRH- 
induced pulsatile LH secretion failed to stimulate testo- 
sterone production above the maximal levels in the morning. 
This implied that the pubertal Leydig cells normally 
function near to their maximal steroidogenïc capacity. 
In infertile patients, an inverse relationship 
between FSH and sperm count or the severity of germ cell 
depletion in testicular biopsies was confirmed. The 
application of FSH measurements to the assessment of 100 
infertile patients was evaluated. Elevated FSH in those 
with sperm density under 5 million /ml indicated severe 
germ cell atrophy. The use of GnRH stimulation and 
multiple measurements of basal gonadotrophins and 
testosterone conferred no advantage. In patients with 
elevated FSH, circulating oestradiol, oestrone and 
14 
oestrone sulphate were significantly raised. There was 
preliminary evidence that the oestrogen excess resulted 
from testicular secretions of oestradiol. Oestrone 
sulphate was not secreted by the testis, being derived 
from unconjugated precursors - oestradiol and oestrone. 
The pathophysiological significance of these findings in 
male infertility and their relevance to normal intra- 
testicular control mechanisms were discussed. 
In conclusion, the development and control of adult 
testicular functions are dependent on a background of 
pulsatile LH stimulation against which the complex 
interactions between FSH, Sertoli and Leydig cells 
ensure a continuous maturation of spermatogonia and the 
optimal production of testicular steroids. 
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SECTION A 




The study of human reproduction has long been 
hampered by religious, social, political and even 
scientific prejudice so that the most fundamental 
knowledge concerning the functions of gonads was not 
forthcoming until the late nineteenth century. The 
gonads, moreover, are unique amongst endocrine glands in 
that they subserve the dual functions of gametogenesis 
and sex hormone production. This has contributed to the 
complexity of the regulatory mechanisms of reproduction 
which are already burdened by the marked influence of 
reproductive cycles, age and extra -gonadal changes in the 
internal and external environments. Against these 
constraints, it is no surprise that the study of human 
reproduction had in the past failed to keep pace with 
advances in other branches of the life sciences. However, 
the rapid acceleration of world population growth after 
the 1950s and the technological advances in the field of 
endocrinology had brought about an intensification of 
scientific studies in reproduction and launched the 
discipline of reproductive endocrinology in the last two 
decades. 
It is ironic that the importance of the testis in 
male virility has been recognised since ancient times. 
In the Neolithic age (7000 BC) when nomadic hunters 
turned to communal farming, animals first became 
domesticated by castration of male livestock (Steinach, 
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1940) - an ancient practice which remains evident in 
modern times. The use of human castration as a form of 
punishment for sexual offences has been recorded in texts 
dating back to the fifteenth century BC (Pritchard, 1955). 
The creation of eunuchs (Greek - eune : bed and echein : 
to hold or keep) by prepubertal castration for social 
purposes (harem attendants and slaves) was prevalent in 
China, India, Moslem Near East and ancient Greece (Spencer, 
1946). In the Christian church, castration of boys to 
produce castrati male sopranos for church choirs was 
commonplace until this practice was terminated by Pope 
Leo XIII as recently as 1878 (Melicow & Pulrang, 1974). 
Aristotle (400 BC) studying the effects of castration in 
roosters and man, noted the differences between pre- and 
post- pubertal castration on secondary sexual characteris- 
tics (Thong n, 1910). Despite the long- recognised 
effects of castration, many centuries were to pass before 
the first experimental study on this phenomenon was made. 
Berthold (1849) showed that transplanting the testes from 
cockerels to long -term castrated capons in ectopic 
positions in the peritoneal cavity could restore the 
growth of the stunted comb and wattle as well as 
stimulating other masculine characteristics such as 
crowing and desire for mating. He concluded that the 
testes produced certain factors which can affect other 
tissues via the blood stream. This historical experiment 
was the first demonstration of the physiological action 
of any endocrine gland. Not only did this study mark the 
conception of male reproductive endocrinology but it also 
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ushered in the beginning of the science of endocrinology 
as a whole. 
The importance of the testes in male fertility was 
in doubt for some 2000 years since Aristotle (400 BC) 
postulated that they merely acted as stabilizing weights 
to prevent the ducts from being drawn up within the 
abdomen. In 1668, de Graaf described the testes as being 
made un of minute convoluted tubules and correctly 
deduced that the fertilizing portion of semen was 
confected in the testes. Hamen, a student ofIeeuwenhoeck, 
observed motile "animacules" in human semen under his 
teacher's simple microscope (L eu wenhoeck, 1678). The 
significance of this observation was slow to be realized 
and the term spermatozoa embodied the prevailing opinion 
that these were parasites or symbiotic protozoa in the 
semen unrelated to fertility (von Baer, 1827). Another 
student, Von Kölliker (1841), stimulated by the cell 
theory of Schleiden and Schwann, made a systematic search 
for the cellular origin of spermatozoa in 37 species of 
invertebrates. He concluded that spermatozoa arose from 
cellular divisions of the seminiferous tubules of the 
testis and were the most essential part of the semen. 
Following this, any remaining doubts regarding the 
significance of spermatozoa was dispelled by the demons- 
tration that they enter and fuse with the female ovum 
(Barry, 1843; Hertwig, 1875). The gametogenic function 
of the testis was thus established. 
After this inordinately long gestational period, the 
infantile discipline of male reproductive endocrinology 
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embarked on a slow prepubertal growth phase (ca 1850- 
1960). During this time, the classical extirpation and 
replacement experiments and fundamental biochemical 
studies of steroid and peptide hormones established the 
foundation for the more sophisticated studies on the 
endocrine regulation of the testis in the modern period. 
Although Leydig first described the clusters of 
epithelial cells in the interstices between the semini- 
ferous tubules in 1850, it was over 50 years later that 
these cells were allocated the role of testicular hormone 
production on morphological and mainly circumstantial 
evidence (Bouin & Ancel, 1903). Using a lipoid extract 
of bull testes, Moore & McGee (1928) and Moore & Gallagher 
(1930) demonstrated reversal of the effects of castration 
on epididymal, seminal vesicular and prostatic functions 
in guinea pigs. Interestingly, it was not the 
appreciation of Berthold's or Moore's physiological 
studies but the popular misbelief that testicular failure 
led to symptoms of senility (Brown -Sequard, 1889) that 
stimulated the efforts to purify the active testicular 
principle. The first androgen to be identified was 
androsterone from urine (Butenandt, 1931). This was 
accomplished by the extraction of 15,000 litres of male 
urine yielding only 15 mg of crystalline androsterone. 
It soon became apparent that the testicular androgen was 
chemically distinct and much more potent than androsterone. 
Testicular testosterone was isolated in crystalline form 
by Laquer and colleages (David et al, 1935), its chemical 
formula identified and the hormone synthesized from 
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cholesterol in the same year (Ruzicka & Wettstein, 1935; 
Butenandt & Hanisch, 1935). 
The first demonstration that the pituitary gland may 
be important in maintaining normal gonadal functions came 
from the simultaneous reports of Smith (1926) and Zondek 
& AschlBim (1926). These workers induced precocious 
ovarian development and sexual maturation in immature 
rats by daily implantation of fresh living rat pituitary 
fragments. Having also perfected the technique of 
selective surgical hypophysectomy by the ventral approach 
through the sphenoid sinus, Smith (1927 & 1930) was able 
to show that selective removal of the pituitary gland 
resulted in atrophy of the gonads, thyroid and adrenals. 
Daily implantation of living rat pituitary fragments led 
to complete cytological restoration in the latter three 
glands with mating and fertility in the hypophysectomized 
animals. This pioneering series of experiments not only 
proved that gonadal functions are normally controlled by 
the pituitary, but also established the concept of 
control of endocrine functions mediated by secretions 
from other endocrine glands. The search for an 
explanation as to how the pituitary can control both the 
follicular and luteal phases of ovarian function led to 
the fractionation of pituitary aqueous pyridine extracts 
into two distinct gonadotrophins, follicle stimulating 
hormone (FSH) and luteinizing hormone (LH) (Fevold et al, 
1931). Extending these findings to the male, Greep et al 
(1936) showed that LH promoted the development and 
function of Leydig cells while FSH stimulated the 
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proliferation of the seminiferous epithelium in normal 
and hypophysectomized immature rats. The concept of dual 
pituitary control of male gonadal functions was thus 
formulated. However, other studies around that time 
indicated that androgens or LH could maintain spermato- 
genesis if replacement was commenced immediately after. 
hypophysectomy (Walsh et al, 1934; Nelson & Merckel, 1938; 
Greep & Fevold, 1937). Hence, the exact physiological 
role of FSH has been cast in some doubt - an issue which 
remained unresolved for many years. 
The effect of gonadal hormones on the pituitary was 
first described when Moore & Price (1932), somewhat to 
their surprise, produced atrophy of the seminiferous 
epithelium by administration of androgens to intact adult 
rats. This rather paradoxical finding was inspiringly 
interpreted as being due to the suppressive effect of 
excessive gonadal hormone on pituitary gonadotrophin 
secretion. Thus, one of the most fundamental dogmas in 
endocrinology, the negative feedback control of product 
on trophic hormone secretion, was introduced. Greep & 
Jones (1950) later confirmed that administration of 
testosterone proprionate lowered pituitary LH secretion 
in gonadectomized rats. The feedback control of FSH, in 
contrast, was much more difficult to establish. Martins 
& Rocha (1931) found that aqueous testicular extracts 
could prevent castration changes in the pituitary of 
castrated partners of intact /castrated parabiotic twin 
rats, while lipoid extracts in sufficient doses to main- 
tain accessory gland functions had no effect. This 
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induced McCullagh (1932) and McCullagh & Walsh (1935) 
to confirm these findings and to postulate a second 
testicular hormone, inhibin, which was water -soluble. 
Acceptance of this hypothesis was hampered by the 
persistent failure to isolate and characterize this 
second active principle from the testis. Its total 
rejection, however, was prevented by a large body of 
evidence from experimental animals and infertile men with 
selective dysfunction of spermatogenesis which gave rise 
to a disproportionate increase in FSH secretion (for 
review, see Setchell et al, 1977). 
The profound influence of external environmental 
stimuli, for example light, heat, food or season, on 
ovulation and the oestrous cycle has also aroused 
interest (Marshall, 1936). In species such as rabbit, 
ferret and mink, the so- called reflex ovulators, sensory 
stimulation of mating and orgasm are prerequisites for 
ovulation (Marshall, 1904; Heape, 1905). The central 
nervous system, being responsible for the perception and 
integration of environmental sensory input, could thus 
modify pituitary gonadotrophin secretion and reproductive 
function as a whole. This concept of neural regulation 
of reproduction was first subjected to experimental study 
when Marshall & Verney (1936) induced ovulation and 
pseudopregnancy in oestrous rabbits by passing a diffuse 
electrical current through the head. The close proximity 
of the adeno- and neurohypophysis in all vertebrates 
provided the necessary anatomical link between the 
anterior pituitary and the base of the brain. Further 
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studies then showed that electrical stimulation of the 
hypothalamus but not the anterior pituitary was followed 
by ovulation (Markee et al, 1946; Harris, 1948). This 
obligatory hypothalamic -pituitary relay was achieved 
within the hypophysial portal vessels (Green & Harris, 
194 7) rather than in the meagre neural supply between the 
neuro- and adenohypophysis. The neurovascular or neuro- 
humoral mechanism of control of the anterior pituitary 
gained further impetus when extracts of hypothalamus were 
shown to be capable of inducing ovulation and releasing 
LH when infused directly into the pituitary or the 
systemic circulation (Campbell et al, 1961; McCann, 1962). 
Intensive study which followed led, a decade later, to 
the isolation and synthesis of porcine and ovine hypo- 
thalamic gonadotrophin releasing factor (GnRH) by the 
groups of Schally and Guillemin to whom the Nobel Prize 
for Medicine was jointly awarded. Sadly, the untimely 
death of Harris deprived him of the opportunity to 
witness the fruition of his pioneering work. 
The stage leading up to the contemporary period is 
incomplete without another Nobel Prize winning achieve- 
ment, this time by Yalow and Berson in the early 1960s. 
For a long time, progress in endocrinology has been held 
up by the non -availability of sensitive techniques for 
the measurement of low concentrations of hormones in body 
fluids. This obstacle was overcome by the technique of 
radioimmunoassay or radioligand assay (Yalow & Berson, 
1960; Ekins, 1960). Utilizing the principle of 
competitive protein binding and the immunological 
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specificity of the antigen- antibody reaction, hormone 
measurements were carried out by comparing the effects 
of unknown samples with that of known standard solutions 
in their ability to competitively inhibit the binding of 
radio -labelled tracer hormones to their specific 
antibodies. These techniques enabled the accurate 
detection of pg amounts of hormones in minute quantities 
of body fluid and constitute the single most important 
methodologic advance in endocrine research and diagnosis. 
In the ensuing sections, a more detailed account of 
the function and regulation of the hypothalamic- pituitary- 
testicular (HPT) axis, with emphasis on work in the last 




One of the two principal functions of the testis is 
the synthesis and secretion of androgens (Greek - aner : 
male, genos : descent). 
2.1 Isolation 
Due to the difficulty in preparation and the low 
yield of active extracts from testicular tissues, the 
first androgen, androsterone, was isolated from urine 
(Butenandt, 1931). However in 1935 David and co- workers 
successfully isolated crystalline testosterone from over 
100 Kg of bull testes and in the same year the chemical 
structure was elucidated and synthesis of the hormone 
achieved (Rucizka & Wettstein, 1935; Butenandt & Hanisch, 
1935). Thus from a relatively early stage pure 
testosterone has been available in sufficient quantity 
and purity for experimentation and clinical purposes. 
2.2 Structure 
Rosenheim & King in 1932 proposed the perhydro- 
cclopentanophenanthrene formula of cholesterol, thus 
establishing the nuclear structure of the steroid 
molecule (Fig 2.1). The stereochemical relationship 
between gonadal steroid hormone and sterols was confirmed 
when Ruzicka et al (1934) showed that epicholestanol 
was degraded to androsterone. Estimation of the andro- 
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The basic structure of the steroid molecule with the ring lettering 
and numbering of the carbon atom as in the cholesterol and 
testosterone molecules. The substituent groups at positions C3 and 
C17 are critical determinants of the biological activities of 
testosterone. 
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that hormonal activity was dependent on the nature of the 
substituent groups and their stereochemical orientation 
around the basic polycyclic steroid nucleus. Hence, 
maximal androgenic activity was associated with 3 -oxo and 
17 -ß hydroxy substituents with a double -bond between C4 -5 
in the 19 carbon androstane nucleus (Fig 2.1). Although 
such a simple concept of stereochemistry is no longer 
tenable and androgenic activity is present in a large 
variety of loosely related steroids, this has nevertheless 
remained a useful tool for descriptive purposes at least. 
2.3 Biological activities and relative potency 
Like other low molecular- weight terminal chemical 
messengers (for example, thyroid hormones and 
catecholamines) testicular androgens have an extensively 
distributed population of target sites and control 
diverse metabolic and physiological processes (á.v.). 
This contrasts sharply with the relatively restricted 
target trophism of peptide hormones such as gonado- 
trophins. The chemical heterogeneity of androgens 
probably further contributes to this diversity of action 
and target organs. Despite this, androgens are often 
defined by their main biological properties of evoking 
the attributes of maleness rather than by chemical 
structures. This classical definition is necessarily 
limited by the available bioassays - for example, 
stimulation of comb growth in fowls and seminal vesicle 
and prostate weight gain in rodents, which does not take 
into account the broader concepts of androgen functions 
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including the promotion of in -utero development of the 
male genital tract (Jost, 1953), trophic effect on 
spermatogenesis (Steinberger, 1971) and the control of 
male sexual behaviour (Perloff, 1949). Androgens are 
also known to have extra -reproductive actions such as 
trophic effects on the kidney, liver and thymus, nitrogen 
retention and protein anabolism, red blood cell 
regeneration and influence on non -sexual hair metabolism 
leading to frontal balding (for review, see Dorfman & Shipley, 
1956). Most of these androgenic functions are difficult 
to define and quantitate so that for the purpose of 
assessing relative potency of putative androgenic 
compounds, the use of capon and rodent assays are still 
standard procedures even though this is not strictly 
correct. As assessed by these two biological end -points, 
testosterone and dihydrotestosterone are by far the most 
potent androgens. Recent progress in the understanding 
of the mechanism of androgen action and the conversion of 
androgens to more active metabolites by the target cells 
further emphasize the limitation of the classical 
concepts of relative potencies. 
2.4 Biosynthesis of testicular steroids 
Qualitatively, steroidogenic pathways in the testis, 
adrenal, ovary and placenta are essentially similar. 
Most of the earlier studies however were conducted by the 
use of radio -labelled substrates in in -vitro perfusion or 
incubation experiments. These were unable to yield 
quantitative information regarding the contribution and 
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relative importance of specific intermediates or pathways. 
In the last decade, the ability to isolate specific 
cellular and subcellular components of the testes (q.v.) 
and the improved sensitivities of radioimmunoassays and 
mass spectrometry have enabled the measurement of 
endogenous steroid levels and production rates in 
isolated testis cellular preparations and subcellular 
components yielding much greater insights into the 
mechanisms and biological significance of various 
steroidogenic pathways. 
2.4.1 Cholesterol and Pregnenolone 
The testis synthesizes testosterone from acetate 
which is converted to cholesterol by a series of reactions 
involving carbon chain elongation, folding and ring 
closure and intermediates of mevalonic acid, farnesyl 
pyrophosphate, squalene and lanosterol (Tsai et al, 
1964; Nightingale et al, 1967). The mechanism of 
conversion of cholesterol to pregnenolone was primarily 
established in the adrenals but the reaction sequence 
is generally acceptable for the gonads as well. The 
hydroxylation of cholesterol involves a simultaneous 
oxygenation of cholesterol at 
C20 
and C22 forming delta 
20 -22 cholesterol, 20,22 -epoxycholesterol and 20a,22R- 
dihydroxycholesterol (Kraaipoel et al, 1975a and b). 
The last compound is then converted by the side -chain 
cleavage enzyme C20 
-22 
lyase to pregnenolone and the 
6- carbon isocaproic acid. This series of reactions 
requires NADPH, oxygen and an electron transport system 
containing a flavoprotein, noneheme iron protein and 
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cytochrome P450 (Hall & Shikita, 1974). Pregnenolone is 
the starting point for the specific enzymatic pathways 
for the synthesis of all steroid hormones. 
2.4.2 Testosterone 
Pregnenolone is converted to testosterone via either 
a A4 (Slaunwhite & Samuels, 1956) or A5 pathway (Oertel & 
Eik -Nes, 1962). The A4 pathway involves the conversion 
of pregnenolone to progesterone by 3ß- hydroxysteroid 
dehydrogenase and 3ß- 5 -ene- ketosteroid isomerase, hydroxy- 
lation of progesterone to 17a- hydroxyprogesterone by 17a- 
hydroxylase, cleavage of a 2- carbon side chain from 17a- 
hydroxyprogesterone to androstenedione by C17_20 lyase 
and the reduction of androstenedione to testosterone by 
173- hydroxysteroid dehydrogenase (17 ketosteroid 
reductase). 
Conversion of pregnenolone to testosterone by the A5 
pathway involves the hydroxylation of pregnenolone to 
17a- hydroxypregnenolone by 17a- hydroxylase, cleavage of 
side chain of 17a- hydroxypregnenolone by C17_20 lyase to 
form dehydroepiandrosterone, which is then converted to 
androstenedione by 3ß- hydroxysteroid dehydrogenase and 
isomerase and the androstenedione converted to testo- 
sterone by 17ß- hydroxysteroid dehydrogenase. An 
alternative route in the A5 pathway is the conversion of 
dehydroepiandrosterone to androstenedione by 173- hydroxy- 
steroid dehydrogenase before conversion to testosterone 
by 313- hydroxysteroid dehydrogenase and isomerase (Fig2.2). 
In humans, the A5 pathway is predominant for the 
synthesis of testosterone (Axelrod, 1965; Bell & Lacy, 
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The pathways of testosterone biosynthesis from acetate and choleste- 
rol. The many steps in the synthesis of cholesterol from acetate and 
the oxidation of cholesterol are not shown. The formation of pregnen- 
olone involving the side -chain cleavage enzyme complex C20_22 lyase 
(1) is the starting point of steroid hormone synthesis. The righthand 
column shows the "A4 pathway ", the lefthand column the "A pathway ". 
The enzymes involved in the various steps are isomerase and 3e- 
hydroxysteroid dehydrogenase (2), 17a- hydroxylase (3), C17_20 lyase 
(4) and 1713- hydroxysteroid dehydrogenase. 
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1974; Yanihara & Troen, 1972) although there is evidence 
that the 04 pathway is not entirely redundant (Steinberger 
et al, 1973). Tamaoki (1973) speculated that the 
predominance of A5 or A4 pathways in different species 
may depend on whether 17a- hydroxylase or 3ß- hydroxysteroid 
dehydrogenase act on pregnenolone first and that these 
membrane- associated enzymes and their structural arrange- 
ments determine the temporal sequence of pregnenolone 
metabolism (vide infra) . 
2.4.3 5a- reduced androgens 
Testosterone is metabolized to 5a- reduced products 
in the testis (and other sites) in many species (Rose et 
al, 1973; Payne et al, 1973). 5a- dihydrotestosterone 
(DHT) is formed by the action of 3- oxo -5a steroid A4- 
dehydrogenase (5a- reductase) which has been partially 
purified from rat prostatic tissue (Shimizaki et al, 1973; 
Taurog et al, 1975). Hydroxylation of DHT at position 3 
yields 5a- Androstane -3a, 17ß diol and 5a- Androstane -3ß, 
17ß diol (3a DIOL and 3ß DIOL respectively). The former 
is a reversible reaction giving rise to a potent androgen 
(possibly via back conversion to DHT) while the latter gives 
a much weaker androgen which is irreversibly converted 
(Robel et al, 1971) (Fig 2.3). 
2.4.4 Oestrogens 
Although androgens are qualitatively and quantitat- 
ively the most important steroids synthesized in the 
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Fig 2.3 
The formation of 5a -dihydrotestosterone and 3a and 3G- Diols from 
testosterone by the enzymes 5a- reductase and 3- ketosteroid 
reductase respectively. 
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has been known for a long time (Goldzieher & Roberts, 
1952). Indeed, the stallion testis is the richest known 
biological source of oestrogen (Beall, 1940). As in the 
ovary and placenta, the substrates for oestrogen synthesis 
are testosterone and androstenedione. The conversion of 
androgen to oestrogen, known as the aromatization 
reaction, is a closely integrated series of steps 
involving 19- hydroxylation, 18 oxidation, scission of the 
methyl side chain at position 10 and dehydrogenation of 
ring A (Fig 2.4). Detailed analysis of substrate- product 
relationship is not possible as the enzymes involved had 
not been characterized. However, it is known that NADPH 
and oxygen are required by the enzymes which are located 
in the smooth -surfaced microsomal membranes of the 
stallion testis (Oh & Tamaoki, 1973). 
2.4.5 Steroid conjugates 
The human testis contains large amounts of sulphated - 
steroids (Ruokonen et al, 1972) some of which are 
secreted directly into the circulation (Laatikainen et al, 
1969). Indeed, next to testosterone, pregnenolone 
sulphate and dehydroepiandrosterone sulphate are 
quantitatively the most important steroids in the human 
testis (Payne et al, 1973). A number of sulphated 
steroids including pregnenolone can act as substrates for 
testosterone synthesis by the human testis (Payne et al, 
1971; Payne & Jaffe, 1975; Yanihara & Troen, 1972). It 
has been postulated that the human testis may utilize a 
pathway of testosterone synthesis involving sulphated 



















The formation of oestrogens from androgens in the 
aromatization sequence of reaction. 
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2.4.6 Age and testicular steroidogenesis 
Studies in the rat have demonstrated a marked age - 
dependency of testicular steroidogenic activity (Rivarola 
et al, 1972; Ficher & Steinberger, 1971; Nayfeh et al, 
1966; Mizutani et al, 1977). In the human, reduced in- 
vitro C17_20 lyase activity has been demonstrated in the 
aged testis (Axelrod, 1965; Bell & Lacy, 1974; Steinberger 
A.et al, 1970; Steinberger E et al, 1970). The pre- 
pubertal testis contains little 5a- reductase activity 
which increases during or after puberty (Kelch et al, 
1971; Bell & Lacy, 1974). Another enzyme, 20a- hydroxy- 
steroid dehydrogenase may be important in the regulation 
of testicular steroidogenesis during puberty. Fan et al 
(1974) proposed that 20a- hydroxysteroid dehydrogenase may 
compete with 17a- hydroxylase for pregnenolone. A higher 
ratio of 20a- dihydroxyprogesterone to 17a- hydroxy- 
progesterone was demonstrated in adult or pubertal as 
compared to prepubertal testicular tissues (Nayfeh et al, 
1975; Berg et al, 1976). The physiological 
significance of these age- dependent changes in testicular 
steroidogenesis is largely unknown. 
2.5 Intratesticular localization of testicular 
steroidogenesis 
Having established some of the qualitative and 
quantitative aspects of testicular steroidogenesis, the 
understanding of testicular function can be extended by 
the localization of these enzymatic processes to 
particular cell types or subcellular organelles. Most 
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steroidogenic enzymes are particulate or membrane -bound 
and purification and solubilization have not been 
achieved. To gain further insight into the functional 
characteristic and molecular mechanisms of specific steps 
in the steroidogenic pathway, the study of structure - 
function relationships is essential. 
2.5.1 Cellular localization 
The recognition that androgens are important in the 
regulation of spermatogenesis (Steinberger, 1971) makes 
it imperative to clarify the exact intratesticular 
cellular source of androgen production. The definitive 
experiments have only been accomplished relatively 
recently considering that Leydig cells were implicated to 
be the site of androgen production since the 1900s. 
Having overcome the practical obstacle of separating 
seminiferous tubules from the interstitial tissue in rat 
testes, Christensen & Mason (1965) found that conversion 
of 14C- progesterone to androstenedione and testosterone 
was two to three times higher in the interstitial tissue. 
The seminiferous tubules had a low but definite capacity 
for androgen conversion from progesterone. Considering 
that cholesterol is a more physiological substrate than 
progesterone, Hall et al (1969) repeated the same 
experiment using 14C- cholesterol. It was found that 
interstitial tissues converted cholesterol to testosterone 
while seminiferous tubules were unable to do so. The 
obvious conclusion however was coloured by the fact that 
cholesterol is rather insoluble and the intact blood - 
testis- barrier may prevent the entry of substrate into 
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the seminiferous tubules. To answer these criticisms, 
Cooke et al (1972) , using a sensitive radioimmunoassay to 
determine endogenous testosterone production in vitro, 
found that seminiferous tubules were unable to synthesize 
testosterone de novo while testosterone concentration 
increased in interstitial tissue and whole testis 
incubates. It is now generally accepted that testicular 
androgen synthesis occurs predominantly or solely in 
Leydig cells under physiological conditions, but the 
potential contribution of seminiferous tubular androgen 
derived from progesterone is unknown. 
In contrast to testosterone, the 5a- reduced 
androgens are preferentially produced in the seminiferous 
tubules (Payne et al, 1973; Rivarola et al, 1972). 
Sertoli cell -enriched preparations were the most 
efficient in conversion of 14C -DHT to 3a -DIOL while the 
spermatocytes were best at producing DHT from testosterone 
(Dorrington & Fritz, 1975). 
The cellular origin of testicular oestrogen is 
contentious. Early evidence (reviewed in Armstrong & 
Dorrington, 1977) suggested that both Sertoli cell and 
Leydig cell tumours were capable of oestrogen synthesis. 
Direct experimental demonstration of Sertoli cell 
synthesis of oestrogen was afforded by de Jong et al 
(1974). They found that oestradiol concentration, though 
lower in the seminiferous tubules initially, increased 
during incubation while that in interstitial tissues 
remained unchanged. Sertoli cell- enriched cultures from 
immature rats were capable of converting added testo- 
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sterone and androstenedione to oestradiol in the presence 
of FSH (Dorrington & Armstrong, 1975). However, two 
groups reported that the site of aromatase activity in 
human (Payne et al, 1976) and rat testis (Canick et al, 
1979; Valladares & Payne, 1979) is located in Leydig 
cells which are responsive to.hCG but not FSH. The 
relative importance of these two possible intratesticular 
sources of oestrogen remains to be clarified but it is 
likely that the cellular origin of testicular oestradiol 
is critically dependent on the age of the animal 
(Pomerantz, 1979). 
2.5.2 Subcellular localization 
Steroidogenesis de novo can be demonstrated in cell - 
free homogenate of steroid secreting tissues (Tamaoki, 
1973) suggesting that the cell structure itself is not 
crucial to steroidogenesis but the subcellular 
organization of steroid secreting cells is of importance. 
It is thus necessary to relate steroidogenic function to 
subcellular organelles. Testicular steroidogenic enzymes 
are tightly bound to membrane structures and particles 
after subcellular fractionation with minimal activity 
escaping into the supernatant or cytosol fraction. 
Enzymes for the side -chain cleavage of cholesterol are 
located in the inner membranes of mitochondria (Moyle et 
al, 1973; Van der Vasse et al, 1974) while the rough - 
surfaced microsomal fraction of endoplasmic reticulum 
contained the various enzymes for conversion of 
pregnenolone to testosterone and oestradiol (Tamaoki, 
1973; Van er Molen et al, 1975). This implies that a 
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system for the intracellular transport of steroidogenic 
intermediates analogous to the intercellular transport of 
steroids must exist. Hence, cholesterol esters are 
hydrolysed to free cholesterol in the cytoplasmic lipid 
droplets and then transported to the mitochondria for 
side -chain cleavage. The pregnenolone thus produced has 
to pass out of the mitochondria to reach the surface of 
the agranular endoplasmic reticulum to be converted to 
testosterone. The mechanism of this intracytoplasmic 
substrate transfer is unknown but recent evidence 
suggests that the action of LH on steroidogenesis may be 
upon this transport system (q.v.). The compartment- 
alization of enzyme complexes and the close association 
of enzyme proteins on or in biomembranes of subcellular 
organelles also raise the possibility that the physico- 
chemical organization of enzyme -membrane structures may 
provide a local mechanism regulating the temporal 
sequence of enzyme reactions. In other words, microsomal 
enzymes do not behave like enzymes in a homogeneous 
system with a uniform distribution of activity. Local 
physical interaction between substrate and enzyme can 
override the substrate preference of different enzymes in 
the same membrane. Evidence for this mechanism was 
convincingly argued by Tamaoki (1973) and Samuels et al 
(1975). They postulated that microsomal enzymes are 
organized on or in the membranes in a genetically - 
determined pattern so that the series of enzyme reactions 
are performed in a fixed sequence which cannot be altered 
by factors such as cofactors, substrate concentration or 
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substrate affinity. 
The cellular and subcellular compartmentalization of 
steroidogenic enzymes provide multiple opportunities for 
the spatial regulatory mechanisms to operate. These 
mechanisms may serve to restrict the huge number of 
steroids that can theoretically be synthesized and also 
to enhance the production of the few steroids that have 
evolved phylogenetically to be the most important for 
the reproductive functions of a particular species. 
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CHAPTER 3 
CONTROL OF TESTICULAR STEROIDOGENESIS 
The synthesis and secretion of androgens by the 
testis are stimulated by LH in intact animals (Eik -Nes, 
1971; Odell et al, 1974), in isolated testicular tissue 
(Cooke et al, 1972; de Jong et al, 1974), isolated inter- 
stitial tissue (Cooke et al, 1972; de Jong et al, 1974) 
and in purified Leydig cells (Janszen et al, 1976; Purvis 
et al, 1978). The mechanisms of control of Leydig cell 
function is a topic that in the last few years has 
yielded a profusion of new data which has somewhat 
outpaced their assimilation into the existing concepts of 
testicular function as a whole. A number of different 
mechanisms can theoretically be involved in the control 
of steroid synthesis - for example, substrate or cofactor 
availability, compartmentalization of substrate and 
enzymes, the induction, inhibition and stimulation of 
enzyme activities. Most investigators have concentrated 
on the activation or inhibition of enzyme systems and it 
is to these parameters that most of the recently 
postulated molecular mechanisms have been related. 
Although LH is undisputedly the prime trophic hormone for 
Leydig cells with an obligatory role, it should be 
emphasized that other factors, local as well as systemic, 
also contribute to the overall physiological control of 
Leydig cell steroidogenesis at different stages of 
testicular function. 
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3.1 Positive regulation of Leydig cells 
3.1.1 Morphological effects of LH /hCG 
There is agreement that chronic LH /hCG treatment 
results in Leydig cell hypertrophy, increase in sub - 
cellular organelles associated with steroidogenic and 
secretory processes (mitochondria, endoplasmic reticulum 
and Golgi apparatus), cytoplasmic lipid depletion and 
changes in nuclear shape and size (de Kretser,.1967). 
The question of hyperplasia in 
response to LH /hCG stimulation is more controversial. 
Although hCG treatment in immature (Chemes et al, 1976) 
and adult rats (Christensen & Peacock, 1980) gave rise 
to increases in Leydig cell numbers, this does not seem 
to be the case in normal adult men (Heller & Leach, 1971). 
3.1.2 Effect of LH /hCG on the steroidogenic pathway 
Commensurate with the observed increase in sub - 
cellular organelles LH /hCG increases or maintains the 
activity of 3ß hydroxysteroid dehydrogenase, 17a- hydroxy- 
lase and 17 -20 lyase (see Hall, 1970; Ewing & Brown for 
review), probably as part of a generalized trophic 
effect on Leydig cells. However it is generally accepted 
that LH has a specific stimulatory action on the rate - 
limiting step of cholesterol side -chain cleavage forming 
pregnenolone (Menon et al, 1967; Hall, 1970). This may 
be effected by the activation of the mitochondrial enzyme 
complex including cytochrome P450 system and NADPH. Other 
possible LH- mediated actions may involve the hydrolysis 
of cholesterol esters to free cholesterol (Moyle et al, 
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1973) and the transport of cholesterol to mitochondria by 
cytoskeleton microfilaments (Hall et al, 1979). 
3.1.3 Mechanism of positive regulation of steroidogenesis 
by LH /hCG 
It is well established that specific hormone binding 
to cell membrane receptors is the first step in the 
mechanism of LH action on its principal target cell in 
the testis, the Leydig cells. The presence of these 
receptors and their specific binding to 
125I- labelled LH 
after in vivo and in vitro exposure was first demonstrated 
in the rat (de Kretser et al, 1969 & 1971). Similar 
binding of hCG in the human adult (Hsu et al, 1978) and 
foetal testis (Huhtaniemi et al, 1977; Frowein & Engel, 
1974) has since been confirmed. Further characterization 
of the binding sites revealed specific receptors in the 
Leydig cell membrane (Mendelson et al, 1975) with high 
affinity (Ka 2.4 x 1010 M -1) and low capacity (10 -12 
mol /G or 20,000 sites /Leydig cell) for LH (Catt et al, 
1972a & b). LH binding to Leydig cell membrane receptors 
activate the inner membrane associated adenyl cyclase 
activity resulting in net formation of cyclic AMP 
(Rommerts et al, 1974; Catt & Dufau, 1976). Dose response 
study of receptor -hormone interaction showed that 
occupation of under 1% of total receptor sites was 
sufficient to stimulate maximal steroid production. Thus 
maximum hCG binding by rat testis was reached at a 
hormone concentration of 200 ng /ml whereas maximum 
steroidogenesis could be stimulated by only 0.5 ng /ml of 
hCG (Catt & Dufau, 1973; Catt et al, 1974). The concept 
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of spare receptors, which originated in pharmacological 
studies of drug responsive tissues (Stephenson, 1956), 
was therefore introduced into the study of hormone - 
receptor interaction. The physiological significance of 
spare receptors, despite many speculations, is still 
uncertain. 
Cyclic AMP increases testosterone synthesis in the 
testis (Sandler & Hall, 1966a & b; Connell & Eik -Nes, 
1968) and is regarded as an obligatory intracellular 
second messenger of LH stimulation. Although some 
discrepancy was shown between the amount of LH required 
to stimulate testosterone synthesis and the intracellular 
rise in cyclic AMP, especially at low gonadotrophin 
concentrations, Dufau et al (1977) were able to confirm 
that testosterone synthesis in response to hCG stimulation 
in rat Leydig cells was paralleled by a significant 
increase in bound rather than total cyclic AMP. The sole 
mechanism by which cyclic AMP acts within eukaryotic 
cells is via activation of cyclic AMP -dependent protein 
kinases. These are widespread enzyme systems that trans- 
fer the phosphate from ATP to a substrate - serine or 
threonine hydroxyl groups in proteins which become 
"activated" by phosphorylation (Rubin & Rosen, 1975 for 
review). Cyclic AMP binds to the regulator subunit of 
the inactive holoenzyme and releases the active catalytic 
subunit of protein kinase. Evidence that these mechanisms 
are operative in LH stimulation of Leydig cell was 
provided by Cooke et al (1975, 1976). It is however not 
clear how the activated protein kinase will influence 
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cholesterol side -chain cleavage, which is the accepted 
rate limiting step in steroidogenesis. The phosphoryl- 
ation of endogenous proteins (Cooke et al, 1977), 
stimulation of overall protein synthesis (Cooke et al, 
1975) and specific protein synthesis (Janszen et al, 
1978) may in some way activate the mitochondrial enzymes. 
The functional properties of these LH- dependent proteins 
are unknown. 
The above series of membrane receptor- triggered 
reactions is typical of peptide or non -steroid hormone. 
Their possible physiological significance has only been 
related to steroidogenesis. Whether the same mechanisms 
mediate the chronic trophic effects seen after LH /hCG 
stimulation (q.v.) is entirely unknown. 
3.1.4 Functional heterogeneity of Leydig cells 
Studies on biochemical mechanisms in isolated cell 
populations can only be meaningful if functionally homo- 
geneous cell populations are used. Unfortunately, it has 
been repeatedly confirmed that within a morphologically 
homogeneous population of interstitial cells, functional 
differences can be recognized (Rommerts & Brinkman, 1981). 
Different steroidogenic responses to LH in the various 
populations of Leydig cells separated under a variety of 
conditions (Payne et al, 1980a & b; Rommerts et al, 1980) 
have recently been reported. The physiological basis of 
the functional differences in Leydig cells, the trans- 
formation between different cell types and their possible 
interactions are but some of the fundamental questions 
still to be answered. 
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3.2 Negative regulation of Leydig cells 
The loss of target cell receptors inversely related 
to circulating hormone concentration was first described 
for insulin and growth hormone (Roth et al, 1975) and 
has since been reported in numerous tissue systems, e.g. 
catecholamines, TRH and epidermal growth factor. The 
loss of LH receptors initiated by the occupation of a 
small proportion of the receptor population following the 
single injections of the homologous hormone (Hsueh et al, 
1976; Sharpe, 1976) conforms to this general pattern of 
ligand regulation of cell surface receptor concentration. 
This dose dependent phenomenon is maximal at 2 -4 days, 
returning to normal after 6 -8 days. Receptor occupancy 
became undetectable 24 -36 hours after hormone injection 
and therefore cannot account for the later loss of much 
larger numbers of LH receptors (Tsuruhara et al, 1977). 
The loss of LH receptors is thought to occur by 
internalization of hormone- receptor complexes and also 
unoccupied receptors (Catt et al, 1979). 
The gonadotrophin- induced loss of LH receptors in 
Leydig cells is accompanied by impaired cyclic AMP and 
reduced steroidogenic response to further stimulation by 
hCG (Hsueh et al, 1977; Sharpe, 1977). This desensitiz- 
ation or refractoriness however can be dissociated from 
loss of LH receptors (Haour & Saez, 1978) and at low 
hormone concentrations, an enhancement of maximal 
testosterone production to hCG could be associated with 
loss of LH receptors (Dufau et al, 1978). However, large 
single doses of hCG reduce the capacity of Leydig cells 
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to synthesize testosterone (Hsueh et al, 1977; Sharpe, 
1977) independently of receptor changes (Tsuruhara et al, 
1977). This gonadotrophin induced steroidogenic lesion 
has been localized to post -cyclic AMP steps most probably 
involving blocks in the action of 17a- hydroxylase and 
17 -20 lyase (Tsuruhara et al,.1977; Cigorraga et al, 1978; 
Chasalow et al, 1979), which become further possible rate 
limiting steps for testosterone production. There is 
some evidence that similar lesions may occur in men 
(Padron et al, 1980; Wang et al, 1980). The similarity 
of this gonadotrophin induced steroidogenic block to that 
of the direct suppressive effect of oestradiol on Leydig 
cells (Samuels et al, 1969; Kalla et al, 1980; Brinkman 
et al, 1980) has led to the suggestion that testicular 
oestradiol may mediate this desensitization process. The 
observation that tamoxifen, an oestrogen antagonist, can 
abolish the gonadotrophin- induced desensitization of rat 
Leydig cells further substantiatesthis theory (Cigorraga 
et al, 1980). 
It has been shown that GnRH or its hyperactive 
analogues were able to bring about almost identical 
changes in LH receptors and steroidogenic enzyme 
activities as observed after hCG injection in intact 
animals (Dufau et al, 1979; Berlanger et al, 1980). 
Similar changes have also been described in man (Bergquist 
et al, 1979). When these same changes could be reproduced 
by GnRH in hypophysectomized animals (Hsueh & Erickson, 
1979; Bambino et al, 1980) the question of a direct 
testicular action of GnRH was considered. This possibility 
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was strengthened by the demonstration of specific, high 
affinity receptors for GnRH and its analogues on rat 
Leydig cells (Clayton et al, 1980; Sharpe& Fraser, 1980a) 
and the secretion by rat Sertoli cells of a "GnRH- like" 
factor which, though immunologically distinct from GnRH, 
can stimulate LH release from pituitary tissue (Sharpe et 
Sharpe, 
al, 1981;1982). Increased levels of this "GnRH- like" 
factor was stimulated by hCG (Sharpe & Fraser, 1980b) 
leading to speculations that this peptide molecule could 
mediate some of the hCG- induced changes in the Leydig 
cells. 
Despite the considerable amount of new information 
briefly outlined above, our understanding of the 
physiological control of Leydig cell function by LH 
remains rather poor. Virtually all the mentioned studies 
used single injections of pharmacological doses of LH /hCG 
in in -vitro studies of isolated Leydig cells and it is 
debatable whether the apparent negative hormone influence 
by receptor down regulation or steroidogenic block has 
any physiological relevance. However, several studies 
with small doses (100 -200 ng /animal) of hCG (Tsuruhara et 
al, 1977; Sharpe, 1977; Dufau et al, 1978) did demonstrate 
loss of LH receptors independent of the effect on steroido- 
genesis in Leydig cells. These concentrations were 
compatible with normal physiological extremes and that 
observed with pulsatile secretion of LH. On the other 
hand, only 1% of the total receptor population is 
required for maximal activation of steroidogenesis. This 
minute degree of receptor occupancy and turnover and an 
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overwhelming abundance of spare receptors may be a 
mechanism which ensures maximum sensitivity of the Leydig 
cells by maintaining a fairly stable surface receptor 
concentration available for LH binding under the extremes 
of the physiological range (Catt et al, 1980). If this 
is true, then receptor down regulation by the homologous 
hormone may serve to limit the sensitivity of response 
when Leydig cells are exposed to high hormone concen- 
trations. Nevertheless, it seems likely that under 
physiological conditions, the negative effects of LH are 
subtle and only become detectable when they are magnified 
by experimental conditions or in pathological situations. 
Thus in patients with chorioncarcinoma of the testes, 
circulating LH reaches extremely high levels but plasma 
testosterone remains within the normal range (Kirschner, 
1970). In testicular feminized (TFM) mice the testes are 
exposed to high LH concentrations. In spite of the 
Leydig cell hyperplasia in these testes, LH receptor 
content remains reduced and their sensitivity to LH 
stimulation in vitro is similarly impaired (Purvis et al, 
1978). It is obvious that further work, with special 
reference to reproducing physiological conditions, will 
improve our understanding of Leydig cell function and 
control. 
3.3 Follicle stimulating hormone 
Although the classical theory of dual gonadotrophin 
control of the testes ascribed no steroidogenic function 
to FSH, some recent evidence suggested that it may have a 
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synergistic action with LH on Leydig cell function 
(Connell & Eik -Nes, 1968; Lostroh, 1969). Direct evidence 
was first provided by the finding that FSH potentiated the 
effect of LH on testicular secretion in the perfused adult 
rabbit testis (Johnson & Ewing, 1971). In immature rats, 
the early rise in FSH was associated with an increase in 
the number of LH receptors on the Leydig cells (Odell & 
Swerdloff, 1976; Ketds] ers et al, 1978). In adult hypo - 
physectomized rats with regressed testes, FSH alone or in 
synergism with LH can increase testosterone secretion (El 
Safoury & Bartke, 1974) and LH receptor content (McNeilly 
et al, 1979). These effects of FSH on the Leydig cells 
must be mediated via the Sertoli cells since FSH receptors 
are found only in the latter cell type (Orth & Christensen 
1977). Two secretory products of Sertoli cells, 
oestradiol (q.v.) and GnRH -like factor (q.v.) can 
influence Leydig cell function but they both have inhibitory 
effects. It remains to be seen whether other "Sertoli 
cell factors" could mediate the effects of FSH on Leydig 
cells. 
3.4 Prolactin 
Although the experiments of Woods & Simpson (1961) 
suggested a synergistic role of prolactin in maintenance 
of Leydig cell function, this was only confirmed and 
extended in the last decade with the availability of 
prolactin RIA and receptor- binding techniques. The 
presence of prolactin receptors in rat Leydig cells has 
been confirmed (Arago a et al, 1977; Charreau et al, 
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1977). Evidence for a positive role of prolactin in 
control of Leydig cell function came from three animal 
experimental models: (1) hypophysectomized rats, (2) 
hereditary dwarf mice deficient in prolactin and growth 
hormone and (3) light- deprived and testicular regressed 
golden hamsters. All three models are characterized by 
testicular atrophy, low circulating prolactin, testo- 
sterone and gonadotrophins, and loss of Leydig cell LH 
receptors. Administration of prolactin increased the LH 
receptor concentration and restored testicular steroido- 
genesis in the presence of LH (Bartke et al, 1978; Purvis 
& Hansson, 1978 for review). In addition, Bartke (1976) 
suggested that prolactin may augment the effect of LH by 
stimulating an accumulation of esterified cholesterol and 
the direct activation of 36- hydroxysteroid dehydrogenase 
and 176 -hydroxysteroid dehydrogenase. In humans, 
nocturnal or pharmacologically -induced prolactin increase 
had been correlated with increases in testosterone 
concentration (Rubin et al, 1975, 1976). Pathologically 
elevated prolactin levels, usually due to pituitary 
adenomata, is associated with impotence, subnormal 
circulating testosterone and possibly impaired fertility 
(Thorner et al, 1977; Carter et al, 1978; Franks et al, 
1978). Thus in spite of the convincing evidence in small 
mammals, the physiological role of prolactin in the human 
male is uncertain and it may be that prolactin possesses 
both positive and negative effects on Leydig cell 
functions depending on its circulating concentration. 
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3.5 Growth hormone 
The effect of growth hormone on gonadal function 
was again first recognized by Woods & Simpson (1961). 
Although the specific binding of growth hormone to 
testicular receptors had not been studied, it was 
possible to show that growth hormone prevented the loss 
of LH receptors after hypophysectomy in immature (Bambino 
et al, 1980) and adult (Zipf et al, 1978) rats. Growth 
hormone is also able to increase testicular responsiveness 
to LH in immature hypophysectomized rats (Swerdloff & 
Odell, 1977). Interpretation of some of these findings 
are complicated by the overlap in biological effects and 
receptor sites (human growth hormone is lactogenic) 
between growth regulation of Leydig cell steroidogenesis. 
3.6 Oestrogens 
The suppressive effect of exogenous oestrogens on 
testicular functions was clearly demonstrated by Moore 
& Price (1932). The conclusion of these workers that 
oestrogens induce testicular atrophy by suppression of 
gonadotrophins rather than by direct action on the testes 
has remained unchallenged until recently. The existence 
of high affinity cytoplasmic and nuclear receptor sites 
for oestradiol in rat interstitial cells (Brinkman et al, 
1972; Mulder et al, 1974) and the confirmation of direct 
inhibitory effects, independent of gonadotrophins, of 
physiological amounts of oestrogens on specific steps in 
Leydig cell steroidogenesis (reviewed by Moger, 1980) is 
strong evidence in favour of a negative regulatory role 
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of intratesticular oestrogens. The cellular site of 
oestradiol synthesis in the testis has been discussed 
already (2.5.1). Whether the source of oestrogen is from 
the Leydig or Sertoli cells is obviously important in 
formulating fundamental concepts such as an ultra short - 
loop feedback mechanism or a functional link between the 
seminiferous tubular and the interstitial compartments 
of the testis. This is at present unresolved. 
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CHAPTER 4 
TESTICULAR STEROID SECRETION 
Examination of synthetic pathways is mainly a 
qualitative study of the capacity to synthesize hormones 
according to enzymic capabilities. To understand the 
quantitative aspects of testicular steroidogenesis, it is 
necessary to consider the secretion of hormones into the 
systemic circulation, the rate of secretion, the inter - 
conversion and metabolism in the circulation and in 
target tissues. The aim of these in vivo studies of the 
dynamics of testicular steroid secretion and inter - 
conversion is to assess the biologically effective 
androgen concentration to which target organs are being 
exposed. This is a necessary preliminary to the under- 
standing of the mechanism of androgen action at the 
target cell and receptor levels. 
Early studies of testicular androgen secretion had 
to be based on indirect methods which estimated the 
urinary metabolites of the hormones under consideration 
(Vande Wiele et al, 1963; Tait & Burstein, 1964). These 
were unsatisfactory for several reasons, amongst which 
the most important were the non -specificity and the 
multiple anatomical compartmentalization in the production 
of the urinary metabolites (Korenman & Lipsett, 1964; Tait 
& Horton, 1964). With the availability of satisfactory 
methods of measuring physiological concentrations of 
testicular steroids in blood, it became possible to study 
the dynamics of testicular steroid secretion in the 
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circulation combined with radioisotope tracer techniques. 
These studies were also instrumental in establishing the 
concept of a prehormone - a substance secreted by 
endocrine glands which is converted peripherally into a 
hormone with enhanced or altered biological activity 
(Baird et al, 1968). This is not unique to gonadal 
steroids and other prehormones including thyroxine, 
vitamin D and angiotensin I have since been described. 
4.1 Principles of steroid dynamics studies 
The principles of these methods were set out in two 
classic papers (Tait, 1963; Baird et al, 1969a). 
4.1.1 Metabolic clearance rate and blood production rate 
The plasma concentration of a compound is determined 
by its rate of entry and rate of removal or clearance 
from the circulation. The latter occurs in a multitude 
of organs and tissues where the active hormone is either 
irreversibly metabolized or excreted. The metabolic 
clearance rate (MCR) is thus the sum total of clearance 
rates in individual organs and tissues and is usually 
defined as the volume of blood which is completely and 
irreversibly cleared of the hormone per unit time. The 
quantity of hormone cleared per unit time will be the 
product MCR x [i] where [i] is the plasma concentration 
of the hormone during the period of study. Under steady 
state conditions where plasma hormone concentration 
remains constant, the rate of production will equal the 
rate of clearance. This concept was utilized in the 
indirect measurement of MCR and blood production rate (PB) 
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which is defined as the total amount of hormone entering 
the peripheral circulation from all sources - by direct 
glandular secretion and /or peripheral conversion of 
precursors. The entry of the hormone into the circulation 
can be simulated in vivo by a constant intravenous 
infusion of an isotopically -labelled hormone at rate (r) 
while the concentration of the radioactive hormone is 
measured in blood or plasma at equilibrium or constant 
concentration (Xc). The MCR is derived by the ratio of 
these two parameters r /Xc since r = MCR x Xc. If the 
total non -radioactive concentration of the hormone in the 
peripheral circulation (i) is also measured, the blood 
production rate can be obtained - PB = MCR x i. The 
validity of blood production rate estimation from MCR is 
critically dependent on the premise that measurements 
were obtained under steady state conditions. This, 
however, is seldom achieved under physiological conditions 
due to the variable blood production rates resulting from 
diurnal variation and pulsatile hormone secretion and 
changing MCRs from the effects of posture. Nonetheless, 
the effects of diurnal variation and posture can be 
allowed for in MCR measurements while the above concepts 
are valid for both constant infusion or single bolus 
injection. Pulsatile changes in hormone concentrations 
moreover are no different from constant secretion as far 
as the total amount of hormone per 24 hours is concerned 
(Santen & Bardin, 1973). The estimations of blood 
production rates by steady state dynamic measurements, 
even in the presence of pulsatile hormone secretion, 
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should be reasonably accurate. 
4.1.2 Protein Binding 
The specific high- affinity binding of testosterone, 
DHT and androstenediol to sex -hormone- binding globulin 
lowers the hepatic extraction and hence the MCR of these 
hormones. Specific plasma protein binding is thus an 
important determinant of MCR - the higher the percentage 
bound the lower the MCR and vice versa. This is well 
illustrated by the difference in the MCR of testosterone 
in males and females and also after acute and chronic 
testosterone administration (Vermeulen et al, 1969; 
Southren et al, 1968). It follows also that specific 
plasma protein binding also determines the unbound 
biologically- active fraction of the circulating hormone. 
Hence if other variables such as hepatic blood flow or 
extrahepatic clearance remain constant, the blood 
production rate (MCR x [i]) rather than the total plasma 
concentration of the hormone is better correlated with 
the biologically active moiety. 
4.1.3 Transfer constants 
Measurement of blood production from MCR in blood 
eliminates the necessity of employing mathematical model 
compartments in the calculation or urinary production 
rate (Vande Wiele et al, 1963; Tait & Horton, 1966). The 
PB is the total amount of hormone entering the circulation 
from whatever source or compartment and equals the 
secretion rate if the hormone is secreted exclusively by 
the endocrine gland (for example, cortisol and aldosterone). 
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In contrast, testosterone, androstenedione and oestradiol 
are also produced in extraglandular compartments by 
peripheral conversion of precursors. If these 
peripherally -produced hormones reach the circulation 
before being metabolized, they will contribute to the 
total blood production. Under these circumstances, 
Pro = Pro Pre (P-1 Pre -Pro where S is 
B B B L JBB 
secrétion rate of precursor (Pre) or product (Pro) and 
CpBBPre -Pro the transfer constant, is the fraction of 
precursor converted to product entering the peripheral 
circulation. The latter is obtained by the constant 
infusion of radiolabelled precursor hormone(s) until 
steady state, when the radioactive hormone concentration 
(X) of both precursor and product are determined. The 
fractional conversion from precursor to product is 
obtained by MCRPro /MCRPre 
XPro /XPre. Knowing the total 
blood production rate and the amount yielded by 
peripheral conversion will allow the glandular secretion 
rate to be assessed indirectly. 
4.1.4 Steroid prehormones 
Although the indirect measurement of secretion rates 
of testicular steroids have been largely superceded by 
the direct measurement of testicular venous effluent 
concentrations (Kelch et al, 1972; Baird et al, 1973; 
Weinstein et al, 1974), the study of dynamics of hormone 
secretion and interconversion introduced an important 
concept in the control of steroid hormone function. Pre - 
hormones, secreted by the gonads, are converted 
peripherally into other active metabolites. This 
60 
represents a separate mechanism of control by peripheral 
target or non -target tissues, independent of the control 
normally operative on the prime source of active hormone. 
The significance of prehormone conversion may reside in 
the enhancement of local specificity or potency of 
hormone action (Baird et al, 1968) or the alteration of 
local or systemic hormone action by changes in body 
composition (Siiteri & MacDonald, 1973). Peripheral 
conversion accounts for the source of testosterone (from 
androstenedione) in prepubertal males, hypogonadal males 
and adult females, and oestrone and oestradiol (from 
androstenedione and testosterone) in children, adult 
males, postmenopausal and anovulatory females. 
4.2 Androgen production in adult males (Table4.1) 
Applying the principles and methods discussed in the 
previous section, it has been possible to establish the 
production and secretion rates of most steroids in the 
biosynthetic sequence of testicular androgens. Although 
it has been postulated that the secretion of some inter- 
mediates is an epiphenomenon secondary to a leaky 
endocrine gland (Short, 1960), the substantial quantity 
of some steroids secreted by the testis allows the 
reasonable speculation that they may subserve some 
biological roles, perhaps as prehormones. This has given 
rise to the approach of studying the "profile" of 
testicular steroids as an overall index of testicular 






























































































































































































































































































































































































































































































































































































































































































































































In the adult male, testosterone is the most 
important androgen quantitatively and qualitatively. 
Testicular vein concentration of testosterone varied 
between 10 -100 pg /dl while the secretion rate is about 
7 mg per day with a wide range of 3.5 -10. The major 
precursors are androstenedione and dehydroepiandrosterone 
which together contribute under 2.5% of blood production. 
This implies that testosterone can generally be regarded 
as exclusivelysecreted by the testis. Thus, testosterone 
concentration in plasma is one of the best indices of 
testicular secretory function. 
4.2.2 Dihydrotestosterone 
The concentration of dihydrotestosterone in the 
peripheral circulation is relatively low - one tenth to 
one fifteenth of testosterone. The blood production rate 
is 280 -390 pg of which 75 -80% are derived from peripheral 
conversion of testosterone and androstenedione. This 
correlated well with spermatic vein concentration 
measurements estimating testicular secretion to 
contribute 20% of blood production. The low peripheral 
concentrations of DHT and its extremely high affinity to 
SHBG is compatible with the concept that it is 
principally a target cell hormone (q.v.). 
4.2.3 5a- Androstane -3a,176 diol (3a -DIOL) 
This 5a- reduced metabolite of testosterone is a 
potent androgen with peripheral concentrations of 77 -190 
pg /ml. The blood production is 208 pg /day of which 70% 
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is converted from testosterone via DHT. 
4.2.4 Androstenedione 
This immediate precursor of testosterone is found in 
the peripheral circulation in concentrations between 870- 
2440 pg /ml. Spermatic venous concentration of this weak 
androgen confirmed that it is secreted by both the testis 
and the adrenal in roughly equal quantities. A small 
fraction (up to 15 %) of the blood production is derived 
from conversion of testosterone and dehydroepiandrosterone 
in similar proportions. Androstenedione is an important 
precursor accounting for two thirds of circulating 
testosterone in prepubertal boys and adult females 
(Frasier & Horton, 1966). It is also an important sub- 
strate for the extraglandular production of oestrogen in 
both males and females. The testicular secretion of 
androstenedione varies little with age. Thus in pre- 
pubertal boys, testicular androstenedione secretion 
exceeds testosterone. This is reversed as the testis 
matures during puberty. The mechanism for this shift in 
oxido- reduction balance of 17- hydroxysteroid dehydrogenase 
at puberty is unknown. 
4.2.5 Dehydroepiandrosterone (DHEA) 
This is the major unconjugated adrenal androgen with 
under 10% of blood production being secreted by the 
testis. It is secreted directly or as the sulphated - 
conjugate. The adrenal vein concentration of DHEA is 
about fifty times higher than that in the testicular vein. 
The daily blood production of DHEA is 7 -9 mg but 15% of 
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this is derived from peripheral conversion mainly from 
the sulphated conjugate. 
4.2.6 Androstenediol 
This is the A5 precursor of testosterone secreted by 
both the testis and the adrenal cortex. In adult males, 
two thirds of the blood production is secreted by the 
testis while peripheral conversion from DHEA accounts for 
about 10 %. The role of androstenediol as a prehormone is 
at present uncertain. 
4.2.7 17a- hydroxvprogesterone and 17a- hydroxypregnenolone 
17a- hydroxyprogesterone is secreted by the testis in 
amounts which account for 90% of its daily blood production 
of 2 mg. It is thus a good index of testicular function 
in normal males. Adrenal suppression has little effect 
on plasma concentration of 17a- hydroxyprogesterone and it 
is unlikely that peripheral conversion of 17a- hydroxy- 
pregnenolone could account for more than 10% of blood 
production. In physiological concentrations, 17a- hydroxy- 
progesterone has virtually no androgenic activity. 
Another notable feature is the extremely marked diurnal 
variation in plasma concentration of 17a- hydroxy- 
progesterone with a much greater magnitude than that of 
testosterone. The specific urinary metabolite of 17a- 
hydroxyprogesterone is pregnanetriol and the measurement 
of these two compounds are of diagnostic significance in 
congenital adrenal hyperplasia with C21 hydroxylase defect. 
Although 17a- hydroxypregnenolone has a similar blood 
production rate (2 mg per day) as its A4 counterpart, 
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only 30 -40% is secreted by the testis. The remainder is 
derived from the adrenals. 
4.3 Oestrogen production in males 
The capacity of testicular tissues to synthesize 
oestrogens has been repeatedly demonstrated (for review 
see Armstrong & Dorrington, 1977). However, the 
knowledge that exogenously administered androgens can be 
converted to oestrogens even in the absence of the testes 
and adrenals (West et al, 1956) raised the possibility 
that oestrogens in the male could be derived from 
conversion of secreted androgen precursors rather than 
by direct secretion. 
4.3.1 Oestrone 
This is the predominant oestrogen in males or in 
postmenopausal and anovulatory females. The plasma 
concentration of oestrone (60 -80 pg /ml) is generally 
found to be one to two times higher than oestradiol. But 
unlike oestradiol, oestrone shows a significant diurnal 
variation where the trough levels around 17.00 hours are 
some 50% of peak levels at 08.00 hours. This obviously 
complicates the estimation of blood production rates 
(Baird et al, 1969a). However, even by using the lowest 
PB value of oestrone (70 pg/day) there remains a 
significant fraction of the blood production not accounted 
for by peripheral conversion of androstenedione (30 -40 pg) 
and oestradiol (6 pg)(Baird et al, 1969a). testicular 
secretion and adrenal secretion, under 8 pg from each 
source (Baird et al, 1973; Weinstein et al, 1974; Baird 
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et al, 1969b). It is therefore likely that another 
physiological precursor of oestrone is yet to be 
identified. 
4.3.2 Oestradiol 
From the substantial concentration difference in 
spermatic (1 -2000 pg /ml) and peripheral (20 -30 pg /ml) 
vein concentrations, it can be estimated that the testis 
secretes around 10 pg of oestradiol daily (Kelch et al, 
1972; Baird et al, 1973; Weinstein et al, 1974). This 
constitutes one quarter of the oestradiol blood produc- 
tion of 40 µg per day (Longcope et al, 1969) while the 
remaining three quarters come from the peripheral 
conversion of testosterone (Baird et al, 1969a). 
4.3.3 Significance of oestrogens in the male 
While the roles of androgens in the female in the 
control of sexual hair growth and maintenance of muscle 
mass are well recognized, the nhysiological functions of 
oestrogens in males, if any, are as yet unknown. The 
fact that peripheral conversion rather than testicular 
secretion provide the major source of oestrogens in man 
create further conceptual difficulties. The ease with 
which oestrogenic effects are manifested when the rate of 
aromatization is increased and /or when the testosterone/ 
oestradiol ratio is depressed as in hepatic cirrhosis 
(Vermeulen, 1977; Gordon et al, 1975; Baker et al, 
1976), obesity (Siiteri & MacDonald, 1973) and ageing 
(Aiman et al, 1978) makes it reasonable to speculate that 
oestrogens may have some as yet undefined physiological 
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functions. 
Receptors for oestrogens in the male have been 
identified in the testicular Leydig cells, prostate, 
adrenals, pituitary and hypothalamus of the rat 
and in the pituitary and hypothalamus 
of foetal human brain (Davies et al, 1975). Furthermore, 
local formation of oestrogen has been demonstrated in the 
diencephalon of the human brain (Naftolin et al, 1975; 
Ryan et al, 1972). It has been suggested that the effect 
of androgens on the brain in the control of sexual 
behaviour are effected via conversion to oestrogens 
locally (McDonald et al, 1970; Beyer et al, 1973). 
Oestradiol is an effective inhibitor of gonadotrophin 
secretion (Kulin & Reiter, 1972; Sherins & Loriaux, 1973; 
Stewart -Bentley et al, 1974) and pituitary response to 
GnRH stimulation (Wang et al, 1975) in men. The exact 
role of oestrogens in relation to androgens in the 
physiological control of gonadotrophin secretion is 
unclear (q.v.). The effect of pharmacological doses of 
oestrogens in raising SHBG concentration is well 
described (Pearlman et al, 1967). However, whether 
physiological levels of oestrogens have any effects on 
androgen function and SHBG binding has not been studied. 
4.4 Steroid conjugates 
Although steroid conjugates are insignificant 
precursors for testosterone blood production, the human 
testis has been shown to secrete them in significant 
quantities (Laatikainen et al, 1969 & 1971). Metabolic 
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changes in the steroid nucleus can occur without 
hydrolysis of the conjugate (Lieberman, 1967). It thus 
remains a possibility that these compounds are not merely 
water- soluble end products of metabolism to be eliminated 
from the body but play a more active physiological role. 
Virtually all tissues in the body except during foetal 
life contain steroid sulphatases which should theoretic- 
ally be capable of releasing free androgens from the 
circulating conjugates with or without further conversion 
to more active metabolites. This hypothetical system may 
allow the expression of androgenic effects in the local 
environment of a wide variety of tissue sites. 
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CHAPTER 5 
TRANSPORT OF CIRCULATING ANDROGENS 
All steroid hormones in the peripheral circulation 
are bound by plasma proteins to various extents by 
dissociable non -covalent bonds. Albumin binds non- 
specifically to steroid hormones with low affinity (Ka 
104 M -1) but high capacity (plasma concentration : - 5.6 x 
10 -4 M). In contrast, a family of glycoproteins bind 
specifically to individual steroids with high affinity 
(Ka,- 108 M -1) but low capacities (plasma concentrations 
10 -6 - 10 -8 M). 
The existence of a specific binding protein in human 
plasma for testosterone was first demonstrated by Mercier 
et al (1966) and shortly afterwards confirmed by Crepy 
et. al (1967). It also binds many other C18 or C19-17ß - 
hydroxysteroids e.g. DHT with two to three times greater 
affinity, androstanediol and.androstenediol with similar 
affinity and oestradiol with 75% of the affinity of 
testosterone (Vermeulen, 1977). This led to the protein 
being named the sex hormone binding globulin (SHBG) or 
testosterone -oestradiol binding globulin (TeBG). 
Recently, more stringent physiological studies of the 
binding characteristics of SHBG revealed that oestradiol 
does not bind to SHBG to any significant extent (Vigerski 
et al, 1979). This therefore is similar to the weaker 
androgens androstenedione, DHEA and DHA- sulphate, which 
are almost exclusively bound to albumen. Testosterone 
also binds to other plasma proteins such as transcortin 
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and al -acid glycoprotein with low affinities only 
(Vermeulen et al, 1971; Kerkay & Westphal, 1968). 
5.1 Physico -chemical properties of SHBG 
SHBG is a (3-globulin produced in the liver, with 
molecular weight of 92,000 (Mercier -Bodard et al, 1979). 
Because of its instability on purification, SHBG of 
sufficient purity has not been available in sufficient 
quantity for detailed physico- chemical studies. Until 
recently therefore, specific RIA was not feasible and 
plasma SHBG concentration must be estimated indirectly by 
means of its binding activity. Since neither the 
molecular weight and the number of binding sites on each 
molecule were accurately known, SHBG concentration was 
expressed in terms of the concentration of steroid 
binding sites in 10 -8 M units. However, as the 
purification procedures have become more satisfactory 
and specific RIAs have become available, SHBG concen- 
trations in plasma can be directly determined (Mercier - 
Bodard et al, 1979). 
In normal males, 2% of circulating testosterone is 
unbound, 56% is SHBG- bound, and 38% is albumen -bound as 
studied by equilibrium dialysis of 1:5 diluted plasma at 
pH 7.4 and 37 °C (Vermeulen, 1977). SHBG concentration 
and hence the free testosterone concentration is not 
constant throughout life. While SHBG binding capacity is 
low in late pregnancy and the newborn (Forest & Bertrand, 
1975), this increases by the second postnatal week to 
three times the adult concentration so that despite the 
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neonatal surge of testosterone, the free testosterone 
fraction is only 0.7% giving paradoxically a lower free 
testosterone concentration than the newborn period. At 
puberty, SHBG concentration declines while the trend is 
reversed during senescence (Vermeulen et al, 1972). The 
concentration of SHBG in normal adult men is about half 
that of non -pregnant adult females and has the capacity 
to bind about double the amount of testosterone normally 
present in the circulation of adult men (Vermeulen et al, 
1969; Corvol et al, 1971; Rosenfield, 1971). 
Drawing on the analogous evidence from cortisol 
(Slaunwhite et al, 1962) and progesterone (Burton & 
Westphal, 1972), it has been postulated that hormone 
binding to specific proteins renders it metabolically 
inert and biologically inactive. Thus only the unbound 
fraction is capable of entering the extravascular and 
intercellular spaces. Mowszowicz et al (1970) provided 
supportive evidence in finding that in vitro aromatization 
of testosterone to oestradiol by rat liver microsomes was 
inhibited by the addition of SHBG. Lasnitzki & Franklin 
(1972) showed that the uptake, conversion to DHT and 
morphological changes induced by testosterone in rat 
prostate explants could be reduced by male serum and even 
more so by pregnant female serum. 
Although hormones specifically bound (with high 
affinity) to plasma proteins are metabolically and 
biologically inactive, non -specific binding to albumen 
has little effect on hepatic metabolism and splachnic 
extraction (Baird et al, 1969). This implies that the 
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degree of specific protein binding is one of the major 
determinants of metabolic clearance of a hormone. A 
survey of different sex steroid hormones in males and 
females confirmed that an inverse relationship between 
the affinity for SHBG and metabolic clearance rates exist 
(Southren et al, 1967, 1968; Longcope et al, 1968; 
Vermeulen et al, 1969; Mahoudeau et al, 1971; Saez et al, 
1972). This is best illustrated by the higher MCR of 
androstenedione than testosterone in males and the lower 
MCR of testosterone in females. However, the importance 
of SHBG in terms of bioavailability of the free hormone 
to target cells must not be overemphasized despite its 
important effect on MCR. The following equations 
demonstrate this point:- 
Unbound Li] = Total Li] x % unbound i 
* Total [i] = PB / MCR 
. unbound [i] = PB x % unbound i 
MCR 
A rise in SHBG will reduce the % unbound i but MCR also 
decreases proportionately. Thus the absolute 
concentration of unbound hormone will not change unless 
PB is altered. It is therefore worth emphasizing that 
blood production rate (PB) rather than SHBG binding is 
the key variable which controls the unbound hormone 
concentration available to target cells. 
* ai = steroid concentration PB = blood production 
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5.2 Biological roles of SHBG 
The solubility of testosterone in saline at 37 °C is 
55 µmol /1 which is 1000 times greater than the maximal 
concentrations found in normal adult males (de Moor et 
al, 1968). Clearly a simple carrier function (such as 
transferrin for iron) is untenable for SHBG. The 
lowering of MCR by SHBG binding prolongs the steroid 
hormone half -life in the circulation and may thus allow 
the maintenance of high functional pools of sex hormones 
with relatively low rates of glandular secretion. 
A more fascinating possibility is that the high - 
affinity SHBG binding in the circulation is part of a 
specific transport system for sex steroids. This system 
starts with glandular secretion and ends in the nuclear 
chromatin receptor sites in target cells. Androgens are 
conveyed along a privileged channel made up of a series 
of specifically- binding proteins with increasing affinity 
for metabolizing enzymes and cytosol and nuclear 
receptors. 
It was suggested even before the existence of SHBG 
had been suspected that protein binding of plasma steroids 
serves to buffer their concentrations against wide 
fluctuations (Daughaday, 1959). Although pulsatile 
secretion of GnRH is essential to the normal function of 
the pituitary, this is not necessarily the case in LH 
control of testicular functions. Unlike the subprimate 
mammals, where a close temporal relationship between 
plasma peaks of LH and testosterone exists, this has been 
difficult to demonstrate in man (Baker et al, 1975; de 
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Kretser et al, 1977). The unpredictable or delayed 
testosterone rise after endogenous or exogenous LH 
stimulation may be the result of the dampening effect of 
a large reserve pool of protein -bound testosterone. 
However, SHBG binding of testosterone in other species, 
e.g. the ram, albeit of lower affinity than humans, does 
not seem to dampen the acute testosterone rise in 
response to pulsatile LH stimulation (Sandford et al, 
1974). Thus plasma protein binding does not invariably 
abolish fluctuations in plasma concentrations of 
hormones. Another possible role for a high affinity, low 
capacity binding protein such as SHBG may be to maintain 
a minimal basal concentration of testosterone while still 
making higher concentrations of the steroid available to 
the target tissues when the secretion rate is greatly 
increased for a short period of time (Tait & Burstein, 
1964). 
A specific physiological role for SHBG cannot at 
present be readily defined. The fact that SHBG is absent 
in some species, e.g. rat, boar (Corvol & Bardin, 1973) 
implies that this protein is not essential for normal 
androgen transport and action in all species. 
5.3 Effect of other hormones on SHBG concentration 
Androgens administered to women will lower the SHBG 
binding capacity (Vermeulen et al, 1969) while 
oestrogens given to males have the opposite effect 
(Pearlman et al, 1967; Migeon et al, 1968; Vermeulen et 
al, 1969). During pregnancy, SHBG binding increases some 
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five times with the sharpest rise being in the first 
trimester (Vermeulen, 1977). Medroxyprogesterone acetate 
and other synthetic androgens decrease SHBG binding in 
plasma of both sexes (Forest & Bertrand, 1972; Makhzangy 
et al, 1979). Corticosteroids in high doses also 
decrease SHBG binding (Vermeulen et al, 1969). Thyroid 
hormone excess induces a significant rise in SHBG 
probably as a result of increased hepatic synthesis 




MECHANISM OF ACTION OF ANDROGENS 
It is interesting that relatively small amounts of 
chemically quite simple androgenic steroid molecules can 
produce such highly specific and widely varying 
biological effects in a diversity of tissues - consider 
androgen- controlled processes such as sexual 
differentiation, pubertal growth, liver enzyme and foetal 
haemoglobin synthesis and the activation of sexual 
behaviour. Any proposed mechanism(s) of action of 
androgens must therefore seek to explain this specificity 
and diversity of action simultaneously. 
6.1 Basic model of molecular mechanism of androgen action 
In the late 1960s, studies of the intracellular 
metabolism of radioactive -labelled testosterone revealed 
that the injected androgen was rapidly and irreversibly 
metabolized by the rat ventral prostate to DHT, in which 
form it is specifically retained in the cell nuclei as 
the principal intracellular androgen (Bruchovsky & Wilson, 
1968; Anderson & Liao, 1968). Shortly afterwards, it was 
demonstrated that soluble cell -free fractions from rat 
ventral prostates contained receptor proteins that 
specifically bind DHT with ten -fold greater affinity than 
testosterone (Fang et al, 1969; Mainwaring, 1969). DHT 
is 2.5 times more potent than testosterone in many bio- 
assays (Dorfman & Shipley, 1956; Bardin & Mahoudeau, 
1970). One of the earliest biochemical responses of 
78 
androgen stimulation - nuclear RNA synthesis - could not 
be induced by testosterone added to prostatic cell nuclei 
in vitro (Liao et al, 1965). These observations suggested 
that DHT might be the locally active metabolite of 
testosterone which binds to specific receptors and 
initiates nuclear mechanisms relevant to the cellular 
androgen response. In subsequent years, most androgen 
responsive tissues have been shown to possess receptor 
proteins capable of binding DHT, testosterone and other 
5a- and 5ß- reduced metabolites of testosterone as well as 
oestradiol (Verhoeven et al, 1975; Attramadal et al, 1976; 
Bardin & Catterall, 1981). Thus it appears that 
specificity of androgen action is achieved by the high 
affinity hormone -receptor interaction while diversity is 
conferred by the local conversion of the parent androgen 
molecule to different active metabolites and by the 
activation of the genetic machineries of different target 
cells each with their respective mode of response. 
Testosterone is therefore considered as both a hormone 
and a prehormone, acting as a precursor for biologically 
active metabolites, the most important of which include 
DHT, oestradiol and 5a- androstanediol (Mainwaring, 1980). 
Other less well- defined local metabolites of testosterone 
may occur in classical target tissues as well as tissues 
previously not thought to be androgen- responsive (Rosness 
& Eik -Nes, 1977). Implicit in this broadened concept of 
androgen action is the belief that the diversity of 
androgen action is introduced by the evolution of 
different local metabolizing enzymes in target tissues 
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and modification of the structure of nuclear chromatin 
rather than by different circulating androgens which will 
put an unreasonable demand on the synthesizing 
capabilities of the Leydig cells. In other words, the 
androgenic response is organ or tissue -specific rather 
than steroid -specific and our understanding of the 
mechanism of androgen action should be advanced by 
focusing attention on the molecular mechanisms of 
androgen metabolism, receptor binding and nuclear 
chromatin activation in diverse tissues. 
6.2 Receptors binding and activation 
At least two forms of receptor proteins for DHT have 
been identified in the rat ventral prostate; the a 
protein and ß protein forming complexes I and II 
respectively with DHT. Only the latter is translocated 
into the nucleus so that only ß protein is regarded as 
the biologically significant androgen receptor (Liao et 
al, 1973a). Unlike SHBG, ß protein has little affinity 
for other steroids except androgens to which it is bound 
with an affinity one to two orders of magnitude higher 
than SHBG. This step up of binding affinity between 
plasma and intracellular binding proteins may be an 
important part of the specific transport system for the 
transfer of androgens from the vascular to the tissue 
compartments against concentration gradients. 
Receptor -DHT binding results in the formation of an 
activated receptor -hormone complex which is temperature 
dependent and associated with changes in the isoelectric 
point and sedimentation constant (Mainwaring & Irving, 
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1973; Liao, 1975). This activated complex can be trans - 
located into the nucleus and is capable of binding to 
nuclear chromatin. Attempts at purification of this 
receptor -DHT complex have so far met with little success 
(Mainwaring, 1977). As in oestrogen receptors, it is 
generally accepted that the duration and extent of 
retention of the receptor -DHT complex in the nucleus is 
crucial to the magnitude of androgen- induced responses 
( Katzenellenbogen et al, 1979). It has also been 
suggested that specialized structural elements exist 
which facilitate the nuclear retention of receptor -DHT 
complexes. The nature of this acceptor site is unknown 
but DNA associated with non -histone protein (Mainwaring & 
Peterkin, 1971) and nuclear associated RNA (Liao et al, 
1973b) have been postulated as likely candidates. In 
general target tissues such as rat ventral prostate have 
a higher capacity to retain the activated receptor -DHT 
complex than non -target tissues (Fang & Liao, 1971; 
Mainwaring & Peterkin, 1971) and nuclear binding of 
androgens, other than 5a Diols which have an exclusively 
cytoplasmic site of action, is the hallmark of their 
response. 
6.3 Biochemical responses 
The observations that cyproterone acetate, an anti - 
androgen that inhibits receptor binding, can abolish the 
early increase in nuclear RNA synthesis (Mainwaring et al, 
1974) and that cytosol preparations of DHT- receptor 
complex can enhance RNA synthesis in cell free prostatic 
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nuclear preparations (Davies & Griffiths, 1974) suggest 
that chromatin binding of the activated receptors acts as 
a trigger for transcription of genetic information stored 
in the DNA of the genome. This initiates a complex and 
poorly understood sequence of molecular events resulting 
in increased synthesis of ribosomal RNA for general 
protein synthesis, messenger RNA to direct specific 
amino acid synthesis and DNA necessary for cellular 
division (for review see Chan & O'Malley, 1976). 
6.4 Other possible mechanisms of androgen action 
The vast majority of data on androgen action was 
derived from one experimental model - the rat ventral 
prostate. There is thus a real possibility of over- 
playing the importance of the DHT receptor binding 
mechanism to the exclusion of other possibilities. The 
related question as to whether testosterone functions 
purely as a prehormone or can initiate cellular response 
itself without further conversion also arises. Two 
important target organs, adult seminiferous tubules 
(Hansson et al, 1975) and skeletal muscles (Gustafsson & 
Pousette, 1975) have minimal 5a- reductase activity and 
display testosterone binding only. DHT cannot restore 
normal male sexual behaviour in castrated rodents which 
respond to testosterone or oestrogens (Davidson, 1972). 
In humans, intrauterine differentiation of Wolffian duct - 
derived structures - seminal vesicles, epididymis and vas 
deferens are testosterone dependent (Imperato- McGinley & 
Peterson, 1976) although in post -natal life, these 
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structures respond preferentially to DHT. It should be 
obvious that DHT is by no means the universal locally - 
active androgen and that requirements of target cell 
responses may vary at different stages of development. 
Nevertheless, the basic model discussed above remains 
unchallenged by other known or postulated molecular 
pathways. Androgens may activate cyclic AMP, modify 
lysosomal and plasma membrane functions or bind with 58 
steroid receptors of target cells but none of these 
mechanisms interact with the classical androgen receptor 
or the nucleus. Examples of these "non- classical" 
androgen actions are encountered in certain enzyme 
synthesis in the prostate and protein synthesis in the 
liver and bone marrow (Bardin & Catterall, 1981). It is 
evident that the action of androgens in some tissues may 
be mediated by a variety of independent mechanisms which 
have yet to be defined. 
83 
CHAPTER 7 
BIOLOGICAL EFFECTS OF ANDROGENS 
Although male sex hormones are not essential for 
survival of the individual, they are however critical to 
the satisfactory propagation of the species. This is 
achieved not only through the effects of androgens on the 
reproductive tract but virtually all tissues in the body 
are influenced by the action of sex steroids. In this 
chapter, those androgen- dependent functions with the 
greatest theoretical interest and /or clinical 
implications are discussed. The effects of androgens on 
spermatogenesis and the physical changes at puberty 
induced by androgens are mentioned but will be dealt 
with in greater detail in subsequent sections. 
7.1 Sexual differentiation 
Sexual differentiation is the result of the trans- 
lation of genetic into gonadal and phenotypic sex 
through an orderly hierarchy or regulatory systems which 
originate in the testis - determining gene in the Y chromo- 
some. The experiments of Jost (1970) established that 
male development is induced in the embryo only in the 
presence of specific hormonal signals from the foetal 
testis. If an ovary develops or if no gonad is present, 
female phenotype differentiation will result. Thus in 
the presence of a Y chromosome and the normally 
functioning testis -determining gene in the pericentric 
region, the male -specific diffusable cell -surface antigen, 
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HY antigen, diverts the inherent inclination of the 
indifferent embryonic gonad from developing into an ovary 
and forms a testis instead (Wachtel et al, 1975; Ohno, 
1976). This occurs at around eight weeks of foetal life. 
Once the foetal testis is formed, it is the secreted 
testicular hormones which magnify and perpetuate the 
genetic message coded in the HY gene of the Y chromosome 
and elicit the development of the male internal and 
external genitalia (Wilson et al, 1980). Normal function 
of the testis and testicular hormones also depend on 
subsidiary regulatory mechanisms and their structural 
genes which may reside in the X chromosome or the auto - 
somes (Haseltine & Ohno, 1981). 
Differentiation of the reproductive tract occurs 
during the first trimester after the formation of the 
gonads. In the male, the Müllerian duct regresses under 
the ipsilateral action of the glycoprotein hormone, 
Müllerian Inhibiting Hormone, produced by the foetal 
Sertoli cells (Josso et al, 1977). Development of the 
wolffian duct into male internal genital tract (epidi- 
dymis, vas deferens, seminal vesicles and ejaculatory 
duct) takes place under the influence of testosterone 
itself since little 5a- reductase activity is detectable. 
However, the urogenital sinus, the genital swelling, 
genital fold and genital tubercle do have an active 
5a- reductase and the preferential binding of 5a- dihydro- 
testosterone directs the embryonic differentiation of the 
prostate, scrotum, urethra and penis (Wilson et al, 1980). 
Two aspects of intrauterine sexual development have been 
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relatively neglected and remain poorly understood at 
present. Testicular descent takes place in the second 
and third trimester. The physical and hormonal factors 
involved are not clearly defined; gonadotrophins, testo- 
sterone and Müllerian inhibiting hormone have all been 
implicated. The early development of the seminiferous 
tubules are also ill- understood. Regions in the Yq arm 
of the Y chromosome can influence the formation and 
development of the spermatogonia (Tiepolo & Zuffardi, 
1976) while the X chromosome must be inactivated prior to 
meiosis (Cattanach et al, 1971). The exact relationship 
between the genetic regulation and the interaction with 
the testicular somatic elements in the early development 
of germ cells constitutes an important area for future 
research. 
Our understanding of the hormonal mechanisms of 
sexual differentiation has been greatly aided by certain 
mutant forms in man and animals. Two foremost examples 
are the testicular feminization syndrome and patients 
with 5a- reductase deficiency. In the former, the X- linked 
gene controlling thè cytosol androgen receptor protein is 
defective. Even though the embryonic testis secretes 
normal amounts of testosterone, none of the cells can 
respond as the androgen receptor is absent or abnormal. 
Consequently, the individuals have a female phenotype but 
the internal genitalia is unformed and they are infertile 
(Morris, 1953; Morris & Mahesh, 1963; Lyon & Hawkes, 1970). 
In the second group of patients, an autosomal recessive 
disorder of 5a- reductase deficiency or malfunction gives 
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rise to a distinct syndrome of abnormal sexual 
differentiation - pseudovaginal permeoscrotal hypospadius 
(Walsh et al, 1974; Imperato- McGinley, 1974). Since the 
testosterone level and androgen receptor are normal, 
these individuals have an essentially male phenotype and 
wolffian duct structures are formed. However, the 
external genitalia are predominantly female with a blind 
vagina and an enlarged clitoris. At the time of puberty, 
increased testosterone secretion stimulates the postnatal 
growth of the phallus and skeletal musculature as well as 
the onset of spermatogenesis. These experiments of 
nature provide excellent models in which to examine the 
theories of sexual differentiation and it can be said 
that the present concepts of genetic and hormonal 
mechanisms of sexual differentiation have been largely 
substantiated. 
7.2 Secondary sexual characteristics and external 
genitalia 
Differentiation of the accessory glands (seminal 
vesicles, prostate, epididymis, periurethral glands) and 
the external genitalia are completed in the first 
trimester of foetal development. Although some growth of 
the external genitalia in the mid and third trimester 
occurs, further growth and functional maturation of the 
accessory glands are deferred until the time of secondary 
sexual development when circulating androgen levels rise 
to the adult range. The effects of prepubertal 
castration and the response of the prostate and seminal 
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vesicles to exogenous androgen replacement have been well 
recognized and indeed provided the basis of one of the 
first bioassay systems available. 
Although this classical mechanism of cytosol receptor 
protein binding, nuclear translocation and chromatin 
activation applies to the whole genital tract, the 
functional response to androgens of different accessory 
glands shows a remarkable degree of tissue specificity. 
Thus in both the seminal vesicles and prostate, approxim- 
ately 40% of total protein synthesized are secreted into 
the urogenital tract, but each gland produces distinct 
and characteristic secretory products (Mann, 1975). 
Tissue specificity of androgen action is further illus- 
trated by the diverse changes in body functions in 
puberty characterized by increased size of external 
genitalia, pubic and body hair growth, enlargement of the 
laryngeal cartilage, increased sebum secretion, 
accelerated growth rate and maturation of the skeletal 
system. Observations in patients with 5a- reductase 
deficiency indicate that these changes in secondary 
sexual development, except those in facial and body hair, 
are mediated by testosterone rather than dihydrotesto- 
sterone. This implies that ontogenic changes in the 
external genitalia involving the 5a- reductase enzyme 
system exist so that dihydrotestosterone provides the 
major stimulus for differentiation while testosterone is 
the critical hormone for postnatal growth and maintenance 
of adult function. 
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7.3 Extragenital actions of androgens 
Testosterone, unlike oestrogen, has major effects on 
the growth and development of many tissues other than 
those of the genital tract (Kochakian, 1975; Bardin & 
Catterall, 1981) as evidenced by the changes observed 
during puberty mentioned above. It is thus the principal 
hormone responsible for sexual dimorphism in non - 
reproductive tissues and organs. The widespread actions 
of testosterone (and other androgens) on extragenital 
organs such as skeletal muscle, bone, liver, kidney and 
red blood cells are collectively known as anabolic effects 
to distinguish them from the virilizing actions on the 
reproductive organs. Prompted by the clinical and 
farming interests in obtaining exclusively anabolic 
steroids, many bioassays were established to select 
appropriate natural and synthetic compounds with non - 
virilizing anabolic properties. Unfortunately, this has 
been hampered by the lack of a universal index of andro- 
genicity and the variability of anabolic effects amongst 
extragenital tissues and amongst different species. It 
is therefore not surprising that the results of animal 
bioassays are often not borne out in clinical practice. 
These observations reinforce the view that androgenic 
actions are organ- specific rather than steroid -specific 
so that it is doubtful whether androgens can be 
completely separated into anabolic and virilizing 
steroids. 
In recent years, significant advances have been made 
in elucidating the mechanism of androgen action on non- 
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genital tissues. These studies not only revealed novel 
molecular mechanisms of androgen action but also provided 
excellent models for the study of genetical control of 
hormonal function. Some of these works are briefly 
mentioned below. 
7.3.1 Skeletal muscle 
The myotrophic effect of testosterone is the basis 
for sexual dimorphism in muscle mass and body weight. 
This is reflected in the greater retention of dietary 
nitrogen in the male and constituted one of the classical 
clinical tests for the anabolic effects of nitrogen 
(Kochakian, 1975). Testosterone rather than dihydro- 
testosterone is believed to be the active androgen in 
skeletal and cardiac muscles where the presence of 
appropriate receptors have been recently demonstrated 
(Dionne et al, 1979; McGill et al, 1980). 
7.3.2 Liver 
Testosterone and to a lesser extent oestrogen 
regulate the concentration and activities of sexual 
steroid -hydroxylases and microsomal enzymes important in 
drug metabolism. Some of these enzyme activities are 
dependent only on a brief exposure to androgens at birth - 
an imprinting process analogous to that observed in the 
central nervous system (Gustafsson & Stenberg, 1974; 
Gustafsson et al, 1980). Other specific androgen - 
dependent, liver proteins such as a2U- globulin in rat 
serum and major urinary proteins in mice urine have been 
characterized (Roy & Neuhaus, 1967; Roy, 1973). The 
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mechanism of androgen control of hepatic protein 
synthesis is through mRNA translation (Kurtz & Feigelson, 
1977) but not all the actions of testosterone on the 
liver are mediated by the classical androgen receptor. 
7.3.3 Kidney 
Sexual dimorphism of the kidney exists in many 
species but the most studied is the mouse where cells of 
the Bowman's capsule and proximal convoluted tubules are 
significantly larger in males than females (Dunn, 1949; 
Mills et al, 1979) and specific protein synthesis - 
glucuronidase, has been extensively characterized 
(Paigen et al, 1975). At least six genes are known to 
regulate this renal hydrolase enzyme, each controlling an 
individual aspect such as synthesis, molecular forms, 
storage, intracellular location and inducibility by 
androgen. These structural and regulatory gene loci are 
activated by the steroid -receptor complex in the nucleus 
but the mechanism of this activation is unknown. 
7.3.4 Red blood cell 
Haemoglobin synthesis in red blood cells is 
stimulated by two independent processes. The renal 
secretion of erythropoietin is increased by androgens via 
cytosol receptor binding (Congote & Solomon, 1975). In 
contrast, 5ß- androgens and 5ß- progestagen metabolites 
directly stimulate the pluripotential stem cells of the 
bone marrow; this effect is mediated by specific 5ß- 
steroid receptors (Spooner & Mainwaring, 1973). 
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7.4 Spermatogenesis 
Although the biological effects of testosterone are 
most dramatically illustrated in the development of 
primary and secondary sexual characteristics and the 
functional maturation of accessory sex organs, it is the 
seminiferous tubules within the testis which constitute 
the single most important androgen- dependent target 
tissue. Teleologically, it seems expedient that the 
development of these specialized androgen- dependent cells 
carrying information from one generation to the next 
should be guaranteed the earliest and highest availability 
of androgens by strategically siting the seminiferous 
tubules immediately adjacent to the source of hormone 
production. Intratesticular concentration of testosterone 
is fifty to one hundred times higher than that in the 
circulation (Steinberger et al, 1974) and there is 
indirect evidence that these extremely high levels of 
testosterone may be essential for the development and 
maintenance of spermatogenesis (Dvoskin, 1944; Ahmad, 
1973; Steinberger et al, 1973). The hormonal control of 




REGULATION OF SEMINIFEROUS TUBULE FUNCTION 
8.1 Spermatogenesis 
Spermatogenesis is a continuous and strictly 
coordinated cytological process in the seminiferous 
tubules of the adult testis. In the seminiferous 
epithelium, the immature spermatogonia proliferate by 
mitotic divisions to form spermatocytes while a minority 
renew themselves to maintain their own numbers (Clermont, 
1966). The diploid spermatocytes go through meiotic 
reduction divisions to form haploid spermatids whose cell 
structures become intricately modified to yield the 
highly differentiated spermatozoa with inherent 
capacities for motility and fertilization. Morphological 
studies of the testis established the presence of 
specific cellular associations in the germinal 
epithelium made up of fixed compositions of various germ 
cells at different stages of development (Clermont, 1963). 
The kinetic basis of the cellular associations was 
revealed by the precise and fixed intervals separating 
each step or cellular divisions in spermatogenesis with 
the use of CH] thymidine labelling (Heller & Clermont, 
1964). The classification of these cellular associations 
into specific stages was achieved by the characteristic 
appearance of the acrosome after Periodic -Acid -Schiff 
haematoxylin staining of the spermatids at different 
phases of development (Leblond & Clermont, 1952). Thus a 
complete cycle of the seminiferous epithelium could be 
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defined as the series of changes in a given area of the 
seminiferous tubule between two successive appearances of 
the same developmental stage. The number of stages 
constituting a cycle is characteristic for each species 
and in man there are six recognisable stages forming one 
cycle of seminiferous epithelium lasting approximately 
sixteen days. The entire course of spermatogenesis in 
man occupied four to five cycles or approximately seventy 
days. This interval of time required for the spermato- 
gonia to develop into a spermatozoa is a biological 
constant characteristic for any one species and cannot be 
altered by any stimulating or inhibiting factors 
(Clermont, 1972). This understanding of the dynamics of 
spermatogenesis has allowed the application to 
quantitative evaluation of changes in the seminiferous 
epithelium under various experimental and clinical 
situations. 
While the morphological aspects of the cytological 
processes taking place during spermatogenesis have been 
extensively studied, many fundamental issues remain to be 
tackled. The molecular aspects of these structural 
modifications, the role of the Sertoli cells, the action 
of trophic hormones and the interactions between Sertoli, 
Leydig and germ cells are but some of the areas that 
require systematic studies. 
8.2 Hormonal requirements of spermatogenesis 
The classical experiments of Smith & Engle (1927) in 
hypophysectomized rodents clearly established the 
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importance of pituitary glandular secretions in spermato- 
genesis. The dual control of testicular function by 
individual gonadotrophins, LH for Leydig cells and FSH 
for spermatogenesis was proposed by Greep et al (1936). 
The functional relationship between LH and Leydig cell 
steroidogenesis has since been amply confirmed (see 
Chapter 4). The role of FSH, however, in spermatogenesis 
has been disputed. The major objection was the finding 
that androgens alone can maintain spermatogenesis in 
hypophysectomized animals (Walsh et al, 1934; Nelson & 
Merckel, 1938). Other studies claimed that a synergistic 
action between LH and FSH is necessary for normal spermato- 
genesis (Woods & Simpson, 1961; Lostroh, 1963). These 
studies suffered from the lack of quantitative analysis 
of spermatogenesis, incomplete hypophysectomy and the use 
of impure gonadotrophin preparations. Their conclusions 
that FSH may not be required for spermatogenesis must 
therefore be regarded with some suspicion. The work of 
Steinberger and colleagues (Steinberger & Duckett, 1967; 
Steinberger & Steinberger, 1969) using oestrogens to 
suppress gonadotrophins in newborn rats and in vitro 
studies on cultures of testicular explants introduced the 
concept that initiation or restoration may have different 
hormonal requirements from the maintenance of spermato- 
genesis and that specific steps in spermatogenesis may 
also have different hormonal requirements (Steinberger, 
1971). 
A more specific and selective approach using passive 
immunization by monospecific antisera against LH or FSH 
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has been used to study this problem. In rats, FSH and LH 
or testosterone are necessary to initiate spermatogenesis 
in immature males (Chemes et al, 1979) while adults 
require only testosterone to maintain spermatogenesis 
(Dym, 1979). In contrast, testosterone alone was 
ineffective in maintaining spermatogenesis in the adult 
ram despite normal levels of testosterone and dihydro- 
testosterone within the testes (Monet -Kunz et al, 1976). 
Both LH and FSH in the form of human chorionic gonado- 
trophin (hCG) and human menopausal gonadotrophin (hMG) 
are required (Courot et al, 1979). In adult Bonnet and 
Rhesus monkeys, FSH was required to maintain quantitat- 
ively normal spermatogenesis (Murty et al, 1979; Wickings 
et al, 1980). In man, both hMG and hCG are needed to 
initiate or restore spermatogenesis in hypogonadotrophic 
or hypophysectomized patients (Mancini et al, 1971). 
These studies clearly indicated that FSH does play an 
important part in spermatogenesis although there are 
important species differences in the specific hormonal 
requirements at different stages of development. 
The positive influence of testosterone on spermato- 
genesis in gonadotrophin deprived animals contrasts with 
its effect in intact males where atrophy of the semini- 
ferous tubules is the usual result unless pharmacological 
doses are employed (Moore & Price, 1932; Ludwig, 1950). 
This differential effect of varying doses of testosterone 
is probably due to gonadotrophin suppression by exogenous 
testosterone with very high doses being able to maintain 
normal spermatogenesis by producing high intratesticular 
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testosterone concentration in spermatogenesis was well 
illustrated in the prepubertal testis of a patient with a 
functioning Leydig cell tumour around which spermato- 
genesis was stimulated beyond meiosis while the contra - 
lateral testis atrophied (Steinberger et al, 1973). The 
intratesticular testosterone concentration in a small 
number of men was around 56 pg /dl which was fifty to one 
hundred times that found in peripheral plasma (Steinberger 
et al, 1974). 
8.3 Sertoli cells 
These tall columnar somatic cells with extensive 
cytoplasm enveloping the developing germ cells are 
traditionally regarded as the supporting or nurse cells 
in the seminiferous tubules. Tight junctions between 
adjacent Sertoli cells form the anatomical basis of the 
blood testis barrier dividing the seminiferous tubule 
into two function units: the basal compartment in direct 
communication with the interstitial space and the 
adluminal compartment which provides a secluded and 
avascular environment in which the leptotene primary 
spermatocytes, secondary spermatocytes and spermatids 
& Waites 
develop (Setchel]k 1975; Setchell, 1980b; Dym & Cavicchia, 
1978) (Fig 8.1 & 8.2) . The Sertoli cells which straddle both 
these functional compartments secrete large amounts of 
hyperosmolar tubular fluid rich in potassium, inositol, 
aspartates and glutamates creating a highly specialized 
microenvironment in the adluminal compartment believed to 
be important for the completion of germ cell meiosis and 
SEMINIFEROUS TUBULE 
Fig 8.1 
Diagrammatic representation of the cellular composition and 
structural relationship between different cell types in the 
testis. SG: spermatogonia; SC: spermatocytes; ST: spermatids 






































































































































































































































































































































































































































































































































spermiogenesis (Fritz, 1978). Besides the elaboration of 
tubular fluid, an array of'other functions have been 
ascribed to the Sertoli cells including protein synthesis, 
phagocytosis of degenerating germ cells, release of 
mature spermatozoa, movement of germ cells from periphery 
towards the lumen and metabolism of steroid hormones 
(Fawcett, 1975). By virtue of their strategic location, 
it is generally accepted that most factors influencing 
germ cell function and development are mediated via the 
Sertoli cells. It is thus of interest to note that 
amongst the heterogeneous cellular elements of the 
seminiferous tubule, only Sertoli cells and spermatogonia 
have been shown to possess specific membrane receptors 
for FSH (Orth & Christensen, 1977) while cytoplasmic and 
nuclear receptors for androgens have been demonstrated in 
isolated Sertoli cells (Sanborn et al, 1977; Tsai et al, 
1977) . 
8.4 Mechanism of action of follicle stimulating hormone 
The application of cell culture techniques and 
methods for preparing Sertoli cell preparations (Welsh & 
Wiebe, 1975; Steinberger A. et al, 1975) has facilitated 
the studies of molecular mechanisms of FSH action on the 
seminiferous tubules. The events following specific FSH 
receptor binding in Sertoli cell membranes are similar to 
that in LH binding with Leydig cells with activation of 
adenyl cyclase and cyclic AMP dependent protein kinase 
(Means et al, 1976). This series of biochemical events 
results in increased RNA and protein synthesis in Sertoli 
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cells which include a number of specific proteins. 
Androgen binding protein (ABP), an androphilic macro- 
molecule with physicochemical properties characteristic 
of a transport protein (Hansson et al, 1975; Sanborn et 
al, 1975) and plasminogen activator (Lacroix et al, 1977) 
are secreted into the rete testis fluid by the Sertoli 
cells. A further two specific proteins - a protein 
kinase inhibitor and y glutamyl transpeptidase, however, 
remain within the Sertoli cells (Beale et al, 1977; 
Hodgen & Sherins, 1973). FSH also regulates the cyto- 
skeletal component of Sertoli cells via stimulation of a 
calcium- dependent regulator protein (calmodulin) coupled 
to the adenyl cyclase -phosphodiesterase system. By 
reorganization of the microtubules and microfilaments of 
the Sertoli cell cytoskeletal FSH may influence the cell 
shape, motility and exocytosis (Means et al, 1978 & 1980). 
All the effects of FSH discussed above have been 
demonstrated only in Sertoli cells from immature rat, and 
little if any FSH action could be elicited by twenty days 
of age, the time at which the Sertoli cell tight junctions 
are formed (Means et al, 1980). This is also the time 
when germ cell meiosis is first encountered, marking the 
onset of full spermatogenesis. The age- dependent change 
in Sertoli cell FSH responsiveness may be due to 
alterations in the isoforms of cyclic AMP- phosphodi- 
esterase (Means et al, 1980) but the apparent inactivity 
of adult Sertoli cells in vitro is one of the most 
important riddles to solve in our understanding of 
testicular function. 
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8.5 Mechanisms of hormonal action on spermatogenesis 
From the physiological studies defining the hormonal 
requirements for normal spermatogenesis and the present 
understanding of molecular mechanisms of action of these 
hormones in the seminiferous tubule, it may be possible 
to formulate some tentative model for the hormonal control 
of spermatogenesis. A great deal of attention has been 
focussed on the androgen binding protein synthesis and 
secretion by Sertoli cells since this is stimulated not 
only by FSH but also testosterone (Elkington et al, 1975; 
Means et al, 1976; Louis & Fritz, 1977). Furthermore, 
the post -hypophysectomy reduction in testicular ABP 
concentration can be prevented if androgen replacement is 
started immediately after the operation. Otherwise if 
testicular regression has occurred, restoration of ABP 
production requires both FSH and androgens (Elkington et 
al, 1975; Weddington et al, 1975). Thus the Sertoli cell 
requirement for ABP production closely parallels the 
hormonal requirement for spermatogenesis in rats. Taken 
together, these observations suggest that ABP may play a 
central role in spermatogenesis although the exact nature 
of its function in the seminiferous tubule is unclear. 
Androgen binding protein, with its high affinity for 
testosterone, may prevent the rapid metabolism of androgen 
to oestradiol or 5a- reduced metabolites so that a high 
intratesticular concentration of testosterone can be 
ensured. There are obvious deficiencies in this highly 
speculative model of seminiferous tubule function. The 
action of testosterone is unlikely to be directly on the 
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germ cells (Lyon et al, 1975) and the mechanism of action 
of androgens on spermatogenesis is completely unknown. 
Even the fundamental tenet that high intratesticular 
testosterone concentration is required for normal 
spermatogenesis has recently been challenged (Cunningham 
& Huckins, 1979). In man and other primates, a specific 
testicular or epididymal ABP distinct from SHBG has been 
difficult to identify (Vigersky et al, 1976). Clearly, 
much more basic information remains to be learned before 
the mechanism(s) of hormonal control of spermatogenesis 




In vertebrates, the pituitary synthesizes two 
gonadotrophins - luteinizing hormone (LH) and follicle 
stimulating hormone (FSH) which regulate gonadal 
functions. 
9.1 Isolation and purification 
Early attempts at isolation of the glycoprotein 
gonadotrophins using ammonium sulphate fractionation or 
precipitation by buffered ethanol produced impure 
preparations which were inadequate for structural and 
functional analysis. The introduction of more 
sophisticated peptide chemical methodology such as ion 
exchange and molecular exclusion, starch gel and poly - 
acrylamidegel electrophoresis and isoelectric focusing 
yielded reasonably pure preparations of gonadotrophins 
for chemical and biological analyses followed by the 
development of radioimmunoassays. Demands on gonado- 
trophins for clinical purposes prompted investigators to 
seek alternative sources of these hormones due to the 
meagre supplies of animal and human pituitaries. Urine 
from post- menopausal women proved the most rewarding 
although these preparations obtained (Human Menopausal 
Gonadotrophins - HMG) contain both LH and FSH which are 
not easily separated from each other. Nevertheless, 
preparations of HMG are suitable for clinical use as well 
as acting as reference standards for bio and immunoassays. 
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Other non -pituitary sources of gonadotrophic hormones 
include human chorionic gonadotrophin (hCG) from the 
urine of pregnant women, with its LH -like activity 
(Diczfalusy & Troen, 1961). The relative abundance of 
HCG in easily available pregnancy urine and its 
similarity in biological actions to pituitary LH make it 
the most widely used glycoprotein hormone for the study 
of structure -function relationships and mode of action of 
this class of hormone. 
9.2 Physico- chemical properties of gonadotrophins 
Gonadotrophins, either crude or highly purified, 
contain more than one immunological and biologically 
active moieties which are regarded as different forms or 
molecular species of the same hormone. This may reflect 
the presence of different forms of gonadotrophins stored 
in the-pituitary or result from artefacts during 
extraction and purification. Whatever the cause, 
hormonal heterogeneity of gonadotrophins, as indeed in 
all peptide hormones, is a phenomenon that endocrinolo- 
gists have to contend with constantly in their enquiries. 
For the same reasons, there is no general agreement 
as to the molecular weight of gonadotrophins which was 
estimated to be between 32,600 to 52,480 for FSH and 
26,000 to 41,690 for LH (Wide, 1976). The carbohydrate 
content is 15% in LH and 30% in FSH; these are covalently 
linked to the peptide chains. The important observation 
of Li and Starman (1964) that ovine LH readily dissociates 
in acid pH paved the way for the subsequent discovery that 
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all glycoprotein hormones including LH and FSH reversibly 
dissociate into dissimilar a and ß subunits each of 100 
amino acids when treated by acidic or high molarity 
reagents that do not disrupt the covalent bonds. 
Dissociated a and ß subunits have little biological 
activity which is restored when they are re- associated 
under appropriate conditions. The nature of this 
restored activity is dependent on the ß subunit (Liao & 
Pierce, 1970; Saxena & Rathnam, 1971) since the a subunits 
in all human glycoprotein hormones have identical amino 
acid sequence (Shome & Parlow, 1974). This within - 
species structural similarity of the a subunits accounts 
for the cross -reactions commonly encountered with anti- 
bodies raised against any one of the glycoprotein 
hormones with the other three (Vaitukaitis et al, 1972). 
On the other hand, ß subunits of human glycoprotein 
hormones show antigenic similarities with those of the 
corresponding hormones of other species (Vaitukait et al, 
1972). Thus within- species immunological cross -reactivity 
resides in the a subunit and the between -species 
immunological cross -reactivity resides in the ß subunit. 
This phenomenon is the basis for enhancing the specificity 
in radioimmunoassays of gonadotrophins using heterologous 
systems, e.g. labelled ovine FSH and anti -human FSH anti- 
serum in measuring human FSH (L'Hermite & Midgeley, 1971). 
Steroid hormones circulate in plasma largely as 
complexes with specific and non -specific carrier proteins. 
This may be related to their insolubility in water even 
though their physiological concentrations do not normally 
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exceed their aqueous solubility. The lipid solubility of 
steroids is compatible with their mainly intracellular 
sites of action requiring easy penetration of the target 
cell membrane. Peptide or glycoprotein hormones, in 
contrast, are 1000 to 100 million times more soluble in 
plasma than steroids and it is generally accepted that 
the native hormones are not bound to any circulating 
carrier proteins (Berson & Yalow, 1970). Binding of some 
moiety of radio -labelled hormone to a2 macroglobulins may 
reflect hormonal damage by plasma peptidases. The much 
higher MCRs of gonadotrophins compared to steroids are 
compatible with the above arguments. 
Secretion and metabolic clearance rate methods have 
been extensively applied to the study of steroid hormones 
where the native and labelled molecules are well 
characterized by chemical and chromatographic purification 
procedures. The application of these techniques to 
peptide hormones are fraught with practical pitfalls, due 
to the heterogeneity of gonadotrophins in the circulation 
and the unavoidable presence of damaged components from 
radiolabelling whose plasma half -lives are spuriously 
prolonged because of their tendency to protein binding. 
Furthermore, for peptide hormones in the physiological 
and pharmacological ranges, metabolic clearance rates 
seldom fluctuate and very few agents or factors 
significantly influence their metabolic degradation 
(Berson et al, 1956). Coupled with the rapid metabolic 
turnover of peptide hormones (Tz usually in minutes), any 
rise and fall in plasma concentrations can effectively be 
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regarded as indicative of increase or decrease in rates 
of glandular secretion. Using constant infusions of highly 
purified labelled and native gonadotrophins, the MCRs of 
gonadotrophins in normal adult males were estimated to be 
64.2 L /day for LH and 9 -14 L /day for FSH. The correspond- 
ing secretion rates were 85 (range 45 -123) I.U. and 25 
(6 -66) I.U. of 2nd IRP HMG respectively (Burger et al, 
1974). The proportion of gonadotrophin production 
excreted in urine was around 40%. Both intact hormone 
and degraded products as well as subunits with 
immunological activity are excreted. Although measure- 
ments of gonadotrophin in the urine generally reflect the 
plasma concentrations reasonably accurately, the renal 
excretion rates are strongly influenced by changes in 
renal function (Wide & Thoren, 1972). In addition, the 
normally large variation in pH and solute concentrations 
in urine may interfere with the immunoassay specificity. 
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CHAPTER 10 
NEUROENDOCRINE CONTROL OF GONADOTROPHIN SECRETION 
The posterior pituitary and the adrenal medulla, of 
all endocrine glands, are the only ones which receive a 
rich nerve supply influencing their secretory activity. 
Yet the functions of the gonads are critically influenced 
by environmental factors such as light, temperature and 
the presence of mates (Marshall, 1936, 1942). The attach- 
ment of the pituitary gland to the hypothalamic area of 
the brain provides a key anatomical link whereby sensory 
stimuli from the external environment can be relayed 
through the CNS neural pathways to the gonads. This 
integration of neural inputs into an endocrine functional 
response is the core of the neuroendocrine concept of 
control of reproduction. 
10.1 Neurovascular control of anterior pituitary function 
Repeated attempts between 1935 -1955 to define a nerve 
supply linking the hypothalamus and pituitary led to the 
inevitable conclusion that it did not exist. Attention 
was consequently turned to humoral or chemical trans- 
mission between the two sites, prompted by Sawyer's 
experiments (Sawyer et al, 1947) showing that ovulation 
in rats was prevented by a adrenergic blocking agents and 
stimulated by intraventricular injection of noradrenaline. 
A delicate portal vessel system between the primary 
capillary plexus in the median eminence and the sinusoids 
of the anterior pituitary was first described by Popa & 
Fielding (1930, 1933). This was subsequently confirmed 
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by Wislocki and King (1936). Later, it was demonstrated 
that the hypophysial portal vessels were widely 
distributed amongst vertebrates (Green, 1951) and that 
they carried blood from the median eminence to the 
pituitary (Green & Harris, 1949). Thus the gross 
anatomical basis for the neurovascular control of the 
anterior pituitary was established. This was further 
supported by ultrastructural studies demonstrating an 
abundance of nerve endings containing secretory vesicles 
in close contact with endothelium of the primary 
capillaries with fenestrations typical of absorptive and 
secretory structures (Barry & Cotte, 1961). 
The essential role of this hypophysial portal supply 
to normal anterior pituitary function was established by 
the elegant work of Harris and Jacobson (1952). They 
found that anterior pituitary tissue transplanted to 
ectopic sites in the body failed to function. However if 
the same tissue was transplanted under the median 
eminence where revascularization by the portal circulation 
can occur, normal function was restored. This series of 
experiments prompted the full acceptance of the neuro- 
vascular theory and set the stage for the search for 
hypothalamic compounds transported in the portal vessels 
which stimulate pituitary hormone production. 
10.2 Isolation, purification and synthesis of Gonado- 
trophin Releasing Hormone (GnRH) 
Drawing an analogy with the posterior pituitary's 
synthesis of neurosecretory peptide hormones, it was not 
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long before the successful isolation of peptide- containing 
hypothalamic extracts capable of evoking ovulation and 
pituitary LH secretion was achieved (McCann et al, 1960; 
Campbell et al, 1961). Despite the minute quantities of 
GnRH present in the hypothalamus, adequate amounts of the 
extract were obtained to allow the determination of the 
structure of porcine GnRH in Schally's laboratory (Matsuo 
et al, 1971a). The linear decapeptide structure was 
confirmed shortly by Guillemin's group in ovine hypo- 
thalamus extracts (Burgus et al, 1972). The synthesis of 
the peptide sequence was quickly accomplished (Matsuo et 
al, 1971b; Geiger et al, 1971) and the potent action in 
stimulating not only LH but also FSH has been confirmed 
in all vertebrate species examined with a seemingly 
complete lack of species specificity in action and 
structure (Fraser, 1981). The availability of synthetic 
GnRH for experimental and clinical use was one of the 
most significant scientific achievements in the last 
decade for which Schally and Guillemin were jointly 
awarded the Nobel prize. 
Under most physiological situations, the LH response 
to GnRH is much greater than that of FSH. However, in 
some instances, FSH secretion can be dissociated from LH 
with preferential release or suppression of the former 
(Chappel & Barraclough, 1976 & 1977). Although these 
could be taken as evidence supporting the existence of a 
separate FSH -RH, the more likely explanation is the 
differential effects of steroid or other substances on 
the pituitary response to a single GnRH. The extensive 
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biochemical analyses of Schally's group has led him to 
conclude that GnRH represents the bulk of FSH -RH activity 
in porcine and bovine hypothalami (Schally et al, 1976). 
10.3 Location of GnRH 
Topographic studies of the brain have all shown that 
the highest concentration of GnRH occurred in the axons 
of the lateral palisade zone of the median eminence where 
the nerve endings contain large diameter (100 -300 nm) 
GnRH secretory granules similar to synaptosomes (Arimura, 
1977; Brownstein, 1977; Krulich & Fawcett, 1977). In 
rodents, the principal area bearing GnRH -containing 
neurones is the preoptic- anterior hypothalamic area from 
where axons run in the hypothalamo - infundibular tract to 
end on proximal capillaries of the portal system. The 
other important area rich in GnRH producing neurones in 
primates is the arcuate nucleus - medial basal hypo- 
thalamus region. Axons from this area also project into 
the median eminence. The presence of GnRH in nerve 
fibres outside the hypothalamus, e.g. Amygdala and 
pineal, and in non -neural reproductive tissue has led to 
intensive studies of possible functions of GnRH outwith 
the gonadotropes of the pituitary (for review see Hsueh & 
Jones, 1981). 
10.4 Biosynthesis and release of GnRH 
Although the in vitro synthesis of GnRH by rat hypo- 
thalamic fractions has been demonstrated (Johansson et al, 
1973), the subcellular site, molecular mechanism and 
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regulatory processes of GnRH synthesis have not been 
studied in detail. However, the relevant mechanisms are 
likely to be similar to other hypothalamic peptide 
hormones (e.g. vasopressin) with ribosomal synthesis of a 
larger prohormone which is cleaved by peptidases before 
being packaged for secretion in the Golgi apparatus. 
The release of GnRH is the end result of the complex 
interactions between environmental, psychological and 
steroidal as well as non -steroidal gonadal feedback 
signals with the neurosecretory neurones in the hypo- 
thalamus. The decapeptide synthesized in the cell bodies 
passes down the axons by axoplasmic flow to the nerve 
endings at the median eminence. There the hormone is 
concentrated in large secretory granules prior to release 
into capillaries of the portal vessels. This release is 
presumably evoked by an action potential originating in 
the cell body in response to stimuli from the afferent 
system. Hence the process of discharge of secretory 
granules from nerve -endings probably follows the all -or- 
none phenomenon for nerve impulse conduction and the 
amount of hormone released into the portal circulation 
will be dependent on the frequency of neuronal pulsatile 
discharge (Hayward, 1977). 
The extremely low concentrations of GnRH in the 
systemic circulation render its measurement in peripheral 
blood unreliable. However with 
the techniques of pituitary stalk blood sampling 
perfected by Fink in Oxford and Porter in Dallas, several 
studies have been able to demonstrate the tonic pulsatile 
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nature of GnRH secretion and the cyclic preovulatory GnRH 
surge in the hypophysial portal circulation (Carmel et al, 
1976; Sarkar et al, 1976; Eskay et al, 1977; Neil et al, 
1977; Tsou et al, 1977), mirroring the two well -described 
patterns of LH secretion in the systemic circulation in 
the female reproductive cycle. These important 
observations confirmed the physiological role of GnRH 
secretion and also validated the use of pulse frequency 
of pituitary LH secretion as an index of hypothalamic 
activity. 
10.5 Neurotransmitter control of GnRH secretion 
Although it was the hypothalamic peptide hormone 
that captured the attention of most investigators in the 
last decade, it should be emphasized that the original 
experiments which fostered the concept of neurohumoral 
transmission between the brain and pituitary suggested 
that adrenergic or cholinergic neurotransmitters were the 
mediators of this communication (Sawyer et al, 1949; 
Sawyer, 1952; Markee et al, 1952). Subsequently, many 
studies have shown that a wide variety of centrally- acting 
agents can block ovulation as well as pulsatile GnRH 
secretion (Bhattacharya et al, 1972; Drouva & Gallo, 1976; 
Arendash & Gallo, 1978) confirming that CNS neurotrans- 
mitters are important in the control of GnRH secretion 
from the hypothalamus and thus reproduction. 
Noradrenaline containing fibres run from the lateral 
tegmental area of the brain stem to the GnRH- containing 
areas of the hypothalamus (Fuxe & Hökfelt, 1969). 
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Extensive experimental evidence in the rat in eliciting 
and blocking the preovulatory LH surge has confirmed an 
excitatory role of noradrenaline on the GnRH- secreting 
neurone (McCann & Ojeda, 1976). 
The highest concentration of dopamine in the brain 
is located in the median eminence where nerve fibres of 
the tuberoinfundibular tract with neurones in the arcuate 
and periventricular areas terminate (Fuxe & Höckfelt, 
1969). The proximity of dopamine and GnRH- containing 
nerve fibres in the median eminence raised the possibility 
that axon -axon synapses may regulate the neurosecretion 
of GnRH. The early in vivo and in vitro experiments of 
McCann suggested that dopamine stimulated GnRH from the 
hypothalamus of rats (McCann & Ojeda, 1976). These 
results however could not be confirmed by others who 
found a consistent inhibitory effect of dopamine in 
several species (Fuxe et al, 1976; Fuxe et al, 1978). 
More recent studies by McCann and colleagues showed that 
dopamine may have different actions on GnRH neurones 
depending on steroid environment, dosage of dopamine, the 
individual agonist or antagonist used and the route of 
administration (Vijayan & McCann, 1978a & b). Dopamine 
is also secreted directly into the hypophysial portal 
circulation (Shaar & Clemens, 1974) where it inhibits the 
pituitary response to GnRH (Yen et al, 1977; Judd et al, 
1978). This may further confound any direct excitatory 
effect of dopamine on GnRH production. 
Systemic and intraventricular injection and the use 
of specific antagonists have shown that serotonin may have 
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an inhibitory effect on GnRH secretion (McCann & Ojeda, 
1976). Electrical stimulation of the arcuate nucleus 
induced pulsatile release of LH which is suppressed by 
serotonin (Gallo & Moberg, 1977). Oestrogens alter 
serotonin turnover, increasing it at night and reducing 
it during the day (Fuxe et al, 1976). This may be 
important in the LH sleep /wake secretory rhythm. However 
most of these studies were performed with pharmacological 
doses and the physiological role of serotonin and other 
putative neurotransmitters in the control of GnRH 
secretion remains to be proven. 
One of the most intriguing issues in neuroendocrin- 
ology is posed by the discovery of a wide variety of 
hypothalamic, pituitary, gastrointestinal and opioid 
peptides in the brain making them potential candidates as 
neurotransmitters and neuromodulators (McCann, 1980; 
Kreiger, 1980). The site of origin, mechanism of bio- 
synthesis and physiological roles of these CNS peptides 
are just beginning to be studied and it is too early to 
say whether any of them would play a significant role in 
the physiological control of GnRH or gonadotrophin 
function. 
Another class of compound, the prostaglandins, is 
found in high concentrations in the median eminence 
(Ojeda et al, 1979). Although PGE2 and El can stimulate 
LH release directly from the pituitary (Labrie et al, 
1976), strong evidence suggests that their principal 
site of action is the induction of GnRH secretion (McCann 
et al, 1976). It has been postulated that activation of 
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noradrenaline release stimulates post- synaptic production 
of PGEs which in turn enhances the release of GnRH 
directly or via cyclic AMP (Ojeda & McCann, 1978). 
10.6 Mechanism of action of GnRH 
As in other peptide hormones, GnRH binds to specific 
cell surface receptors (Grant et al, 1973). However, the 
predominant low affinity ligand binding and tracer 
degradation prevented the accurate measurement and 
meaningful studies of the physiologically important high 
affinity binding sites on the gonadotrope cell membranes. 
In the last few years, the use of radioiodinated agonist 
analogue of native GnRH as the ligand in radioreceptor 
assays has eliminated these methodological obstacles 
(Clayton et al, 1979) and the physico- chemical character- 
istics of the physiological GnRH receptor defined. Using 
this approach, evidence supporting the existence of 
mechanisms regulating GnRH receptor numbers in the 
pituitary by gonadal steroids and endogenous GnRH 
secretion has been obtained (for review see Clayton & 
Catt, 1981). The post- receptor mechanisms of GnRH action 
is at present unclear. Data on the role of cyclic AMP 
and cyclic GMP as the intracellular second messenger 
after membrane receptor binding are conflicting 
(Wakabayashi et al, 1973; Conn et al, 1979; Noar et al, 
1978; Noar & Catt, 1980). Recent evidence reviewed by 
Conn et al (1981) suggests that although cyclic nucleo- 
tides may be involved in the regulation of GnRH- induced 
LH biosynthesis, they could be readily uncoupled from LH 
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release. There is growing support at present for the 
role of cytosolic calcium and its intracellular binding 
protein, calmodulin, being the mediator of GnRH- induced 
gonadotrophin release in the pituitary gonadotropes 
(Marian & Conn, 1979; Conn et al, 1979). Calmodulin is 
known to regulate the assembly and disassembly of micro - 
tubules (Means & Dedman, 1980) which are important in 
the secretion of gonadotrophins (Khar et al, 1979). 
Although the pituitary gonadotrophin store is rapidly 
depleted implying that GnRH also induces de novo hormone 
synthesis (Labrie et al, 1973), nonetheless short term 
treatment of pituitary with puromycin or cycloheximide 
did not decrease the initial or acute gonadotrophin 
release in response to GnRH (Vale et al, 1968). This is 
the basis for the concept of the existence of two pools 
of secreted LH - the initial release of hormone from a 
readily releasable pool followed by the secretion of 
stored or newly synthesized hormone from a second pool 
after prolonged GnRH stimulation (Bremner & Paulsen, 1974; 
Wollensen et al, 1976; Yen, 1977). These two functional 
rather than anatomical compartments of LH are closely 
integrated as illustrated by the self -priming phenomenon 
where successive GnRH stimulation shifts the storage into 
the releasable pool and increases the secretory response 
to subsequent stimulation (Aiyer et al, 1974; Fink, 1979). 
10. 7 Metabolism of GnRH 
The plasma clearance of exogenous radiolabelled GnRH 
is extremely rapid. At least two components can be 
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recognized with half life of the initial fast component 
of four minutes and a second slower component of fifty 
minutes (Nett et al, 1973; Keye et al, 1973). This 
pattern is similar in all species studied (Arimura et al, 
1974). The highest tissue uptake of circulating GnRH 
occurs in the liver and kidney indicating that these 
organs may be the primary sites for GnRH inactivation 
(Yukitaka et al, 1973). 
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CHAPTER 11 
BIORHYTHM OF REPRODUCTIVE HORMONE SECRETION 
The classical studies and thinking based on bioassay 
of urinary hormones fostered the concept that hormones 
are secreted by endocrine glands at a steady constant 
rate throughout the twenty -four hours. This is now known 
to be untrue. Indeed, rhythmic fluctuations in hormone 
synthesis and secretion are characteristic of mammalian 
endocrine systems and may be part of some fine- tuning 
control mechanisms at the target cell or receptor level. 
Despite this upsurge in interest in the rhythmic pattern 
of hormone secretion, it should be said that the 
valuable data from experiments based on steady state 
steroid dynamics remain valid since the estimations on 
daily blood production rates and conversion constants can 
allow for or integrate the fluctuating levels of hormones 
in the circulation. Hormones which regulate reproductive 
functions have several recognizable patterns of variation 
with different periodicities superimposed on each other. 
11.1 Circhoral rhythm 
With the availability of simple, sensitive and 
precise radio -ligand assays on small volumes of 
biological fluids, repeated determinations of circulating 
hormone concentrations at frequent intervals became 
possible. Using the technique of frequent blood sampling 
(Vankirk & Sassin,1969) the rhythmic or pulsatile 
oscillation of plasma LH concentration was first 
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demonstrated in ovariectomized Rhesus monkeys (Dierschke 
et al, 1970). These workers used the term circhoral 
rhythm to describe the. hourly LH oscillations in peri- 
pheral plasma and this has now been expanded to include 
other high frequency hormone rhythms even though the 
periodicity usually exceeds one hour. The existence of 
rhythmic fluctuation of LH concentration was soon 
confirmed in gonadectomized and intact animals in other 
species (man: Nankin & Troen, 1971, Midgley & Jaffe, 
1971; bull: Katongoleet al, 1971; rat: Gay & Sheth, 1972; 
ram: Sandford et al, 1974; rabbit: Moore & Younglai, 
1975). In the adult human male, data from many different 
studies are essentially in agreement (for review see 
Baker et al, 1975 and Judd, 1979). A typical LH pulse 
rises sharply to a peak in five to forty minutes with 
increments of 30 -300ó followed by a slower decline over 
one half to four hours before reaching basal levels. The 
apparent decay time of 100 to 130 minutes for LH pulses 
exceeds the half -life (29 -63 minutes) of the exogenous 
radiolabelled hormone in hypophysectomized subjects 
(Kohler et al, 1968; Schalch et al, 1968; Yen et al, 
1968), suggesting that pulsatile secretion may occur on a 
background of modest continuous secretion (Yen et al, 
1972a; Vande Wiele & Ferin, 1974). The interval between 
LH pulses varied between one to six hours with an average 
of 100 minutes (Santen & Bardin, 1973; Baker et al, 1975). 
In the intact subject, FSH pulsatile secretion is 
less marked with a slower rise and non -linear slopes of 
decay (Yen et al, 1972b) -. This pattern is compatible with 
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(1) lower absolute levels of FSH; (2) more moderate 
response of FSH to GnRH; (3) longer plasma half -life of 
FSH (Yen et al, 1970) and (4) different modulating 
effects of gonadal steroids at the pituitary. Despite 
these features, LH and FSH are usually closely correlated 
temporally (Yen et al, 1972b;.Santen & Bardin, 1973; 
Alford et al, 1973) reinforcing the belief that a single 
releasing hormone stimulates the synthesis and release of 
both gonadotrophins (Schally et al, 1976). 
The secretion of testosterone is also pulsatile to a 
certain extent in man although the pattern is less well - 
defined than that of LH being of smaller magnitude and 
more irregular in frequency (for review see Baker et al, 
1975 and Judd, 1979). By increasing the frequency of 
sampling to two minute intervals, Smith et al (1974) were 
able to show distinct and rapid oscillations in testo- 
sterone which was not apparent with lower sampling 
frequencies. Although the biological significance of 
this finding is obscure, it serves to emphasize the 
importance of the optimal sampling frequency for the 
study of pulsatile secretion depending on the pulse 
interval and the plasma half -life (Goldzieher et al, 
1976). 
Variations in plasma concentrations of hormones may 
be due to changes in production /secretion rate, metabolic 
clearance rate or volume of distribution. Since the MCR 
of gonadotrophins (Kohler et al, 1968; Coble et al, 1969) 
and testosterone (Southren et al, 1968) remain relatively 
constant at most times and the effect of posture and 
122 
changes in plasma volume could not possibly account for 
the minute to minute changes in hormone concentration, 
the circhoral or ultradian variation of these hormones 
must therefore reflect changes in secretion rate. 
Although direct proof by measuring changes of hormone 
concentration with time in the venous effluent of the 
relevant glands is still lacking, it is now generally 
accepted that hormones showing episodic changes in plasma 
concentrations are secreted in a pulsatile fashion. 
Episodic secretion of gonadotrophins may be an 
intrinsic property of the pituitary or the result of 
pulsatile stimulation by hypothalamic GnRH or both. The 
former mechanism is supported by the persistence of short 
term fluctuation of LH during continuous GnRH infusion 
(Mortimer et al, 1974; Vande Wiele & Ferin, 1974; Bremner 
et al, 1976). The evidence for pulsatile GnRH stimulation 
however is much more convincing. Pituitary stalk section 
without revascularization leads to rapid falls in gonado- 
trophin levels (Vaughan et al, 1980). More selective 
inhibition of GnRH by active or passive immunization with 
anti -GnRH antisera abolishes pulsatile LH secretion in 
all species studied (reviewed by Fraser, 1981). Although 
these experiments demonstrated the obligatory role of 
hypothalamic GnRH in pituitary gonadotrophin synthesis 
and secretion, it remains to be proven whether GnRH also 
stimulates pulsatile gonadotrophin release. It has 
already been mentioned in the last chapter that measure- 
ment of GnRH in blood collected from the hypophysial 
portal circulation in monkeys showed that this neuro- 
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hormone is indeed released in a pulsatile manner with 
pulse intervals between one and three hours (Carmel et al, 
1976). A separate study using a different technique of 
portal blood sampling which does not require pituitary 
stalk section was able to demonstrate a temporal 
correlation between portal blood GnRH and peripheral 
blood LH during the proestrous LH surge in rats (Sarkar 
et al, 1976). 
Unlike the bull or the ram (Katongole et al, 1971; 
Sandford et al, 1974), a close temporal relationship 
between episodic LH and testosterone secretion in adult 
men is not immediately apparent (Alford et al, 1973; 
Murray & Corker, 1973; Naftolin et al, 1973; de Lacerda 
et al, 1973). This is somewhat surprising in view of the 
fact that LH is the major stimulus for testicular 
steroidogenesis. One possible explanation may be a 
rather sluggish Leydig cell response in humans to LH. 
This is suggested by the significant correlation between 
LH and corresponding testosterone concentrations one to 
four hours later (Rowe et al, 1975). This inertia in 
testicular response is further supported by the poor 
testosterone response to increased LH produced by GnRH 
(de Kretser et al, 1975a)and LH infusion (Marshall et al, 
1973). The exact reasons for the delayed or attenuated 
testicular response to LH in humans is not clear. 
The biological significance of these high frequency 
oscillations in hormones of the hypothalamic- pituitary- 
testicular axis has recently been elegantly demonstrated. 
In rhesus monkeys with destructive lesions in the arcuate 
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nucleus, pulsatile exogenous GnRH stimulation resulted in 
sustained increases in LH and FSH whereas continuous 
administration led rapidly to a fall off of pituitary 
gonadotrophin response (Belchetz et al, 1978). Similar 
studies in patients with hypogonadotrophic hypogonadism 
also confirmed the importance of intermittent or 
pulsatile GnRH administration in optimizing the treatment 
regime (McArthur & Crowley, 1980). Presumably, the inter- 
mittent stimulation of GnRH minimizes the degree of 
receptor down regulation (Catt & Dufau, 1976) and allows 
the self -priming and trophic effects of GnRH on the 
gonadotropes to develop. This argument also applies to 
the LH stimulation of Leydig cells (Catt et al, 1980) but 
as yet the importance of these negative regulatory 
effects in the physiological control of the testis is 
unknown. From the satisfactory virilization of hypo - 
gonadal patients by exogenous androgens, it seems unlikely 
that pulsatile stimulation of androgen target organs is 
essential to their normal function. It may be said that 
the further is the hormonal signal from the brain, the 
less important is the temporal or frequency modulation 
component of the stimulus. This is compatible with the 
view that the normal functioning of the HPT axis involves 
the transformation of an electrochemical signal from the 
brain to the steroid molecule decoding of genetically 
determined functions of various target organs. 
11.2 Circadian rhythm 
Early studies with sampling frequencies of four to 
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six hours suggested the presence of a circadian 
periodicity in plasma LH and FSH concentration (Faiman & 
Ryan, 1967; Faiman & Winter, 1971; Saxena et al, 1968). 
These reports however could not be confirmed by more 
frequent sampling (20 minute intervals) in adult males 
(Krieger et al, 1972; Boyar et al, 1972a;Alford et al, 
1973). In young men, the magnitude of LH pulses seems to 
be highest just before waking in a twelve hour overnight 
study (Nankin & Troen, 1972). This pattern is even more 
pronounced in pubertal boys in whom Boyar et al (1972b) 
showed that augmented LH secretion clearly occurred 
throughout the period of sleep. This highlights the 
importance of neuroendocrine factors in the control of 
gonadotrophin secretion and may have important theoretical 
and clinical implications. 
Although early reports disagreed due to inadequate 
sampling frequencies, there is now little doubt that a 
circadian rhythm in plasma testosterone concentration 
exists with peak levels at 03.00 - 10.00 h and trough at 
16.00 - 02.00 h (Nieschlag, 1974; Licoln et al, 1974). 
Compared to that of circhoral rhythm, the amplitude of 
the circadian rhythm is small - 20 -40 %. Furthermore, the 
timing of the testosterone peak and trough shows 
considerable variation within and between patients. 
The mechanism of the circadian variation in plasma 
testosterone does not depend on posture or activity - 
related changes in MCR (Lipsett et al, 1966; Southren, 
1967 & 1968) or adrenal steroidogenesis (Judd et al, 
1974). Since 95% of testosterone blood production is 
126 
secreted by the testes (see Chapter 4), the circadian 
rhythm of testosterone results from changes in the rate 
of testosterone secretion. The absence of similar 
rhythmic changes in gonadotrophins and the different 
patterns of prolactin secretion (see Chapter 13) tend to 
exclude any direct effects of these hormones in the daily 
cycle of testosterone secretion. The effect of catechol- 
amines on testicular blood flow may contribute to the 
circadian variation in testosterone secretion since a 
similar cycle in urinary excretion of catecholamines has 
been demonstrated (von Euler et al, 1955). Seventeen -a- 
hydroxyprogesterone levels fluctuated in parallel with 
testosterone whereas androstenedione and DHEA, being 
adrenal androgens, were more closely associated with the 
cortisol periodicity (Sjöberg et al, 1979). 
11.3 Ci annual rhythm 
Many animal species have seasonal rhythms in their 
reproductive process in order that rearing of offspring 
is timed to coincide with optimal environmental 
conditions in terms of climate, food supply and predation 
pressure. These environmental variables are unreliable 
as signals for animals to determine the season. Hence a 
wide variety of animals have evolved a system relying on 
the relatively stable annual cycle in daylength to 
synchronize their seasonal reproductive cycles. Bence 
changes in photoperiod can induce regression and develop- 
ment of the gonads via its effect on hypothalamic - 
pituitary activity. The mechanism underlying this 
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neuroendocrine phenomenon is unclear. It requires a 
photoreceoptor organ - retina in mammals, an endogenous 
circadian clock involved in the measurement of day - 
length and a mechanism of information transfer from the 
endogenous clock to the hypothalamic -pituitary unit. 
There is increasing evidence that the pineal gland and 
its indolamine or peptide secretory products may be 
intimately involved in the latter function and mediate 
the antigonadotrophic action at the appropriate seasons 
(Licoln & Short, 1980; Turek & Campbell, 1979; Reiter, 
1980). 
In humans, reproduction is a continuous process 
after puberty. Although there is a gradual decline in 
reproductive function with age, the marked seasonal 
changes seen in some animals are absent. However, the 
activation of gonadotrophic functions during the dark 
phase of the twenty -four hour cycle in human puberty has 
certain features akin to the seasonal activation of 
gonadal function in animals. There is some evidence that 
a circannual rhythm in testicular function may exist in 
humans. Smals et al (1976) studied fifteen adult men at 
three monthly intervals and found significantly higher 
results in July- October than January- April. The 
magnitude of this variation is small (16 -22 %). Reinberg 
et al (1975) found similar results in five men. Burger 
et al (1972) observed higher testosterone levels in the 
Australian spring rather than winter. Bearing in mind 
that these studies were based on single samples of testo- 
sterone estimated at various intervals (three times 
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weekly to three monthly) and that the amplitude of the 
variation is small, it is doubtful whether a true 




FEEDBACK CONTROL OF GONADOTROPHIN SECRETION 
The early studies of Moore & Price (1932) and Greep 
& Jones (1950) on the effect of gonadal hormones 
established the concept of feedback control in endocrine 
physiology which has since been applied to virtually all 
hormone producing systems. Thus removal of the adult 
gonads leads to increased gonadotrophin secretion while 
the administration of exogenous gonadal steroids in 
sufficient quantities will suppress gonadotrophin 
secretion in intact or gonadectomized animals (for review 
see Davidson, 1969; Brown- Grant, 1977). It was suggested 
that the negative feedback system operates physiologically 
to maintain a constant level of gonadotrophin and steroid 
hormone in the circulation. Although the principle of 
negative or inhibitory feedback is firmly accepted, there 
are many important details in the mechanism still to be 
clarified. The quantitative study of the dynamics of 
negative feedback of gonadotrophin secretion only became 
possible in the last decade with the availability of 
sensitive radioimmunoassays. The discovery of pulsatile 
gonadotrophin secretion added a new dimension to the 
analysis of feedback mechanisms while the interconversion 
of secreted gonadal steroids further complicated the 
picture. The response of LH and FSH under different 
physiological or pathological conditions may be discordant. 
The molecular mechanisms and sites of gonadal steroid 
feedback at the brain, hypothalamus and pituitary and the 
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existence of short -loop feedback by gonadotrophins and 
ultrashort -loop feedback by GnRH are areas that are just 
beginning to be explored. Thus what appears at first 
glance to be a simple on -off mechanism of steady -state 
secretion is in reality a highly complicated one with 
multiple integrated levels of.function and control. 
12.1 Feedback control of LH 
12.1.1 Negative feedback 
Castration in adult men leads to a prompt fall in 
plasma testosterone and although both LH and FSH increase 
within 24 to 72 hours, peak levels are reached only in 
the subsequent three to four weeks (Burger et al, 1972; 
Walsh et al, 1973). Changes in the pulsatile pattern of 
gonadotrophin secretion may be expected in castrated or 
agonadal men but, surprisingly, no report in the 
literature has examined this issue in any detail. In 
animals, although pulsatile gonadotrophin secretion has 
been well described in a number of species, there is only 
one study which compared the frequency and amplitude of 
pulsatile gonadotrophin secretion in castrated and intact 
rams - both parameters were increased (Licoln & Short, 
1980). In the human postmenopausal or agonadal female, 
the frequency of LH pulses was similar to that in the 
follicular phase of premenopausal women but the amplitude 
of each pulse was increased (Yen et al, 1972b;Santen & 
Bardin, 1973). 
Since it is the major secretory product of the 
testis, testosterone has come to be regarded as the 
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principal negative feedback signal in the control of 
pituitary LH secretion. However, it has recently been 
demonstrated that both oestradiol and dihydrotestosterone, 
the two steroids derived from metabolism of testosterone 
at target organs, have distinct and independent negative 
feedback effects on gonadotrophin secretion (Santen, 
1977; Santen & Ruby, 1979; Winters et al, 1979). The 
relative importance of the three steroids in the physio- 
logical feedback control of gonadotrophin secretion is 
at present unknown but these studies emphasized the point 
that androgens and oestrogens exert independent effects 
on gonadotrophin secretion probably via different 
mechanisms and perhaps at different sites. So far, it 
has been difficult to differentiate between a pituitary 
or hypothalamic site of action of steroid negative feed- 
back. The suppressive effect of testosterone on the 
pituitary response to exogenous GnRH stimulation in man 
and animals (Caminos- Torres et al, 1977; Debeljuk et al, 
1972) and the reduction in LH pulse frequency after 
testosterone infusion in man (Santen, 1977) suggest that 
both the pituitary and hypothalamus can mediate the 
negative gonadal steroid feedback independently. Steroid 
receptors are detectable in the pituitary, hypothalamus 
as well as the brain (McEwen, 1980). It is possible that 
steroids may modify gonadotrophin secretion via 
modification of electrical activities of CNS neurones, 
neurotransmitter concentrations and turnover or alteration 
in GnRH receptor populations in the pituitary. These 
novel aspects of steroid action in relation to gonado- 
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trophin and GnRH control are little understood at present. 
The multiple sites and possible mechanisms of action of 
steroid negative feedback amply illustrate the 
complexity of gonadotrophin regulation, which ultimately 
represents the end result of interactions between neuro- 
endocrine and gonadal influences on the hypothalamus and 
pituitary. 
12.1.2 Positive feedback 
The cyclical nature of gonadotrophin secretion in 
the female is characterized by a positive feedback 
mechanism in which oestradiol triggers the preovulatory 
LH release. This phenomenon is absent in intact male rat 
and ram (Caligaris et al, 1972; Karsh & Foster, 1975) but 
could be elicited by supraphysiological doses of 
exogenous oestrogen in monkeys and man (Stearns et al, 
1973; Karsh et al, 1973; Hodges, 1980; Barbarino et al, 
1979, 1980). In the subprimate species at least, sexual 
dimorphism is descernable in the steroid -gonadotrophin 
interaction and the function of the hypothalamic - 
pituitary unit. Studies in the female rat and ewes 
showed that prenatal or neonatal exposure to androgens 
(or oestrogens) abolished the positive feedback mechanism 
in adult life and these females secrete gonadotrophins 
acyclically (Gorski, 1971; Short, 1974). This 
organizational effect of gonadal steroids on the brain 
and hypothalamus is akin to that described for the 
differentiation of sexual behaviour. In female 
rhesus monkeys and humans, pre or postnatal exposure to 
androgens failed to abolish positive feedback in adult 
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life (Treloar et al, 1972; Goy & Resko, 1972; Erhardt et 
al, 1977). These studies illustrate that gonadal 
steroids can exhibit both inhibitory and stimulatory 
effects on the hypothalamic -pituitary unit and may also 
direct the subsequent pattern of gonadotrophin secretion 
by virtue of its action on the developing brain. 
12.2 Inhibin 
FSH secretion can vary independently of LH even 
though a single releasing hormone stimulates the 
production of both gonadotrophins simultaneously. This 
indicates that either testicular steroids influence LH 
and FSH secretion in different ways or that some other 
non- steroidal testicular factor can inhibit FSH secretion 
exclusively or predominantly. Evidence for the existence 
of such a testicular factor, inhibin as it has come to be 
known, has been extensively reviewed (Baker et al, 1976; 
Setchell et al, 1977; Davies et al, 1978; Main et al, 
1979; Franchimont et al, 1979). By definition therefore, 
inhibin is a non -steroidal and non -androgenic substance 
produced in the seminiferous tubules which specifically 
or preferentially regulates FSH secretion. 
In rodents, damage to the seminiferous epithelium 
induced by bilateral efferent duct ligation, irradiation, 
heat, cryptorchidism and anti -spermatogenic chemicals 
produced an elevation of FSH which is accompanied by 
hypersecretion of LH. This implied either that in the 
rat, seminiferous tubules play a part in the control of 
LH as well as FSH or that the Leydig cells are damaged at 
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the same time as the seminiferous epithelium or that 
Leydig cell functions are secondarily affected by local 
factors from the damaged tubules. Thus in rats, in which 
FSH and LH secretion are seldom dissociated, the 
significance of inhibin in relation to testicular 
steroids in the feedback control of FSH is not established. 
Rodents therefore are not satisfactory experimental 
models for study of the role of inhibin in humans. In the 
other subprimate species (sheep) in which the control of 
testicular functions has been intensively studied, hemi- 
castration, efferent duct ligation and local heating of 
the testes have produced small but selective increases in 
FSH (Walton et al, 1978; de Jong et al, 1980). Inter- 
pretation of these experiments however is complicated by 
the seasonal pattern of reproduction in this species. 
The evidence for the existence of inhibin in the 
human male is probably stronger than in any other species. 
In infertile patients with disordered seminiferous 
tubular function, plasma FSH concentrations are elevated 
while LH and testosterone are usually normal or only 
slightly outwith the normal range. An inverse 
correlation between FSH and sperm count or germ cell 
population of the seminiferous epithelium in subfertile 
men has been demonstrated (see Section C ). In men who 
underwent unilateral orchidectomy or chemotherapy for 
malignancies, monotrophic rise in FSH is observed 
(Bramble et al, 1975; Van Thiel et al, 1972). FSH - 
inhibiting activity was low or undetectable in the 
seminal plasma of men with severe seminiferous tubule 
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disease as indicated by azoospermia and elevated FSH 
(Franchimont, 1972; Scott & Burger, 1980). Using a 
radioimmunoassay, Vaze et al (1980) also demonstrated a 
lower concentration of "inhibin" in seminal plasma of 
oligospermic compared to normospermic men. So far no 
study has demonstrated a reciprocal relationship between 
circulating "inhibin" and FSH levels. 
It is well recognized that under certain experimental 
conditions, exogenously administered testosterone can 
suppress FSH as well as LH secretion (for review see 
Baker et al, 1976). In most instances, pharmacological 
doses have been employed so that the physiological role 
of steroidal feedback control of FSH could not be 
assessed. Physiological concentrations of testosterone 
in the circulation produced by subcutaneous silastic 
implants do maintain normal levels of LH and FSH in the 
castrated rat and monkey (Moger, 1976; Davidson et al, 
1976; Plant et al, 1978). However it has been demons- 
trated that the stable plasma concentrations achieved by 
testosterone implants may be more effective in suppressing 
LH and FSH secretion than the fluctuating levels seen in 
the intact animal (Dasmassa et al, 1976; Smith et al, 
1977). The active and passive immunization of male 
animals against testosterone (Nieschlag et al, 1975; Gay 
& Kerlan, 1978) and the analogous inherited condition of 
testicular feminization (Naess et al, 1976) are associated 
with raised FSH as well as LH levels. These observations 
suggest that testosterone may well play a significant if 
not exclusive role in the physiological control of FSH as 
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well as LH secretion. 
A preferential suppression of FSH secretion has been 
ascribed to oestrogens - especially oestradiol 
(Franchimont et al, 1975). In the castrated male monkey, 
physiological concentrations of testosterone and 
oestradiol produced by simultaneous silastic implants can 
maintain normal levels of LH and FSH after bilateral 
orchidectomy for up to twenty days (Resko et al, 1977). 
A synergistic role between testosterone and oestradiol in 
the feedback regulation of FSH was postulated. Other 
testicular steroids such as 5a- dihydrotestosterone, 
17a- hydroxyprogesterone, 3a- and 38- androstanediols did 
not show any selective suppression of FSH secretion 
(Swerdloff et al, 1973; Zanisi et al, 1973; Stewart - 
Bentley et al, 1974). 
In man as well as experimental animals, selective 
lesions of the seminiferous tubules result in elevated 
plasma FSH concentrations which are considerably lower 
than that after surgical castration (Main et al, 1978). 
It is therefore possible that both testicular steroids 
and inhibin may contribute to the overall testicular 
feedback control of FSH secretion. This concept is 
supported by the elegant studies of Morris & Jackson 
(1978). Destruction of the germinal epithelium was 
induced by a chlorohydrin which produces obstructive 
cysts in the efferent duct and caput epididymis. This 
resulted in a selective rise of circulating FSH 
concentrations whose magnitude was only 30% of that seen 
after castration. In these same rats, destruction of 
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Leydig cells by ethane dimethane sulphonate caused 
further increases in FSH (and LH) indistinguishable from 
values seen after castration. The pattern of gonado- 
trophin response following the selective and consecutive 
removal of inhibin and androgen feedback suggests that 
inhibin probably plays a synergistic and minor role in 
the control of FSH secretion in the rat. 
12.2.1 Sources of inhibin 
Several biological fluids and testicular preparations 
have recently been shown to have inhibin -like activity 
based on the property of selective or preferential FSH 
suppression. The only human (male) source of inhibin so 
far detected is in seminal plasma (Franchimont et al, 
1979; Vaze et al, 1979; Scott & Burger, 1980). In the 
latter two studies, there is evidence that the prostate, 
not the testes, contains the highest concentration of 
inhibin -like bio- or immunoactivity. In animals, inhibin 
activity has been detected in bull seminal plasma 
(Franchimont, 1975), ram rete testis fluid (Setchell & 
Sirinathsinghji, 1972), bovine spermatozoa extract 
(Lugaro et al, 1974) and ram testicular aqueous extract 
(Keogh et al, 1976). The cellular source of inhibin in 
the testes and testicular fluids is most probably the 
Sertoli cells (Steinberger & Steinberger, 1976; A. 
Steinberger, 1979; de Jong et al, 1978 & 1979). 
Although historically inhibin is a testicular 
hormone elaborated in the seminiferous tubules, recent 
evidence suggests that a similar FSH- inhibitor can be 
detected in ovarian follicular fluids from several species 
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including man (reviewed by Setchell, 1980). 
12.2.2 Physico- chemical properties of inhibin 
Most investigators are now convinced that the active 
material in preparations containing inhibin -like activity 
is a peptide or glycoprotein molecule. Steroid 
concentrations in these preparations are negligible and 
charcoal adsorption does not alter their activity. 
However, there is considerable disagreement as to the 
molecular weight ranging from 5,000 to 160,000. No doubt 
this is related to the impure preparations used in most 
studies. On the other hand, inhibin may have a hetero- 
geneous composition consisting of polymers or it may be 
associated with a carrier or a precursor molecule 
yielding smaller active fragments. 
12.2.3 Detection and measurement of inhibin 
The controversy surrounding inhibin is partly the 
result of the lack of sensitive methods of detection 
suitable for the measurement of this molecule in physio- 
logical fluids. To date, most available methods of 
inhibin measurement are bioassays based on the inhibition 
of pituitary FSH secretion. In vivo methods utilize 
intact or castrated animals or the inhibition of hCG 
augmented uterine weight gain in developing females. 
More sensitive and reliable are the in vitro techniques 
using either hemipituitary glands or pituitary cells in 
culture in which the basal or GnRH stimulated gonado- 
trophin levels are measured after several days incubation 
with the test material. However even the best of these 
in vitro bioassays lack the required sensitivity, 
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precision and reproducibility to study the physiological 
or pathological secretion of inhibin. Radioimmunoassays 
and radioligand assays of inhibin are at the preliminary 
stages only due to the lack of purified and homogeneous 
material for preparation of antibody and tracer. This 
will no doubt be more easily available in the near future 
and the wider study of the physiology of inhibin should 
be forthcoming. This topic was recently reviewed by 
Hudson (1979) . 
12.2.4 Mode of action of inhibin 
There is little doubt that inhibin can exert 
negative effects on the basal synthesis and release of 
FSH and response to GnRH in pituitary gonadotropes. This 
has been demonstrated in both in vitro (Baker et al, 1976; 
Franchimont et al, 1978) and in vivo experiments (Blanc 
et al, 1978; Franchimont et al, 1977; Rush & Lipner, 
1979). Surprisingly, in most in vivo studies, a prompt 
reduction in mean LH concentration and LH pulsatile 
secretion was observed during the infusion of inhibin. 
The explanation of this interesting observation is not 
clear. A latent period of 4 -12 hours was observed before 
FSH suppression and this persists for up to 24 hours 
after the cessation of the infusion. This time course of 
FSH suppression favours the inhibition of pituitary FSH 
synthesis as the major mechanism of inhibin action. 
The hypothalamic action of inhibin was suggested by 
the reduction of circulating FSH after injection of a 
bull spermatozoa extract into the third ventricle of male 
rats (Lugaro et al, 1974). In isolated rat hypothalami, 
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the GnRH content could be reduced after short term 
incubation with various inhibin- containing preparations 
(Demoulin et al, 1979). These preparations may also have 
direct effects on germ cells as indicated by the decreased 
incorporation of tritiated thymidine in type B spermato- 
gonia from the developing rat (Franchimont et al, 1979). 
For inhibin to exert its extratesticular effects, it 
has to be transported to the systemic circulation. Two 
possible routes for the exit of testicular inhibin have 
been proposed. The first is the caput epididymis where 
the rete testis fluid is actively reabsorbed (Setchell et 
al, 1977). The second, and probably more important, is 
from the basal surfaces of Sertoli cells where inhibin 
molecules can bypass the blood -testis barrier and find 
their way into the interstitial space (Setchell et al, 
1977). 
12.2.5 Physiological role of inhibin 
Although evidence supporting the existence of 
inhibin in some species has grown rapidly in recent years, 
it remains difficult to define specific phsyiological 
role(s)for this elusive molecule. Experimental 
manipulations often do not and cannot completely isolate 
seminiferous tubular function from that of Leydig cells. 
This has resulted in a great deal of confusion in the 
interpretation of experimental data investigating the 
relative importance of steroidal and non -steroidal feed- 
back control of FSH. Perhaps the most significant 
message from these studies is that normal function of 
the testis involves the intimate interaction between 
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Leydig, Sertoli and germ cells and disruption of the 
integrity of one will inevitably result in dysfunction of 
the other two testicular elements. It is therefore not 
surprising to find that the best studies in the 
literature usually suggest a synergistic relationship 
between inhibin, testosterone and oestradiol. However, 
unlike testosterone and oestradiol, the existence of 
inhibin in the circulation has so far not been confirmed. 
Thus the detection of inhibin in the systemic circulation 
and the demonstration of a reciprocal relationship with 
FSH remain the most important objectives in ascertaining 





Although the existence of prolactin in mammals as a 
lactogenic hormone has long been recognized, the 
isolation of human prolactin as an individual entity 
distinct from growth hormone and human placental lactogen 
was achieved only in 1971 (Lewis et al, 1971). This was 
soon followed by the development of specific radioimmuno- 
assays (Hwang et al, 1971) enabling the rapid expansion 
of information concerning prolactin physiology and patho- 
physiology. Prolactin is a peptide hormone with 198 
amino acid in a linear sequence (Shome & Parlow, 1977) 
synthesized by a specific pituitary cell type, the lacto- 
tropes, localized mainly to the postero -lateral wings of 
the pars distalis. The structure of human prolactin is 
similar to ovine, porcine and rat prolactin but distinct 
from that of growth hormone. The molecular weight of 
prolactin is 21,000 (Guyda, 1975). Several molecular 
forms can be recognized in pituitary and serum prolactin 
(Guyda, 1975; Suh & Frantz, 1974). The major fraction in 
the circulation is the monomeric form constituting 75 -80% 
of total prolactin. A larger molecule MW 40,000 'big' 
prolactin, is also present in the circulation to the 
extent of 10 -15 %. Occasionally, a very high molecular 
weight form, 'big big' prolactin, can be found in the 
circulation in pregnancy and in some cases of prolactin- 
secreting pituitary adenomas. 
Early studies on prolactin were performed on pigeon 
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crop sac bioassay and the induction of lactational 
response in pseudopregnant rabbits. Apart from the low 
sensitivity, these bioassays do not distinguish between 
the lactogenic effects of primate growth hormone and 
human placental lactogen from that of prolactin. This 
lack of specificity presented great obstacles to the 
purification and separation of these hormones in early 
studies. The immunological specificity of these hormones 
finally permitted their separation and the development of 
radioimmunoassay followed shortly. 
13.1 Control of prolactin secretion 
Prolactin, unlike gonadotrophins, is controlled by 
both inhibitory and stimulatory influences from the hypo- 
thalamus. In mammalian species, prolactin synthesis and 
release is predominantly under tonic hypothalamic 
inhibition (Everett, 1954). Using a sensitive paired 
pituitary incubation technique, Sharr & Clemens (1974) 
showed that physiological amounts of dopamine inhibited 
the release of prolactin from pituitaries in vitro. 
Intraventricular infusion of dopamine can suppress 
prolactin secretion in the intact rat (Kamberi et al, 
1971). A porcine hypothalamic preparation prepared by 
Takahara et al (1974) inhibited prolactin secretion when 
infused into the hypophyseal portal system in rats in a 
way closely correlated with the dopamine content. The 
demonstration of dopamine receptors in the anterior 
pituitary provides further evidence to support the 
physiological role of this catecholamine (Brown et al, 
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1976). Although the dopamine concentrations in the portal 
vessels exceed that in the systemic circulation, plasma 
prolactin levels are not always appropriately correlated 
with dopamine in portal blood (Ben- Jonathan et al, 1977; 
Gibbs & Neill, 1978). Two explanations have been 
suggested to account for this apparent discrepancy. 
Dopamine may not be the only prolactin inhibiting factor 
(PIF) in the hypothalamus and other compounds like GABA 
may also have PIF activity (Schally et al, 1977). 
Alternatively, a prolactin releasing factor (PRF) may 
antagonize the influence of PIF so that plasma prolactin 
concentration is determined by the balance between the 
two opposing factors. More remains to be learned about 
the physiological mechanisms controlling prolactin 
secretion. 
The evidence for the existence of a prolactin 
releasing factor is limited. Although many spontaneously 
occurring peptides (8 endorphin, neurotensin, substance P, 
bombesin) can stimulate prolactin release, they act on 
the brain to modify PIF release rather than stimulate the 
pituitary directly (Meites et al, 1979 for review). 
Thyrotrophin releasing hormone (TRH) is a potent 
stimulator of prolactin release (Tashjian et al, 1971). 
However a physiological role for TRH in the control of 
prolactin is unlikely since the secretion of these two 
hormones can be clearly dissociated under various 
physiological conditions, e.g. pregnancy and lactation. 
Recent studies suggest that vasoactive intestinal poly - 
peptide (VIP) may fulfil the role of physiological PRF 
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(Said et al, 1978; Samson et al, 1978). This will 
require further confirmation. 
A short -loop feedback of prolactin secretion may 
exist. This is thought to be mediated via the hypo- 
thalamus and involves alterations in the metabolism and 
turnover of dopamine (Fuxe et al, 1977) in the tubero- 
infundibular neurones. This may furnish a basis whereby 
elevated prolactin levels could alter the control of 
gonadotrophin and GnRH by influencing the common mono - 
amine metabolism in the brain (Neil, 1974). Oestrogens 
stimulate prolactin secretion via actions on the hypo- 
thalamus and pituitary (Labrie et al, 1978). Prolonged 
oestrogen stimulation in rats gives rise to proliferation 
of pituitary lactotropes raising the possibility of 
induction of prolactinoma in women exposed to the 
contraceptive pill (Lloyd et al, 1975). 
As is the case for other pituitary hormones, 
prolactin is secreted episodically with intervals of 
20 -30 minutes. This is in keeping with the short 
circulating half -life of this hormone. A distinct 
diurnal variation in prolactin secretion exists (Nokin et 
al, 1972; Sassin et al, 1973; Parker et al, 1973), and 
maximal concentrations occur some six to eight hours 
after sleep onset. A variety of stimuli can lead to 
increased prolactin secretion. In the female, pregnancy 
and lactation are well recognized to be associated with 
increased prolactin in the circulation. Other stimuli 
include physical and psychological stress, sexual inter- 
course, nipple manipulation and changes in plasma 
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osmolality. Seasonal changes in light and temperature 
can also affect prolactin secretion in some species, e.g. 
hamster and sheep. 
13.2 Mode of action and biological effects of prolactin 
Although over one hundred physiological actions have 
been ascribed to prolactin (Nicholl et al, 1977), only 
its role in lactation and reproduction in humans has been 
established. It is beyond the scope of this chapter to 
discuss the role of prolactin in lactation and ovarian 
steroidogenesis. In the male, interests in the effect of 
prolactin on reproductive function are comparatively 
recent and poorly documented. The first relevant study 
was the demonstration of a synergistic effect between LH 
and prolactin in restoring and maintaining accessory 
gland weight and spermatogenesis in hypophysectomized 
rats (Woods & Simpson, 1961). Using the same experimental 
model, subsequent studies showed that prolactin alone was 
ineffective and did not potentiate the effect of testo- 
sterone on spermatogenesis (Bartke, 1971a;Hafiez et al, 
1972). The effect of LH on Leydig cell steroidogenesis 
in hypophysectomized rats was increased by prolactin. 
The action of prolactin on Leydig cells was supported by 
the demonstration of specific receptor binding for this 
hormone in the interstitium of the rat testis (Aragona et 
al, 1977; Charreau et al, 1977). Although prolactin is 
detectable in human seminal plasma (Sheth et al, 1975) 
its role in spermatogenesis or maturation of sperms has 
not been convincingly demonstrated. 
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Several possible mechanisms for the testicular action 
of prolactin have been postulated. Prolactin may increase 
the concentration of testicular LH receptors (Zipf et al, 
1978; Purvis et al, 1979) or increase substrate availa- 
bility for steroidogenesis (Bartke, 1969, 1971b) or enhance 
the activity of testicular 17R- hydroxysteroid dehydrogenase 
(Musto et al, 1972) and 38- hydroxysteroid dehydrogenase 
(Hafiez et al, 1971). The relative importance and inter- 
relationships between these postulated mechanisms of 
action remain to be established. In considering the 
biological effects and mechanism of action of prolactin, 
the most striking feature is the interaction with other 
hormones to achieve the observed target response. 
Especially in the male, prolactin action seems to be a 
permissive rather than a critical one based on modific- 
ation of the interaction of more specific trophic hormones 
and their receptors in target organs. 
Reproductive functions in male patients with hyper - 
prolactinaemia have not been studied extensively. 
Erectile impotence and diminished sex drive seem to be 
the most prominent clinical symptoms which are out of 
keeping with the minimally depressed circulating androgen 
concentrations (Thorner et al, 1977; Segal et al, 1976; 
Carter et al, 1978; Franks et al, 1978; Peillon et al, 
1979). Neither the evidence for Leydig cell dysfunction 
nor that impotence is directly related to hyperprolactin- 
aemia rather than testosterone deficiency can be regarded 
as conclusive. There is a great need for basic controlled 
endocrine, pathophysiological and fertility studies in 
male patients with hyperprolactinaemia. 
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SECTION B 




1.1 Definition of puberty 
Puberty is generally referred to as the phase of 
development during which reproductive capacity is 
attained. In all mammals, the reproductive system is the 
last organ system to mature. Puberty thus represents the 
climax of an individual's overall growth and development, 
a biological watershed linking immaturity to maturity, 
which henceforth gives way to the process of ageing. 
With the better understanding of the hormonal and 
genetical mechanisms of prenatal sexual differentiation 
and development (Jost, 1972; Ohno, 1976; Wilson, 1980) 
puberty has come to be regarded as the final stages of a 
continuous series of genetically -programmed and hormone - 
mediated events spanning from conception to adulthood 
(Grumbach, 1980) which culminates in the optimal 'function 
of the hypothalamic -pituitary- testicular axis. 
1.2 Physical changes of puberty 
In animals, puberty can be temporally defined by 
the time of completion of spermatogenesis or when first 
ovulation occurs. In humans, however, these parameters 
cannot be precisely delineated on clinical examination 
or even by laboratory investigation. Puberty in man has 
therefore traditionally been equated with a series of 
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developmental changes in the secondary sexual character- 
istics. Indeed, the term puberty is derived from the 
word pubes (Greek - hair) denoting the stage when certain 
areas of the body become covered with hair which 
characterizes sexual maturity. The physical changes of 
puberty involve both sexual and non sexual organs and can 
be grouped into: (1) a general increase in the growth 
rate of the skeleton, muscle and viscera known as the 
adolescent growth spurt; (2) sex -specific changes in 
circulatory, respiratory, musculo- skeletal systems and 
the quantity and distribution of body fat, leading to an 
enhancement of sexual dimorphism in physical strength, 
endurance and body proportions; (3) the development of 
the gonads, reproductive tracts and secondary sexual 
characteristics (Tanner, 1974; Marshall & Tanner, 1974; 
Forest, 1981). It is obvious that puberty is not a 
single isolated event but a conglomerate of physical, 
psychological and social changes centred around the 
maturation of hypothalamic, pituitary and gonadal 
functions. These gradual changes develop concurrently 
over a period of years but are variably related to each 
other in sequence and tempo and also to chronological and 
skeletal age (Marshall & Tanner, 1974). Thus, although 
all the physical changes in puberty can ultimately be 
attributed to gonadal hormone actions (Short, 1980), each 
of them merit individual consideration independently 
(Tanner, 1974). A detailed account of the adolescent 
physical growth and metabolic changes is beyond the scope 
of this chapter, which deals primarily with the hormonal 
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aspects of puberty. It is sufficient here to mention 
that the adolescent growth spurt is a well- defined period 
during which height increase reaches a maximum (about 10 
cm /yr). This occurs at a mean age of 14.06 ± 0.14 in boys 
(Tanner, 1974) but some two years earlier in girls. The 
growth spurt often provides a better biological reference 
point during puberty than either chronological or bone 
age against which other parameters can be aligned. 
The pubertal changes in the reproductive system have 
been systematically studied (Schonfeld & Beebe, 1942; 
Schonfeld, 1943; Reynolds & Wines, 1951; Tanner, 1962; 
Zachmann et al, 1974). The most widely accepted scheme 
for the rating of physical changes in the reproductive 
system is that proposed by Tanner (1962). According to 
this classification, male puberty is divided into five 
clinical stages by the progressive changes in external 
genitalia and pubic hair. 
1.2.1 Genital (G) stages, 
G1 - Size and general appearance of the testes, scrotum 
and penis are about the same as in early childhood - 
. 
prepubertal. 
G2 - The scrotum and testes have enlarged and there is 
some reddening and change in texture of scrotal skin. 
G3 - The penis has increased in length and to a lesser 
extent in breadth. There is a further growth of the 
testes and scrotum. 
G4 - The length and breadth of the penis have increased 
further and the glans has developed. Testes and 
scrotum have further enlarged with darkening of the 
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scrotal skin. 
G5 - Genitalia are adult in shape and size. 
1.2.2 Pubic Hair (PH) stages 
PH1 - No true pubic hair. Only vellus hair present. 
PH2 - There is a sparse growth of long straight or only 
slightly curled and lightly pigmented hair chiefly 
at the base of the penis. 
PH3 - The hair spreads sparsely over the junction of the 
pubes and is considerably darker, coarser and more 
curled. 
PH4 - The hair is now adult in type but covers a 
considerably smaller area than adults. There is 
no spread to the medial surface of the thighs. 
PH5 - Hair is distributed as an inverse triangle as in 
the adult female. It has spread to the medial 
surface of the thighs but not up the linea alba 
or elsewhere above the base of the triangle. 
Most men's pubic hair develops more extensively than 
stage PH5 but this occurs gradually over the decade after 
completion of puberty, and the extent of this further 
development is subject to individual and racial 
variations. 
1.2.3 Testis size 
Testicular growth during puberty can be monitored 
conveniently by the increasing testicular volume or 
diameter, providing a useful clinical index of 
seminiferous tubular size and function. The assessment 


























































































































































































































































































































































































































































or tactile comparison of volume with a series of standard 
elipsoids first used by Schonfeld & Beebe (1942) and 
modified and popularized by Prader (1966). Others have 
chosen to use calipers to measure testicular length and 
width in order to calculate the volume (August et al, 
1972; Waaler et al, 1974). The results of pubertal 
testicular size increase have been validated (Schonfeld 
& Beebe, 1942) and values from different studies are 
comparable (Table 1.1). Considerable overlap in mean and 
individual testicular volumes was observed in all stages 
of puberty in these cross -sectional studies. A consistent 
finding was that the prepubertal testicular volume was 
usually 1 -2 ml while volumes of 3 -4 ml or more were 
generally compatible with early or impending sexual 
maturation. In their classic paper, Schonfeld & Beebe 
(.1942) were particularly struck by the sharp distinction 
between prepubertal and pubertal testicular volumes. 
They .consequently recommended the measurement of 
testicular volume as a valuable clinical criterion for 
determining the onset of puberty. However, once puberty 
has started, isolated estimation of testicular volume on 
its own may not be particularly meaningful due to the 
wide range of sizes at each stage of puberty. Serial 
measurements of testicular volume combined with genital 
and pubic hair ratings in individual pubertal subjects 
are useful in assessing the progress of sexual development. 
1.2.4 Onset of spermatogenesis 
An important aspect of male puberty which is 
difficult to assess in humans is the time at which sperm 
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production first occurs. This after all is one of the 
hallmarks of sexual maturity (see definition of puberty). 
Earlier histological studies of the testes were difficult 
to interpret due to the lack of clinical and hormonal 
data (Sniffen, 1950; Charny et al, 1952; Albert et al, 
1953; Mancini et al, 1960; Vilar, 1970). Not 
surprisingly, these reports on the sequence of maturation 
of various cell types in the seminiferous tubules were 
conflicting. Recently, the presence of sperms in the 
urine (spermaturia) has been used as an indicator of 
mature spermatogenesis in puberty (Richardson & Short, 
1978). It was demonstrated that the mean age at which 
spermaturia was first detected was 13.3 ± 0.12 years. 
Although no genital examination was carried out, it could 
be concluded that spermatogenesis is established before 
most of the androgen- dependent secondary sexual 
characteristics. Even though spermaturia cannot be 
equated with fertility, this still contrasts sharply with 
female puberty where menarche occurs in the later stages 
and ovulatory cycles do not regularly occur until much 
later (Tanner, 1962; Billewicz et al, 1980). 
1.2.5 Other maturational markers of puberty 
Hair on the face, axilla, trunk and extremities and 
temporal recession appear about the same time in late 
puberty - around G4, PH4 or two years after the onset of 
pubic hair growth (Tanner, 1974; Forest, 1981). However, 
these features are so variable in extent that they are of 
little value as indices of puberty. Growth of facial and 
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body hair is seldom complete until well after the 
completion of puberty. 
Enlargement of the thyroid and cricoid cartileges 
and the lengthening of the vocal cords from growth of the 
larynx are responsible for breaking or deepening of the 
voice (Daw, 1970). This usually begins at the time of 
peak height velocity in mid -puberty or around age 13.5 
years (Karlberg et al, 1976) and is completed at the end 
of puberty. Again this has limited clinical value. 
Peak height velocity in boys occurs between stages 
G4 -G5. This is markedly different from girls whose peak 
height velocity occurs much earlier - between breast 
stages 2 -3 or nearly two years earlier than boys 
(Marshall & Tanner, 1969). 
The occurrence of first ejaculation was closely 
correlated to the appearance of pubic hair according to. 
Kinsey et al (1948). Spontaneous nocturnal emission in 
this study occurred a year later. 
1.2.6 Variation in pattern of puberty 
There are wide variations in age at which boys 
reach the individual stages of genital and pubic hair 
development (Marshall & Tanner, 1970). It follows that 
stages of sexual development are poorly correlated with 
chronological age. Although often assumed not to be the 
case, the work of Marshall (1974) has shown that skeletal 
age is equally variable when correlated with pubertal 
stages. The average age in British boys at the onset of 
puberty (G2) is 11.64 ± 1.07 years with a range of 9.5- 
13.5 at 95% confidence limit. 
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Pubic hair and genital development are not very 
closely correlated with each other (Marshall & Tanner, 
1970). This is why puberty ratings should be designated 
by G and PH stages separately. It is however true that 
genital development is usually in advance of pubic hair 
in the present scheme. 
The duration of the various stages and hence the 
total period of pubertal development also display 
considerable variability (Marshall & Tanner, 1970). 
Some boys may remain in stage G2 for up to 22 years while 
others may complete the entire genital development in 
under this time. The mean duration between G2 and G5 in 
boys is 3.05 years (1.86 -4.72, 95% confidence limit). 
1.3 Hormonal changes of buberty 
A large body of physiological studies has 
established that the interaction between the gonads and 
the hypothalamic -pituitary unit is operative from early 
childhood (Critchlow & Bar -Sela, 1966; Donovan, 1963). 
Bioassays for gonadotrophins provided further supportive 
evidence with the demonstration of both LH and FSH 
activities in the urine of normal prepubertal children 
(Brown, 1958). However, the insensitivity of bioassays 
and the inaccuracy of urine collections militated against 
the precise quantitation of gonadotrophin and steroid 
secretion. The availability of sensitive radio -ligand 
assays in small quantities of biological fluids has 
enabled investigators to study the interrelationships 
between the gonads and pituitary in childhood and puberty. 
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The principal questions the early studies attempted to 
answer were: (1) at what stage of development do gonado- 
trophins begin to rise towards adult levels; (2) what is 
the subsequent time course once the increase has begun; 
(3) what is the temporal relationship between changes in 
concentrations of gonadal steroids, gonadotrophins and 
the development of physical changes in puberty; (4) does 
the above information help to formulate the physiological 
mechanisms underlying the initiation and progression of 
puberty. 
To a large extent, the .first two questions have been 
satisfactorily answered despite some discrepancies 
between different studies. The latter two more complex 
questions have still to be comprehensively tackled. 
Designs in the earlier studies were subject to various 
criticisms. Hormonal values during puberty are less 
meaningful when correlated only to chronological age 
which is widely variable at each stage of development. 
Although the stages of pubertal development are more 
informative, the same variability in timing of onset and 
duration seriously undermined the 
value of these cross - sectional studies of puberty which 
tended to obscure the changes across time during sexual 
maturation. As pointed out by Tanner (1962), it is this 
rate of change in growth and hormone function in a given 
time illustrated by longitudinal studies which are of 
most value in unravelling the complex interrelationships 
and mechanisms of puberty. Other confounding factors in 
the study of hormonal changes in puberty are the episodic 
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nature of hormone secretion which becomes detectable for 
the first time during normal puberty and the diurnal 
patterns of hormone secretion in relation to sleep in 
early and mid -puberty. In the ensuing summary of 
hormonal patterns at different stages of puberty based 
mainly on single sample day -time cross -sectional studies, 
it is useful to bear these reservations in mind. 
1.3.1 Peripubertal basal hormone patterns 
The information summarized from the large number of 
studies (Blizzard et al, 1972; August et al, 1972; Burr 
et al, 1970; Winter & Faiman, 1972; Knorr et al, 1974; 
Gupta, 1975; Sizonenko et al, 1975) is expectedly hetero- 
geneous but a few general trends can be demonstrated. 
Luteinizing hormone, FSH, testosterone, dihydrotesto- 
sterone, oestrone and adrenal andorgens all progressively 
increased from very low levels characteristic of early 
childhood to adult levels during puberty. However the 
time of onset, rate of increase and the extent of the 
increments varied considerably in different studies. 
Nevertheless, most studies would agree that LH and 
testosterone usually increased in parallel with LH 
changes usually preceding testosterone. Plasma testo- 
sterone rise occurred after the first signs of testicular 
enlargement. FSH increased early in puberty in most 
studies and a good correlation has been obtained with 
increase in testicular size. The greatest increase in 
testosterone occurred in stages PH2 -3 while the levels 
continued to rise even after stage 5. LH increments were 
greatest during early puberty and then plateaued out after 
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mid -puberty, even though testosterone continued to 
increase. FSH increments were smaller in magnitude than 
LH and reached adult levels earlier. Although 
statistically significant increases in mean LH and FSH 
levels were seen in all studies with advancing age or 
maturation, there was substantial overlap amongst 
individuals in different pubertal stages. 
Dihydrotestosterone and 3a- androstanediol increased 
in parallel with testosterone except during the earliest 
stages of puberty when there was a relative, but 
transient, abundance of the 5a- reduced androgens compared 
with the prepubertal and adult periods. 
A modest increase in oestradiol and oestrone can be 
observed in boys during puberty (Bidlingmaier et al, 1973; 
Angsusingha et al, 1974; Gupta et al, 1975; Lee & Migeon, 
1975; Ducharme et al, 1976; Thorner et al, 1977; Large & 
Anderson, 1979). 
Plasma concentrations of adrenal androgens, 
dehydroepiandrosterone (DHEA) and its sulphate (DHAS) and 
androstenedione (A) started to rise from at least two 
years before the onset of gonadal development (Lee & 
Migeon, 1975; Hopper & Yen, 1975; Sizonenko & Paunier, 
1975; Ducharme et al, 1976; Korth -Schutz et al, 1976a & b; 
Sizonenko et al, 1976; de Peretti et al, 1976 & 1978; 
Parker et al, 1978) and continued to do so until adult 
levels were reached by about stage 3 -4 of gonadal puberty. 
The onset of increasing adrenal androgen secretion around 
the age of seven years was associated with the increase 
in relative size of the zona reticularis in the adrenal 
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(Dhom, 1973) and has been called the adrenarche to 
distinguish it from gonadarche which followed later. 
Although adrenarche and gonadarche are normally 
temporally linked, they can be dissociated from each 
other under pathological conditions without affecting the 
timing or function of the other (Sklar et al, 1980). 
Thus normal gonadarche can occur in the absence of 
adrenarche - for example in Addison's disease - and 
normal adrenarche can occur without gonadarche - for 
example hypogonadism. It seems unlikely therefore that 
adrenal androgens exert a major influence on the timing 
of gonadal pubertal onset (Cutler & Loriaux, 1980). 
The foetal and postnatal adrenal can produce high 
levels of adrenal androgens comparable to the adult 
(Forest et al, 1978). The rapid fall in peripheral 
plasma concentration of these hormones is paralleled by 
the involution of the foetal zone of the adrenal glands 
(Beck, 1971). The low levels of adrenal androgens are 
maintained in early childhood until the abrupt resurgence 
of secretory activity in the zona reticularis at around 
seven years. This ontogenic pattern of adrenal androgen 
production bears a remarkable resemblance to that of 
gonadal function (Forest et al, 1978) suggesting that CNS 
factors may regulate the ( ?pituitary) trophic control 
of the adrenal in a similar way to the neuroendocrine 
control of gonadal puberty. The indirect clinical 
evidence supporting the existence of a pituitary factor 
acting in synergy with ACTH to control adrenal androgen 
production was recently reviewed (Grumbach et al, 1978). 
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Despite the many similarities between gonadarche and 
adrenarche, our present understanding of the mechanism 
and control of the latter lags considerably behind that 
of gonadal puberty. 
Although plasma oestradiol and oestrone concent- 
rations show a small but significant rise during puberty 
(Bidlinymaier et al, 1973; Angsusingha et al, 1974; Gupta 
et al, 1975; Lee & Migeon, 1975; Baker et al, 1976; 
Thorner et al, 1977), the mean prolactin concentration 
is not different between boys and adult males (Guyda & 
Frieson, 1973; Lee et al, 1974; Ehara et al, 1975; Aubert 
et al, 1977; Thorner et al, 1977). Recent studies have 
also confirmed the lack of pubertal change in prolactin 
secretion in 24 hour profiles (Finkelstein et al, 1978; 
Large et al, 1980; Beck & Wuttke, 1980). 
SHBG binding capacity in the plasma of children of 
both sexes are similar but higher than adults (August et 
al, 1969). During puberty SHBG falls in both boys and 
girls but to a greater extent in males whose SHBG level 
is approximately 50% that of the adult females. This 
amplifies the relative increase in unbound testosterone 
in the male during puberty. 
1.3.2 Pulsatile aonadotrophin secretion in puberty 
The adult male's pattern of gonadotrophin secretion 
is characterized by nine to twelve secretory episodes 
every twenty -four hours superimposed on a stable baseline 
(Boyar et al, 1972a; Santen & Bardin, 1973). The 
episodic gonadotrophin secretion probably reflects the 
pulsatile release of GnRH from the median eminence into 
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the hypophyseal portal circulation (Carmel et al, 1976; 
Eskay et al, 1977; Neil et al, 1977). In prepubertal 
children, the very low peripheral plasma basal concent- 
rations of gonadotrophins are associated with either 
undetectable or minimal pulsatile fluctuations, which 
first become apparent just prior to the clinical onset of 
puberty (Judd et al, 1977; Boyar, 1978). This important 
marker of the activation of the hypothalamus at the onset 
of puberty has been construed as evidence supporting the 
prime importance of neuroendocrine mechanisms of pubertal 
onset. Moreover, this concept is further supported by 
the finding that episodic gonadotrophin secretion in the 
early stages of puberty is only observed during sleep, 
either at night or daytime (Boyar et al, 1972b & 1974a;Kapen 
et al, 1974). These exciting data, obtained by the 
combined use of frequent blood sampling, sensitive RIA 
methods and polygraphic sleep recording, entirely 
reshaped the perspective of hormone secretory dynamics 
during puberty and attributed an important biological 
role to sleep, a functional neuronal activity state, in 
normal sexual development. As puberty advances, episodic 
gonadotrophin secretion becomesevident during the waking 
hours and at maturity, the uniform pattern with no sleep - 
wake differential in adults is established (Weitzman et 
al, 1975). FSH secretion is also augmented synchronously 
with nocturnal sleep in pubertal children although the 
pulsatile pattern is less clearly defined than LH due to 
the longer circulating half -life of FSH (Yen et al, 1970). 
The importance of sleep- entrained LH secretion in 
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sexual development is further substantiated by the 
demonstration of a close temporal relationship between 
testosterone and LH secretion during nocturnal and 
diurnal sleep (Boyar et al, 1974; Judd et al, 1974). 
These data also add weight to the argument against the 
critical role of shifting negative- feedback threshold of 
gonadal steroids as the mechanism for pubertal initiation. 
This, together with the findings that patients with 
gonadal dysgenesis have a qualitatively similar pattern 
of pubertal sleep- related gonadotrophin secretion (Boyar 
et al, 1973) suggest that central neuroendocrine 
mechanisms must be primarily responsible for the 
initiation of hypothalamic GnRH secretion at the onset of 
puberty. The nature of the mechanism(s) and their 
relationship to sleep is unknown but neurotransmitter 
monoamines are likely to be intimately involved (Jouvet 
et al, 1963). 
1.3.3 Urinary gonadotrophins 
Radioimmunoassay of excreted gonadotrophins in urine 
has been used to detect changes, especially during sleep, 
in rate of gonadotrophin secretion during puberty. 
Although good correlations between mean plasma concent- 
rations and 24 -hour urinary gonadotrophin excretion have 
been obtained (Kulin et al, 1975 & 1976) the data with 
shorter timed urine collections are inconsistent (Beitins 
et al, 1976; Urban et al, 19.79; Chipman et al, 1981). 
Furthermore, reservations concerning the variability in 
bio- and immuno- activity between plasma and urinary 
gonadotrophins (Raiti et al, 1975; Ascoli & Puett, 1976) 
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and that produced by different extraction procedures 
(Blizzard et al, 1972) render the validity of urinary 
measurements questionable. 
1.3.4 Pituitary responsiveness in puberty 
The pubertal rise in plasma gonadotrophin concent- 
rations may be induced by increased GnRH stimulation but 
enhanced pituitary responsiveness with advancing sexual 
maturity can also contribute a significant part. Studies 
using exogenous GnRH in single bolus stimulation (Kastin 
et al, 1972; Job et al, 1972; Roth et al, 1972; Grumbach 
et al, 1974) and continuous infusion (de Lange et al, 
1974; Reiter et al, 1976; Huseman & Kelch, 1978) confirmed 
that the LH, and to a more variable extent FSH, responses 
increased with pubertal maturation. There is thus an 
expansion of the pituitary reserve of gonadotrophins 
during sexual development which may result from the 
priming effects of hypothalamic GnRH stimulation 
(Grumbach et al, 1974; Mortimer et al, 1974; Reiter et 
al, 1975 & 1976; Boyar et al, 1976). With prolonged GnRH 
stimulation by continuous infusion, there is also evidence 
that the presence of an immediately releasable and a 
reserve pool of LH can be elicited in adult and pubertal 
but not prepubertal subjects (Reiter et al, 1976). 
1.3.5 Gonadal responsiveness in puberty 
During puberty, the two to three -fold rise in plasma 
LH is associated with a twenty -fold increase in testo- 
sterone secretion. This indicates that an amplification 
step also occurs at the gonadal level. This is confirmed 
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by the enhanced testosterone response to hCG stimulation 
at puberty (Winter et al, 1972; Schöller et al, 1975). 
The mechanism of this augmented testicular response to 
trophic stimuli at puberty may take several forms. 
Hyperplasia or hypertrophy of the Leydig cells (Hooker, 
1970; Christensen & Peacock, 1980), increased LH receptor 
numbers (Odell & Swerdloff, 1976), alterations in 
steroidogenic or metabolic enzyme activities within the 
Leydig cells (Frasier et al, 1969; Strickland et al, 1970; 
Payne & Jaffe, 1975) could all contribute to the gonadal 
component of pubertal maturation represented by the 
increased testosterone production (and onset of spermato- 
genesis). The roles of FSH and prolactin in these 
functional changes of Leydig cells in puberty have 
recently been reviewed by Bartke (1978). Although the 
evidence for a significant contribution of these two 
pituitary hormones in animals are strong, data in humans 
are scanty and unconvincing. 
The foregoing review described a hormonal pattern 
compatible with a sequential maturation of the hypo- 
thalamus, pituitary and testis which coincides with the 
progressive physical changes of puberty. It can be pos- 
tulated that the central neural signals at the onset of 
puberty are translated or integrated by the hypothalamus 
into discrete pulses of GnRH secretion. These endocrine 
signals are then magnified at the level of the pituitary 
and again at the gonads so that the original neural 
signals have been amplified several hundred or thousand 
fold. This forward or open -loop system should be 
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considered alongside the alternative closed -loop system 
whereby the role of steroid negative - feedback sensitivity 
adjustments are of overriding importance. It would be 
interesting to consider these two concepts of 
hypothalamic -pituitary- testicular dynamic control in 
the light of the above descriptive data to see if a 
physiological mechanism for the initiation and 
progression of puberty can be formulated. 
1.4 The mechanism of puberty 
The very specific temporal and physiological 
conditions under which sexual function is activated have 
led to the supposition that puberty inducing mechanisms 
and timing devices must exist. However, puberty is also 
part of an ontogenic sequence of gonadal function which 
begins in foetal life. Thus any proposed mechanisms have 
not only to explain the peripubertal hormonal events but 
also to take into account the earlier changes in the 
hypothalamic -pituitary- testicular functions. 
1.4.1 Ontogeny of oonadal function in foetal life and 
early childhood 
The foetal hypothalamus and pituitary are not only 
active towards the end of the first trimester but are 
functional at the adult level quantitatively near mid - 
gestation when LH and FSH concentrations reach adult 
castrate levels (Faiman et al, 1981). From this point 
until term, oestradiol, presumably from the placenta 
(Siiteri & MacDonald, 1966), gradually increases while 
gonadotrophins and testosterone fall towards very low 
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levels. This indicates the acquisition of oestrogen 
negative feedback mechanisms. At the end of the first 
post -natal week, coincidental with the fall in 
circulating placental hCG and oestrogen, LH and FSH 
concentrations rise sharply with a concomitant increase 
in testosterone. From six months to two years of age, 
serum gonadotrophins and testosterone concentrations fall 
again to very low levels and remain so until the onset of 
puberty. It is believed that the mechanism(s) which 
restrain the hypothalamic -pituitary- testicular function 
and hence pubertal development for the next decade become 
established at this stage (between one to two years of 
age) in early childhood. 
1.4.2 Reactivation of the hypothalamus 
Immature gonads are able to secrete steroids in 
response to exogenous gonadotrophins (Price & Ortiz, 
1944). The experiments of Harris & Jacobson (1952) showed 
that immature pituitaries transplanted under the median 
eminence of adult hypophysectomised female rats can main- 
tain full ovarian functions. Recently, complete pubertal 
development has been successfully induced in immature 
female monkeys bearing lesions in the hypothalamus by 
exogenous pulsatile GnRH treatment (Wildt et al, 1980). 
It has also been demonstrated that immature rat hypo- 
thalamus contains considerable amounts of GnRH (Araki et 
al, 1975) with a functional portal system capable of 
delivering the releasing hormone to the pituitary (Halasz 
et al, 1972). These and other experimental studies 
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summarized in Donovan & Van der Werff ten Bosch (1965) 
established beyond doubt that the reproductive tract, 
the gonads, the pituitary and hypothalamus are all in a 
complete state of readiness to assume adult functions 
long before the normal time of puberty. The only 
qualification to this statement is the evidence that 
germinal tissues in most mammals have to undergo specific 
developmental changes before becoming responsive to 
gonadotrophins (Woods & Simpson, 1961; Critchlow & Bar - 
Sela, 1966). Otherwise all that is required for the 
onset of puberty is the reactivation or de- repression 
of hypothalamic GnRH secretion - the reversal of those 
mechanisms which suppressed the hypothalamus during the 
past eight to ten years. Two different theories have 
been put forward to explain the nature of this pre- 
pubertal restraint on hypothalamic GnRH secretion: (1) a 
highly sensitive negative feedback mechanism effected by 
gonadal steroids - closed -loop system - and (2) extra - 
hypothalamic inhibitory mechanisms either within or 
outwith the CNS - open -loop system. 
1.4.3 Closed -loop system (Gonadostat Hypothesis) 
The existence of an intact feedback relationship 
between the gonads and pituitary /hypothalamus was 
established by numerous physiological studies in the rat 
(Raimirez, 1973, for review). The greater sensitivity of 
the hypothalamic -pituitary unit to feedback inhibition of 
gonadal steroids before than after sexual maturation was 
also first demonstrated in the rat (Byrnes & Meyer, 1951; 
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Raimirez & McCann, 1963). These observations 
formed the experimental basis of the gonadostat hypo- 
thesis (Donovan & Van der Werff Ten Bosch, 1959; McCann & 
Raimirez, 1964) which postulated that a highly sensitive 
gonadostat is responsible for the suppression of gonado- 
trophins in prepuberty even in the presence of very low 
levels of gonadal steroids. At the onset of puberty, a 
reduction in the sensitivity of the gonadostat causes the 
increase in GnRH and gonadotrophin secretion which in 
turn stimulates gonadal functions. This downward shift 
in gonadostat sensitivity eventually stabilizes after 
adult concentrations of gonadotrophins and gonadal 
steroids are achieved and a new equilibrium is 
established. Support for this hypothesis was obtained in 
humans when urinary gonadotrophin secretion rate in pre- 
pubertal children were shown to be five to ten times more 
sensitive than adults to the inhibitory effect of 
exogenous ethinyloestradiol (Kelch et al, 1972 & 1973). 
A similar decrease in sensitivity to the oestradiol 
inhibitory feedback action on plasma LH has been demons- 
trated in the ovariectomized female lamb during puberty 
(Ryan & Foster, 1979). One criticism of some of the 
experiments in castrated rats and sheep centres 
around the fact that the castration response itself is 
age- dependent so that tests of feedback sensitivity in 
castrated may not be comparable to that in intact animals 
(Dierschke et al, 1974). An additional drawback of the 
gonadostat hypothesis is that it cannot easily explain 
the changes in hypothalamic -pituitary- testicular function 
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in the intra- uterine and early childhood phases without 
there being repeated upward and downward shifts in the 
gonadostat set point. Furthermore, in prepubertal 
agonadal girls, despite the higher basal concentrations 
of LH and FSH, the pattern of gonadotrophins is similar 
to normal intact children with the fall in concentration 
years 
around age one to twox and subsequent rise at the expected 
age of puberty (Conte et al, 1975). The pituitary 
response to GnRH stimulation in these agonadal children 
also paralleled the diphasic pattern of basal gonado- 
trophins (Conte et al, 1980). The sleep- entrained 
episodic enhancement of gong otrophin secretion typical 
of normal puberty is also present in subjects with 
gonadal dysgenesis at the time of puberty (Boyar et al, 
1973). These interesting clinical studies clearly 
demonstrated that changes in patterns of gonadotrophin 
secretion in childhood and puberty can occur independently 
of gonadal steroids without the need to invoke negative 
feedback mechanisms. 
1.4.4 Open -loop system (Neuroendocrine Hypothesis) 
The existence of CNS mediated mechanisms capable of 
inhibiting the activities of GnRH- secreting hypothalamic 
neurones has been postulated since the recognition of 
clinical associations between precocious puberty and 
lesions in and around the hypothalamus and pineal 
(Thamdrup, 1961; Donovan & Van der Werff Ten Bosch, 1965). 
Presumably, these lesions can interrupt the inhibitory 
neuronal input or exert direct irritative effects on the 
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hypothalamus (Ruf et al, 1974) causing premature increase 
in GnRH output. Numerous studies attempting to identify 
and localize hypothalamic and extra -hypothalamic 
structures involved in the control of puberty have 
produced conflicting results. Essentially, the anterior 
and posterior hypothalamus, amygdala, hippocampus and 
pineal have all been implicated and perhaps the best 
explanation of these results is that the neuronal control 
of the hypothalamus depends on the balance between 
excitatory and inhibitory inputs from some or all of 
these areas whose roles may change with age of the animal 
(Gorski, 1974; Ramaley, 1980). In recent years, 
interest in the pineal has intensified since the 
recognition that pineal hormones such as melatonin and 
arginine vasotocin may have anti -gonadotrophic or anti - 
gonadal effects (Pavel & Petrescu, 1966; Reiter, 1974; 
Reiter & Vaughan; 1977; Benson, 1978). The unconfirmed 
data of Silman et al (1979) described a dramatic fall in 
circulating melatonin levels in 51 children aged 111/2-14 
years shortly before the onset of puberty. It is of 
further interest that the pineal gland evolved from a 
primitive photoreceptor organ and mediates several 
rhythmic biological functions including the seasonal 
reproductive cycles in several species - ram, hamster, 
ferret and vole (Licoln, 1981). That the sleep -wake 
cycle in man is intimately involved in the initiation of 
gonadotrophin secretion at the onset of puberty is in 
concordance with the experimental data supporting the 
prime importance of CNS modulation of hypothalamic 
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function. However, the major drawback to the CNS- 
disinhibition hypothesis is our lack of basic under- 
standing of the nature and site of the neural or neuro- 
humoral mechanisms involved. Despite this, the evidence 
for the existence of such mechanisms is convincing and the 
open -loop neural activation concept of puberty is gaining 
wide acceptance. A change in feedback sensitivity of 
the pituitary and hypothalamus may well exist concurrently 
as a secondary phenomenon to the more basic mechanisms of 
CNS activation of the hypothalamus. Clearly, our present 
understanding of the complex events and mechanisms of 
puberty is inadequate and more basic information is 
required. 
1.5 Timing of pubertal onset 
Although the gradual sequence of events during 
sexual maturation is genetically programmed, the timing 
of the initiation of puberty is closely linked to the 
external and internal environmental factors through 
modification of the neuroendocrine mechanisms. The 
twenty -four hour clock rhythm is closely associated with 
the maintenance of normal function in several endocrine 
systems including the triggering of the pre -ovulatory 
gonadotrophin surge in the female rat (Everett et al, 
1977) and the ACTH /cortisol diurnal secretion (Weitzman 
et al, 1971; Gallagher et al, 1973). From preliminary 
studies in rats using simple biological parameters such 
as daily weight gain or other endocrine marker rhythms, 
Ramaley (1980) suggested that the onset of puberty may be 
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temporally correlated with the maturation of endogenous 
biological rhythms generated by the suprachiasmatic 
nucleus of the hypothalamus. The onset of puberty may 
be associated with the development of the capacity of the 
individual to reset endogenous biological rhythms in 
response to environmental cues such as the light -dark or 
sleep -wake cycles and to link the endogenous GnRH neuro- 
secretory rhythm to clock rhythms. This hypothesis has 
its parallel in the seasonal breeding of mammals whose 
sexual cycles are controlled by the interaction between 
the hypothalamic -pituitary -gonadal axis and another 
environmental variable - seasonal change in day- length or 
photoperiod (Licoln & Short, 1980). The entrainment of 
gonadotrophin or GnRH secretion to the sleep phase of the 
sleep -wake cycle in humans may be a further example of 
the biological role of synchronization of endogenous 
biorhythms to variables in the external or internal 
environments. 
The concurrent acceleration of physical growth and 
sexual maturation during puberty has been discussed (1.2). 
The increase in body size and weight is associated with 
changes in body composition - for example increase in 
percentage fat per unit body weight in females and the 
reverse in males. The important question arises as to 
whether these changes in body composition or metabolism 
could provide biological signals outside the CNS to 
activate the dormant neuroendocrine mechanisms at the 
onset of puberty. The initial studies of Kennedy & Mitra 
(1963) indicating that puberty in rats occurred at a set 
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body size regardless of age or growth rate was used by 
Frisch to construct an analogous model for humans (Frisch 
& Revelle, 1970 & 1971). They suggested that menarche in 
pubertal girls was related to the attainment of a 
critical body weight of 47 Kg or degree of fatness - 
26 -28% fat per unit body weight (Frisch & McArthur, 1974). 
This hypothesis was supported by the association of 
secondary amenorrhoea and pubertal patterns of gonado- 
trophin secretion with anorexia nervosa (Boyar et al, 
1974b). Increased body fat is associated with enhanced 
aromatization of androgens to oestrogens (Grodin 
et al, 1973) and decreased transformation of oestrogens 
to non -uterotrophic 2- hydroxylated metabolites, catechol- 
oestrogens (Fishman, 1976). This state of relative hyper - 
oestrogenization may stimulate the neuroendocrine 
mechanisms of puberty. This superficially attractive 
hypothesis has many flaws which have prevented its wide 
acceptance. The initial rat experiments on nutritional 
influences of sexual maturation could not be confirmed 
(Glass & Swerdloff, 1980). The cross -sectional data on 
body -fat content was calculated by indirect methods whose 
validity cannot be substantiated (Reeves, 1979). The 
postulated mechanisms cannot possibly apply to boys and 
such a fundamental sex difference in the earliest stages 
of puberty is extremely unlikely. Finally, the most 
severe criticism levelled against the views of Frisch and 
colleagues is that menarche in human puberty is a late 
event which has no direct bearing on the events leading 
to the initiation of puberty. These comments however 
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should not be set against the original concept that 
changes in body composition during physical growth may 
provide metabolic signals for the reactivation of the 
hypothalamus at the onset of puberty. Further 
experiments to test this hypothesis must be forthcoming. 
1.6 The strategy of puberty in humans 
Humans have the longest period of prepubertal growth 
amongst mammals. This is teleologically desirable so 
that ample opportunity is available to establish verbal 
communication and learning as well as consolidating social 
bonding of the family unit. This contrasts with most 
other animals whose period of prepubertal growth is in 
terms of weeks and months rather than the ten years as in 
humans. The existence of neural -inhibitory mechanisms 
which suppress the hypothalamic -pituitary unit from the 
end of the first year until the onset of puberty may be 
unique to humans or higher primates that have a prolonged 
period of prepubertal growth and development. It should 
also be noted that larger animals tend to have later 
puberty (Raimirez, 1973) so that attainment of an adequate 
physical size not only for reproduction but also for 
foraging and protection of offspring may be another 
factor in the prolonged inhibition of pubertal onset. 
1.7 Rationale and approach to present studies 
The hypothalamic -pituitary control of gonadal 
functions in the adult male is a comparatively stable 
system without the cyclical pattern which characterizes 
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the female menstrual cycle. Similarly, the dampened 
activities of the hypothalamic -pituitary- testicular axis 
in childhood are not ideal for the study of control 
mechanisms therein. The dramatic alterations in dynamic 
relationships between individual components of the hypo- 
thalamic- pituitary -testicular axis, telescoped into the 
pubertal years, offer a good opportunity for examining 
the functional characteristics of the system. 
From the clinical standpoint, puberty is the time 
when hypogonadal disorders first become apparent. 
Unfortunately, due to the wide normal age range at the 
onset of puberty and the low levels of reproductive 
hormones in prepuberty, it is difficult to make an early 
diagnosis of hypogonadotrophic hypogonadism in contra- 
distinction to constitutional delayed puberty. By 
definition, 2.5% of the population in the pubertal age 
group may have delayed onset of puberty (Prader, 1975). 
This presents a considerable clinical problem and the 
importance of precise hormonal definition of stages of 
sexual maturation cannot be overemphasized. 
The established views on the mechanism of puberty 
based on changes in negative feedback sensitivity was 
founded on the concepts of closed -loop control dynamics 
and information gleaned from single sample cross - 
sectional studies of basal hormone levels. The more 
recent findings derived from multiple and frequent 
hormone estimations over prolonged periods confirmed the 
existence and indeed the onset of pulsatile hormone 
secretion and diurnal variations in the secretion rates 
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in pubertal subjects. These observations fundamentally 
altered the concepts on the mechanisms of puberty, 
conferring a pivotal role to the CNS modulation of 
pituitary and gonadal functions via hypothalamic 
pulsatile GnRH secretions. To date, clinical data 
supporting the neuroendocrine hypothesis of pubertal 
onset is still relatively scanty. 
The present studies attempt to analyse four inter- 
related aspects of the hypothalamic control of pituitary 
and testicular fianctions simultaneously in a group of 
subjects at various stages of puberty. Firstly, the 
twenty -four hour periodicity of gonadotrophin and 
gonadal steroid secretions entrained to the sleep -wake 
cycle is examined in order to define its temporal 
relationships with other hormonal and physical events in 
puberty. This allows a more accurate description of the 
pubertal hormonal changes than previously possible and 
should therefore improve our understanding of the 
mechanisms of puberty as well as highlighting the 
clinical potential of nocturnal hormone -sleep studies. 
Secondly, the analysis of nocturnal LH pulsatile 
secretion permits an indirect assessment of the frequency 
and to some extent the amplitude of hypothalamic GnRH 
secretion from the earliest stages of puberty onwards. 
Since the pituitary responsiveness in these patients is 
also known, the amplitude of GnRH pulsatile secretory 
episodes may be evaluated. The physiological mechanism 
and relative importance of GnRH pulse frequency and 
amplitude modulation of pituitary and testicular function 
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in puberty may thus be clarified. Thirdly, pituitary 
responsiveness during puberty is assessed by a multiple 
low -dose GnRH stimulation regime in order to reproduce 
the endogenous physiological pattern. By considering the 
pituitary response in terms of an immediately releasable 
and a reserve gonadotrophin pool, it may be possible to 
gain some insight into the relative importance of gonadal 
steroid negative feedback and the priming effects of GnRH 
on the pituitary during pubertal development. Fourthly, 
the testicular response to endogenous and exogenous GnRH/ 
LH pulsatile stimulation can be assessed and compared. 
This may throw some light on the importance of pulsatile 
trophic stimulation on Leydig cell steroidogenesis. 
By evaluating how much, how frequently and when 
hypothalamic GnRH secretion occurs and correlating the 
effects of pulsatile GnRH stimulation on the pituitary 
and testes, it may be possible to confirm that sleep - 
related central mechanisms, translated into endocrine 
signals by the hypothalamus, are the prime movers behind 
the onset and progression of the final lap of sexual 
development in man. 
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CHAPTER 2 
PATIENTS AND METHODS 
2.1 Patients 
Sixteen patients attending Endocrine Clinics in 
the Royal Infirmary, Western General Hospital and Royal 
Hospital for Sick Children, Edinburgh with retarded 
sexual development and /or short stature were recruited 
for this study with the approval of the attending 
physician, the family practitioner and the Reproductive 
Medicine Ethical Sub -Committee of the Royal Infirmary and 
Simpson Memorial Maternity Pavilion, Edinburgh. After 
careful explanation of the objectives and nature of the 
study, written consent was obtained from each patient 
and his parents. The clinical details of the sixteen 
patients are summarized in Table 2.1. Puberty stages 
were rated according to the criteria of Tanner (1962) and 
assessment of testicular size by comparison with Prader's 
orchidometer (Prader, 1966). The genitalia (G), pubic 
hair (PH) ratings and testicular volumes combined to give 
an overall score (P stages) which subdivided the pre- 
pubertal group into stage P1A and P1B with the latter 
representing those late prepubertal subjects showing some 
testicular enlargement but no genitalia or pubic hair 
development. 
On entry into the study, nine patients were pre- 
pubertal, three were in stage P2, and two each in stage 
P3 and P4. The age range of the group was between 14.14 
Table 2.1 
Summary of clinical details, including treatment and 
final diagnosis in 16 prepubertal and pubertal subjects 
followed for up to 39 months. All growth hormone 
deficient patients had been receiving HGH 5 IU three 
times weekly for over one year before first entering 
this study. Androgen or gonadotrophin treatment were 
started after a variable period of observation (1 -12 
months) following the last hormone study. *The 
exception was subject 5, who received a 12 -week 
course of HCG (Pregnyl) 3000 IU twice weekly after 
the first study. As a result, the subsequent three 
studies in this patient have been excluded from the 
analyses of group data where all results were obtained 
before the commencement of androgen or gonadotrophin 
therapy. The studies where sleep stage recordings 
were undertaken are denoted in parenthesis. 
P U B E R T Y S T A G E 
Chrono- 
logical Skeletal Pubic Testes 
Age Age Height Weight Genital Hair Volume Total 
Subjects (yrs) (yrs) (cm) (Kg) Score Score (mis) Score 
1 KK 24.00 15.4 168.9 65.0 G1 
2 SK 14.62 12.8 144.1 54.7 G1 
3 ACh 14.14 13.5 143.0 35.4 G1 
4 RC 16.71 14.5 142.3 33.3 G1 
5 ST 15.48 12.5 153.9 41.1 G1 
6 ACal 15.90 11.5 142.5 35.7 G1 
7 RS 14.98 10.8 139.2 30.0 G1 
8 AR 14.89 11.7 137.5 48.4 G1 
9 DC 15.10 13.7 132.8 29.1 G1 
10 GG 14.73 12.8 149.0 38.9 G2 
11 CA 15.66 14.8 146.6 43.8 G2 
12 CR 14.58 13.4 148.2 38.9 G2 
13 DF 16.58 14.5 152.3 37.3 G3 
14 GFitz 15.89 13.0 145.5 44.8 G3 
15 GMcK 16.11 14.7 162.3 54.1 G4 























Additional Clinical Findings 
Anosmia. Positive family history 
L undescended testis 
HGH deficient. Encephalitis aged 
5 _vr. Red /green colour blindness 28 
Aneurysm R radial A. 
Balanced translocation 3,8 chr. 
46XY. t(3:8)(c?27;P122) Bilateral 
mixed conductive /perceptive 24 
deafness. L branchial cartilege 
remnant excised aged 3 yr. 












HGH deficient. Obesity. 
Bilateral cataracts. IQ 86. 28 
Bilateral orchidopexy aged 11 yr. 
Emotional /social deprivation 15 
Insulin -dependent diabetes 
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to 24.00 years with a mean ± SD of 16.3 ± 2.67 years and 
median age of 15.57 years. All patients underwent full 
pituitary assessment with insulin hypoglycaemia, TRH and 
GnRH stimulation tests prior to entry into the present 
study. The oldest of these patients (subject 1) has 
Kallmann's syndrome (hypogonadotrophic hypogonadism with 
anosmia) and presented with a complete lack of sexual 
development and left undescended testis. He was included 
as a member of the prepubertal group. Three patients 
(subjects 2, 4 and 8) were growth hormone deficient and 
had been receiving MRC growth hormone injections, 5 I.U. 
three times weekly. Subjects who had already entered 
puberty at the start of the study were included to 
provide the widest possible cross -sectional spectrum of 
sexual maturity for testing. The study group was followed 
up clinically for periods varying between six to 39 months 
with a mean ± SD duration of 22.4 ± 8.5 months. The 
patients were assessed clinically at three and six -monthly 
intervals when height, weight, and puberty stage were 
recorded and testes size measured. Six patients (subjects 
1,2,3,7,10 and 15) underwent sleep /hormone profile study 
on only one occasion at the beginning of the period of 
observation. Five patients (subjects 4,6,8,9 and 11) were 
studied on two occasions six to ten months apart. Three 
patients (subjects 13,14 and 16) were studied three times 
at six -monthly intervals. The remaining two patients 
(subjects 5 and 12) were studied on four occasions, the 
first three at six -monthly intervals and the fourth being 
carried out fourteen months after the third study. 
183 
With the exception of subject 5, no patient received 
any treatment with reproductive hormones prior to their 
last or only sleep /hormone profile study. Subject 5 
received a twelve -week course of human chorionic ganado- 
trophin (Pregnyl, Organon) 1500 I.U. twice -weekly 
immediately following the first study. However, further 
pubertal maturation occurred spontaneously without con- 
tinuing treatment. For this patient, the endocrine data 
from the second to the fourth study was therefore not 
included in the group analyses. In the six patients that 
required treatment, testosterone oenanthate (Primoteston 
Depot, Schering) or human chorionic gonadotrophin, hCG 
(Pregnyl, Organon) were commenced at various intervals 
after the last sleep /hormone profile study. Subject 6 
received only a total of 300 mg of testosterone oenanthate 
over a six -month period and it was reported by his family 
doctor that he subsequently developed to full sexual 
maturity with no further treatment. Two growth- hormone 
deficient subjects (4 & 8) were started on testosterone 
even though they showed significant nocturnal LH secretion 
in the second study. This was because the psychosocial 
circumstances in these two subjects were such that further 
delay in virilization was undesirable (see Chapter 6). 
2.2 Blood sampling technique 
Blood samples were obtained at twenty minute inter- 
vals throughout the twenty -one hour period of study via 
an indwelling 18G Venflon intravenous cannula (Viggo AB, 
Helsingborg, Sweden) attached to a three -way stopcock 
with luer -lock connector (Vygon, Aachen, West Germany) 
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placed in the ante -cubital vein and kept patent between 
samples by 0.2 -0.3 ml of heparinized saline (400 units 
heparin /ml of normal saline). After discarding the 
initial 0.5 ml of each sample, 4 or 10 mis of blood were 
collected in lithium -heparinized plastic tubes, centri- 
fuged within ten minutes at room temperature at 500 G 
for ten minutes and the plasma separated and kept frozen 
at -20 °C until assay. 
During sleep, an extension cannula (200 cm manometer 
line, Portex, Hythe, England) which passed through a hole 
in the bedroom wall to the next room was used so that 
blood sampling can continue without the sleeping subjects 
being disturbed (Fig 2.1). The length of the cannula was 
adequate to allow for a reasonable degree of freedom of 
movement during the night. To ensure that the sámpling 
channel remained air -tight and intact during sleep, a 
special connecting device was made from two male luer- 
lock metal connectors soldered together so that it could 
be securely attached to the intravenous cannula at one 
end and the extension cannula at the other. The dead 
space of 5 ml in this system was primed by heparinized 
saline initially and cleared with the same volume at the 
end of each blood sampling. Removal of heparinized 
saline from the dead space of the sampling system and 4 
or 10 ml of blood under favourable conditions and the 
refilling of the dead space with heparinized saline could 
usually be accomplished in under three minutes. 
Selection of the largest forearm veins for cannulation, 
adequate splinting of the arm at optimal positions and 
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Fig 2.1 
Artist's impression (courtesy of Dr T.A. Bramley) of the sleep 
laboratory. The subjects slept undisturbed while, in an adjacent 
room, blood sampling via an extension cannula running through a 
hole in the wall can continue through the night. The scalp, orbital 
and submental electrodes were connected to the electroencephalograph 
for recording polygraphic sleep. 
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the ensurance of a good flow rate through the cannula in 
the period before sleep were important in minimizing the 
potential difficulties in blood sampling during sleep. 
Spontaneous venous spasm, for which there was little 
remedy or precaution, seldom lasted for longer than 30 
minutes and samples missed for this reason were 
negligible. The technique of serial blood sampling 
during sleep was modified from that described by 
Vankirk & Sassin (1969) and Rubin et al (1971). 
2.3 Blood sampling schedule 
In each sleep /hormone profile study, two patients 
were sampled together. They arrived in the sleep 
laboratory at 18.00 - 18.30 h when the intravenous 
cannula was inserted and secured in position in the 
forearm. Blood sampling commenced at 20.00 h and 
continued at twenty minute intervals for the following 
twenty -one hours finishing at 17.00 h the following day 
(Fig 2.2). The extension cannula and electrodes for 
electrophysiological recordings (see 2.4) were connected 
and prepared in the hour before lights -out at 23.00 h. 
The patients were awakened at 07.00 h the next morning 
when the extension cannula and electrodes were discon- 
nected. From 09.00 h, 10 µg of GnRH (Gonadorelin, 
Ayerst, Andover, England) was administered as an intra- 
venous bolus injection every two hours on four occasions. 
Four mls of whole blood was collected at twenty minute 



















































































































































































































































































































































































































































































































































































































































































































































of LH, FSH and testosterone. A further 6 ml of blood was 
obtained at hourly intervals between 20.00 and 09.00 h 
for measurement of oestradiol, prolactin and for storage. 
The total blood volume venesected during each study was 
353 ml. The patients were ambulant during the waking 
hours of study. They spent the time reading, watching 
television or playing card games and had unrestricted but 
normal food and fluid intake. 
2.4 Sleep Stage Recording 
Sleep stage recordings were performed in ten 
patients in a sleep laboratory on one to three occasions 
so that a total of nineteen studies were carried out with 
electrophysiological monitoring. Each patient underwent 
four adaptation nights before the study night. Silver 
electrodes were placed below and above each outer canthus 
providing two bipolar eye- movement recording channels, 
one pair of parietal- occipital electrodes providing one 
channel of electroencephalogram recording and one pair of 
submental electrodes for the recording of muscle tone. 
The electrodes were attached to the face with adhesive 
tapes and to the scalp in the midline with Colloidin. 
Eight foot long leads connected these electrodes to a 
headbox leading to a Gras polygraph recording device in 
the next room (Fig 2.1). Recordings of electrical 
potentials were made at a paper speed of 15 mm/sec giving 
page units of twenty seconds each. The records were 
scored visually in twenty- second epochs according to the 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































knowledge of the identity and stage of development of 
the subject. The visual scores were further analysed by 
computer to give the absolute and relative amounts and 
distribution of sleep stages in each study. Hormone 
sampling in those studies without sleep stage monitoring 
was carried out in a hospital side -ward without any 
adaptation nights but otherwise following the same 
sampling schedule. 
The results of the sleep stage analysis in Table 2.2 
showed that polygraphic sleep in all except two patients 
(RC & GG) was well- organized and minimally disrupted. 
Sleep stage content was normal and showed no consistent 
pattern of change with increasing maturity either in 
the group as a whole or in the same subject studied 
repeatedly. 
2.5 Analysis of episodic gonadotrophin release 
The fluctuation in plasma gonadotrophin concen- 
trations during frequent sampling at twenty minute 
intervals subscribed to a pulsatile pattern with an 
abrupt rise followed by a slower exponential decline 
towards the baseline. Since the clearance rate of 
gonadotrophins did not change acutely, the observed 
fluctuations in plasma concentration must reflect the 
pulsatile release of pituitary gonadotrophins. A 
gonadotrophin secretory pulse was defined by the 
following criteria: 
1) plasma concentration of gonadotrophin in at least 
two consecutive samples were higher than the 
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previous (basal) sample, and 
2) the increase from basal in at least one of the peak 
samples was significantly higher than might be 
expected on the basis of the within -assay variation - 
greater than twice the within -assay coefficient of 
variation. 
For each gonadotrophin pulse, the absolute amplitude was 
calculated from the difference between the highest peak 
and the basal values. 
2.6 Analysis of gonadotrophin response to multiple GnRH 
stimulation 
The GnRH response was assessed by two criteria. 
The absolute maximal incremental response (A Max) was 
obtained from the difference between the highest post - 
stimulation value and the basal value immediately pre- 
ceding the GnRH stimulation. The integrated response 
area (: area) was the cumulative value of the difference 
in gonadotrophin concentration between the five post - 
stimulation samples and the basal sample immediately 
preceding the GnRH injection. This was directly related 
to the area circumscribed by the gonadotrophin response 
profile (Kandeel et al, 1979). 
To assess the response of the four consecutive GnRH 
stimuli at two -hourly intervals, the first response was 
compared with the mean of the second, third and fourth 
as well as the mean of all four responses. 
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2.7 Statistical analyses 
The data from this mixed cross-sectional/longitudinal 
study was analysed by the method of unbalanced mixed model 
analysis of covariance (Dixon & Brown, 1979). This 
involves the construction of a model with separate terms 
for the estimation of within -patient and between -patient 
variabilities. In testing for trends in hormonal 
concentrations across the stages of puberty, the following 
model for value Yij on subject i at stage j was used: 
Yij = bi + cj + eij 
where b represented the deviation of subject i from the 
group mean value expected at a given stage, c represented 
the average level expected at the stage, and e the error 
term representing all unexplained deviations in the data 
from the additive model involving b and c. In considering 
the hormonal trends in individual patients studied at 
different stages of development longitudinally, e 
corresponded to the failure of all lines joining two 
given successive stages to be parallel while b represented 
some of these lines lying consistently above others at 
given stages of puberty and c the line joining the average 
hormone concentration expected at specific stages. Since 
the data was unbalanced (i.e. each subject was at a 
different set of stages), a maximum likelihood method for 
estimating the hormonal parameters and testing for 
significance was used. The programme selected was BMDP3V 
(Dixon & Brown, 1979). This was used to test for 
significant stage effects in the analysis of all the 
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hormonal measurements and also to test whether a linear 
stage effect produced as good a fit as a more general 
"factor" for stage. This analysis was also performed 
using other criteria for pubertal development such as 
pubic hair and testis size so that it was possible to 
see if they gave a better fit to the hormonal model than 
the total score puberty stage classification. 
Kendall's rank correlation test was used to examine 
the relationships between the various mean and pulsatile 
parameters of gonadotrophin secretion and the GnRH 




HORMONAL CORRELATES OF THE PHYSICAL CHANGES IN PUBERTY 
3.1 Introduction 
Puberty is characterized by a series of physical 
changes brought about by the functionally integrated 
increase in activity of the hypothalamic- pituitary- 
testicular (HPT) axis. The state of development of the 
physical characteristics of puberty can be said to 
reflect the functional maturity of the HPT axis and is 
important in the clinical assessment of the progress of 
sexual maturation. These physical markers of puberty 
also provide standard criteria against which other changes 
of puberty can be compared. Several investigators have 
developed composite classifications of male sexual 
development (Schonfeld, 1943; Tanner, 1962; Prader, 1966; 
Zachman et al, 1974). Although these studies were largely 
based on anthropometric surveys, endocrinological changes 
in puberty are likely to relate more meaningfully to the 
physical changes of sexual maturation than to chrono- 
logical age. This is due to the wide individual variation 
iñ the age of onset and rate of progression of pubertal 
development (Marshall & Tanner, 1970) . and the fact that 
the physical changes at puberty are hormonally- induced 
(Short, 1980). A number of studies confirmed that 
increasing concentrations of basal gonadotrophins and 
testicular steroids correlated with the clinical stages 
of puberty (Blizzard et al, 1972; Burr et al, 1970; Kelch 
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et al, 1972; Faiman & Winter, 1974; Lee et al, 1974). 
However, considerable discrepancy in the timing, 
magnitude and pattern of hormonal changes exist amongst 
these earlier reports based on single blood samples 
obtained during the day. It is now accepted that gonado- 
trophins are secreted predominantly during nocturnal 
sleep in early puberty (Boyar et al, 1972b) and that both 
pituitary and gonadal hormones are secreted episodically 
(Baker et al, 1975). Thus it is important to confirm and 
extend the existing data on the hormonal concentrations 
at different stages of puberty, taking into account the 
sleep- related and episodic nature of gonadotrophin and 
testosterone secretion. A prerequisite however is to 
determine which of the physical markers characterizing 
sexual development are most closely related to the 
hormonal changes and to establish a rational basis for 
the clinical assessment of pubertal maturation. 
3.2 Results 
The mean concentrations of plasma LH, FSH, testo- 
sterone and oestradiol in the evening (20.00 -23.00 h), 
night (23.00 -07.00 h) and morning (07.00 -09.00 h) in 
thirty studies from sixteen pubertal subjects grouped 
into external genitalia (G) and pubic hair (PH) clinical 
stages are presented in Figure 3.1. Similarly the mean 
LH pulse frequency and amplitude during the evening 
(20.00 -23.00 h) and night combined with morning (23.00- 
09.00 h) are illustrated in Figure 3.2. The night and 







































































































































































































































































































































































































































































































































61 2 3 4 5 PH 1 
NIGHT . MORNING 
3 1. 5 
61 2 3 4 5 PH1 2 3 4 5 
PUBERTY STAGE 
Fig 3.2. 
Mean (SEM) frequency and amplitude of pulsatile LH secretion during 
the evening (20.00 -23.00 h) and night combined with morning (23.00- 
09.00 h) in 16 subjects (30 studies) in the five stages of puberty 
determined either by genitalia (G) or pubic hair (PH) ratings 
according to Tanner (1962). 
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latter is too short to be considered on its own for pulse 
frequency estimations and the last LH pulses in the night 
were often seen to encroach into the morning period. A 
rising trend in mean LH concentration was apparent in 
both G and PH stages of puberty in all three periods of 
the day and night. In both instances, the most rapid 
rate of LH increase was seen in the early stages. The 
overlap between subjects in puberty stage G1 -2 and PH1 
accounted for the major difference in mean LH concent- 
rations between G and PH staging in early puberty. Mean 
FSH concentrations in G and PH stages were similar. In 
both stage G1 and PH1, the ratio of LH:FSH was less than 
one in the evening and morning but greater than one 
during the night. In subsequent stages, both G and PH, 
LH values exceeded those of FSH throughout the twenty -four 
hours and this persisted into adulthood. 
Mean plasma testosterone concentrations showed a 
progressive rise during puberty, plateauing out between 
PH4 -5. Differences in testosterone concentrations 
between G and PH staging was significant only in the 
first two stages during the night and morning. There 
was no difference in the pattern of oestradiol 
concentrations during puberty between G and PH stages. 
Significant difference in LH pulse frequency between 
G and PH staging was only observed in prepubertal 
subjects in the combined night and morning period. LH 
pulse amplitude showed a progressive increase throughout 
puberty in both G and PH stages. 
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4 5 PHt 2 3 1. 5 
Fig 3.3 Mean (SEM) maximal incremental (Q Max) and integrated 
area LH and FSH response to the first and the average of the second, 
third and fourth 10 µg bolus GnRH stimulation at two -hourly intervals 
in 30 studies on 16 subjects in the five stages of puberty determined 
either by genitalia (G) or pubic hair (PH) ratings according to 
Tanner (1962). In three studies, only one or two GnRH boluses were 
given instead of the usual four. 
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the mean response of the second to the fourth boluses 
assessed by maximal increment and integrated response 
area are shown in Figure 3.3. The two parameters of GnRH 
response to either the first or subsequent stimulation 
gave very similar patterns in both LH and FSH. The 
progressive increase in LH in response to GnRH was more 
clearly demonstrated in the G stages while PH stages 
showed a tendency to plateau with increasing maturity. 
However, the only statistically significant difference 
between G and PH stages in the LH response to GnRH was 
between Gl and PHl. The FSH response to GnRH showed no 
obvious change in either G or PH stages during puberty. 
The individual values (N =30) of six of the most 
informative hormonal parameters - (a) mean nocturnal LH, 
(b) mean morning FSH, (c) mean nocturnal testosterone, 
(d) mean nocturnal and morning LH pulse frequency, (e) 
mean nocturnal and morning LH pulse amplitude (f) mean 
maximal incremental LH response to the first of the four 
GnRH boluses - are shown in Figure 3.4 a -f in relation to 
testicular size and G or PH stages. Longitudinal data 
from repeat studies in the same patients are indicated by 
straight lines joining successive hormone values. There 
was considerable overlap between successive G and PH 
stages in all five hormone parameters especially in the 
later stages of puberty. Testicular volume was well 
demarcated by G staging but showed a great deal more 
overlap in relation to PH stages. A linear relationship 
existed between the mean nocturnal LH, LH pulse frequency, 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































G1 -2. The nocturnal LH pulse amplitude and testosterone 
concentration correlated with testicular volume 
throughout puberty. Thus the combination of testicular 
size and G stages provided the best clinical assessment 
of pubertal development in terms of their hormonal 
relationships. The hormonal trends revealed by the 
longitudinal studies in individual patients mostly 
paralleled that for the group means. 
Of the nine subjects studied on more than one 
occasion, peak height velocity (PHV) was achieved in one 
during the period of study (subject 12 who was studied 
on four occasions). The PHV in this patient occurred 
between stage G3 -4 and testes volumes between 8 -10 ml 
with testosterone concentrations between 400 -500 ng /dl. 
The other four patients who reached stage G5 during the 
study period had all progressed beyond their PHV before 
entry into the study. These results indicate that PHV 
is usually associated with testosterone concentrations 
at or just below the lower limit of the normal adult 
range. 
3.3 Discussion 
Since neither the chronological nor bone age are 
reliable indicators of pubertal maturation, determination 
of the precise temporal and quantitative relationships 
between hormonal changes in puberty must be interpreted 
with reference to the state of maturity evidenced by the 
development of sex -hormone dependent physical character- 
istics. To gain insight into the physiological mechanisms 
208 
of puberty, it is therefore necessary first to ascertain 
which of the different physical markers of puberty are 
most closely associated with the measurable changes in 
hormone secretion. 
The present results confirmed that the principal 
difference between G and PH staging of puberty can be 
explained by the earlier development of genitalia changes 
than pubic hair growth (Marshall & Tanner, 1974; Lee et 
al, 1974). Thus the hormonal changes in relation to G 
and PH stages are likewise shifted temporally by these 
arbitrary classifications. The discrepancy between the 
two classifications was most obvious amongst subjects 
around the onset of puberty (Fig 3.4). This implies that 
pubic hair changes are further removed in time from the 
hormonal mechanisms responsible for the initiation of 
puberty and are consequently less reliable as clinical 
indices of early pubertal development. 
Our results also confirmed that testicular enlarge- 
ment (Schonfeld, 1943; Tanner, 1962; Zachmann, 1974) and 
increase in plasma concentration of LH and /or FSH (Burr 
et al, 1970; August et al, 1972; Winter & Faiman, 1972a & 
1974; Lee et al, 1974; Baker et al, 1976) occurred before 
signs of genitalia development, appearance of pubic hair 
or any appreciable increase in circulating testosterone 
concentration. Estimation of gonadotrophin concentrations 
during nocturnal sleep in this study showed that in peri- 
pubertal boys, enlargement of the testes above 1 -2 ml in 
volume was closely associated with the onset of nocturnal 
LH secretion (Fig 3.4a & d) which was also reflected by 
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the greater nocturnal LH:FSH ratio compared to the 
morning and evening in stage G1 (Fig 3.1). A concurrent 
increase in pituitary responsiveness to GnRH can also be 
detected at this stage (Fig 3.4f). The attainment of 
testicular volume of 4 ml or more indicated well 
established nocturnal LH secretion which was usually 
followed by increased testosterone secretion and further 
pubertal development. These considerations in the peri- 
pubertal period together with the finding that testicular 
volumes could be conveniently demarcated by subsequent G 
stages suggested that the combination of G staging and 
testicular size estimation provided the best physical 
criteria for the assessment of puberty. The application 
of this combination as the working "total" score of 
puberty staging (P stages) would therefore only involve 
modifying the established G staging system by subdividing 
Gl into PIA where testicular size was 1 -2 ml and P1B for 
those with testes volumes above 2 ml but not more than 4 
ml while stages P2 -5 would be equivalent to G2 -5. 
Testicular enlargement during sexual maturation is 
the result of increases in seminiferous tubular diameter 
and length (Charny et al, 1952; Richardson & Short, 1978) 
and is associated with the initiation and establishment 
of mature spermatogenesis. Previous studies have 
demonstrated correlations between testicular size and 
circulating FSH concentration (Winter & Faiman, 1972a; 
Burr et al, 1970) and testosterone concentration (Knorr 
et al, 1974) in pubertal subjects. This study found that 
the increase in testicular size was only correlated with 
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rising LH and FSH secretion in early puberty, P1 -2 (Fig 
3.4 a & b). The subsequent increase in testicular size 
was associated with only insignificant changes in mean 
gonadotrophin levels. In contrast, a linear relationship 
between testicular size and testosterone concentration 
and LH pulse amplitude was maintained from stage P1A -5. 
These results are compatible with the hypothesis that 
testosterone as well as gonadotrophins are required for 
the initiation of spermatogenesis while the maintenance 
and further development of the seminiferous tubules to 
adult proportions is dependent on increasing concen- 
trations of intratesticular testosterone (Steinberger, 
1971; Steinberger et al, 1978). The discovery of sperms 
in the urine of early pubertal boys (Richardson & Short, 
1978) indicating the establishment of spermatogenesis 
before the full development of secondary sexual 
characteristics is also compatible with the present 
findings and interpretations. 
Gonadal steroids are responsible for the development 
of secondary sexual characteristics as well as the more 
general metabolic changes in puberty (Short, 1980). 
Testosterone rather than dihydrotestosterone is the major 
effector hormone in male puberty since subjects with 5 - 
reductase deficiency can go through a virtually normal 
puberty and also initiate qualitatively normal spermato- 
genesis (Peterson et al, 1977). Unbound circulating 
testosterone increases in puberty to a greater extent 
than total testosterone due to a fall in sex hormone 
binding globulin (SHBG) concentration (August et al, 
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1969). However, there may be some delay in this fall in 
SHBG after the increase in total circulating testosterone 
concentration in puberty (Lee & Gisriel, 1980). This may, 
to some extent, explain the considerable latent period 
between androgen target tissue response observed 
clinically and the increase in total plasma testosterone 
concentration. It does not, however, account for the 
temporal dissociation between pubic hair and genitalia 
development, which must be explained at the level of 
target cell responsiveness. These factors affecting 
circulating testosterone presumably do not apply to the 
seminiferous tubules, being adjacent to the source of 
androgen synthesis where androgen can diffuse freely 
across the blood -testis barrier (Setchell, 1980). This 
ensures that seminiferous tubules are the first tissue to 
be exposed to sufficient concentrations of testosterone 
from the earliest stages of sexual maturation. Further- 
more, yet another safety device exists in some species in 
the form of an intratubular androphilic macromolecule - 
androgen binding protein (Fritz, 1978) which may prevent 
the rapid metabolism of testosterone and further enhance 
its local availability within the seminiferous tubules. 
These differences in proximity and transport mechanisms 
for testosterone may account for the early response to 
androgens of seminiferous tubules compared to the other 
distant androgen target organs. 
In summary, pubertal development indicated by the 
physical changes in external genitalia, pubic hair and 
testicular size were compared in terms of their 
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relationships with hormonal changes represented by the 
nocturnal episodic secretion of gonadotrophins and 
testicular steroids as well as the pituitary response to 
GnRH stimulation. Testicular size was found to be the 
best single physical index of sexual maturation and 
reflected the endocrine events in puberty more 
accurately than either genitalia or pubic hair develop- 
ment especially in the early stages of puberty. The 
combination of genitalia stages and testicular volume 
assessment provided the most satisfactory overall 




HYPOTHALAMIC- PITUITARY DYNAMICS IN PUBERTY 
4.1 Introduction 
It is now generally accepted that puberty in animals 
is initiated by functional alterations in the hypo- 
thalamic- pituitary -gonadal axis. In humans, episodic 
gonadotrophin secretion becomes detectable in the peri- 
pheral circulation around the onset of puberty, at first 
only during sleep (Boyar et al, 1972b). The pituitary 
becomes increasingly responsive to GnRH stimulation 
(Kastin et al, 1972; Job et al, 1972; Roth et al, 1972) 
while testicular steroidogenesis is greatly enhanced in 
response to the rising gonadotrophin levels (Winter 
et al, 1972; Schöller et al, 1975). The increase in 
sex steroid and gonadotrophin secretion initiates 
spermatogenesis and development of secondary sexual 
characteristics (Steinberger, 1971; Tanner, 1974). 
Although these events are individually well -described, 
the timing of onset, the sequence as well as their 
relationships to each other have not been precisely 
défined. 
A growing body of evidence has accumulated from 
clinical and experimental studies to suggest that the 
initiation of puberty is dependent on neuroendocrine 
mechanisms (Donovan & Van der Werff Ten Bosch, 1965; 
Critchlow & Bar Sela, 1966; Gorski, 1974) where the hypo- 
thalamus provides the crucial link between the neural 
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and hormonal components (Grumbach, 1980; Knobil, 1981; 
Desjardins, 1980). The neural signal is translated into 
the frequency -coded pulsatile GnRH secretion of the hypo- 
thalamus, the activation of which is central to the 
awakening of the pituitary -gonadal axis at the onset of 
puberty ( Licoln & Short, 1980; Goodman & Karsch, 1981). 
Since GnRH is found in the peripheral circulation in 
quantities too low to be reliably measured by conventional 
RIA ( Kelch et al, 1975; Mortimer et al, 1976), episodic 
changes in circulating gonadotrophin levels have come to 
be regarded as an indirect but valid index of pulsatile 
GnRH secretion by the hypothalamus (Carmel et al, 1976; 
Eskay et al, 1977; Neill et al, 1977; Licoln & Fraser, 
1979). The transient entrainment of pulsatile gonado- 
trophin secretion to sleep at the onset of puberty may be 
a manifestation of an underlying neuroendocrine mechanism 
important in the initiation of human puberty (Boyar, 1978). 
As yet, the physiological significance of this overt 
neuroendocrine phenomenon has not been studied in 
relation to the other well -described changes in functional 
dynamics in the hypothalamic- pituitary -testicular axis in 
pubertal subjects. By using frequent blood -sampling 
techniques during nocturnal sleep as well as during the 
day this study aims to analyse the endogenous GnRH/ 
gonadotrophin secretory patterns and diurnal profiles of 
gonadotrophin and sex steroid secretion at specific 
stages of puberty. Concurrently, the pituitary and 
testicular responsiveness to multiple submaximal doses of 
endogenous GnRH is assessed in a manner similar to the 
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endogenous pulsatile stimulation. By collating these 
data in a mixed longitudinal and cross -sectional group 
of pubertal subjects at various stages of maturity, it 
may be possible to gain further insight into the 
mechanisms underlying the initiation and progression 
of pubertal development in the human male. 
4.2 Results 
Individual profiles of plasma LH, FSH and 
testosterone in the sixteen patients studied on one 
to four occasions are shown in Appendix II. The 
mean basal hormone concentrations, the GnRH response, 
and the nocturnal LH pulse frequency and amplitude in 
the thirty studies from sixteen subjects are shown in 
increasing order of maturity in Table 4.1. The same 
data grouped into the six clinical stages of puberty 
are shown in Tables 4.2a, 4.2b and 4.2c. 
4.2.1 Hormone profiles 
Representative hormone profiles from three 
different subjects in pre, early and late puberty are 
depicted in Figures 4.1a, 4.1b and 4.1c respectively. 
Spontaneous LH but not FSH pulsatile secretion was 
observed in each of the three phases of puberty 
although the characteristic LH pulse frequencies and 
amplitudes are quite different. A similar pattern of 
change in LH pulsatile secretion from pre to late 
puberty could also be observed in the longitudinal series 
Table 4.1 
The mean (SD) LH, FSH, testosterone, oestradiol and 
prolactin; LH pulse frequency and amplitude; the LH 
and FSH (maximal incremental and integrated response 
area) response to four 10 µg GnRH bolus stimulation 
and the mean testosterone concentration during GnRE 
stimulation in 30 individual studies from 16 pubertal 
subjects. Repeat studies in 9 subjects are indicated 
by roman numerals. Evening (E) 20.00 -23.00 h, night 
(N) 23.00 -07.00 h and morning (M) 07.00 -09.00 h. 
Each basal hormone value represents the mean of 10, 24 
and 6 samples respectively taken at 20 minute intervals 
during these three periods. 
LH u/1 FSH u/1 Testosterone ng /dl Oestradiol pq /ml Prolactin 
mu /1 LH LH Pulse LH Response to GnRH 
SUBJECT Mean Mean Mean Mean Mean 
Pulse Night and 
Puberty (SD) (SD) (SD) (SD) (SD) 
Evening Morning A Max Integrated Area 
Stage 
Freq/ Amp Freq/ Amp Mean Mean 
1st 2nd 3rd 4th 1st 2nd 3rd 4th 
(SD) 
Testes Vol. E N M E N M E N M N M E N N E 10h u/1 10h u/1 (SD) 
1 
2 
G1 PH1 0.77 0.73 0.80 1.01 0.97 1.03 42.7 40.6 53.5 37.0 23.4 25.5 
1/1 (0.09) (0.09) (0.06) (0.09) (0.09) (0.05) (8.6) (11) (5.6) (8.6) (4.0) (4.5) 
G1 PH1 0.86 0.96 0.95 0.86 0.79 0.90 26.0 18.7 19.8 21.5 26.8 29.0 









O 0 0 0 1.6 0.9 0.8 0.2 





5.0 1.7 1.7 0.3 





FSH Response to GnRH 
Max Integrated Area 
1st 2nd 3rd 4th 
Mean 
1st 2nd 3rd 4th 
(SD) 
1.8 1.3 1.1 1.1 





8.5 6.9 4.7 4.9 
8.7 5.8 4.2 3.1 
G1 PHi 0.52 0.71 0.52 1.78 1.85 1.88 31.7 36.7 38.8 12.0 12.4 13.0 _ - 0 0 1 0.5 4.6 - - - 16.2 - - - - 2.9 - - - - 14.3 2/2 (0.04) (0.15) (0.04) (0.17) (0.13) (0.13) (8.9) (14) (13) (3.0) (1.4) (0) 
G1 PH1 1.05 1.06 0.88 2.39 2.26 2.33 57.b 49.8 60.3 19.0 20.0 18.0 149 408 249 0 0 1 1.0 2.5 2.5 2.1 1.9 
2.25 
11.1 7.3 5.3 4.7 
7.13 3.4 2.4 1.6 1.5 
2.23 
17.9 11.2 5.6 4.8 
2/2 (0.15) (0.26) (0.04) (0.23) (0.26) (0.09) (5.4) (8.7) (8.4) (1.4) (3.3) (0) (17) (155) (32) (0.26) (2.50) (0.76) 
1.1 1.4 1.1 1.0 
1.15 
5.3 6.7 3.7 4.1 
G1 PH1 1.17 2.17 1.35 1.46 1.81 1.78 20.0 28.0 20.0 22.0 20.7 24.0 86 426 158 o 0 2 
1.15 
2.6 2.3 2.1 2.0 
2.25 
9.0 7.9 6.1 5.5 
7.13 
(0.15) (1.17) (3.0) 2/2 (0.17) (0.35) (0.10) (0.08) (0.26) (0.07) (0) (9.2) (0) (3.6) (2.0) (0) (20) (149) (48) (0.15) (0.23) (1.40) 
G1 PHi 0.67 1.81 1.28 0.97 1.14 1.35 12.4 23.9 35.0 29.0 24.0 21.0 800 981 690 0.93 4.58 12.1 0.7 0.7 0.5 0.6 
0.63 
3.7 2.9 1.8 2.1 
2.63 23.8 26.7 26.5 26.7 25.9 
6 
3/3 (0.08) (0.60) (0.31) (0.07) (0.17) (0.10) (3.2) (11) (12) (3.9) (2.2) (3.0) (572) (567) (843) 
0 0 3 
(0 12) 
5.8 4.1 3.9 4.5 
(0 74) 
17.8 10.9 8.8 10.8 
(3.40) (0.08) (0.74) (6.5) (2.9) (4.3) (4.9) 
G1 PH1 0.87 1.76 1.97 1.78 1.69 1.92 38.1 84.9 164.5 1.45 2.1 1.3 - - - 9.2 9.0 
144 177 
7 _ - 0 0 2 (0.05) 9.1 7.6 - - - 35.2 26.8 - - - - - - (25) (23) - - - 3/3 (0.11) (0.89) (0.39) (0.10) (0.20) (0.19) (7.7) (45) (14) 
Mean 
(SD) 
Testosterone ng /dl 
in response to GnRH 
Mean (SD) 




6.25 43.8 52.3 44.2 50.2 47.6 
(1.56) (6.1) (5.2) (4.3) (3.6) (6.0) 
5.45 15.7 18.7 19.7 20.3 19.0 
(2.11) (2.6) (3.3) (2.4) (4.4) (3.7) 
27.8 
(3.5) 
9.88 60.7 68.0 59.3 56.0 61.0 , 
(5.25) (8.5) (6.2) (7.4) (4.2) (8.0) 
4.95 21.3 32.7 34.7 39.3 32.0 
(5.4) (6.0) (6.0) )6.6) 
(5.0) 
8 
G1 PH1 1.05 2.50 1.37 1.65 1.79 1.88 21.0 33.0 31.3 19.3 17.8 18.0 
3/3 (0.10) (0.80) (0.09) (0.14) (0.19) (0.09) (3.8) (9.5) (3.3) (1.9) (4.0) (0) 
4 II 
G1 PH1 2.25 4.26 3.43 2.56 2.56 3.35 70.8 81.7 97.0 18.5 22.1 24.5 
3/4 (0.21) (1.27) (0.86) (0.20) (0.38) (0.15) (6.8) (14) (12) (1.0) (5.5) (2.5) 
9 
G1 PH1 2.11 4.71 2.37 1.57 1.74 1.72 44.7 101 83.0 23.5 27.0 30.0 
4/3 (0.25) (1.01) (0.24) (0.08) (0.16) (0.07) (4.0) (32) (12) (4.1) (3.5) (0) 
8 II 
G2 PH1 3.17 5.10 4.03 2.30 2.30 2.70 74.4 156 137 17.0 17.9 25.0 
4/4 (0.39) (1.40) (0.51) (0.10) (0.30) (0.25) (9.7) (30) (14) (2.9) (3.8) (0) 
G2 PH1 1.16 3.66 2.88 1.76 1.95 2.27 53.2 337 349 31.8 33.5 34.0 
4/4 (0.11) (1.61) (0.77) (0.12) (0.23) (0.16) (10) (136) (76) (2.9) (2.9) (0) 
6 II 
G2 PH1 1.31 3.62 1.72 0.96 1.12 1.12 45.5 181 162 
5/5 (0.44) (0.97) (0.40) (0.19) (0.32) (0.07) (16) (64) (36) 
G2 PH1 1.34 4.90 2.42 2.36 3.27 3.37 17.5 80.5 79.0 19.5 35.6 31.0 




G2 PH2 2.06 6.99 3.18 1.75 2.03 2.23 
5/5 (0.36) (1.66) (0.57) (0.13) (0.17) (0.07) 
57.2 99.9 121 16.3 22.9 18.0 
(17) (31) (9.7) (3.1) (5.5) (0) 
9 II 
G2 PH2 3.61 5.27 4.27 2.32 2.29 2.47 164 332 393 25.5 50.0 47.5 




1.00 4.33 5.25 2.49 3.00 3.97 31.6 201 315 
(0.12) (1.70) (1.45) (0.48) (0.43) (0.30) (17) (113) (45) 
G3 PH2 3.46 6.11 4.73 1.89 1.87 2.18 308 523 546 34.7 33.1 38.0 





2.36 7.12 5.12 2.01 2.43 2.95 85.2 374 404 18.3 22.5 24.5 
(0.71) (1.83) (1.30) (0.17) (0.31) (0.10) (31) (96) (76) (2.5) (4.7) (0c5) 
G3 PH3 2.78 3.15 3.38 2.20 2.12 2.48 216 241 293 32.3 30.9 32.0 
8/8 (0.53) (1.03) (0.92) (0.16) (0.26) (0.23) (20) (46) (51) (3.2) (4.5) (0) 
15 
G4 PH3 3.64 8.21 3.00 2.29 2.67 2.73 196 484 422 17.0 23.0 21.5 
12/12 (0.95) (2.50) (0.35) (0.19) (0.26) (0.17) (64) (117) (89) (1.0) (2.8) (0.5) 
12 III 
G4 PH3 4.89 6.05 4.13 3.13 3.22 3.60 300 465 497 23.0 22.8 
10/10 (1.31) -(1.90) (0.79) (0.28) (0.30) (0.12) (73) (68) (30) (3.7) (5.0) 
13 II 
G4 PH4 2.76 4.57 4.53 2.18 2.13 2.47 223 464 494 25.7 27.0 29.0 
12/12 (0.51) (0.93) (0.65) (1.40) (0.19) (0.27) (50) (152) (81) (4.0) (4.0) (2.0) 
14 II 
G4 PH4 3.31 5.03 3.80 3.19 3.26 3.72 196 284 323 20.3 25.9 27.0 
10/10 (1.12) (1.73) (0.70) (0.19) (0.32) (0.11) (31) (57) (26) (1.5) (4.2) (0) 
16 
04 PH4 3.01 4.93 4.38 2.47 2.44 2.60 211 476 523 35.0 33.8 21.0 

















2.78 5.41 3.85 1.73 1.82 2.05 2.44 552 618 258 34.1 34.0 
(0.43) (1.35) (0.91) (0.09) (0.20) (0.11) (8.4) (128) (32) (4.0) (3.2) (6.0) 
2.45 7.25 3.90 3.44 3.87 4.32 337 647 632 21.5 23.5 
(1.28) (2.75) (0.79) (0.30) (0.33) (0.16) (134) (59) (43) (3.3) (5.1) 
4.08 4.37 2.85 3.68 3.23 3.55 287 304 346 29.5 29.4 





4.11 5.38 5.22 2.46 2.21 2.48 248 402 477 25.7 27.4 
26.0 
(0.88) (1.93) (1.06) (0.15) (0.18) (0.18) (52) (121) (69) (3.2) (4.2) (1.0) 
3.12 5.20 3.93 2.03 1.97 2.17 242 485 479 23.3 22.9 
(0.77) (1.69) (0.55) (0.13) (0.16) (0.07) (33) (115) (33) (1.5) (6.0) 
30.5 
(9.5) 
178 363 152 
(47) (173) (29) 
326 499 412 
(66) (132) (147) 
463 478 178 
(103) (109) (38) 
244 458 335 
(42) (223) (98) 
120 299 136 
(10) (130) (24) 
239 392 228 
(89) (159) (130) 
197 . 718 260 
(38) (590) (73) 
235 458 215 
(44) (167) (66) 
453 673 470 
(133) (152) (174) 
190 315 233 
(179) (165) (42) 
136 327 230 
(9.9) (106) (94) 
280 467 392 
(44) (154) (85) 
115 220 466 
(9.5) (165) (235) 


































o o 3 
o o 5 
o o 2 
o o 4 
O 0 5 
1 0.9 5 
O 0 5 
O 0 4 
O 0 5 
O 0 5 
1 1.1 3 
1 0.9 4 
1 1.2 5 





1 1.30 3 









1 0.9 5 
1 5.6 3 
1 2.4 4 















































5.1 4.9 4.5 4.0 
7.4 4.2 3.7 3.8 
10.0 11.1 5.9 3.6 
9.2 4.3 4.4 7.5 
7.9 5.1 3.9 4.1 
7.0 5.9 5.3 4.4 
11.5 7.5 5.8 6.4 
14.1 9.5 6.9 7.9 
13.3 9.6 11.3 6.8 
16.2 13.4 11.3 8.4 
9.0 9.9 8.4 7.8 
19.1 11.8 9.7 11.0 
7.2 4.4 3.7 2.5 
12.5 
22.1 11.9 10.5 9.6 
7.5 9.2 6.7 9.4 
19.5 9.8 10.0 5.9 
11.6 10.8 6.7 8.0 
9.1 8.3 5.8 7.8 
20.9 12.1 14.1 9.2 
11.8 7.2 5.8 3.8 
20.5 13.0 14.2 12.5 













































17.7 12.2 12.7 9.5 
35.6 16.8 13.5 11.6 
35.0 25.3 13.6 8.7 
33.8 15.4 14.9 21.8 
33.9 15.1 7.8 13.9 
22.9 14.4 14.8 13.5 
44.0 22.0 14.4 18.8 
45.1 22.7 12.4 20.9 
50.8 36.7 26.5 13.2 
48.2 30.1 22.9 20.1 
35.5 26.2 22.3 24.2 
72.4 26.7 20.4 30.2 
31.3 10.9 12.3 4.9 
42.2 
64.4 37.3 23.6 23.2 
32.7 22.7 22.7 29.1 
65.6 22.5 19.6 17.9 
45.4 26.4 19.5 24.8 
28.7 25.3 14.0 15.6 
84.9 27.4 35.9 17.6 
40.9 17.8 17.7 12.8 
75.9 34.8 35.8 34.4 
60.7 27.2 19.6 21.8 
13.0 
(2.96) 
0.6 1.0 0.5 0.5 
19.4 2.1 1.4 0.8 0.5 
9.55) 
17.7 0.8 0.6 0.4 0.4 
(13.2) 
21.5 0.9 0.7 0.4 0.6 
(7.60) 
17.7 1.6 1.3 0.6 0.3 
0.3 0.4 0.5 0.5 
2.4 1.7 2.6 1.0 
0.7 0.6 0.4 0.2 
31.8 1.3 1.0 1.0 0.5 
0.8 1.4 1.1 1.2 
0.6 0.4 0.7 1.8 



































2.1 1.5 1.0 0.9 
0.9 0.7 0.2 0.4 
1.9 0.9 1.2 0.8 
1.5 0.8 0.7 0.2 
0.7 0.5 0.3 0.6 
1.5 0.8 0.8 1.5 
1.2 1.1 0.7 0.5 
1.0 0.7 0.4 0.4 



























2.0 5.0 2.1 2.0 
10.5 6.8 2.3 1.4 
4.0 2.6 0.4 1.6 
4.1 2.9 1.3 0.4 
3.9 4.7 1.1 0.3 
1.8 0.7 0.7 2.4 
9.4 7.4 4.2 3.7 
2.9 3.3 0.9 0.5 
6.9 3.9 3.2 0.8 
1.9 5.3 4.4 2.4 
-0.1 1.3 2.2 5.3 
5.5 3.5 -0.9 4.9 




















10.4 6.9 2.4 4.4 
4.7 3.7 0.3 1.6 
9.9 4.1 4.5 2.8 
6.1 3.5 2.3 -0.4 
2.2 2.3 0.7 1.6 
7.3 2.6 2.9 4.8 
9.7 4.0 2.8 2.3 
5.1 2.4 1.1 0.5 
3.9 2.6 0.2 1.9 
2.78 26.8 31.3 31.7 40.7 32.6 
(1.29) (2.3) (3.1) (1.4) (4.0) (5.8) 
5.25 98.0 102 102 102 101 
(3.66) (15.9) (9) (11) (17) (14) 
2.15 87.5 107 112 134 109 
(1.32) (8.3) (14) (3) (12) (19) 
2.18 130 135 128 131 131 
(1.43) (13) (8.5) (6.0) (8.0) (9.6) 
2.50 299 340 343 322 326 
(1.84) (71) (25) (18) (19) (44) 
1.40 112 172 159 188 158 
(0.73) (30) (10) (74) (20). (34) 
6.18 66.2 94.8 93.5 107 90 
(2.30) (12) (9.6) (9.5) (6.7) (18) 
1.90 120 139 123 132 129 
(1.20) (17) (2.2) (16) (18) (7.5) 
3.70 377 496 409 373 414 
(2.20) (58) (22) (62) (25) (67) 
3.50 282 284 316 360 313 
(1.40) (18) (15) (24) (36) (41) 
2.18 543 579 529 587 562 
(1.98) (70) (45) (24) (70) (60) 
4.13 369 404 342 366 370 
(1.14) (51) (30) (20) (38) (36) 
4.58 273 318 277 292 290 
(2.40) (52) (14) (30) (11) (36) 
327 
(75) 
6.03 459 498 459 416 458 
(3.00) (49) (21) (18) (37) (29) 
2.58 509 531 485 507 508 
(1.73) (79) (48) (54) (43) (60) 
5.33 302 318 292 334 312 
(2.70) (52) (22) (26) (27) (37) 
3.08 465 478 482 646 519 
(2.10) (38) (16) (32) (116) (99) 
1.70 562 632 651 754 650 
(0.64) (29) (38) (28) (33) (76) 
4.40 576 625 584 681 617 
(1.90) (72) (44) (15) (89) (55) 
4.70 347 363 352 381 361 
(2.95) (18) (32) (21) (29) (29) 
2.30 474 548 593 553 542 
(1.80) (31) (57) (72) (77) (75) 
2.15 485 511 478 538 503 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































of four profiles from one subject over a period of 27 
months (Fig 4.2a -c). 
The earliest detectable change in this series of 
studies was the nocturnal rise in plasma LH concentrations 
and Appendix II 
associated with sleep (Figs 4.1 & 4.24). This was observed 
before there was any clinical evidence of pubertal onset 
in terms of testicular enlargement to 4 mis or more and 
pubic hair development. At this time, FSH concentrations 
were invariably higher than that of LH. Early puberty 
was characterized by small amplitude and high frequency 
nocturnal LH pulsatile secretion with considerable shifts 
of the baselines values during the night compared with 
morning or evening. In late puberty, higher amplitude 
but lower frequency LH pulses were observed in the night 
as well as during the evening. However, the difference 
in baseline concentrations of LH between the sleep and 
awake periods was relatively small. Although a distinct 
pulsatile pattern of FSH secretion was not consistently 
present at any stage, most patients showed a progressive 
elevation of plasma FSH concentrations during the night 
with peak values being achieved in the morning. 
Both LH and FSH secretions were stimulated by the 
repeated exogenous GnRH injections in all subjects. The 
LH response increased with pubertal maturation but no 
obvious potentiation or exhaustion of the pituitary 
responsiveness was elicited by the two -hourly frequency 
of GnRH stimulation. Subjects in stage LA tended to have 
higher FSH responses than those in later stages of 
development. Testosterone concentrations increased 
SUBJECT 5 ST I 
15.48 yrs G1 PI-11 2/2 
LIGHTS OUT /SLEEP GnRH 10ugIV 






LH u/t -+- 







20 00 2300 0700 09.00 11.00 13.00 15.00 1700 
CLOCK TIME 
TESTOSTERONE ng /dt -.- 
Fig 4.1a 
Profiles of plasma LH, FSH and testosterone in subject 5 ST I 
representative of late prepuberty. The hormone concentrations 
were determined at 20- minute intervals for 21 hours. The pituitary 
and testicular responsiveness was assessed by four GnRH (10 µg) 



















SUBJECT 9 DC II 
15-83 yrs G2 PH2 6/5 
LIGHTS OUT 1 SLEEP 
LH ull -s- 
FSH ull -0- 
l 
Gn RH 10 ug IV 
Fig 4.1b 
Profiles of plasma LH, FSH and testosterone in subject 9 DC II 
representative of mid -puberty. The hormone concentrations were 
determined at 20- minute intervals for 21 hours. The pituitary 
and testicular responsiveness was assessed by four GnRH (10 µg) 
intravenous bolus injections at two -hourly intervals. 
TESTOSTERONE ng /dl - 










SUBJECT 16 GF III 
1965 yrs G5 PH5 20/20 
LIGHTS OUT / SLEEP 
LH u l l -*- 
F S H u / l --0- 
GnRH 10,uq IV 





TESTOSTERONE ng /dl- -- 
0 
2000 23 00 07 00 0900 11.00 13-00 15.00 1700 
CLOCK TIME 
Fig 4.1c 
Profiles of plasma LH, FSH and testosterone in subject 16 GF III 
representative of late puberty. The hormone concentrations were 
determined at 20- minute intervals for 21 hours. The pituitary 
and testicular responsiveness was assessed by four GnRH (10 µg) 
bolus injections at two- hourly intervals. 
SUBJECT 1 2 C R I 
14.58 yrs G2 PH2 5/5 
LIGHTS OUT/SLEEP 
18 
Gn RH 10 ug IV 








20 00 23.00 0700 0900 1100 13-00 15.00 1500 
CLOCK TIME 
TESTOSTERONE ng /dl 
Fig 4.2a 
Profiles of plasma LH, FSH and testosterone in one subject 
(subject 12 CR) studied in early puberty over a period of 12 
months. The hormone concentrations were determined at 
20- minute intervals for 21 hours. The pituitary and 
testicular responsiveness was assessed by four GnRH (10 µg) 


















20 00 23 00 
SUBJECT 12 CR 
15.10 yrs G3 PH3 8/8 
LIGHTS OUT / SLEEP 
LH ull 
F S H u l l -- 
GnRH 10ug IV 
TESTOSTERONE ngldl - - 
225 
07.00 09.00 11.00 13.00 15.00 17-00 
CLOCK TIME 
Fig 4.2b 
Profiles of plasma LH, FSH and testosterone in one subject 
(subject 12 CR) studied in mid puberty over a period of 12 
months. The hormone concentrations were determined at 
20- minute intervals for 21 hours. The pituitary and 
testicular responsiveness was assessed by four GnRH (10 µg) 



















SUBJECT 12 CR III 
1558 yrs G4 PH3 10/10 
LIGHTS OUT I SLEEP Gn RH 10 jig IV 
1 1 1 1 
20 00 2300 07.00 09.00 1100 1300 1500 17 :00 
CLOCK TIME 
Fig 4.2c 
Profiles of plasma LH, FSH and testosterone in one subject 
(subject 12 CR) studied in late puberty over a period of 
12 months. The hormone concentrations were determined at 
20- minute intervals for 21 hours. The pituitary and 
testicular responsiveness was assessed by four GnRH (10 µg) 
intravenous bolus injections at two- hourly intervals. 
227 
during the night from early puberty onwards but adult 
levels were not reached until late puberty. No distinct 
pulsatile pattern of testosterone secretion was seen in 
most subjects. 
4.2.2 Mean diurnal plasma hormone concentrations 
Changes in mean plasma concentrations of LH, FSH, 
testosterone and oestradiol across the six different 
clinical stages of puberty are illustrated in Figure 4.3. 
The greatest rate of increase in plasma LH concentration 
was observed at night between stages 1A, 1B and 2 with 
little further change in subsequent stages. A similar 
pattern was present in plasma LH in the morning with the 
peak levels being achieved at stage 3. A more gradual 
and linear rise in plasma LH concentration was seen in 
the evening. Mean plasma FSH concentrations showed a 
significant linear rising trend (p <0.001) over the six 
clinical stages of puberty in all three periods (evening, 
night and morning) of the twenty -four hour cycle. 
Similar linear rising trends were also present in the 
mean evening, night and morning testosterone levels 
across the pubertal stages, the magnitude of this 
increase being several fold greater than that observed in 
gonadotrophins. Adult concentrations of plasma testo- 
sterone were reached by stage 3 or 4 in some patients in 
the morning or night but somewhat later in the evening. 
Oestradiol levels remained low (20 -40 pg /ml) throughout 
puberty with no discernible trends in any part of the day 
or night. 









































































































































































































































































































































































































































LH, FSH, testosterone and oestradiol in each of the six 
clinical stages of puberty are shown in Figure 4.4. 
Significant nocturnal elevation of LH was first 
encountered in stage 1B. This constituted the earliest 
detectable hormonal change which heralds the onset of 
puberty. The greatest absolute or percentage increase 
in nocturnal LH occurred in stages 2 and 3 although the 
diurnal pattern of LH persisted into stage 5. LH levels 
declined in the morning on waking but they remained 
higher than those in the evening between stage 1B to 
stage 5. No significant nocturnal FSH rise was observed 
at any stage of puberty but mean plasma FSH concentrations 
in the morning were significantly elevated from the 
nocturnal levels in stages 2 to 5. In early prepubertal 
subjects (stage 1A), FSH concentrations in peripheral 
plasma were higher than LH throughout the day and night 
with the LH:FSH ratio of less than one. The reverse was 
the case in sexually mature subjects (stage 5). The 
change in LH:FSH ratio from less to greater than one 
during puberty occurred in stage 1B during the night, 
stage 2 during the morning and stage 3 during the evening, 
generally reflecting the onset of enhanced LH secretion 
with pubertal development at specific portions of the 
twenty -four hour cycle. The diurnal pattern of testo- 
sterone during puberty showed .nocturnal increases 
becoming detectable from stage 1B onwards and persisting 
into stage 5. Unlike LH whose concentrations fell on 
waking in the morning, the elevated nocturnal levels of 
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further. Oestradiol displayed a consistent lack of 
diurnal variation during puberty. 
4.2.3 Pulsatile LH secretion 
The frequency and amplitude of LH secretion during 
puberty are shown in Figure 4.5. The morning and night 
periods were considered together as the duration of the 
former on its own was too short for pulse analysis. 
Nocturnal LH pulse frequency increased rapidly in the 
peripubertal period and the highest values, four to five 
pulses per ten hours, were achieved at stage 2 - the 
clinical onset of puberty. Between stage 2 and stage 5, 
nocturnal LH pulse frequency became attenuated although 
this did not reach the 5% level of statistical 
significance. Nocturnal LH pulse amplitude increased in 
a linear fashion from stage lA to stage 5. Although the 
duration of the evening period was only three hours, it 
proved possible to estimate the LH pulse frequency and 
amplitude reasonably accurately. No LH pulses were 
detectable in stages lA or 1B. Infrequent LH pulses were 
present in stage 2 which increased steadily to peak 
values of four to five pulses per ten hour at stage 4 and 
5. The LH pulse amplitude increased linearly between 
stages 2 and 5. Thus pulsatile LH secretion in the 
evening, and possibly for the rest of the waking hours, 
followed a pattern similar to the nocturnal period from 
















































































































































































































































































































4.2.4 Pituitary responsiveness to GnRH 
A significant pituitary LH and FSH response could 
be elicited by the present submaximal but repeated GnRH 
stimulation regime in all subjects including the most 
sexually immature individuals (Fig 4.1, Appendix II) 
For the maximal incremental or integrated area of LH 
response, the first bolus of GnRH always produced a 
greater rise than the subsequent three, to which the 
responses were not significantly different from each 
other. The maximal incremental LH response to the 'first 
bolus of GnRH increased steadily during pubertal 
maturation from stage lA onwards (Fig 4.6). The mean 
maximal incremental LH response to the second, third and 
fourth GnRH bolus demonstrated a parallel increase to the 
first response across the pubertal stages (Fig 4.6). The 
integrated LH response area to the first and subsequent 
pulses of GnRH followed closely the pattern of the 
maximal incremental response (Fig 4.7). The similarity 
between maximal incremental and integrated area response 
to GnRH was also observed in FSH to both the first and 
subsequent boluses. However, unlike LH, the maximal FSH 
response (A Max as well as integrated area) to exogenous 
GnRH stimulation was seen in stage 1A, following which 
the magnitude of response was diminished and remained 
unchanged in the subsequent stages of puberty (Fig 4.7). 
The dynamics of LH- secretion elicited by exogenous 
GnRH stimulation in the six stages of puberty is 
summarized in Table 4.3. The apparent half -lives of 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































integrated LH response area to each bolus of GnRH divided . 
by the maximal LH increment and multiplied by twenty 
minutes. The mean apparent half -lives of circulating LH 
secreted in response to the pulsatile exogenous GnRH 
stimulation remained remarkably constant during sexual 
maturation irrespective of the increasing magnitude of 
pituitary response. In each of the six stages of puberty, 
mean apparent half -life of LH in the first induced 
response was significantly greater than the subsequent 
three, whose LH apparent half -lives were very similar. 
Thus the relationship between the first and subsequent 
three responses to pulsatile GnRH stimulation has 
remained constant throughout puberty. 
4.2.5 Endogenous GnRH /pulsatile secretion 
Since the qualitative aspects of pituitary LH 
secretion in response to exogenous GnRH have been shown 
to remain relatively constant during pubertal development, 
it may be assumed that the pituitary responded to 
endogenous GnRH in a similar manner. With knowledge of 
both the nocturnal spontaneous LH pulse amplitude induced 
by endogenous GnRH pulses as well as the LH pulse 
amplitude (A Max) produced by exogenous GnRH pulses in 
the same subject, it was possible to estimate the 
magnitude of endogenous GnRH pulses using a liner log - 
dose relationship (Kelch et al, 1975; Wollensen et al, 
1976). Injection of a 10 ug bolus of GnRH into the 
antecubital vein would produce a concentration of GnRH 
in the hypophysial circulation which was dependent on the 











































































































































































































































































































































































































(Kelch et al, 1975) provided there was no immediate 
metabolism or preferential uptake by the hypothalamus. 
The concentration of exogenous GnRH in the hypophysial 
circulation (a) could then be used to calculate the 
endogenous nocturnal GnRH concentration (b) by relating 
to the mean A Max LH response to exogenous GnRH (y) and 
the mean nocturnal LH pulse amplitude (x). Thus the 
estimated endogenous GnRH concentration, Log b = Log a 
x x /y. The estimated peak concentrations of endogenous 
nocturnal GnRH pulses secreted into the hypophysial 
portal circulation in the six stages of puberty are 
shown in Table 4.4. There was no significant change in 
the magnitude of hypothalamic GnRH pulsatile secretion 
during pubertal development. The estimated range of 
GnRH concentration in the hypophysial portal circulation 
varied from 1.6 -119 pg /ml. 
4.3 Discussion 
The present results confirmed the pubertal increase 
in plasma concentrations of gonadotrophins and testo- 
sterone described in previous studies based on day -time 
samples (Burr et al, 1970; August et al, 1972; Winter & 
Faiman & Winters 
Faiman, 1972;/ 1974; Lee et al, 1974; Baker et al, 1976). 
The presence of nocturnal sleep -related gonadotrophin and 
testosterone secretion in puberty was also confirmed in 
boys with delayed puberty (Boyar et al, 1972b & 1973). 
Amongst these earlier studies, however, conflicting data 
on the timing and magnitude of the various hormonal 
changes were present. Thus, Faiman & Winter (1974) found 
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that plasma FSH rise preceded that of LH while Lee et al 
(1974) demonstrated the reverse. The precise determin- 
ation of temporal relationships in LH and FSH secretion 
in puberty is important in advancing the understanding of 
the mechanism of puberty and the initiation of spermato- 
genesis with respect to the augmented Leydig cell 
steroidogenesis. Furthermore, how the nocturnal sleep - 
related gonadotrophin and testosterone secretions fit 
into the day -time pattern of hormonal changes with 
advancing sexual maturation has not been systematiéally 
studied. 
Our results demonstrated that the pattern of LH and 
FSH secretion, particularly in early puberty, varied 
considerably depending on the clock -time of blood 
sampling (Figs 4.3 & 4.4). A recent study (Beck & Wuttke, 
1980) in normal children aged 1 -15 years has also yielded 
very similar results. The earliest and also the greatest 
rate of LH increase occurred at night while the morning 
samples showed FSH levels at their maximum although the 
rate of FSH rise through puberty at different parts of 
the day were not different. The diurnal variation in LH 
and to a lesser extent FSH may account for some of the 
discrepancies in previous studies based on single blood 
samples taken at different or unspecified times of the 
day. The difficulty in interpretation of pubertal 
hormone data without taking into account the important 
nocturnal period is self- evident. 
Since the weight of evidence at present favours the 
existence of a single hypothalamic GnRH which stimulates 
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the pituitary release of both LH and FSH (Schally et al, 
1976), the dissociated pattern of LH and FSH secretion 
during puberty, especially highlighted in the nocturnal 
period, must result from differences in dynamics of 
pituitary secretion of the two gonadotrophins and the 
longer half -life of FSH in the circulation (Yen et al, 
1970). Nocturnal LH secretion was characterized by the 
acute rise and fall of plasma LH concentration compatible 
with its shorter circulating half -life (Yen et al, 1968; 
Santen & Bardin, 1973) and the episodic stimulation of 
its release by pulsatile endogenous GnRH secretion of the 
hypothalamus. The FSH secretory pattern showed a much 
slower rise and fall in plasma concentrations with small 
but more sustained peak levels which may not return to 
baseline before the start of the next secretory episode. 
Both patterns of endogenous gonadotrophin secretion were 
also well demonstrated by the contrasting response 
patterns of LH and FSH to repetitive exogenous pulsatile 
GnRH stimulation at different stages of maturation (Figs 
& Appendix II 
4.1 & 4.2k). The stepwise upward shift in baseline FSH 
concentrations produced by exogenous GnRH pulses resulted 
in peak values being attained at the end of the 
stimulation period. This same pattern of pituitary FSH 
secretion can probably account for the observed increase 
in plasma FSH from night to morning in response to 
nocturnal endogenous GnRH pulsatile stimulation. These 
results and their interpretations are consistent with 
similar observations on the pituitary response to 
repetitive GnRH stimulation in humans (Reitano et al, 
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1975; Krabbe & Shakkebaek, 1977), rams (Licoln, 1979) 
and rats (Johnson & Mellampiani, 1975). 
This study also confirmed that in early prepubertal 
and hypogonadotrophic subjects, stable but low 
circulating levels of LH and FSH were characteristic. 
In addition, FSH concentrations were consistently higher 
than those of LH in sexually immature patients, being the 
reverse of the adult pattern. The first detectable 
change indicating the onset of pubertal development was 
the presence of nocturnal pulsatile GnRH /gonadotrophin 
secretion coinciding with the reversal of the LH:FSH 
ratio to greater than unity at night in stage 1B (Figs 
4.3 & 4.4). This reversal of the LH:FSH ratio occurred 
one or two stages later in the morning and evening, again 
temporally correlated with the later appearance of 
pulsatile GnRH secretion at these times. It is 
reasonable therefore to suggest that the reversal of 
plasma concentrations of LH and FSH during puberty may be 
the result of an increasing frequency and /or amplitude of 
pulsatile GnRH stimulation of the pituitary gonadotropes 
producing larger, acute but brief LH secretory episodes 
in contrast to the smaller, more sluggish but longer - 
sustained FSH secretion. Recent studies in the 
ovariectomized monkeys bearing hypothalamic lesions 
showed that lowering the frequency of pulsatile GnRH 
stimulation from one pulse per hour to one pulse per 
three hours produced a disproportionately large FSH 
response compared to LH and a reversal of the LH:FSH 
ratio (Wildt et al, 1981). It appears that at lower 
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pulse frequencies, the effect of the 3 -fold longer FSH 
half -life is exaggerated although this may not be the 
only explanation. Whatever the mechanism, that study 
emphasized the importance of frequency modulation of 
pituitary gonadotrophin secretion on the absolute and 
relative concentrations of circulating LH and FSH. Apart 
from the obvious parallel in the pattern of gonado- 
trophins in puberty as demonstrated in this study, 
similar changes in LH:FSH ratio have also been observed 
in other physiological or pathological situations such as 
recovery from post -lactational or postpartum amenorrhoea 
(Rolland et al, 1975; Plant et al, 1980) and in the 
polycystic ovarian syndrome (Yen, 1980). 
In women with gonadal dysgenesis or after the 
menopause and in adult castrates of both sexes, plasma 
FSH concentrations are usually in excess of LH despite 
the presence of normal or even enhanced pulsatile GnRH 
stimulation (Yen et al, 1972a-& b; Root et al, 1972; 
Conte et al, 1975). This implies that a negative 
feedback signal from the gonad that preferentially 
suppresses pituitary FSH secretion must normally exist. 
This is compatible with the finding that maximal FSH 
responsiveness to exogenous GnRH is present in early 
prepubertal subjects (stage 1A) which rapidly became 
attenuated in stage 1B with the first sign of testicular 
enlargement. The exaggerated FSH response to GnRH during 
the earliest part of sexual maturation has also been 
observed recently in hypogonadotrophic patients treated 
by low -dose pulsatile GnRH administration (Jacobson et al, 
244 
1979; Valk et al, 1980) or by a superactive GnRH analogue 
(Crowley et al, 1980a). In some of these cases, 
especially females, a decline in FSH response to GnRH was 
observed after the initiation of treatment. It is 
obvious that there is little increase in testicular 
steroid secretion at this early stage to account for the 
enhanced negative feedback. On the other hand, the 
establishment of sertoli cell function, seminiferous 
tubular growth and germ cell differentiation are believed 
to take place in early puberty (Steinberger et al, 1978; 
Richardson & Short, 1979). It seems likely that the 
negative feedback of pituitary FSH secretion established 
in early puberty is effected by seminiferous tubular 
factors. The seminiferous tubules at this stage of 
development are unlikely to contain any germ cells more 
mature than early spermatids (Sniffen, 1950; Charny et al, 
1952; Albert et al, 1953) so that the source of the 
tubular negative feedback signal for FSH must reside in 
either the Sertoli cells or the immature germ cells. 
This is consistent with the findings of A. Steinberger 
(1979) which suggested that Sertoli cells in culture can 
elaborate a factor which inhibited pituitary cell FSH 
release. The relative importance of gonadal negative 
feedback versus the frequency modulation of GnRH 
stimulation in producing the change in pattern of LH and 
FSH secretion in puberty remains to be clarified. 
However, it is interesting to note that despite the early 
attenuation of pituitary FSH responsiveness to GnRH, mean 
FSH levels in subsequent pubertal stages continued to 
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rise until late puberty (Fig 4.9). This could possibly 
reflect the relatively minor role in the negative feed- 
back control of FSH contributed by the seminiferous 
tubules compared to the later and more significant 
effects of testicular steroids (Morris & Jackson, 1978). 
The change in frequency and amplitude of pulsatile 
LH secretion is one of the crucial events in pubertal 
development. This study has clearly demonstrated that 
the appearance of sleep -related episodic LH secretion is 
the earliest detectable change in hypothalamic -pituitary 
function. From the low and stable baseline concentrations 
of LH in stage 1A, maximal LH pulse frequency of 4.7 ± 0.5 
pulses per ten hours or a pulse interval of 128 ± 12 
minutes was attained as early as stage 2, indicating the 
early functional maturity of the hypothalamus at what is 
clinically the onset of puberty. Thereafter, nocturnal 
LH pulse frequency showed a tendency to decline although 
this did not reach the 5% level of statistical 
significance (see later). Nocturnal LH pulse amplitude 
however demonstrated a progressive five -fold increase 
from stage lA to 5. These changes were associated with 
an increase in mean nocturnal LH from stage lA to stage 2, 
whereupon no subsequent rise occurred - a pattern closely 
paralleled to that of nocturnal LH pulse frequency rather 
(Fig 4.9) 
than amplitude. This is not unexpected considering the 
short circulating half -life of LH. Thus changes in the 
mean concentration of this hormone are rarely seen with- 
out concurrent alterations in the frequency of episodic 









































































































































































































































































































































































































































































































































































































































































































amplitude may not be so critical provided the secretory 
pulse interval is not appreciably shorter than the 
duration of a secretory episode. This point is well 
demonstrated by the relatively stable mean LH concen- 
tration in puberty stages 4 and 5 despite the continuing 
increase in LH pulse amplitude. It can be inferred that 
the mean circulating concentration of LH during puberty 
is predominantly dependent on the frequency rather than 
amplitude of episodic secretion. This interpretation is 
consistent with the view that modulation of the frequency 
of hypothalamic GnRH secretion is probably the most 
important mechanism regulating the development of 
pituitary gonadotrope function during puberty. 
The progressive increase in LH pulse amplitude in 
puberty is mainly dependent on two factors: the pituitary 
responsiveness to GnRH and the amount of GnRH released 
into the hypophysial portal circulation in each secretory 
episode. The former can be directly assessed by 
exogenous GnRH stimulation of pituitary LH (and FSH) 
production. The latter, because of the extremely low 
concentrations of GnRH found in the peripheral circulation, 
can only be estimated indirectly by comparing the 
exogenously and endogenously- induced LH pulse amplitudes. 
The present results failed to show any progressive 
increase in the magnitude of hypothalamic pulsatile GnRH 
secretion during puberty with mean values in the six 
clinical pubertal stages varying from 15 -35 pg /ml. The 
range of estimated GnRH concentrations (1.6 -119 pg /ml) is 
in the same order of magnitude as that obtained by direct 
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measurement of GnRH in hypophysial portal blood in adult 
Rhesus monkeys (Carmel et al, 1976; Neil et al, 1977) and 
rats (Sarkar et al, 1976; Eskay et al, 1977) which 
yielded values varying from undetectable to 1000 pg /ml. 
Kelch's group, using a similar approach to ours, 
estimated the pituitary portal GnRH concentration in 
human pubertal and adult males to be between under 30 -300 
pg /ml (Kelch et al, 1975; Huseman & Kelch, 1978; Corley 
et al, 1981). In the adult Soay ram, the estimated 
magnitude of hypothalamic GnRH secretion increased and 
subsequently declined during the transition from the 
regressed to the active stages of the seasonal reproduct- 
ive cycle with pituitary portal GnRH concentrations 
between 60 -217 pg /ml. These estimates of GnRH secretion 
are based on the assumptions that injected GnRH is 
uniformly distributed in the circulation, that it was not 
immediately metabolized or preferentially taken up by the 
hypothalamus and that the concentration of GnRH in the 
systemic venous circulation is equivalent to that in 
blood entering the hypophysial portal vessels. It is 
further assumed that exogenous and endogenous GnRH evoked 
qualitatively similar resonses in the pituitary through- 
out the twenty -four hours. Despite these possible 
sources of inaccuracy, gross underestimation of 
endogenous GnRH production is unlikely since the twenty - 
minute sampling frequency in the present study tends to 
underestimate the peak LH response to exogenous GnRH 
stimulation. Support for the absence of a pubertal rise 
in GnRH pulse amplitude is also provided by the 
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concurrent seven -fold increase in pituitary responsive- 
ness to GnRH. The latter can more than account for the 
five -fold rise in nocturnal LH pulse amplitude during 
puberty without the need to invoke any changes in 
(Fig 4.9) 
magnitude of GnRH secretion It appears that in man the 
pubertal rise in LH pulse amplitude is the direct result 
of the maturation of pituitary gonadotropes with the 
concomitant enhanced responsiveness to GnRH stimulation. 
These changes of the pituitary may be induced by the 
priming effect of increased frequency of hypothalamic 
GnRH stimulation. Support for this is found in patients 
with Kallmann's syndrome (congenital deficiency of hypo- 
thalamic GnRH) and other disorders of HPT axis where 
prolonged treatment with exogenous GnRH can restore 
normal responsiveness in the pituitary (Yoshimoto et al, 
1975; Hashimoto et al, 1975). It can be said that the 
increase in both frequency and amplitude of pulsatile LH 
secretion in puberty are directly or indirectly related 
to the increased frequency of hypothalamic GnRH 
stimulation. 
The availability of synthetic GnRH and miniaturized 
programmable infusion pumps has facilitated the treatment 
of hypogonadotrophic hypogonadism by the pulsatile 
administration of small doses of GnRH (Jacobson et al, 
1979; Crowley & McArthur, 1980a; Valk et al, 1980). 
Although the early results are favourable, the dose of 
GnRH administered varied from 25 ng /Kg body weight to 
40 ug per pulse. Since unphysiological doses of GnRH may 
produce negative effects on both pituitary and testicular 
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functions (Linde et al, 1981; Comite et al, 1981), it is 
important to optimize the dose regime of pulsatile GnRH 
treatment of hypogonadotrophic patients. Based on the 
results of this study, the dose of exogenous GnRH 
administered which produces physiological concentrations 
of GnRH and pituitary responses similar to spontaneous 
GnRH pulses in puberty is 92 ng /Kg body weight or 3.8 ug 
per bolus. Thus the administration of around 4 ug of 
GnRH intravenously at one to two hourly intervals should 
theoretically yield optimal pituitary- testicular responses 
with minimal inhibitory effects on prolonged treatment. 
Closer scrutiny of the individual hormonal profiles 
disclosed a further aspect of nocturnal LH secretion 
which was not apparent from the meaned data (Figs 4.1, 
4.2 & Appendix II). In the early pubertal profiles, the 
nocturnal rise in LH took the form of frequent but small 
amplitude secretory episodes producing a marked and 
sustained upward shift of the LH baseline concentration. 
However, due to the short interval between LH secretory 
episodes and the comparatively long sampling interval of 
twenty minutes, the exact frequency of nocturnal LH 
secretory episodes tended to be underestimated in this 
study. The mean nocturnal LH concentrations in early to 
mid puberty, despite the much smaller amplitude of 
individual LH pulses, were comparable to later stages. 
This implies that the nocturnal LH pulse frequency in 
early to mid puberty must be significantly higher than 
can be gauged from the present methods of sampling or 
analysis. From puberty stage 4 onwards, the nocturnal LH 
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secretory pattern showed a distinct but gradual change to 
less'frequent LH pulses with greater amplitude each of 
which returned towards baseline before the onset of the 
next secretory episode. This is reminiscent of the 
response pattern to the two -hourly exogenous GnRH 
stimulation and suggests that the frequency of endogenous 
GnRH pulses during sleep in early puberty must be 
considerably in excess of one every two hours. The 
pattern of LH secretion in the evening was similar to the 
nocturnal period except that the high frequency and low 
amplitude pulsatile secretion of early puberty was absent 
or undetectable. Since the evening LH pulse amplitudes 
were comparatively small even at stage 5, it is possible 
that any low amplitude fluctuations in plasma LH 
concentration in early puberty would have been below the 
sensitivity of the assay. 
It has already been mentioned that low -dose 
pulsatile GnRH administration by programmed infusion 
pumps could induce the "maturation" of the pituitary 
gonadotrophin secretory pattern in patients with hypo - 
gonadotrophic hypogonadism. It may therefore be inferred 
that pulsatile GnRH stimulation at two hourly intervals 
in the doses used may be able to emulate the functional 
maturation of the pituitary and testes in spontaneous 
puberty. However, the duration of these studies are 
relatively short and final conclusions must await longer - 
term results. Experimental studies in monkeys and lambs 
(Knobil et al, 1980b; Steiner & Bremner, 1981; Foster et 
al, 1978; Ryan & Foster, 1980) have unequivocally 
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confirmed that GnRH stimulation at the optimal pulse 
frequency for these species of one hourly was successful 
in inducing the full development of the immature gonads. 
Foster et al (1978) also showed that GnRH /LH pulse 
frequency became attenuated at the peripubertal period in 
the ram -lamb. This observation suggested that the 
pubertal changes in functional dynamics of the hypo- 
thalamic- pituitary testicular axis may involve additional 
factors other than a simple feedforward cascade mechanism 
initiated by an increase in pulsatile GnRH secretion. 
This is compatible with the pattern of LH /GnRH secretion 
observed in human puberty in this study. Thus the barely 
detectable levels of LH in prepuberty was succeeded by 
the high frequency and low amplitude fluctuations in 
early puberty which then gave way to the lower frequency 
and high amplitude LH secretory pattern in late puberty 
and adulthood. It may be speculated that the high 
frequency GnRH secretion at the onset of puberty is a 
unique ontogenic phenomenon in humans transiently 
entrained to CNS activities such as sleep. Once pubertal 
development is under way and the pituitary gonadotropes 
have developed adequate synthetic capacities in mid - 
puberty, the endogenous hypothalamic rhythm (two- hourly 
pulses) manifestsitself predominantly while the high 
frequency sleep- related rhythm is either lost or sub- 
merged. In this formulation, sleep entrainment of GnRH 
secretion can be regarded as a neuroendocrine mechanism 
which man has phylogenetically evolved to trigger the 
onset of puberty at an appropriate stage of physical and 
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CNS maturity. The only other situation where sleep - 
related gonadotrophin secretion is encountered is in the 
active phase of anorexia nervosa (Boyar et al, 1974b) 
where the loss of body mass is said to mimic the reversal 
of changes during pubertal development and thus allows 
the re- emergence of sleep- related gonadotrophin secretion. 
Sleep- associated gonadotrophin secretion, to the best of 
the author's knowledge, has not been described in any 
other species apart from humans. A recent report 
described the presence of diurnal variation in the 
pulsatile LH secretion of intact male adult rhesus 
monkeys (Plant et al, 1981) but the relationship to the 
sleep -wake cycle was not ascertained. 
There is evidence for a different though not 
mutually exclusive explanation for the observed changes 
in the pattern of pulsatile GnRH /LH secretion during 
pubertal development. In the adult male, LH pulse 
frequency averagéd about one per two hours (Nankin & 
Troen, 1971; Santen & Bardin, 1973; Huseman & Kelch, 
1978) which is more or less similar to that found in late 
pubertal subjects in this study. In adult premenopausal 
females, frequent (one pulse per ninety minutes) small 
amplitude LH pulses typify the follicular phase while in 
the mid and late luteal phase, low frequency (one pulse 
per two to six hours) and high amplitude pulses are 
characteristic (Yen et al, 1974). This change in 
pulsatile pattern of LH secretion, not unlike that seen 
during puberty, is attributed to the feedback effects of 
oestradiol and progesterone on the hypothalamic- 
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pituitary unit during the latter half of the menstrual 
cycle (Yen et al, 1975). It is possible that in the 
presence of relatively stable levels of testosterone, the 
LH secretory pattern in the adult male is intermediate 
between the follicular and luteal phase in the female. 
In postmenopausal or agonadal females and those with 
gonadal dysgenesis, LH pulse frequency is not different 
from that in the follicular phase of menstruating women - 
the high mean gonadotrophin concentrations resulting from 
increased pulse amplitude exclusively (Yen et al, 1972 a & 
b; Root et al, 1972). This implies that physiological 
concentrations of oestradiol in the female have minimal 
effects on LH pulse frequency - a finding supported by 
the feedback studies of Wallach et al (1973) and 
Rosenfield et al (1973). By analogy, the high frequency 
GnRH secretion in early male puberty may be equivalent to 
the follicular phase in premenopausal females and as the 
testes mature, testosterone feedback gradually reduces 
the GnRH pulse frequency. That the negative feedback of 
testosterone has a preferential or selective effect on LH 
pulse frequency while leaving pulse amplitude unchanged 
or even enhanced was clearly demonstrated by Santen (1977) 
and Winterset al (1979). Furthermore, the pituitary 
response to GnRH stimulation during testosterone infusion 
remained unchanged (Santen, 1977). These findings 
together with those in this study strongly support the 
crucial role of testosterone in modifying the frequency 
of hypothalamic GnRH pulsatile secretion in the latter 
half of pubertal development. The major weakness of this 
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hypothesis is that it does not explain the sleep - 
entrained nature of gonadotrophin secretion in early and 
mid -puberty nor does it elucidate the mechanism of the 
delayed onset of GnRH secretion during the day. 
From the foregoing discussion, it is evident that 
neither sleep- entrained GnRH secretion nor the gonadal 
feedback mechanisms individually can fully account for 
the evolution of the pattern of pulsatile gonadotrophin 
secretion during puberty. It is conceivable that both 
mechanisms combine to produce the changes observed in 
this study. The onset of puberty may be triggered by the 
high frequency GnRH discharges which, by some unknown 
mechanisms, require the specific neurohumoral environment 
provided by the state of sleep in the maturing brain. 
Further development of the CNS after the onset of puberty 
presumably allows the facilitatory neurohumoral ambience 
to be maintained throughout the twenty -four hours and 
GnRH secretion can be stimulated throughout the sleep - 
wake cycle. Presently, testicular maturation has also 
advanced to the extent that the increasing circulating 
concentrations of testosterone or other gonadal secretory 
products were capable, by negative feedback, of further 
modifying the pattern and amount of GnRH and gonado- 
trophin sythesis and release. Thus the GnRH pulse 
frequency is slowed while the magnitude of LH secretory 
episodes continue to increase until a new equilibrium is 
achieved in late puberty which is maintained in adulthood. 
The role of testosterone in puberty, apart from the 
initiation of spermatogenesis and induction of secondary 
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sexual characteristics, may be to modify the rate of GnRH 
secretion so that the pituitary and gonads do not become 
desensitized by the increasing levels of GnRH (Clayton & 
Catt, 1981). Curiously, the relatively simple study of 
examining the pulse frequency and amplitude of LH 
secretion in pre and post -pubertal male castrates has not 
yet been performed. 
A close relationship between specific sleep stages 
and gonadotrophin secretion was suggested by the 
correlation between the number of LH secretory episodes 
and the number of sleep cycles - four to six per night on 
average in adults. The LH secretory pulse interval of 90 
minutes also matches the 80 -90 minute periodicity of the 
REM (rapid eye movement) and non -REM sleep cycle 
(Weitzman et al, 1975). These authors further suggested 
that LH secretion was initiated during non -REM sleep and 
terminated during or close to REM sleep in pubertal boys 
and girls (Boyar et al, 1972b). There is evidence that 
non -REM sleep is initiated and maintained by serotonin- 
ergic mechanisms and REM sleep is initiated by 
serotoninergic but maintained by noradrenergic and 
cholinergic mechanisms (Jouvet, 1969). The same neuro- 
transmitters are also involved in the control of 
hypothalamic GnRH secretion (McCann & Ojeda. 1976). It 
has been speculated that neurotransmitter functions may 
provide the chemical basis linking sleep stages and 
gonadotrophin secretion (Boyar, 1978). However, the 
effect of serotonin on GnRH secretion and LH secretion is 
inhibitory (Gallo & Moberg, 1977) while noradrenaline is 
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generally regarded as a stimulator of pulsatile GnRH 
secretion (Bhattacharya et al, 1972; Drouva & Gallo, 
1976). It is therefore not surprising that a direct 
relationship between LH secretion and specific sleep 
stages in pubertal subjects has not been confirmed 
(Parker et al, 1975). In the present study, the onset 
of LH secretory episodes was randomly distributed between 
REM, stage I & II and III & IV sleep (Fig 4.8). Similar 
findings in adult men have also been reported (Yen et al, 
1974; Alford et al, 1973) although the study of Rubin et 
al (1972) showed a 14% higher concentration of plasma LH 
during REM than non -REM sleep. Collectively, these 
results suggest that the transient temporal association 
between the rest phase of the sleep -wake cycle (rather 
than specific sleep stages) and GnRH /LH secretion may be 
due to certain common neural mechanisms which are 
maturity- determined and may involve changes in neuro- 
transmitter functions. The further elucidation of the 
neurohumoral basis of sleep -related pubertal mechanisms 
will have to depend on neuropharmacological studies 
designed to investigate the relationships between sleep - 
wake cycle, neuroendocrine secretions and biological 
rhythm control. 
The secretion of growth hormone is closely linked to 
slow -wave (stage III & IV) sleep (Takashashi et al, 1968; 
Honda et al, 1969; Parker et al, 1969; Sassin et al, 1969). 
Growth hormone has widespread effects on protein, carbo- 
hydrate and fat metabolism and is considered to be one of 
the principle anabolic hormones (Korner, 1965). This has 
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given rise to the hypothesis that sleep, in particular 
slow -wave sleep, subserves a restorative role facilitating 
the shift in metabolic balance from degradative to 
synthetic processes (Adam & Oswald, 1977). LH can also 
be considered to be an anabolic hormone by virtue of its 
stimulation of gonadal steroidogenesis and the sex 
steroids in turn promote protein synthesis and 
accumulation of cyclic AMP. LH also has direct trophic 
effects on the Leydig cell population. However, the 
results in this study and those of Alford et al (1973) 
and Judd et al (1974) did not confirm a direct relation- 
ship between LH secretion and specific sleep stages. 
Furthermore, the secretion of LH during the night cannot 
be acutely shifted in sleep reversal studies (Kapen et al, 
1974). These observations do not support the hypothesis 
that specific sleep stages are critically involved in 
anabolic metabolism, at least not in those processes 
under the influence of LH and sex steroids directly. It 
can also be said that the changes in pattern of GnRH or 
gonadotrophin secretion in puberty are unlikely to be a 
direct consequence of any modification in the pattern or 
content of polygraphic sleep stages during the 
individual's growth and development. 
Over the last two decades, the pineal hormone, 
melatonin, has been shown to have photoperiod- induced 
antigonadotrophic effects in animals, especially well 
demonstrated in seasonal breeding species such as the 
hamster (Turek & Campbell, 1979). In the human, early 
clinical studies established the association between 
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tumours of the pineal gland and precocious puberty 
(Thamdrup, 1961). It has therefore been suggested that 
the pineal gland can keep puberty in check by means of 
inhibitory hormones. Melatonin secretion in humans is 
augmented during nocturnal sleep (Weinberg et al, 1979) 
and melatonin also induces the synchronization of EEG 
activity during slow -wave sleep (Anton -Tay et al, 1971). 
Silman et al (1979) reported in a cross -sectional study 
of 51 boys and girls aged 112 to 14 years that an abrupt 
decline in plasma melatonin concentration occurred gat the 
onset of puberty in boys. However, other reports were 
unable to confirm the presence of any meaningful changes 
in plasma or urinary melatonin concentration during or 
before puberty (Fevre et al, 1979; Lenko et al, 1981; 
Tetsuo et al, 1982; Ehrenkranz et al, 1982). Another 
pineal hormone, arginine vasotocin, a neurotransmitter 
peptide with higher nocturnal concentrations in the 
cerebrospinal fluid (Pavel, 1979) can both induce slow - 
wave sleep (Pavel et al, 1979) and inhibit LH secretion 
(Pavel & Petrescu, 1966). However, there is currently no 
good evidence that arginine vasotocin is directly or 
indirectly involved in the mechanism of puberty. Although 
the role of the pineal in human reproduction and puberty 
remains rather obscure at present, the prominent rhythmic 
fluctuations of pineal activity and its intimate relation- 
ship with seasonal changes in neuroendocrine- testicular 
functions in seasonally- breeding animals (Reiter, 1974; 
Licoln & Short, 1980) possess certain features analogous 
to the rhythmic control of nocturnal hypothalamic GnRH 
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secretion at the onset of puberty in humans. 
The pituitary responsiveness to exogenous GnRH in 
puberty has been assessed by a number of investigators 
(Roth et al, 1972; Job et al, 1972; Kastin et al, 1972; 
Grumbach et al, 1974; Franchimont et al, 1975; Dickerman 
et al, 1976) using a single bolus injection. The later 
use of continuous GnRH infusion (de Lange et al, 1974; 
Reiter et al, 1976) has revealed the possible existence 
of two separate pools of LH in pubertal subjects in 
response to a more prolonged, continuous (Bremner & 
Paulsen, 1974) or intermittent GnRH stimulation (Wang et 
al, 1976). The first was considered to be an immediately - 
releasable LH pool while the second a reserve or storage 
pool possibly requiring protein synthesis. Using 
repeated pulses of GnRH at a dose and frequency (10 µg 
per 2 hours) that did not exceed the capacity of the 
pituitary gonadotropes, Yen et al (1975) were able to 
delineate the differential effects of gonadal steroid 
feedback on these two hypothetical pools of LH during the 
human menstrual cycle. Further support for the concept 
of two functional compartments in pituitary LH secretion 
was provided by the finding that the ratio of bio- to 
immuno- reactivity was greater in LH from the second 
compared to the first pool (Dufau et al, 1976; Beitins et 
al, 1977). An additional rationale for adopting the 
repetitive low -dose GnRH stimulation in this study is the 
attempt to reproduce the endogenous pattern of pituitary 
stimulation so that assessment of responsiveness may 
relate more closely to the physiological state. 
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The present results showed that a constant relation- 
ship between the first and second LH pools elicited by 
repetitive GnRH stimulation during puberty was present. 
They increased in parallel through the six stages of 
puberty with the magnitude of the second pool remaining 
at 60 -67% of the first. There was no preferential 
increase in either LH pools and a priming effect on the 
pituitary response by the first GnRH bolus was not 
evident. Indeed, the subsequent responses were always 
smaller than the first. This pattern is most likely to 
be the result of the particular dose and frequency of 
GnRH stimulation rather than any preferential shifts of 
LH between the two pools or the disproportionate negative 
feedback of testosterone on the second LH pool. It is 
reasonable to conclude that the increase in gonadotrophin 
secretion in puberty is associated with a parallel 
increase in the size of the releasable and reserve LH 
pools in the pituitary. Recent studies in rats showed 
that GnRH receptors correlated closely with intra- 
pituitary LH content and serum gonadotrophin concentration 
during sexual maturation in both males and females 
(Clayton & Catt, 1981). Thus maturational changes in 
pituitary GnRH receptors may mediate some of the 
biological action of endogenous hypothalamic GnRH 
secretion during puberty. It is hoped that having over- 
come the technical problems of studying pituitary GnRH 
receptor functions in vitro, further studies in this 
promising area may elucidate the molecular and sub - 
cellular mechanisms involved in the dynamics of 
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pulsatile GnRH stimulation of the pituitary. 
Another way of enhancing the pituitary response is 
by increasing the duration of gonadotrophin release to 
each pulse of GnRH. Since the metabolic clearance rate 
of gonadotrophins does not change during sexual 
maturation (Ross, 1970; Licoln, 1978), any alteration 
in the apparent half -life of an LH secretory pulse must 
result from a change in the secretory dynamics of the 
pituitary. From the present results (Table 4.3) it is 
evident that the apparent half -life of each of the four 
consecutive LH pulses induced by exogenous GnRH remained 
remarkably constant throughout puberty. This reaffirms 
the belief that a relatively simple quantitative increase 
in LH reserve is characteristic of the functional 
maturation of the pituitary during puberty. A related 
finding is that the apparent half -life of the first 
induced LH pulse is significantly higher than the sub- 
sequent three. This suggests that the pituitary response 
to the first GnRH bolus is more sustained than the later 
ones. This may be indicative of desensitization or down - 
regulation of pituitary gonadotropes induced by the supra - 
physiological GnRH stimulation (Clayton & Catt, 1981; 
Nett et al, 1981). 
In summary, this study examines the nocturnal 
episodic gonadotrophin secretory pattern and the pituitary 
responsiveness to repetitive GnRH stimulation during 
sexual maturation in a group of boys with delayed puberty. 
Considering that the majority of these subjects consisted 
of those with constitutional delayed puberty while the 
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few with hypogonadotrophic hypogonadism could be 
said to represent the prepubertal or early pubertal 
states, there is no reason to believe that the 
longitudinal or cross -sectional pattern of hormonal 
changes described here should not be applicable to normal 
puberty. It was found that (1) the earliest detectable 
hormonal indicator of pubertal development was the 
presence of nocturnal pulsatile LH secretion; (2) the 
pattern of nocturnal LH secretion altered quantitatively 
and qualitatively due to the GnRH frequency modulation of 
the pituitary combined later with the effects of gonadal 
steroid negative feedback and possibly other less well - 
defined neuroendocrine factors; (3) the ratio of plasma 
LH:FSH concentrations reversed during early puberty 
either as a result of the differential effects of gonadal 
steroidal and /or non -steroidal feedback or changes in the 
frequency of GnRH pulsatile stimulation; (4) the enhanced 
pituitary responsiveness during puberty was associated 
with an increase in both the releasable and reserve pools 
of LH; (5) the estimated magnitude of pulsatile GnRH 
secretion did not increase during puberty. 
The relevance of these changes to the mechanism of 
puberty should be assessed against the background of the 
gonadostat and the neuroendocrine hypotheses (see Section 
B, Chapters 1.4.3 and 1.4.4) as well as the broader 
perspective of the earlier ontogenic pattern in the pre - 
and postnatal HPT axis. There is little doubt that sex 
steroid negative feedback is operative before puberty 
(Raimirez, 1973; Grumbach et al, 1974). There is also 
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ample experimental and clinical evidence that the 
negative feedback threshold of gonadotrophin secretion is 
raised from prepuberty to adulthood (Kulin & Reiter, 1972; 
Kelch et al, 1973; Negros -Vilar et al, 1973; Smith et al, 
1977). It could therefore be postulated that the 
initiation of pulsatile GnRH secretion at the onset of 
puberty is the result of a rise in negative feedback 
threshold to gonadal steroids in the hypothalamic gonado- 
stat. There is however no direct or indirect evidence 
from these studies to support it. Furthermore, the 
diphasic pattern of basal and GnRH- induced gonadotrophin 
secretion from infancy to adulthood is qualitatively 
similar in normal and agonadal individuals (Conte et al, 
1975; Conte et al, 1981). The fall in GnRH /gonadotrophin 
secretion between 4 and 11 years in normal and agonadal 
children strongly suggests that intrinsic CNS inhibitory 
mechanism(s), independent of sex steroids, are responsible 
for the restraint of gonadotrophin secretion before 
puberty. It follows that the suppression of the neural 
inhibitory mechanism(s) at the onset of puberty may be 
responsible for the reactivation of pulsatile hypothalamic 
GnRH secretion irrespective of the level of gonadal 
steroid negative feedback. The finding in this study that 
pulsatile GnRH / gonadotrophin secretion, heralding the 
sequential maturation of the pituitary and gonads, was 
present only in association with nocturnal sleep in the 
peripubertal period favours a neural disinhibitory or 
excitatory mechanism in the initiation of puberty. That 
the same pattern of sleep- related hormonal changes are 
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present in patients with hypothalamic precocious puberty 
(Boyar et al, 1973a) and those with gonadal dysgenesis 
(Boyar et al, 1973) lends further weight to the neuro- 
endocrine hypothesis. 
The studies of Ojeda (1980) in rats showed that the 
decrease in negative feedback sensitivity became evident 
only after the occurrence of the first ovulation. This 
suggests that changes in feedback sensitivity are a 
consequence rather than the cause of the pubertal process. 
Our results are in accordance with this view. The 
increased frequency of hypothalamic GnRH stimulation at 
the onset of puberty primes the pituitary so that the 
basal secretion of both LH and FSH (with ratio reversed) 
and the LH response to GnRH became steadily enhanced even 
in the presence of rising gonadal steroid output. The 
fact that this peripubertal pattern of gonadotrophin 
secretion can be reproduced virtually identically in 
monkeys with hypothalamic lesions or in sexually 
infantile monkeys treated by intermittent (one hourly) 
GnRH administration (Knobil et al, 1980; Wildt et al, 
1980) further highlights the primacy or neural mechanisms 
acting on the hypothalamus. In the light of these 
findings it seems reasonable to suggest the the original 
gonadostat hypothesis places an inappropriate emphasis on 
gonadal steroid negative feedback which we believe to be 
of peripheral significance only in the mechanism of 
puberty. The neuroendocrine control of puberty epitomizes 
the way in which a primarily frequency -coded neuronal 
signal, relayed by afferent inputs to the arcuate nucleus, 
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can be translated into an intermittent pulsatile hormonal 
message by the GnRH- secreting neurones. This study was 
able to demonstrate how small changes in the frequency of 
GnRH discharge can produce quite dramatic and acute 
changes in pituitary function. Thus in the temporal 
pattern of hormone secretion from the hypothalamus 
resides a novel mechanism, that of frequency- modulation, 
of intercellular communication which assumes major 
physiological importance in the initiation of puberty. 
The exact mechanism by which the brain reactivates 
the GnRH- secreting neurones in the medial basal hypo- 
thalamus is unknown. In non -seasonal breeding species 
such as man, it appears that melatonin does not play an 
active role in the control of gonadotrophin secretion in 
puberty (Fevre et al, 1979; Lenko et al, 1981; Tetsuo et 
al, 1982; Ehrenkranz et al, 1982). It is 
interesting to note that CNS opiods (Morley et al, 1980; 
Quigley et al, 1980a; Moult et al, 1981) and dopamine 
(Huseman et al, 1980; Quigley et al, 1980b) may have 
tonic inhibitory effects on GnRH on gonadotrophin 
secretion. The suppression of these inhibitory influences 
by neuronal mechanisms in some way connected with sleep 
may be responsible for the initiation of puberty. This 
could be coupled with the concept that changes in the 
internal environment or body composition, when the 
individual reaches an appropriate stage of physical 
maturity, can provide the necessary signal for the brain 
to remove the inhibitory control on the hypothalamic 
"pulse generator ". However, the nature of these 
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pulsatile metabolic signals for the initiation of 
puberty has so far eluded identification (Glass & 
Swerdloff, 1980). An alternative view derived from the 
study of seasonal breeding in animals is that the onset 
of puberty is dependent on the ability of certain areas 
of the brain to integrate the endogenous biological 
rhythms (including endocrine ones) with the 24 -hour 
clock rhythm through sensory cues such as the light -dark 
or sleep -wake cycles provided by the external environment 
(Licoln & Short, 1980; Ramaley, 1980). Presumably, these 
maturational changes in the brain will depend to some 
extent on the formation or re- establishment of appropriate 
neuronal synapses at the region of the arcuate nucleus. 
There is some evidence from experimentally induced 
precocious puberty in rats that increased hypothalamic 
synaptogenesis may be associated with sexual maturation 
(Matsumoto & Arai, 1977; Arai & Matsumoto, 1978). 
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CHAPTER 5 
THE GONADAL RESPONSE IN PUBERTY 
5.1 Introduction 
The gonads play an active part in sexual maturation 
as suggested by the enhanced testicular responsiveness to 
hCG stimulation (Winter et al, 1972; Schöller et al, 1975). 
The mechanism for this gonadal amplification of the 
primary neuroendocrine signal for sexual development is 
still unclear in spite of an increasing body of animal 
experimental data on the regulation of Leydig cell 
functions (for review see Purvis & Hansson, 1978; Bartke, 
1978; Catt et al, 1980; Swerdloff & Heber, 1981; 
Risbridger et al, 1981; Sharpe, 1982). From these 
studies, it is becoming clear that not only LH, which is 
traditionally the primary trophic hormone, but also FSH 
and prolactin may be necessary for the development and 
maintenance of adult Leydig cell functions in some lower 
animals (rodents mainly). In humans, the situation is 
complicated by the presence of circadian and circhoral 
variations in several of the relevant pituitary and 
gonadal hormones which first become manifest at this 
stage of development. Hence prior to extrapolating some 
of the newly- acquired understanding in testicular 
physiology to human puberty, it is necessary to examine 
in some detail the temporal relationships between 
observed changes in testicular steroidogenic response and 
the putative trophic or regulatory hormones - LH, FSH and 
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prolactin, taking into account both the episodic and the 
sleep -related secretory patterns of these hormones. A 
further object of this study is to consider the role of 
LH in the development of Leydig cell function in puberty 
in terms of the pulsatile or intermittent nature of the 
trophic stimulus. 
5.2 Results 
A significant linear rising trend (p <0.001) in mean 
testosterone concentration in the evening (20.00 -23.00 h), 
night (23.00 -07.00 h) and morning (07.00 -09.00 h) was 
present across the six stages of puberty (Fig 5.1). 
Adult levels of testosterone ( >350 ng /100 ml) were 
reached around stage 3 to 4 in the morning and a little 
later during the night. The time at which maximal rate 
of increment and peak concentrations of testosterone were 
achieved lagged behind that for LH by one or two clinical 
stages (Fig 5.1). In the later stages of puberty, when 
no further increase in mean LH concentrations occurred, 
testosterone nonetheless continued to rise. However, a 
significant nocturnal elevation in mean testosterone 
concentration was first detectable in stage 1B, the time 
when sleep- related LH secretion also became established 
(Fig 5.2). The nocturnal rise in testosterone 
concentrations continued throughout puberty and indeed 
increased in magnitude with maturity so that the largest 
increments were observed in stages 4 and 5 (Fig 5.2). 
Although LH levels fell abruptly on waking in the 













































































































































































































































































































































































































































































































































































































































































































































































































































significant decline (Fig 5.2). Mean LH concentration 
correlated well with mean testosterone levels during 
puberty in the evening, night and morning (Kendall's rank 
correlation 0.62, 0.60 and 0.57 respectively). Mean FSH 
concentration correlated less well with testosterone than 
LH in all three parts of the 24 -hour cycle (Kendall's 
rank correlation 0.39, 0.30, 0.33 for evening, night and 
morning respectively). Examination of the testosterone 
profiles (Appendix II) revealed no distinct large - 
amplitude episodic fluctuations which could be regarded 
as indicative of pulsatile glandular secretion. Instead, 
comparatively small amplitude irregular and unpredictable 
fluctuations (mean CV 21.3% ± 12.7) were seen both asleep 
and awake. There were however occasional exceptions, for 
example subject GFII, in whom a distinct pulsatile 
pattern of testosterone bearing a constant temporal 
relationship to LH pulses could be demonstrated (Fig 5.3). 
The nocturnal rise in testosterone usually started some 
60 -90 minutes after the onset of sleep and LH secretion. 
Peak concentrations of testosterone were not as a rule 
achieved until the last quarter of nocturnal sleep 
following which a decline was observed on waking in the 
morning. This hour -to -hour LH and testosterone relation- 
ship demonstrating the phase- delayed testicular response 
to nocturnal pituitary LH secretion was only apparent on 
scanning individual profiles (Appendix II). Thus although 
the mean morning and nocturnal testosterone concentrations 
were not significantly different at any stage of puberty, 
the profiles consistently demonstrated the declining 
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Fig 5.3 
Plasma LH, FSH and testosterone concentrations between 20.00 -17.00 h 
in study II of subect 16 GF. Unlike the majority, pulsatile 
fluctuations of testosterone concentration were discernible in this 
subject. The testosterone peaks bore a constant temporal 
relationship to LH, lagging behind the endogenous nocturnal LH 
pulses by 20 -40 minutes. The relationship between the GnRH- 
induced LH peaks and the fluctuating testosterone concentration 
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Comparison between the testicular testosterone response to the 
endogenous nocturnal LH increase and the GnRH- induced supra - 
physiological LH rise. E = evening (20.00 -23.00 h), N = night 
(23.00 -07.00 h), M = morning (07.00 -09.00 h) and D = day 
(09.00 -17.00 h). A significant (P <0.05) increase in plasma 
testosterone associated with the nocturnal rise in LH was 
observed from stage 1B onwards. In contrast, despite the 
greater magnitude of LH increase induced by exogenous GnRH, 
there was no significant difference between the morning (M) 
and daytime (D) concentrations of testosterone at any stage 
of puberty. 
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levels of testosterone after waking. 
When nocturnal LH was considered in terms of pulse 
frequency and amplitude, it was evident that the most 
rapid increases in pulse frequency in stages lA to 2 
were associated with minimal Leydig cell secretion of 
testosterone. Nocturnal LH pulse frequency was poorly 
correlated with testosterone concentration (Kendall's 
rank correlation 0.36). In contrast, the steady increase 
in nocturnal and evening LH pulse amplitude was better 
correlated with the progressive elevation of the 
corresponding testosterone levels (Kendall's rank 
correlation 0.64 in each instance). 
Endogenous nocturnal LH secretion produced 
significant testicular responses in the form of 
elevations in plasma testosterone concentrations from 
stage lB to stage 5 (Fig 5.4). After a two -hour interval, 
exogenous pulsatile GnRH stimulation produced a two to 
three fold increase in LH pulse amplitude and mean plasma 
LH which rose to the supraphysiological range. This 
however did not produce a further increase in the plasma 
testosterone concentrations from those in the morning 
(Fig 5.4). The testosterone profiles demonstrated that, 
during this eight hour period of exogenous GnRH 
stimulation, the declining trend normally present after 
waking was reversed and the relatively high testosterone 
levels of the early morning was maintained for the 
duration of this spell. 
Oestradiol levels remained low (20 -35 pg /ml) during 
puberty with no obvious diurnal variation (Fig 5.2). No 
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significant change in mean evening or night oestradiol 
concentrations was observed across the pubertal stages. 
A significant stage effect was however found in the mean 
morning oestradiol with concentrations rising to 33.1 ± 8 
and 31.5 ± 6 pg /ml in stages 2 and 3 respectively (Figs 
5.1 & 5.2). This early to mid pubertal oestradiol 
increase was not sustained towards the second half of 
puberty when oestradiol levels were not significantly 
different from stage lA and 1B. 
Results of mean prolactin concentrations in the 
evening, night and morning during puberty are presented 
in Figures 5.1 and 5.2. Nocturnal rise of prolactin was 
observed in all stages of puberty although this only 
reached the 5% level of statistical significance from 
stage 2 onwards. The mean evening and nocturnal 
prolactin concentrations did not show any significant 
change during puberty. A small but significant (p <0.05) 
linear trend of increasing prolactin concentration in the 
morning was present. Individual prolactin profiles 
demonstrated the enhanced episodic secretion during 
nocturnal sleep (Fig 5.5). Although three to four 
secretory episodes were observed in most patients during 
the eight hours of sleep, there was no consistent pattern 
in nocturnal prolactin secretion during puberty. 
5.3 Discussion 
In this section, the control of gonadal development 
in human male puberty was studied. The use of multiple 
day- and -night blood sampling has made it possible to 
Fig 5.5 
Plasma prolactin profiles in two subjects DF and ST studied 
on three and four occasions respectively as they progressed 
through puberty. The nocturnal rise in prolactin with three 
to four major secretory episodes was observed in all stages 
of puberty. There was no apparent trend in the pattern or 
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examine the circadian and circhoral relationships between 
gonadal steroids and pituitary hormones. The significant 
correlation between mean plasma LH and testosterone at 
different parts of the 24 hour cycle during gonadal 
development is compatible with a prime trophic role for 
this gonadotrophin. The FSH pattern was temporally less 
well correlated to Leydig cell function as indicated by 
circulating testosterone concentration during puberty. 
Prolactin and oestradiol changes were comparatively 
insignificant. 
A great deal of the present understanding of Leydig 
cell development is derived from experimental studies, 
mostly on the rat testis. In this animal, the number of 
Leydig cells per testis increases three to ten fold 
between 36 -60 days of age (Clegg, 1966; Knorr et al, 
1970; Pahne et al, 1975). This is brought about by a 
combination of differentiation from precursor mesenchymal 
cells and by mitosis of fully differentiated Leydig cells. 
It is likely that the human testis undergoes a similar 
sequence of events to attain the adult complement of 
Leydig cells by early to mid puberty (Kaler & Neaves, 
1978). The second major developmental change is in the 
number of testicular LH receptors which increase about 
twenty fold from 14 -70 days of age in the maturing rat 
(Pahne et al, 1975; Ketelslegers et al, 1978). Even 
though most of this increase in receptor numbers reflects 
the expanding Leydig cell population, there is some 
evidence to support an increase in number of LH receptors 
per cell (Thanki & Steinberger, 1976). That the 
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development and maintenance of the testicular LH receptor 
population is under gonadotrophin control is suggested by 
the finding that hypophysectomy results in a dramatic 
fall in LH receptor numbers (Frowein & Engle, 1975; 
Thanki & Steinberger, 1976). No comparable data in the 
human testis exist at present. The testicular steroido- 
genic pathway provides the third mechanism for gonadal 
activation during puberty. The steroidogenic response to 
LH stimulation in adult rats is five to six times higher 
than that in immature animals (Odell et al, 1974). With 
the exception of l78- hydroxysteroid dehydrogenase, 
activities of all other enzymes in the biosynthetic 
pathways of testosterone are at a maximum in the Leydig 
cells of the rat by 30 -35 days of age ( Inano et al, 1967; 
Payne et al, 1977). Five alpha -reductase activity is 
high in the prepubertal rat testes so that the major 
androgens produced at this time are 5a- reduced 
metabolites of testosterone such as 3a -Diol and andro- 
sterone (Moger, 1977 & 1979; Foldesy & Leatham, 1980; 
Purvis et al, 1980). The gradual fall in 5a- reductase 
activity with increasing maturity is responsible for the 
shift in testicular androgen synthesis and secretion in 
favour of testosterone compared to 5a- reduced androgens. 
Thus, despite the fifteen to twenty fold increase in 
testosterone production with maturity, the total 
production of 178- hydroxy androgens (testosterone, 5a- 
dihydrotestosterone, 3a -diol, 38 -diol and androsterone) 
per Leydig cell may actually decrease during sexual 
development. In humans, the principle androgen in 
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prepubertal subjects is androstenedione which increases 
only minimally during puberty compared with testosterone 
(Frasier & Horton, 1966). In vitro studies in 
testicular biopsy tissues from two prepubertal hypo - 
gonadotrophic patients demonstrated increased conversion 
of precursors to 5a- reduced metabolites (Steinberger et 
al, 1974a). It has also been postulated that decreased 
activity of 20a- hydroxysteroid dehydrogenase at puberty 
reduces the competitive inhibition of 17a- hydroxylation 
of pregnenolone and progesterone (Fan et al, 1974). It 
seems therefore that in humans, as in lower animals, 
qualitative changes in testicular steroidogenesis during 
puberty are as important as quantitative changes. 
Luteinizing hormone has well- recognized trophic 
effects on Leydig cells inducing both hypertrophy (de 
Kretser et al, 1967; Heller & Leach, 1971) and 
proliferation in both immature (Chemes et al, 1976) and 
adult (Christensen & Peacock, 1980) rats. In immature 
animals, the early effect of_hCG was to stimulate Leydig 
cell mitosis subsequently followed by increased 
differentiation of precursor to Leydig cells ( Chemes et 
al, 1976). The progressive fall in Leydig cell 
responsiveness in adult hypophysectomized rats can be 
prevented by LH administration (El Safoury & Bartke, 
1970; Van Beurden et al, 1976; Zipf et al, 1978). 
However, maintenance of steroidogenic activities in 
Leydig cells may merely reflect the effect of chronic 
LH /hCG treatment on Leydig cell hypertrophy or hyper - 
plasia. Whether these non -physiological changes can be 
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related to functional alterations of the qualitative or 
quantitative aspects of steroidogenesis as discussed 
above is yet to be established. 
Results in this study indicated that LH plays a 
dominant role in the development of enhanced testicular 
responsiveness during puberty in humans. LH changes 
paralleled but preceded that of testosterone and the 
nocturnal rise in circulating testosterone in early and 
mid puberty always followed a significant increase in LH 
secretion. It may be speculated that the nocturnal high 
frequency small amplitude LH stimulation, which is 
characteristic of early puberty and gives rise to only 
minimal increase in mean testosterone levels, is 
important in stimulating Leydig cell differentation and 
mitosis and increasing the number of LH receptors per 
Leydig cell. As puberty advances, the increasing 
amplitude of LH secretion may induce the various shifts 
in the pattern or enhanced rates of steroidogenesis in 
the full complement of Leydig cells producing the rapidly 
increasing testosterone response seen in later stages. 
Thus an appropriately high frequency of LH pulses may be 
the crucial factor governing the increase in Leydig cell 
numbers and LH receptors but given a stable pulse 
frequency of once every two hours, it is the amplitude 
changes which modify the steroidogenic pattern. 
Obviously, much more work is needed before these 
postulates can be verified. A similar priming effect on 
Leydig cells by repeated small doses of LH has been 
demonstrated in the juvenile monkey (Arslan et al, 1978). 
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There is also evidence that repeated small priming doses 
of LH are responsible for the acquisition of LH 
responsiveness during early sexual development of the 
rat (Purvis et al, 1979). 
The physiological regulation of Leydig cell function 
by LH normally operates through the activation and 
utilization of a minute fraction ( <1 %) of the total 
receptor population (Catt et al, 1978). The large 
population of spare receptors may serve to maintain 
optimal sensitivity of the Leydig cells to hormone 
stimulation. When the Leydig cells are exposed to high 
sustained concentrations of endogenous or exogenous LH, 
receptor loss by internalization is induced (down 
regulation)(Hsueh et al, 1976; Sharpe et al, 1976; Catt 
et al, 1979). When receptor loss exceeds replenishment, 
a net fall in receptor numbers occurs with the resultant 
fall in sensitivity to LH stimulation. The priming 
effect of repeated small doses as opposed to sustained 
high doses of LH may serve to increase the steroidogenic 
capacity of Leydig cells and enhance or maintain their 
responsiveness to LH without incurring a degree of 
receptor loss that negates against these effects. The 
pulsatile stimulation by physiological concentrations of 
LH intermittently erodes a tiny percentage of the total 
receptor population which can be replenished before the 
next LH stimulus. It is conceivable that not only the 
maintenance but also the differentiation of adult 
responsiveness in Leydig cells is governed by similar 
principles. 
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In pubertal boys, as in adults, episodic changes in 
plasma concentrations of testosterone are not clearly 
recognizable as discrete secretory pulses. This 
contrasts with the distinct pulsatile pattern of LH to 
which plasma testosterone fluctuations bear a relatively 
loose temporal relationship. Unlike humans, pulsatile 
variations in plasma LH and testosterone are tightly 
coupled in lower species (rat - Desjardins, 1981; ram - 
Sandford et al, 1974; monkey - Plant et al, 1981). This 
apparent discrepancy may be attributed to the sluggish 
Leydig cell response in man to LH stimulation so that an 
LH secretory pulse is followed by a detectable rise in 
plasma testosterone only after an interval of 20 -180 
minutes (Naftolin et al, 1973; Judd et al, 1974b; Rowe 
et al, 1975; de Kretser et al, 1977). A similar phase - 
delayed (60 -90 minutes) testosterone response induced by 
LH secretion associated with sleep was observed in the 
present and previous studies (Boyar et al, 1974a; Judd et 
al, 1974a). Several factors may contribute to this 
phenomenon. The presence of sex hormone binding globulin 
greatly increases the half -life of circulating testo- 
sterone in humans and provides a large capacity 
reservoir which dampens down any rapid fluctuations 
(Baird et al, 1969; Anderson, 1974). However, the 
presence of sex hormone binding globulin in the ram 
(which shows well defined pulsatile testosterone 
secretion), albeit of lower affinity than in man, argues 
against this as the sole explanation. The Leydig cell 
response to LH may be genuinely delayed, reflecting 
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perhaps the relatively high intratesticular and 
circulating testicular concentrations in man compared to 
other species (de Kretser et al, 1977; Serio et al, 1980). 
Thus if the Leydig cells are already functioning at near 
maximal capacity under basal conditions, it may not be 
possible for the testis to respond to further LH 
stimulation by acute increases in pulsatile testosterone 
secretion of large amplitudes. A third possible 
explanation may be provided by the finding that a 
reduction in the LH pulse frequency by a synthetic 
androgen resulted in a closer temporal relationship 
between plasma LH and testosterone concentrations 
(Vigersky et al, 1976). The adjacent LH pulses may be 
so closely spaced that the relationship between LH and 
testosterone is obscured. Further work in this area is 
required before any one of these possible explanations 
can be substantiated. 
Nocturnal plasma testosterone steadily increased 
towards peak levels before waking in response to the 
endogenous sleep related pulsatile LH secretion. Raising 
the LH concentration further, even at the presumed 
optimal pulse frequency (2 hourly), by GnRH stimulation 
failed to increase the testosterone concentrations beyond 
the maximal concentrations found in the early morning. 
This implies that at each stage of pubertal development, 
Leydig cell steroidogenesis operates at near maximal 
capacity. This interpretation is compatible with the 
observation that intratesticular and circulating 
testosterone concentrations in man are relatively high 
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compared to other species, as mentioned earlier. That 
the Leydig cells are not refractory to LH stimulation in 
the morning is suggested by two observations. Firstly, 
testosterone concentrations normally decline steadily 
from the early morning peak to a nadir some time in late 
evening (Boyar et al, 1974a; Sjöberg et al, 1979). The 
explanation of this diurnal variation in plasma testo- 
sterone concentration is not clear. Secondly, in all 
cases in the present study, this decline in testosterone 
concentration in the morning was reversed shortly after 
the start of exogenous GnRH stimulation so that maximal 
concentrations were maintained through the day by the 
supraphysiological LH stimulus. These findings suggest 
that the human Leydig cells, from an early stage of 
development, function normally with little additional 
steroidogenic reserve and /or that negative regulatory 
mechanisms come into play as soon as the physiological 
range of stimulus is exceeded. The finding that 
pharmacological doses of hCG or LH produced a biphasic 
rise of testosterone levels in man (Forest et al, 1979; 
Wang et al, 1980) does not detract from this inter- 
pretation since the testicular response in those 
situations is mainly dependent on the trophic effects on 
Leydig cells rather than a direct stimulation of 
steroidogenesis. Irrespective of whether LH levels are 
pharmacological or supraphysiological, it is likely that 
significant loss in testicular LH receptors accompanied 
by the desensitization of steroidogenesis would have been 
induced in each instance (Hsueh et al, 1976; Sharpe, 1976; 
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Zipf et al, 1978). Furthermore, GnRH may have direct 
negative effects on Leydig cell LH receptors and 
steroidogenesis (Hsueh & Erikson, 1979; Bambino et al, 
1980; Sharpe, 1981). These negative regulatory 
mechanisms may prevent the Leydig cells from being over- 
stimulated and imposes a ceiling to their responsiveness. 
Luteinizing hormone rise during puberty in the rat 
is comparatively small and correlates rather poorly with 
morphological changes in Leydig cells (Swerdloff et al, 
1971; de Jong & Sharpe, 1977; Payne et al, 1977; 
Ketelslegers et al, 1978). FSH on the other hand rises 
early in puberty in many species (rat - Swerdloff et al, 
1971; de Jong & Sharpe, 1977; 
ram - Lee et al, 1976; human - Faiman & Winter, 1974; 
Grumbach et al, 1974) showing a striking correlation with 
the increase in Leydig cell population in puberty (van 
der Molen & Rommerts, 1981). Although Leydig cell 
responsiveness in adult hypophysectomized rats can be 
maintained by LH alone, FSH as well as LH are required in 
immature hypophysectomized animals (El Safoury & Bartke, 
1974; Van Beurden et al, 1976). There is evidence 
showing that FSH can increase the number of LH receptors 
in the immature rat testis (Odell & Swerdloff, 1976; Chen 
et al, 1976 & 1977). In cryptorchid boys and hypogonado- 
trophic subjects, basal testosterone and the response to 
hCG were correlated with FSH but not LH (Sizonenko et al, 
1977). This has been interpreted as evidence that FSH is 
important in the control of Leydig cell function in the 
immature human testis. FSH levels also paralleled the 
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increase in 178- hydroxysteroid dehydrogenase activity in 
the maturing rat and is also able to stimulate the 
activity of the enzyme in the hypophysectomized immature 
rat (Payne et al, 1977; Murono & Payne, 1979). It is 
interesting to note that the trophic effect of FSH has 
been demonstrated exclusively in the immature testis. 
Taken together, these studies present an impressive body 
of evidence, albeit indirect, supporting a role for FSH 
in the control of the development of testicular responsive- 
ness in the immature rat. One reservation against the 
full acceptance of this view is the fact that FSH binds 
only to Sertoli cells and some germ cells in the testis 
(Orth & Christensen, 1977). Thus any effect of FSH on 
Leydig cells is likely to be mediated via the Sertoli 
cells. It is possible that the Sertoli cells, when 
stimulated by FSH, produce local testicular factor(s) 
that exert trophic effects on Leydig cells (Risbridger et 
al, 1981). 
The present study showed that FSH concentrations 
were higher than those of LH at the onset of puberty and 
that FSH gradually increased during puberty although the 
mean concentrations were poorly correlated with testo- 
sterone. These data are compatible with the concept that 
FSH may have a synergistic role in the early stages of 
puberty in the differentiation of Leydig cells and their 
LH receptor population. It is less likely, although not 
completely excluded, that FSH plays a significant part in 
the subsequent development of Leydig cell steroidogenesis. 
The role of FSH on spermatogenesis and seminiferous 
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tubular development has been discussed elsewhere (Chapter 
3). Immature rat Sertoli cells in vitro can synthesize 
oestradiol in the presence of FSH and testosterone 
(Dorrington & Armstrong, 1975). In the pubertal animal, 
increasing circulating and intratesticular concentrations 
of FSH and testosterone may provide the appropriate 
stimulus to the developing Sertoli cells for oestrogen 
synthesis. It is therefore interesting to note that in 
this and previous studies (vide infra) a small but 
definite increase in oestradiol and oestrone plasma 
concentrations has been found. The consequence of 
increased intratesticular oestrogen in the developing 
testis is unknown but the rising circulating oestradiol 
level may be expected to have distant effects such as 
gynaecomastia (Large et al, 1980) or raised pituitary 
prolactin secretion. 
Prolactin differs from pituitary LH and FSH in many 
aspects of its control and functions. The two relevant 
features in the context of testicular development are (1) 
that prolactin by itself does not have any known 
biological action on the testes and (2) that increased 
levels of this hormone are associated with enhanced 
Leydig cell function in some species, e.g. rat and 
hamster (Bartke, 1978), but regressed function in others, 
e.g. ram (Licoln & Short, 1980). 
In the immature rat, plasma prolactin rose between 
30 to 55 days of age (Negro -Vilar et al, 1973; Dohler & 
Wuttke, 1975) in parallel with the increase in 
circulating testosterone and expanding number of 
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testicular LH receptors. Further, the effects of 
prolactin in the hereditary dwarf mice or hypophysecto- 
mized rats on testicular functions was not unlike that 
seen in sexual maturation (Bartke, 1978). These 
observations formed the basis for the belief that 
prolactin, in conjunction with LH and FSH, is required to 
effect the optimal gonadal developmental changes during 
puberty in rodents. In human puberty, published reports 
are in agreement that prolactin levels do not increase in 
the male (Guyda & Frieson, 1973; Lee et al, 1974; Ehara 
et al, 1975; Aubert et al, 1977; Thorner et al, 1977). 
None of these studies however took note of the episodic 
secretion of prolactin and the increased rate of 
secretion during nocturnal sleep (Sassin et al, 1973; 
Parker et al, 1973). More recently, the nocturnal sleep - 
related prolactin secretion in prepubertal and pubertal 
children has been confirmed (Finkelstein et al, 1978; 
Warne et al, 1979; Large et al, 1980; Beck & Wuttke, 
1980). There was no difference in the diurnal pattern of 
pulsatile secretion. 
The present study provided further information on 
the diurnal secretory pattern of prolactin in subjects 
representing all stages of pubertal development. 
Longitudinal data from follow -up studies were available 
from nine out of sixteen boys. The results confirmed 
the enhanced prolactin secretion during nocturnal sleep. 
However the most striking finding was the tremendous 
variability in the timing and magnitude of prolactin 
secretory episodes during sleep such that no progressive 
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patterns were discernable during pubertal maturation even 
within individual subjects studied repeatedly. This is 
in agreement with the findings in previous studies 
(Finkelstein et al, 1978; Warne et al, 1979; Large et al, 
1980; Beck & Wuttke, 1980). Surprisingly, mean prolactin 
concentration on waking in the morning (07.00 -09.00 h) 
did show a small but significant (p <0.05) rising trend 
during pubertal maturation. The interpretation of this 
finding is rather difficult considering the lack of 
similar trends at other parts of the 24 hour cycle and 
the insignificant correlation between mean prolactin and 
oestradiol concentrations found in this and other studies 
(Thorner et al, 1977; Large et al, 1980) in pubertal boys. 
It is interesting that the mean oestradiol 
concentration in the morning did increase in this study 
but the rise showed a different pattern to that of 
prolactin being significantly higher in stages 2 and 3 
only. This rather peculiar pattern in plasma oestradiol 
in the morning has not been observed in previous studies 
(Bidlingmaier et al, 1973; Angsusingha et al, 1974; Gupta 
et al, 1975; Lee & Migeon, 1975; Baker et al, 1976; 
Thorner et al, 1977) which demonstrated a small but 
significant progressive increase in oestradiol 
concentrations between stage 2 and stage 5 of puberty. 
The source of circulating oestradiol in children and 
adolescents has not been studied although it is well 
established in adults that a quarter of oestradiol blood 
production is derived from testicular secretion while the 
remainder is formed by peripheral conversion from 
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testosterone (Longcope et al, 1969; Kelch et al, 1972). 
The fact that there is no diurnal variation in oestradiol 
concentration while testosterone shows distinct peaks in 
the early morning may imply that the rise in oestradiol 
concentrations in puberty may be due to an independent 
increase in testicular secretion rather than peripheral 
conversion of testosterone. Although the above data 
lend themselves to various interpretations, it is 
resonable to speculate that in male as in female puberty 
the rise in testicular oestradiol secretion is responsible 
for the small prolactin rise observed in this study, even 
though the temporal correlation between the two is rather 
poor. If that is the case it follows that prolactin is 
unlikely to have an active trophic effect on gonadal 
development in the human. 
This study attempted to investigate the gonadal 
mechanisms in puberty in man by relating the diurnal 
patterns in circulating reproductive hormones to the 
known morphological and functional changes in the 
developing testis. Although direct extrapolation of 
experimental findings in lower animals to the human is 
inadvisable, it is nevertheless reasonable to interpret 
some of the present data in the light of the current 
concepts of Leydig cell regulation. Although significant 
advances have been made in the last five years in our 
understanding of the regulation of Leydig cell functions, 
a great deal remains to be learned about the control of 
Leydig cells in the initiation of spermatogenesis during 
pubertal maturation. 
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In summary, this study confirmed the role of LH and 
FSH in the development of adult Leydig cell function 
during puberty. Testicular steroidogenesis during 
puberty operates with little functional reserve. This 
may be one of the explanations of the lack of a distinct 
pulsatile pattern in circulating testosterone. The role 
of prolactin in puberty and the physiological significance 
of a transient rise in plasma oestradiol remain unclear. 
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CHAPTER 6 
DIAGNOSIS AND MANAGEMENT OF DELAYED PUBERTY 
6.1 Introduction 
Hypogonadal disorders first manifest themselves at 
the time of adolescence when signs of puberty fail to 
appear. Although the simultaneous presence of multiple 
trophic hormone deficiencies or somatic defects such as 
anosmia can facilitate the diagnosis of gonadotrophin 
deficiency, in the majority of cases it is impossible to 
differentiate between isolated hypogonadotrophic hypo - 
gonadism and simple constitutional delayed puberty during 
the early years of adolescence on clinical grounds alone. 
Both groups of patients present with lack of sexual 
development associated with low gonadotrophin and sex 
steroid production so that basal measurements of these 
hormones are unhelpful. Some reports have described 
minimal elevations in basal plasma gonadotrophin concen- 
trations before the clinical onset of puberty (Johanson 
et al, 1969; Winter & Faiman, 1972). However, the small 
magnitude of this initial rise and the low values of 
gonadotrophins near the assay detection limit render 
their interpretation hazardous. 
The availability of synthetic GnRH and its successful 
application to the study of pituitary responsiveness in 
children has provided an additional diagnostic test in the 
management of disorders of puberty. Early reports 
confirmed the increasing gonadotrophin reserve of the 
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pituitary during normal pubertal development (Kastin et 
al, 1972; Job et al, 1972; Roth et al, 1972) raising the 
possibility that the GnRH stimulation test may resolve 
the diagnostic difficulties in subjects with delayed 
puberty. Further studies however revealed that the 
pituitary response to GnRH in normal children and 
adolescents varied considerably within a wide range 
showing substantial overlap between prepubertal and 
pubertal subjects. Furthermore, the GnRH responses 
amongst patients with organic hypogonadotropic disorders 
were also variable and unpredictable, making the 
differentiation between primary hypothalamic and 
pituitary abnormalities impossible (Bell et al, 1973; 
Madeiros -Neto et al, 1973; Mortimer et al, 1973; 
Chaussain et al, 1974; Coscia et al, 1974; Grumbach et 
al, 1974; for review see Job et al, 1977). Despite these 
drawbacks, several studies claimed that the GnRH response 
may distinguish between constitutional delayed puberty 
and isolated gonadotrophin deficiency (Illig et al, 1973; 
Grumbach et al, 1974; Sagel et al, 1975; Franchimont et 
al, 1975), stressing the prognostic value of this test. 
This was not confirmed by Job et al (1976 & 1977) who 
found no clear -cut separation between these two conditions 
in terms of their pituitary responses to single -dose GnRH 
stimulation. The application of more prolonged pituitary 
stimulation by continuous GnRH infusion (Bremner & 
Paulsen, 1974; Kley et al, 1974; de Kretser et al, 1975a) 
or multiple GnRH bolus stimulation (Wang et al, 1975; 
Hoff et al, 1977) consistently obtained not only a 
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greater FSH response but also a biphasic LH response 
which may represent two functional components of 
pituitary gonadotrophin production (see Chapter 4). 
Continuous GnRH infusion in children showed that the 
biphasic pattern of LH response could only be detected in 
pubertal but not prepubertal subjects (de Lange et al, 
1974; Reiter et al, 1976; Huseman & Kelch, 1978). 
Prolonged or repetitive GnRH stimulation tests may thus 
improve on the diagnostic accuracy of the single dose 
version in the assessment of the functional maturity of 
the hypothalamus /pituitary in disorders of puberty. 
The value of GnRH tests in the management of delayed 
puberty can be assessed in two ways. The most obvious is 
to compare the GnRH response in patient groups whose 
clinical outcome and eventual diagnoses are known. This 
is the approach used in all previous studies (Illig et 
al, 1973; Grumbach et al, 1974; Franchimont et al, 1975; 
Job et al, 1976). The alternative is to correlate the 
pituitary response to exogenous GnRH in these subjects to 
other changes in hypothalamic -pituitary function which 
characterize the onset and progression of pubertal 
development. The nocturnal sleep- related gonadotrophin 
secretion first described by Boyar et al (1972b) is now 
generally accepted as a precise biological marker of 
pubertal onset in humans (Boyar et al, 1973a & b; 
Weitzman et al, 1975; Parker et al, 1975; Judd et al, 
1977; Giusti et al, 1979). This early indicator of 
puberty is detectable in late prepubertal children prior 
to the onset of clinical puberty (Lee et al, 1976; Judd 
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et al, 1977; Boyar, 1978; Giusti et al, 1979) and the 
nocturnal rise in gonadotrophin is believed to be 
responsible for stimulating the gonads to synthesize and 
secrete sex steroids in a diurnal pattern during sexual 
maturation (Boyar et al, 1974a; Judd et al, 1974; Parker 
et al, 1975). If the pituitary response to exogenous 
GnRH during pubertal development can be related to 
nocturnal gonadotrophin secretion as well as the eventual 
clinical diagnosis, the diagnostic and prognostic 
usefulness of both these hormonal parameters in the 
management of delayed puberty may be better understood. 
These considerations prompted us to study the 
nocturnal gonadotrophin secretion and the GnRH response 
simultaneously in a group of boys with impaired or 
delayed puberty whose progress was followed for up to 39 
months. Pituitary responsiveness was assessed by 
multiple submaximal doses (10 µg) of GnRH administered 
as I.V. boluses at two hourly intervals in order to mimic 
the nocturnal endogenous GnRH pulsatile stimulation of 
the pituitary. 
6.2 Results 
The individual values of mean plasma LH and FSH 
concentrations, spontaneous LH pulse frequency and 
amplitude and the maximal incremental and integrated area 
response to the four 10 µg bolus of GnRH are shown in 
Table 4.1. Kendall's rank correlation coefficients 
between each of the thirteen LH and nine FSH measures 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































and 6.2. The mean nocturnal plasma LH concentration 
and nocturnal pulse amplitude were best correlated with 
the pituitary response to the first GnRH bolus or pulse 
(A Max, r = 0.64 + 0.67 and E area, r = 0.61 + 0.64 
respectively (Kendall's rank correlation). The mean of 
the second to the fourth or of all four consecutive LH 
responses to exogenous GnRH pulses correlated with the 
two measures of nocturnal LH secretion less well (r = 0.53- 
0.64). Nocturnal LH pulse frequency was poorly 
correlated with either mean basal gonadotrophin levels 
or the GnRH response. Nocturnal plasma FSH concentration 
was best correlated with the morning levels (r = 0.87). 
The maximal LH incremental response and integrated 
area under the response curve to GnRH stimulation were 
significantly correlated (r = 0.86 for first pulse; 
r = 0.82 for the mean of second to fourth pulses and 
r = 0.85 for the mean of four pulses). Similarly the 
pituitary LH response to the first GnRH bolus correlated 
with the mean response to four consecutive 10 µg bolus 
(r = 0.65 for A max and r = 0.73 for E area) but less so 
with the mean response to the second to fourth boluses. 
For FSH, although the maximal incremental and integrated 
responses were highly correlated (first pulse r = 0.83, 
second to fourth pulse r = 0.79, all four pulses r = 0.85) 
the response to the first bolus was only poorly 
correlated with that to the subsequent stimuli 
(r = 0.24- 0.44). 
The linear relationships between mean nocturnal LH 





8 10 12 14 16 18 20 22 24 26 
LH A Max 1st pulse GnRH Response U/l 
Fig 6.1 
The relationship between mean nocturnal LH concentration and 
the maximal incremental (A Max) LH response to the first of the 
four 10 ug GnRH bolus stimulation in 16 pubertal subjects 
studied on 3Ooccasions. Linear regression analysis: 
y = 1.45 +0.263x; Kendall's rank correlation T = 0.64, p <0.001. 
Puberty stage lA =0, stage 1B =a, stage 2 =II, stage 3 = O, 
'stage 4 = and stage 5 = A. Solid lines indicate follow -up 
studies in the same pre- or peripubertal subject approximately 
6 months after the initial one. All the subjects with a GnRH- 
induced LH increment of 5 u/1 or more were either established 
in puberty at the time of study or progressed into puberty on 
follow -up. Although subject 7 did not undergo a second sleep 
study, his subseouent pubertal development was satisfactory. 
Neither the diagnosis nor the prognosis could be determined in 


















































































































































































































































































































































































































































hand and the maximal LH incremental response to the first 
GnRH bolus on the other are shown in Figures 6.1 and 6.2. 
Stage lA prepubertal patients generally had lower values 
for both nocturnal gonadotrcphin measures and smaller 
GnRH response. The considerable overlap of individual LH 
values in different clinical stages of puberty especially 
in the more mature patients was not minimized by 
combining basal nocturnal plasma LH measurements with the 
GnRH response. The use of four consecutive GnRH 
pulsatile stimulations instead of the single dose test 
did not significantly alter the distribution of the 
various clinical pubertal groupings (data not shown in 
figures). 
Maximal LH incremental response to the first 10 µg 
GnRH stimulation exceeding 5 u/1 was found in all 
patients who showed some signs of pubertal development 
when first studied. This included those four subjects 
with minimal testicular enlargement (Stage 1B). Despite 
the lowish nocturnal LH secretion in three out of the 
four subjects in stage 1B when first studied (Fig 6.1), 
all of them showed significant advances in the clinical 
pubertal ratings or an increase in magnitude of nocturnal 
LH secretion or both in the following six to twelve 
months (Figs 6.1 & 6.2, also see Table 2.1). One of 
these patients (subject 8), a growth- hormone deficient 
individual with low I.Q., showed a dramatic maturation in 
his gonadotrophin secretory pattern (see profiles in 
Appendix II) between the first and second study with a 
six -month interval. Nevertheless, androgen treatment was 
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instituted shortly after the second study due to 
increasing parental and social pressures. 
All patients in stage lA had a maximal LH 
incremental response to the first GnRH bolus less than 
5 u /l. One of these (subject 4) with growth hormone 
deficiency showed a substantial increase in nocturnal LH 
secretion and pituitary responsiveness when re- studied 
six months later (Figs 6.1 & 6.2). Again androgen 
treatment had to be commenced shortly afterwards because 
of his advancing age and the fact that he was leaving 
school to seek employment. A further patient in stage lA 
(subject 5) received a twelve week course of hCG (Pregnyl) 
3000 I.U. twice weekly immediately following the first 
study. Three months after the termination of the treat- 
ment course (six months from the first study) the gonado- 
trophin and testosterone profile (Fig 4.1) showed a 
dramatic maturation and this patient subsequently 
developed to full sexual maturity with no further 
treatment. Although this patient (subject 5) underwent 
serial hormonal studies on four occasions in a 26 -month 
period of follow -up (Appendix II) the subsequent three 
studies had not been included in the group data analyses 
because of the possible confounding effects of the 
twelve week course of treatment. The other three 
patients in stage lA (subjects 1, 2 and 3) were 
characterized by insignificant nocturnal LH secretion, 
low GnRH response even on repeated stimulation and 
somatic abnormalities such as anosmia, colour blindness, 
cryptorchidism and deafness (Table 2.1). In the two 
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younger patients, one of whom is also growth hormone 
deficient (subject 2), no significant sexual development 
occurred spontaneously in the subsequent twelve months 
following which testosterone replacement was instituted. 
The older patient with Kallmann's syndrome was started, 
immediatedly after his sleep study, on Sustanon 
injections and later changed to hCG with HMG after he 
married. On the evidence from these five patients, the 
LH response to GnRH stimulation either by single or 
multiple doses was unable to differentiate the three 
definitely hypogonadotrophic patients from the other two 
which showed significant advancement in hypothalamic - 
pituitary function six months later. Interestingly, the 
nocturnal plasma LH concentration and pulse amplitude 
were both slightly higher in the latter two patients. 
The rest of the study group consisted of patients 
with constitutional delayed puberty in more mature stages 
of development. All of these patients advanced their 
pubertal ratings in the 39 -month period of follow -up even 
though not all of them had repeat hormonal studies. Five 
patients (subjects 12, 13, 14, 15 and 16) with 
constitutional delayed puberty reached full maturity at 
the end of the study (Table 2.1). 
6.3 Discussion 
Pubertal maturation involves the programmed and 
sequential development of the brain, hypothalamus, 
pituitary and gonads - the chemical messengers produced 
at each level in maturation being responsible for 
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activating the next (Styne & Grumbach, 1978; Grumbach, 
1980). Investigations of puberty initiation should 
therefore concentrate on the most proximal or highest 
parts of this functional hierarchy. Unfortunately, our 
efforts at present are limited to. studying the part of 
the brain -hypothalamus -pituitary -gonadal axis distal to 
hypothalamic GnRH which is present in barely detectable 
amounts in the peripheral circulation (Arimura et al, 
1974; Jeffcoate et al, 1975; Kelch et al, 1975; Mortimer 
et al, 1976). It has therefore been necessary to resort 
to indirect tests of endogenous hypothalamic GnRH 
secretion in the investigations of pubertal disorders. 
Ideally these investigations should aim to evaluate the 
degree of hypothalamic function from the time when it is 
activated and also to predict that progression to full 
maturity will take place. 
The pituitary response to exogenous GnRH is said to 
reflect the degree of previous priming of the gonado- 
tropes by endogenous hypothalamic GnRH (Grumbach et al, 
1974; Mortimer et al, 1975; Hashimoto et al, 1975; Reiter 
et al, 1975 & 1976; Boyar et al, 1976). Since hypo- 
thalamic GnRH secretion is believed to be pulsatile 
(Sarkar et al, 1976; Carmel et al, 1976; Neil et al, 
1977; Eskay et al, 1977) a multiple submaximal dose GnRH 
stimulation protocol was adopted in an attempt to 
reproduce the endogenous pattern and to study the 
dynamics of pituitary gonadotrophin secretion in terms 
of an immediately releasable first pool and a newly 
synthesized reserve second pool (Yen et al, 1975; Yen, 
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1977). In conjunction, the episodic gonadotrophin 
secretion during sleep in late prepubertal and pubertal 
children was used to provide a fairly precise index of 
hypothalamic GnRH secretion during puberty (Boyar et al, 
1976; Boyar, 1978). 
The results in this study confirmed that both 
nocturnal LH secretions and the pituitary response 
elicited by multiple low -dose pulsatile stimulation 
progressively increased in magnitude from prepuberty to 
adulthood. Consequently, both parameters of gonado- 
trophin production can apparently be regarded as valid 
indices of pubertal maturation of hypothalamic function. 
However, nocturnal LH levels and pulse amplitude as well 
as the GnRH response were all rather variable. 
Individual hormone values showed considerable overlap in 
consecutive and even non -consecutive stages of puberty 
especially amongst the more mature subjects. It follows 
that neither nocturnal LH nor the GnRH response were 
adequate in identifying individual pubertal subjects at 
specific stages of maturity. Nevertheless, the latter 
investigation may, within certain confines, be 
successfully deployed to follow serially the progress of 
individual patients over a period of time (see later). 
The variability of pituitary gonadotrophic function in 
this study is in accordance with that found in previous 
reports (Job et al, 1977; Sizonenko, 1978 for review) and 
is perhaps to be expected in view of the inherent 
variability in onset and duration of specific stages of 
puberty in different individuals (Marshall & Tannery1970). 
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The pituitary LH response to four consecutive 
boluses of GnRH assessed by incremental maximal or 
integrated area under the dose -response curve provided 
the same information. The response to the first GnRH 
bolus correlated closely with the responses to the 
subsequent three boluses, so that they displayed similar 
relationships to the parameters of nocturnal LH secretion. 
Thus the repetitive mode of pituitary stimulation did not 
contribute any additional information clinically to that 
obtainable from the single dose (10 µg) stimulus. It can 
therefore be concluded that the best and most convenient 
hormonal parameter for the clinical assessment of 
pituitary responsiveness and indirectly hypothalamic 
function in puberty is the maximal incremental LH 
response to the first 10 µg bolus of GnRH. 
The fixed dose of 10 gg selected for repeated sub - 
maximal challenge of the pituitary (Rebar et al, 1973) 
delivered between 170 -340 ng /Kg body weight of GnRH to 
individual patients in this group. Within this range, 
the trend was for the more mature boys to receive 
slightly lower amounts of GnRH per unit body weight. 
This has not prevented the demonstration of the 
progressive rise in pituitary responsiveness during 
puberty similar to that described in previous studies 
(reviewed in Job et al, 1977). Judging from the dose - 
response studies of Grumbach et al (1974), the small 
differences in GnRH dosage per unit weight in this study 
is unlikely to have made any significant differences to 
the results obtained. 
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A maximal LH incremental response to the first 10 µg 
bolus of GnRH of 5 u/1 or more in this study is usually 
compatible with the presence or imminent onset of 
significant nocturnal gonadotrophin secretion and 
testicular volumes of at least 3 mis or more. The vast 
majority of patients in this category will progress to 
full sexual maturity spontaneously. These patients are 
considered to have constitutional delayed puberty. In 
those with a GnRH response of under 5 u/1 of LH, it is 
not possible to differentiate between those who will 
develop spontaneously from others with hypogonadotrophic 
hypogonadism. The eventual diagnosis will only become 
apparent by performing follow -up hormone studies or 
monitoring the progress of the individual patient over a 
period of time. In some cases, an unequivocal diagnosis 
may not be possible. In two patients (subjects 4 and 8) 
the clinical situation demanded that rapid virilization 
can be induced by treatment even though there was 
definite evidence of spontaneous development. It is 
interesting that both these patients were deficient in 
growth hormone as well. They had been receiving growth 
hormone replacement for at least two years prior to the 
present study, but this is unlikely to influence either 
the pituitary response to GnRH or the eventual outcome of 
pubertal development (Kelch et al, 1976). That these 
two patients, despite the presence of significant 
nocturnal LH secretion and adequate GnRH response on 
follow -up study, were still barely into puberty is 
contrary to the findings of Sauder et al (1981). These 
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workers found subnormal LH concentrations and GnRH 
response in boys with isolated growth hormone deficiency 
even after normal progression of sexual maturation. It 
may be possible that growth hormone deficient boys may 
secrete LH with both greater (Lucky et al, 1980) or 
lesser (as in our patients) than normal biological to 
immunological potency ratio. Whatever may be the case, 
this further emphasizes the limitation of both the GnRH 
test and nocturnal LH concentrations in the diagnosis of 
hypogonadotrophism in boys with growth hormone deficiency. 
Nevertheless, in the third patient in this series with 
growth hormone deficiency (subject 2), there was little 
doubt regarding the associated gonadotrophin deficiency. 
Apart from the immature pattern of gonadotrophins, he had 
a past history of encephalitis, multiple congenital 
somatic defects and a complete lack of clinical progress 
in the following twelve months. 
Pubertal development should be regarded as a 
reactivation of the hypothalamic -pituitary -testicular 
axis (Grumbach, 1980). In males with normally 
differentiated external and internal genitalia, normal 
prenatal function of the hypothalamic- pituitary- 
testicular axis is implied (Jost, 1972; Ohno, 1976; 
Wilson, 1978). In patients with delayed pubertal develop- 
ment, most of whom have normally differentiated genitalia, 
the hypothalamus, pituitary and testes must have had the 
potential for normal function given the suitable 
stimulation at the appropriate time. Delayed secondary 
sexual maturation in most instances must reside in the 
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defective or delayed CNS reactivation of the hypothalamic 
signal generator. It is conceivable that the complex 
bimodal nature of sexual development in humans increases 
the likelihood of functional abnormalities especially in 
the reactivation phase giving rise to clinical disorders 
such as delayed puberty or hypogonadotrophic hypogonadism. 
It may be relevant that girls, whose onset of puberty is 
approximately two years earlier than boys, have a much 
lower incidence of delayed puberty. One interpretation 
of these observations is that simple delayed puberty and 
hypogonadotrophic hypogonadism are extreme examples of a 
spectrum of CNS- hypothalamic abnormalities where the 
stimulus for hypothalamic GnRH synthesis and release is 
either temporarily delayed or permanently deranged. This 
concept is supported by the heterogeneous pattern of 
gonadotrophin secretion in patients with idiopathic 
gonadotrophin deficiency (Bell et al, 1973; Zarate et al, 
1973; Boyar et al, 1973 & 1976; Spitz et al, 1974) 
resulting from different degrees of endogenous GnRH 
deficiency. This may have arisen from the failure of 
initiating or of the continuing progression of neuro- 
secretory mechanisms which activate the hypothalamus. 
Constitutional delayed puberty, as its name implies, is 
simply due to the later attainment of CNS maturation 
necessary for the initiation of the peripubertal hypo- 
thalamic GnRH secretion. This is compatible with the 
clinical observation that earlier growth patterns in 
boys with constitutional delayed puberty are frequently 
at or below the third percentile of the normal range 
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(Prader, 1975; Brooks, 1981) so that their overall growth 
and physical development are relatively retarded. It is 
also relevant that patients with isolated growth hormone 
deficiency frequently have chronologically delayed sexual 
maturation but they enter puberty at a normal bone age 
(Tanner & Whitehouse, 1975). 
Accepting that constitutional delayed puberty and 
idiopathic hypogonadotrophic hypogonadism share common 
pathophysiological mechanisms varying only in timing and 
severity, it should therefore not be surprising that both 
the pituitary responsiveness and the nocturnal GnRH 
secretion are so variable and unpredictable in patients 
with delayed sexual maturation. Both these parameters 
are seldom characteristic of specific physiological or 
pathological states but they simply reflect the extent 
of hypothalamic development and the degree of previous 
exposure of the pituitary to endogenous GnRH. Neither 
the pituitary response to GnRH nor the measurement of 
nocturnal gonadotrophin secretion in prepubertal subjects 
without serial determinations over a reasonable duration 
of observation can be expected to have much predictive or 
prognostic value in individual patients. In practice, 
some patients with extreme delay in pubertal onset or 
unusually slow progression from the early stages of 
puberty are often treated by sex hormones regardless of 
the definitive diagnosis. This further emphasizes that 
the distinction between constitutional delayed puberty 
and hypogonadotrophic hypogonadism is not always 
possible and may sometimes depend on arbitrary clinical 
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definitions or yield to overriding therapeutic 
considerations. 
In summary, this study showed that the pituitary 
response to exogenous GnRH can differentiate between 
subjects in late prepuberty or early puberty from those 
in early prepuberty. In the latter group, however, the 
GnRH response cannot differentiate between patients with 
gonadotrophin deficiency from those with constitutional 
delayed puberty. The assessment of nocturnal gonado- 
trophin secretion and the use of multiple -dose GnRH 
stimulation did not confer any additional diagnostic or 
prognostic accuracy. The limitation of gonadotrophin 
measurement, whether basal or stimulated, in patients 
with growth hormone deficiency was, discussed. 
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SECTION C 





In the previous section, studies on the development 
and control of testicular functions were based on the 
measurement of testosterone and testicular volume. 
Although Leydig cell steroidogenesis can be adequately 
assessed by circulating testicular steroid concentrations, 
spermatogenesis in adolescent subjects is less amenable 
to investigations. As mentioned, testicular volume is a 
valid but rather crude index of spermatogenesis. The 
detection of spermaturia (Richardson & Short, 1978), 
though convenient, is subject to a significant incidence 
of false negative and is probably masturbation -related. 
Obviously, semen analysis and testicular biopsy in these 
pubertal patients are not practical nor can they be 
ethically justified. It follows that seminiferous tubule 
functions may be more fruitfully investigated in adult 
subjects. 
The study of hormonal control of spermatogenesis is 
complicated by the presence of different functional/ 
anatomical components within the seminiferous tubules 
(see Section A, Chapter 8) and the lack of convenient 
parameter(s) of Sertoli cell functions. In addition, the 
ill -defined functional interrelationship between Sertoli 
cells and germ cells further complicates the picture. 
Although not all these difficulties can be bypassed, one 
approach to the study of the endocrine control of 
spermatogenesis is to examine the hormonal changes 
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resulting from primary seminiferous tubule damage in 
infertile men. This provides an opportunity not only to 
assess the value of further diagnostic parameters in 
conjunction with semen analysis, but also to explore the 
functional interrelationships between spermatogenesis. 
gonadotrophins and testicular steroidogenesis. The 
latter includes, apart from androgens, the synthesis and 
secretion of oestrogens (Kelch et al, 1972) for which no 
definite physiological function has been ascribed. FSH 
can stimulate the production of oestradiol in cultured 
rat Sertoli cells (Dorrington & Armstrong, 1975) while 
oestrogens preferentially suppress FSH secretion in vivo 
(Kulin & Reiter, 1972). These findings seem to imply 
that oestrogens, under certain circumstances, may have a 
similar spectrum of biological properties to inhibin - 
the putative seminiferous tubular factor which selectively 
suppresses FSH. A further aspect of testicular oestrogens 
is the possibility that they may play a role in the 
intratesticular control of Leydig cell function (Dufau 
et al, 1978). This is of particular interest in view of 
the evidence that androgen production may be impaired in 
infertile men (de Kretser et al, 1972). The altered 
endocrine environment created by seminiferous tubular 
damage in infertile men afforded a unique opportunity to 
evaluate the possible physiological functions or 
pathophysiological significance of testicular oestrogens. 
It has been estimated that 10-15% of marriages 
experience difficulty in producing children (Behrman & 
Kistner, 1975). In 20% of childless marriages, the 
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abnormality lies solely with the husband and in a further 
20% both husband and wife contribute to the infertility 
(Buxton & Southam, 1958). The male causes of infertility 
are mainly due to defects in the semen such as 
oligospermia, azoospermia, poor motility and abnormal 
morphology (Hotchkiss et al, 1938). The American 
Fertility Society recommended that the lower limit of 
normal sperm density is 40 million /ml, but it is now 
widely accepted that there is little increase in 
fertility with sperm densities above 20 million /ml if the 
other semen parameters are constant (Macleod & Gold, 1951). 
Other authors were able to demonstrate a statistically 
significant reduction in pregnancy rate only when the 
sperm density has fallen below 10 million /ml (Smith et al, 
1977; Sherins et al, 1977). It is obvious that the 
assessment of fertility potential by semen analysis is 
based on the principle of probability and the diagnosis 
of male subfertility cannot be absolute. Thus any male 
who is not azoospermic will stand some chance of fecundity 
and subjects with normal semen parameters are not 
necessarily fertile (e.g. in the presence of high titres 
of anti -sperm antibodies). Barriers to fertilization may 
also result from sexual difficulties, penile abnormalities 
or other extraneous factors such as infections and use of 
certain lubricants. The aetiological factors in male 
infertility are listed in Table 1.1. Despite the 
numerous factors that may disrupt the functions of the 
seminiferous tubules and accessory glands, the 
aetiological factor(s) in over 50% of patients with 
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Table 1.1 Aetiological factors in male infertility 
Defects in Technique 
Infrequent and poor timing of intercourse 
Impotence and ejaculatory failure 
Use of sperm -toxic lubricants 
Testicular Factors 
Idiopathic 




Orchitis - Mumps 
Trauma, torsion 
Heat - occupation or local 
Toxic chemicals and cytotoxic drugs 
Chromosomal disorders - Klinefelter's (47XXY) syndrome 
Irradiation 
Endocrine deficiency - hypogonadotrophic hypogonadism 
Androgen end -organ insensitivity 
Outflow Tract /Accessory gland pathology 
Agenesis of vasa deferentia and seminal vesicles 
Obstruction of epididymis or vas 
Prostatovesiculitis 
Anti -sperm antibodies 
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infertility are unknown. However, with the rare 
exceptions of those with hvpogonadotrophic hypogonadism 
and chronic illnesses, testicular factors are responsible 
for the vast majority of cases of male infertility (Van 
Zyl et al, 1975; de Kretser, 1979). Irrespective of the 
nature of the individual testicular aetiological factors 
in the infertile male, the end result is the depletion of 
germ cells and /or arrest of their maturation, producing 
failure of spermatogenesis. The hormonal changes 
resulting from injury to the seminiferous epithelium are 
the subject of the following studies. 
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CHAPTER 2 
ENDOCRINE ASSESSMENT OF THE SUBFERTILE MALE 
2.1 Introduction 
In assessing the reproductive capacity of the human 
male, it is not feasible, as it is in animal husbandry, 
to test the fertility potential of an ejaculate against 
multiple female recipients. In vitro tests of 
fertilization, though a promising research technique, has 
not reached the stage of routine clinical use as yet. 
Semen analysis has therefore been the mainstay in 
fertility assessment in men (Eliasson, 1975) even though 
there is no direct evidence that the commonly measured 
semen characteristics are critically related to the 
fertilizing potential of ejaculates in humans. 
Furthermore, because of the inherent variability in 
testicular sperm production (Freund, 1963) and the 
difficulties in standardizing sample collection (Freund, 
1962), the accuracy and precision of semen analysis fall 
short of the ideal. Consequently, there is no clear cut 
demarcation between a normal and an abnormal ejaculate 
and the prediction of fertility or infertility based on 
semen analyses can at best only be approximate (Eliasson, 
1975; Rehan et al, 1975; Sherins et al, 1977). Other 
methods of investigations have therefore been employed to 
complement semen analysis in the assessment of male sub - 
fertility. Testicular biopsy has been a useful way of 
directly assessing the morphological state of the semini- 
ferous epithelium (Charny, 1940; Hotchkiss, 1942; Nelson, 
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1953; Rosen -Runge, 1956; Johnsen, 1970a; Meinhard et al, 
1973; Wong et al, 1973; Aafjes et al, 1974 & 1978). 
However, considerable expertise and time are required in 
the meaningful quantitative interpretation of testicular 
histology and the procedure is not without morbidity. 
With the wider availability of hormone assays, the 
measurement of FSH and other reproductive hormones has 
added a new dimension to the investigation of male sub - 
fertility. Several studies reported a reciprocal relation- 
ship between urinary or plasma FSH and the number of germ 
cells in seminiferous tubule cross sections (Johnsen, 
1970b;Franchimont et al, 1972; de Kretser et al, 1974; 
Baker et al, 1976). Sperm density has also been shown to 
have an inverse relationship to FSH (Rosen & Weintraub, 
1971; Mauss & Börsch, 1973; Kjessler & Wide, 1973; Hunter 
et al, 1974; Christiansen, 1975; Aafjes et al, 1977). 
This however was not confirmed by others (Leonard et al, 
1972; Franchimont et al, 1972; de Kretser et al, 1972). 
Thus the role of plasma FSH measurement as a quantitative 
index of seminiferous tubule function and its relationship 
to histological changes in testicular biopsies in male 
infertility are not entirely clear. We therefore decided 
to further evaluate the efficacy of plasma FSH in 
assessing the degree of seminiferous tubule damage at 
different levels of sperm density in men presenting with 
infertility. 
GnRH has been used in dynamic tests of the hypo- 
thalamic- pituitary- testicular axis in a variety of 
hypogonadal conditions (Franchimont et al, 1975). 
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Exaggerated FSH response to GnRH proportional to basal 
levels has been reported in patients with oligospermia 
and azoospermia (Isurgi et al, 1973; Mecklenberg & 
Sherins, 1974; Franchimont et al, 1975; Roulier et al, 
1976; Guay et al, 1977). However, Lipschultz et al (1977) 
found exaggerated FSH response to GnRH in oligospermic 
patients with normal basal FSH levels. This implied that 
the GnRH response (rather than basal FSH) may be a more 
sensitive index of seminiferous tubular function. The 
clinical value of the GnRH test in comparison with basal 
FSH measurements in male subfertility therefore needs 
further evaluation. 
Although clinically apparent degrees of androgen 
deficiency are uncommon in subfertile males, evidence of 
Leydig cell dysfunction can be detected in those with 
more severe forms of seminiferous tubular damage. This 
is suggested by elevated basal LH (Kjessler & Wide, 1973; 
Mauss & Börsch, 1973; Christiansen, 1975; Hunter et al, 
1974), exaggerated LH response to GnRH stimulation 
(Isurgi et al, 1973; Mecklenberg & Sherins, 1974; de 
Kretser et al, 1975; Roulier et al, 1976; Guay et al, 
1977) and more directly indicated by statistically lower 
testosterone levels or impaired response to hCG 
stimulation (de Kretser, 1972 & 1975b). Study of the LH- 
testosterone axis may therefore also furnish diagnostic- 
ally useful information in addition to FSH measurements 
in the investigation of male fertility status. Since LH 
and testosterone, and to a lesser extent FSH, are 
secreted episodically (Nankin & Troen, 1971; Naftolin et 
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al, 1973; Santen & Bardin, 1973; Alford et al, 1973; 
Smith et al, 1974) multiple measurements of these 
hormones may provide more accurate information than 
single estimations. 
The aims of the present study are to evaluate and 
compare the clinical application of (1) single basal 
measurements of FSH, LH and testosterone; (2) multiple 
measurements of FSH, LH and testosterone and (3) the GnRH 
response, in the assessment of subfertile males in terms 
of their relationship with testicular histology and sperm 
production. Having established the best hormone 
parameter(s) and their limitations, the approach to 
investigation of the subfertile male and the indications 
for testicular biopsy can then be rationalized. 
2.2. Patients and methods 
2.2.1 Patients 
A total of 103 consecutive patients referred to the 
Male Subfertility Clinic, Royal Infirmary, Edinburgh with 
average sperm density under 40 million /ml were studied. 
All patients were normally virilized and had normal male 
chromosome karyotype (46XY). The median age was 34 and 
range 24 -45 years. The clinical histories, summarized in 
Table2.l,revealed no abnormalities in three quarters of 
the group. A history of unilateral or bilateral crypt - 
orchidism could be elicited in eleven patients while six 
had infections in the genital tract such as mumps, 
gonorrhea and nonspecific urethritis. One patient 








































































































































































































































































































































































































































































































litis while another underwent unilateral orchidectomy 
following a road accident. Two patients reported psycho- 
sexual difficulties. No abnormalities were found on 
physical examination in half of the patients (Table 2.1). 
Bilateral (27) and unilateral (7) small testes - under 
15 ml volume as measured by Prader's orchidometer, were 
found in 34 patients. Twelve patients had clinically 
detectable varicocoeles and four had palpable abnormal- 
ities of the epididymis or vas deferens. Phimosis and 
hydrocoele were each present in one patient. 
Thirteen healthy normal subjects who had fathered 
one or more children within the past five years were also 
investigated hormonally as controls. Their median age 
was 31 and range 24 -37 years. 
2.2.2 Endocrine investigations 
In the first 63 patients and the 13 controls, basal 
samples of LH, FSH and testosterone were obtained at 30 
minute intervals for 11 hours. This was followed by an 
IV bolus injection of 50 µg GnRH (Gonadorelin, Ayerst) 
and samples for LH and FSH collected at 30, 60 and 90 
minutes afterwards. In the subsequent 40 patients, only 
single samples of basal LH, FSH and testosterone were 
obtained. 
2.2.3 Analysis of GnRH response 
Examination of the LH and FSH profiles after GnRH 
stimulation (Fig 2.1) suggested that a model of exponential 
decline might be appropriate, with a relatively slower 
decline in FSH which might effectively be zero for the 












































































































































































































































































































All gonadotrophin values were log transformed since both 
LH and FSH in the one hundred blood donors had log normal 
distributions. For each individual, a straight line fit 
to log (stimulated -mean basal) LH and FSH values with time 
was obtained by least squares. Pooled estimates of the 
slopes of these straight lines for the whole group were 
obtained for each gonadotrophin. This assumed that the 
half -life for the hormones were the same for all subjects 
studied. This assumption was tested by analysis of 
variance between individual and common slope models. A 
common slope for all subjects which corresponded to an LH 
half -life of 1.36 hours (1.20 -1.56 - 95% confidence 
interval) after GnRH stimulation was confirmed. It also 
confirmed a constant stimulated level of FSH for each 
individual, with no increase or decrease between 30 and 
90 minutes after GnRH stimulation. In the following 
analyses, the gonadotrophin measures for each individual 
were designated as follows: - 
Basal LH (LB) - the geometrical mean of 4 basal LH values 
before GnRH stimulation. 
Basal FSH (FB) - the geometrical mean of 4 basal FSH 
values before GnRH stimulation. 
Peak LH (LP) - estimated 30 minute value (minus LB) 
obtained by fitting a straight line with 
the common slope to the set of Log (peak - 
basal) LH readings for each individual. 
Peak FSH (FP) - the geometrical mean of the 3 stimulated 
FSH values minus FB. 
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2.2.4 Testicular biopsy and histology 
Under general anaesthesia, unilateral testicular 
biopsies in 90 patients and bilateral biopsies in 12 were 
obtained through small scrotal incisions. One of the 
latter group had very different histological appearances 
in the two testes and one patient refused to undergo the 
procedure after his endocrine investigations. These two 
patients were excluded from subsequent analyses involving 
testicular histology. The biopsies were fixed in Bouin's 
solution and embedded in paraffin. The sections (5 u 
thick) were stained with haematoxylin and eosin. 
Testicular histology was graded according to the 
proportion of seminiferous tubules showing spermatogenic 
activity and the degree of such activity within tubules 
(Mcllree et al, 1966; Chandley et al, 1976). Definition 
of the gradings were as follows: - 
- All tubules show active spermatogenesis with 
production of mature sperms. 
- Some or all tubules show depression or arrest 
of spermatogenesis at various stages or a 
diminished number of germ cells. No tubules 
show a complete absence of germ cells. 
- Some but not all tubules show a complete absence 
of germ cells and contain only Sertoli cells. 
- Germ cells are absent from all tubules examined, 
their only content being Sertoli cells. 
Thickening of the tunica propria, hyalinization of the 
tubules, or increase in Leydig cell numbers may occur in 






2.2.5 Semen analysis 
Semen analysis was based on the method described in 
Chandley et al, 1976. The sperm density was estimated 
by haemocytometer method using an improved Neubauer 
chamber. The well -mixed seminal fluid was counted in 
1:10 or 1:20 dilution depending on an initial estimated 
count. The diluent consisted of 50 G NaHCO3 and 10 ml 
of 35% formalin made up to a final volume of 1000 ml 
with distilled water. All spermatozoa were counted in 
the large central square of the haemocytometer, which 
has a multiplication factor of 10,000. For the samples 
with very low sperm densities, five large squares of the 
haemocytometer were counted with 2000 being the 
multiplication factor. Sperm density was expressed as 
numbers of sperms (in millions) per millilitre of semen. 
In each patient the mean sperm density from at least two 
separate samples was used. Although the sperm motility 
and morphology were analysed, only mean sperm density 
was used for the present analysis. 
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2.3 Results 
The distribution of testicular histology and sperm 
density in the 100 patients is presented in Table2.2. Of 
the 24 patients with Grades 3 and 4 histology only one 
had an average sperm density over 5 million /ml. In 
contrast, the full range of sperm density from azoospermia 
to 40 million /ml was encountered in the 76 patients with 
Grades 1 and 2 histology. Alternately, in patients with 
sperm density over 5 million /ml, all except one had Grade 
1 or 2 histology. In those with sperm density under 5 
million /ml, any histological grade could be present. It 
is in this last group that hormone studies may prove to 
be most helpful. 
The relationship between testicular histology and 
the gonadotrophin and testosterone levels in the first 63 
patients who underwent GnRH testing is shown in Table 2,3. 
Although there was no significant difference in testo- 
sterone between any of the patient or control groups, the 
four gonadotrophin measures (FB, FP, LB and LP) separated 
the patients into two broad histological groups: Grade 1 
with 2 and Grade 3 with 4. This pooling of gonadotrophin 
measures in terms of similar means and standard deviations 
is particularly well illustrated by the profiles of FSH 
responses to GnRH in Fig 2.1. 
To determine the best gonadotrophin measure(s) in 
distinguishing between the two histological groupings 
(Grades 1 and 2 from Grades 3 and 4), multivariate 
discriminant analysis (Marriot, 1974) was used. This 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































which give the differences between the two patient groups 
and controls in standard deviation units allowing for the 
correlation between the variables (Table2.4). Either 
basal FSH or peak FSH alone could provide the best 
separation between the two histological groupings and no 
increase in discrimination was obtained by including 
further hormonal parameters. The difference in LH 
between the histological groups could entirely be 
explained by the correlation between LH and FSH measures 
(r = 0.63- 0.74). Basal and peak FSH were highly 
correlated (r = 0.75, p<0.00001) in the patient and 
control groups (Fig 2.2)so that either one of these 
measures would not improve the discriminant function of 
the other. Using basal FSH alone with the upper limit of 
the normal range at 6.7 U /1, elevated values were found 
in 81% (13/16) of Grades 3 and 4 biopsies and normal 
values in 91% (41/45) of Grades 1 and 2 biopsies. 
The best discrimination between normal controls and 
the two subfertile patient groups was provided by the LH 
measures (Table2.4). Peak LH was the best single parameter 
distinguishing controls from patients with Grade i or 2 
histology. The addition of other measures did not 
significantly improve the discrimination. Although either 
peak FSH or peak LH alone provided a very clear cut 
separation between controls and patients with Grade 3 or 
4 histology, the best discrimination was given by the 
combination of basal and peak LH. 
The relationship between sperm density and the five 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































patients with normal FSH and Grade 1 or 2 testicular 
histology were considered to have obstructions in the 
excurrent ducts and were excluded from this analysis. 
Both basal and peak FSH showed a significant linear 
rising trend (p <0.0001) with decreasing sperm density 
(Fig2.3). Mean basal FSH remained fairly constant until 
sperm densities fell below 5 million /ml and only exceeded 
the upper limit of normal basal FSH range (6.7 u /l) with 
sperm densities under 1 million /ml. Peak FSH showed a 
linear rising trend over the whole range of sperm 
densities from 40 million /ml to azoospermia but the 
magnitude of the increase at each level was smaller than 
that seen in basal FSH. Neither testosterone, basal LH 
or peak LH differed significantly with changes in sperm 
density but the latter two measures did show a weak 
degree of linearity. 
Thus in the analysis of the first 63 patients, basal 
FSH was the best single hormonal parameter in terms of 
its relationship to testicular histology and sperm 
density. The GnRH response did not contribute any 
additional useful information in these respects. The 
within- patient coefficient of variation for four basal 
samples of FSH at 30 minute intervals was so small (10%) 
that using a single measurement instead of the mean of 
four did not alter the conclusions of the above analyses 
significantly. 
In the remaining 40 patients, only single samples of 
basal FSH, basal LH, testosterone and testicular histology 









































































































































































































































































































































































































































basal FSH to be the best parameters in distinguishing the 
two histological categories. The addition of basal LH 
and testosterone did not improve the discriminant function. 
Elevated basal FSH was found in 75% (4/6) of Grades 3 and 
4 histologies and normal FSH in 97% (30/31) of Grades 1 
and 2 histologies. This was similar to the findings in 
the first 63 patients. The linear rising trend in basal 
FSH with decreasing sperm density was also confirmed. 
Thus the relationship between a single basal FSH and 
testicular histology and sperm density in the additional 
40 patients followed the same pattern as the first 63. 
The findings in 100 patients are summarised in Fig2.4. 
and demonstrate the interrelationship between basal FSH, 
testicular histology and sperm density. In the 19 azoo- 
spermic patients, basal FSH clearly differentiated the 
six with severe germ cell damage (Grades 3 and 4 
histologies) from the 13 with Grades 1 and 2 histologies. 
Of the latter 13 patients, one had maturation arrest at 
the primary spermatocyte stage and five were confirmed to 
have bilateral agenesis of the vasa deferentia on scrotal 
exploration. One had patent vasa bilaterally on 
vasography and the obstruction was presumed to be in the 
epididymis. Six patients were not submitted to either 
scrotal exploration or vasography as they were reluctant 
to pursue further investigations or treatment. These 13 
patients form a separate aetiological group and were 
excluded from subsequent analyses. In the other 81 
patients (oligospermic) normal FSH and Grades 1 and 2 
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Basal FSH, sperm density and testicular histology (grades 1 -4, 
see text) in 100 subfertile men. Horizontal line respresents the 
upper limit of the normal range (6.7 u /l) for basal FSH in 100 
healthy male blood donors. The markers indicate patients who 
subsequently impregnated their wives with or without treatment. 
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over 5 million /ml with the exception of three patients. 
On the other hand, the majority of patients with sperm 
density under 1 million /ml had elevated FSH and Grades 3 
and 4 histologies. Between these two extremes, there was 
an intermediate group with sperm densities of 1 -5 
million /ml and greater overlap of the histological groups. 
The diagnostic value of FSH is highlighted in Tables 
2.6 & 2.7. In patients with sperm densities over 5 million/ 
ml (Table 2.6)42 out of 43 (97.7 %) had Grade 1 or 2 testic- 
ular histology. With the use of FSH, all patients with 
normal levels ( <6.7u/l) had Grade 1 or 2 histology. Of 
the three patients with elevated ( >6.7 u /l) FSH, Grade 1 
or 2 testicular histology was still present in two. Thus 
the contribution of FSH is limited in patients with sperm 
densities over 5 million /ml who, with very few exceptions, 
are likely to have Grade 1 or 2 histology. In patients 
with sperm density under 5 million /ml (Table 2.6) 48% had 
Grade 1 or 2 and 52% Grade 3 or 4 histologies. With the 
use of FSH, 78% (18/23) with normal levels had Grade 1 or 
2 and 83% (18/21) with elevated values had Grade 3 or 4 
histologies. In patients with sperm densities under i 
million /ml (Table 2.7) 83% had Grade 3 or 4 histology and 
only 17% had Grade 1 or 2 histology. All these patients 
with elevated FSH had Grade 3 or 4 histology but in those 
with normal FSH, both histological groups were found with 
similar frequencies - 57% Grade 3 or 4 and 43% Grade 1 or 
2. Thus, in subfertile patients with sperm densities of 
under 5 or 1 million /ml, the finding of elevated FSH 
levels would confirm severe germ cell damage but normal 















>5 - 42 (97.7%) 1 (2.3%) 43 
>5 <6.7 40 (100%) 0 40 
>5 >6.7 2 (67%) 1 (33%) 3 
<5 - 21 (48 %) 23 (52 %) 44 
<5 <6.7 18 (78 %) 5 (22 %) 23 
<5 >6.7 3 (17 %) 18 (83 %) 21 
Table 2.6 
Distribution of 87 subfertile patients according to 
sperm density (over or under 5 million /ml), basal FSH 
(normal - under 6.7 U/1 or elevated - over 6.7 U /1), 
and testicular histology (Grades 1 and 2 or Grades 3 
and 4). Thirteen patients with obstructive azoospermia 
were excluded. 
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Sperm Basal Testicular Testicular 
Density FSH Histology Histology Total 
m /ml U/1 1& 2 3& 4 
>1 - 59 (94%) 4 (6%) 63 
>1 <6.7 54 (96%) 2 (4%) 56 
>1 <6.7 5 (71%) 2 (29%) 7 
<1 - 4 (17%) 20 (83%) 24 
<1 <6.7 4 (57%) 3 (43%) 7 
<1 <6.7 0 17 (100%) 17 
Table 2.7 
Distribution of 87 subfertile patients according to 
sperm density (over or under 1 million /ml), basal FSH 
(normal - under 6.7 U/1 or elevated - over 6.7 U /1) 
and testicular histology (Grades 1 and 2 or Grades 3 




In the assessment of male infertility, two key 
issues are central to the management of the patient, the 
fertility potential of the individual and the degree of 
damage to the seminiferous tubules. The present findings 
are mainly, though not exclusively, concerned with the 
latter aspect. Although conventional semen analysis can 
provide some indication of changes in the seminiferous 
epithelium (Johnsen, 197Oa; Kjessler & Wide, 1973; Aafjes 
et al, 1977) the degree of abnormality in spermatogenesis 
is not always accurately reflected by this investigation 
(for example, obstruction in the excurrent ducts and 
spermatogenetic arrest). Biopsy of the testes has 
therefore been employed to enable seminiferous tubular 
histology to be assessed directly. In common with other 
feedback control systems, dysgenesis'or damage to the 
seminiferous tubules will result in increased secretion 
of gonadotrophins, especially FSH, due to the reduction 
or loss of negative feedback. This reciprocal relation- 
ship of FSH to both sperm density (Johnsen, 197Ob; 
Kjessler & Wide, 1973; Mauss & Börsch, 1973; Hunter et al, 
1974; Christiansen, 1975; Aafjes et al, 1977) and 
testicular cytology (Johnsen, 197Ob; Rosen & Weintraub, 
1972; Kjessler & Wide, 1973; Mauss & Börsch, 1973; Hunter 
et al, 1974; Christiansen, 1975; Aafjes et al, 1977) may 
thus improve the correlation between these two parameters 
of seminiferous tubule function and obviate the need for 
testicular biopsy. 
Our findings showed that in terms of the inverse 
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relationships with sperm density and the degree of germ 
cell loss demonstrated by testicular histology, basal FSH, 
amongst the various combinations of hormone measures, 
gave the greatest discriminant value. This confirmed the 
findings in previous studies (Johnsen, 1970b; Rosen & 
Weintraub, 1972; Kjessler & Wide, 1973; Mauss & Börsch, 
1973; de Kretser et al, 1974; Hunter et al, 1974; 
Christiansen, 1975; Aafjes et al, 1977). The variation 
of basal FSH at intervals of 30 minutes was small and 
single estimations were representative. The additional 
measurements of basal LH, testosterone and the GnRH 
response did not contribute further to the discriminant 
function of basal FSH alone. 
In our analysis of testicular histology, endocrine 
studies clearly differentiated between patients with 
complete absence of germ cells in some or all tubules 
(Grade 3 or 4) from those in which germ cells were present 
in normal or reduced numbers. This is in agreement with 
the findings of de Kretser et al (1972), Franchimont et 
al (1972) and Hunter et al (1974), who used similar 
qualitative analyses of testicular histology. De Kretser 
et al (1974), using quantitative methods, confirmed the 
inverse relationship between FSH and the number of germ 
cells in seminiferous tubular cross -sections. However it 
is doubtful whether such time -consuming quantitative 
analyses of testicular histology are more useful than the 
simpler qualitative classification used in this study in 
the clinical assessment of infertility. 
The finding that the FSH response to GnRH stimulation 
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was highly correlated with basal FSH confirms the 
previous studies (Isurgi et al, 1973; Mecklenberg & 
Sherins, 1974; Franchimont, 1975; Roulier et al, 1976). 
Lipschulz et al (1977) however, demonstrated an 
exaggerated FSH response to 250 µg of GnRH in spite of 
normal basal levels in oligospermic patients with sperm 
density under 10 million /ml. This discrepancy may be due 
to the difference in GnRH dose employed and the different 
criteria for selection of oligospermic patients (under 40 
million /ml in the present study). A further explanation 
lay in the different relationship of sperm density to 
basal and peak FSH. Basal FSH remained fairly constant 
and only increased outwith the normal range when sperm 
density fell below 5 million /ml. A similar finding has 
been reported by Mauss & Börsch (1973) although the 
critical level of sperm density was 10 million /ml. The 
FSH response to GnRH (peak FSH) however showed a linear 
rising trend over the entire range of sperm density from 
40 million to azoospermia. Thus patients with sperm 
density around 5 -10 million /ml may have basal FSH within 
the normal range but exaggerated FSH response to GnRH - 
the group of patients that Lipschultz et al (1977) 
selected for investigation. However, even in that study, 
basal FSH in the oligospermic patients were significantly 
elevated compared to controls, though the individual 
levels remained within the normal range. Furthermore, 
the magnitude of the GnRH response was proportional to 
basal FSH in all patient groups and controls. Their 
findings are therefore entirely compatible with those of 
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the present study. 
The observation that the GnRH response was superior 
to basal FSH in distinguishing between normal fertile 
controls and the subfertile patients implies that the 
former measure may be an index of fertility potential - 
the lower the GnRH response, the higher the fertility. 
The small numbers of fertile controls and their lack of 
semen analysis data in this study do not permit any firm 
conclusions but further studies are indicated. 
The elevated and peak LH found in patients with 
Grades 3 and 4 histology confirmed the reports of de 
Kretser et al (1972), Hunter et al (1974) and Christiansen 
(1975).. However, the testosterone levels in our patients 
were normal and a tendency for lower testosterone in 
patients with severe germ cell damage was not demonstrated. 
de Kretser et al (1972), however, found lower or subnormal 
levels of testosterone and impaired response to HCG 
d Kretser et al, 
stimulation 1975b)in patients with seminiferous tubular 
hyalinization of Sertoli cell only syndrome although 
there was no clinical evidence of androgen deficiency. 
This apparent discrepancy is due to the exclusion of 
patients with chromosomal abnormalities (Klinefelter's 
and variants) and the smaller proportion of patients with 
more severe seminiferous tubular damage in the present 
study. The elevated LH with or without low testosterone 
may be the result of compensated Leydig cell failure 
presumably caused by the same aetiological factors which 
affected the seminiferous tubular compartment. Recent 
evidence from in vitro studies (Rodriguez -Rigau et al, 
354 
1978; Weiss et al, 1978) confirmed abnormalities in 
Leydig cell functions in infertile men but the 
possibility of Leydig cell failure being a consequence of 
germ cell damage cannot be excluded. It is interesting 
to note that low plasma testosterone found in subfertile 
patients with varicoeles reverted to normal after 
surgical ligation of the internal spermatic vein 
(Comhaire & Vermeulen, 1975). 
Summarizing the clinical implications of the fore- 
going considerations: the most informative endocrine 
investigation in the management of severely oligospermic 
and azoospermic patients is a single estimation of basal 
FSH, raised levels of which are indicative of severe and 
probably irreversible germ cell damage. The response to 
GnRH stimulation confers very little additional 
information and is not indicated in routine management of 
male infertility. Measurement of LH and testosterone has 
limited value in assessing the degree of germ cell damage 
in patients without clinical evidence of androgen 
deficiency, although they may be useful for detection of 
androgen insensitivity (Aiman et al, 1979). 
Having established the role of endocrine investi- 
gations it will be necessary to reconsider the indications 
for testicular biopsy in the assessment of male 
infertility. From the results of this study and that of 
Pryor et al (1978), it is clear that in azoospermic 
patients, FSH can differentiate those with efferent duct 
obstruction and maturation arrest from those with germ 
cell depletion (Fig2.4) The latter group with elevated 
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FSH will not require further investigation and can be 
advised to consider the alternatives of adoption or 
artificial insemination by donor at an early stage. 
For the azoospermic patients with normal FSH, scrotal 
exploration, vasogram and testicular biopsy should be 
performed in order to demonstrate the obstruction and 
prior to epididymo -vasostomy. The importance of 
testicular biopsy, especially when the epididymides 
appear normal on exploration, should be emphasised. This 
enables germ cell maturation arrest to be recognized as 
these patients are not suitable for epididymo -vasostomy. 
Baker et al (1976) found that 52% of patients with germ 
cell arrest had elevated FSH levels. The classification 
of testicular histology in our study did not identify 
germ cell arrest as a separate entity so that this 
finding could not be confirmed. Patients with agenesis 
of the vasa deferentia can be diagnosed on clinical 
examination and confirmed by the absence of fructose in 
the semen without resorting to scrotal exploration or 
testicular biopsy (Amelar & Hotchkiss, 1963). For oligo- 
spermic patients with sperm density under 5 million /ml, 
elevated FSH has virtually the same implications as in 
azoospermic patients. If FSH is normal, testicular 
histology cannot be reliably predicted and biopsy is 
required if clinical decisions are made on the basis of 
histological changes in the seminiferous epithelium. 
The value of vasography in this group of patients is at 
present unknown. For oligospermic patients with sperm 
density over 5 million /ml, neither testicular biopsy nor 
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FSH estimation is required since the vast majority have 
normal levels of FSH and Grade 1 or 2 histology (Fig 2.4). 
There were a number of patients that did not conform 
with predictions in this diagnostic scheme: five patients 
with elevated FSH but Grades 1 and 2 histology and five 
with normal FSH but Grades 3 and 4 histology. Valid 
explanations may be presented for these apparent 
anomalies. Unilateral biopsies were performed in all 
except twelve cases. Where the two testes in a patient 
were of dissimilar size or consistency, the one considered 
more normal clinically was biopsied. Although it is 
generally held that testicular size is a good index of 
spermatogenesis in adults (Rifka & Sherins, 1978) several 
studies have emphasized that this may not be entirely 
reliable (Meinhard et al, 1973; Pryor et al, 1976; Guay 
et al, 1977). In the present context, the five patients 
with normal FSH and Grade 3 or 4 histology may have more 
active spermatogenesis in the unbiopsied contra - lateral 
testis providing an adequate feedback to suppress FSH. 
The alternative explanation may be that of pituitary 
failure resulting in inappropriately low FSH. Two out of 
these five patients subsequently underwent full pituitary 
function testing, the results of which were normal. The 
finding that all five patients had normal LH and testo- 
sterone and a normal or exaggerated response to GnRH 
makes the possibility of pituitary failure very unlikely. 
Nevertheless, this may be the group of patients in which 
gonadotrophin therapy should be considered. 
One interesting finding in this study is that 
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amongst the six patients with unilateral atrophic or 
absent testes, three had elevated basal levels in spite 
of relatively good sperm production of over 15 million /ml. 
In a further two patients in this group the FSH response 
to GnRH was greatly exaggerated even though basal FSH was 
normal. This may be interpreted as a state of compensated 
spermatogenic failure with the hypothalamic -pituitary unit 
being readjusted to a higher set point in response to the 
lower level of testicular feedback due to unilateral 
testicular atrophy. Whether compensatory hypertrophy 
occurs in the contralateral testis in these patients 
could not be assessed from the present study. Laron et 
al (1975) postulated that compensatory hypertrophy occurs 
in the normal contralateral testis in patients with 
unilateral cryptorchidism although the seminiferous 
tubular diameter remains unchanged. They also found FSH 
to be elevated in these patients with unilateral crypt - 
orchidism, a finding which was subsequently confirmed by 
Werder et al (1976) and Lipschultz et al (1976). In our 
patients, however, unilateral testicular atrophy resulted 
not only from cryptorchidism but also from varicocoele, 
mumps orchitis, orchidectomy and radiation. The clinical 
significance of our finding is that in the presence of 
obvious unilateral atrophic or absent testes from 
whatever aetiology, elevated FSH levels are compatible 
with relatively good sperm production or even fertility 
and do not necessarily indicate severe germ cell failure. 
The finding of selective or preferential hyper - 
secretion of FSH associated with failure of spermato- 
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genesis in man is frequently cited as evidence supporting 
the negative feedback role of the seminiferous tubular 
hormone - inhibin (Section A, Chapter 12). Yet, the 
FSH concentrations even in those patients with grade 4 
testicular histology (Sertoli cell only), were 
considerably lower than those found in castrate or 
agonadal men. This finding confirmed the experimental 
results of Morris & Jackson (1978) and suggests that the 
seminiferous tubules are only partially responsible for 
the negative feedback control of FSH. Although it may be 
argued that the Sertoli cells may retain their inhibin- 
producing capacity even in the face of germ cell aplasia, 
the alternative explanation that testosterone and /or 
oestradiol are important in FSH negative feedback control 
is an attractive one. Total circulating testosterone 
concentrations in infertile men in this study are normal. 
However, sex hormone binding globulin, unbound 
testosterone and oestradiol were not studied. A 
physiological role for testicular oestrogens has not 
been defined and this remains a promising area for 
investigation. If either testosterone or oestradiol in 
physiological concentrations can suppress FSH, it begs 
the question of whether FSH might also play a role in 
the regulation of testicular steroidogenesis. In hypo - 
physectomized animals, FSH can potentiate the trophic 
effect of LH (Bartke, 1978) although the mechanism and 
the site of action are unknown. These observations pose 
the interesting possibility that Sertoli and Leydig cells 
interact closely in the physiological regulation of 
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testicular steroidogenesis and spermatogenesis. Thus 
the endocrine and exocrine functions of the testis, 
though occurring in different anatomical compartments, 
are functionally integrated possibly by local intra- 
testicular regulatory mechanisms. 
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CHAPTER 3 
OESTROGENS IN MALE INFERTILITY 
3.1 Introduction 
In the majority of cases of male infertility, 
the underlying aetiology and pathogenesis of defective 
spermatogenesis remains unknown. With the realization 
that androgens are essential for spermatogenesis 
(Steinberger, 1971; Steinberger et al, 1978) more 
attention has been focused on Leydig cell function in 
infertile males. Testosterone in infertile men has 
been found to be lower than normal (Rosen & Weintraub, 
1971; de Kretser et al, 1972; Aloysio et al, 1974; 
Purvis et al, 1975; Nieschlag et al, 1978) although 
this was not confirmed by others (Ruder et al, 1974; 
Lawrence & Swyer, 1974; Nankin et al, 1977). In 
vitro studies of testicular biopsy tissue from 
oligospermic men showed abnormalities in testicular 
steroidogenesis (Rodriguez -Rigau et al, 1978; Oshima 
et al, 1977) but, again, this was not substantiated 
(Nieschlag et al, 1979). There was more general agreement 
in the finding of elevated LH levels (de Kretser et al, 
1972; Hunter et al, 1974; Christiansen, 1975) which may 
be compatible with primary Leydig cell failure. 
Furthermore, the hCG response was subnormal in some 
severely oligospermic men (de Kretser et al, 1975b). The 
weight of available evidence would support the presence 
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of Leydig cell dysfunction in men with primary defects 
of spermatogenesis. The mechanism underlying this 
observation is at present unknown. 
In man, the normal testis secretes oestrogens (Kelch 
et al, 1972; Baird et al, 1973; Weinstein et al, 1974) 
although their physiological function is unclear. Dufau 
et al (1978) recently suggested that oestrogens may have 
an intratesticular role in the local control of Leydig 
cell function. The ability of FSH to stimulate the 
formation of oestradiol from testosterone and androstene- 
dione in rat Sertoli cells in vitro was demonstrated by 
Dorrington and Armstrong (1975). Oestrogens may therefore 
be important in the pathogenesis of Leydig cell 
dysfunction in infertile men with elevated FSH. 
The nature of the negative feedback control of FSH 
by the testes is controversial. FSH inhibiting activity 
is known to reside in the water -soluble rather than the 
organic extracts of the testes (MCullagh, 1932). However, 
oestrogens have also been shown to preferentially suppress 
FSH secretion (Kulin & Reiter, 1972; Sherins & Loriaux, 
1973; Franchimont et al, 1975). The most abundant 
circulating oestrogen in adult males is a water -soluble 
oestrogen conjugate, oestrone sulphate; yet no information 
is available on this steroid in men with elevated FSH 
resulting from seminiferous tubule damage. 
The aim of this study is to investigate the circul- 
ating levels of oestrogens in infertile men with 
pathologically elevated FSH. Oestrone sulphate, oestrone 
and oestradiol are quantitated in peripheral plasma to 
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provide comprehensive indices of the oestrogenic status 
in men with primary disorders of seminiferous tubules. 
3.2 Patients and methods 
Peripheral venous blood samples were obtained from 
twenty patients attending the Male Subfertility Clinic, 
Royal Infirmary, Edinburgh. These patients were selected 
by the finding of one or more elevated plasma FSH level 
(normal male range 1.6 -6.7 U /l) in association with 
repeated azoospermia or oligospermia (sperm density under 
10 million /ml). Thirteen oligospermic patients had a 
mean sperm density of 3.1± 2.3, range 0.25 -8.5 million /ml. 
Seven patients were azoospermic. The mean age of this 
infertile group (n =20) was 28.9 ± 4.3 years. All 
patients had a normal 46 XY karyotype and normally 
developed secondary sexual characteristics. Details of 
the clinical findings are summarized in Table 3.1. 
The control group was represented by thirteen men 
whose wives had delivered normal infants within the 
previous 4.6 ± 4 months in the Simpson Memorial Maternity 
Pavilion, Edinburgh. No semen analysis was performed in 
this group. Blood samples were also obtained from eight 
male partners of infertile couples attending the 
Gynaecological Infertility Clinic, Royal Infirmary, 
Edinburgh; they were considered fertile by virtue of 
repeatedly normal semen analyses (mean sperm density - 
181.5 ± 84.2, range 86 -327 million /ml) and the absence of 
any abnormalities in the history or examination. The 
mean age of the normal fertile control groups (n =21) was 
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History Examination 
Mumps orchitis - 1 L. varicocoele - 2 
R. Inguinal herniorraphy - 1 R. undescended testis - 1 
Bilateral orchidopexy - 3 Small atrophic testes 
- unilateral - 1 
Unilateral testicular torsion - 1 - bilateral - 7 
Table 3.1 
Clinical findings in 20 infertile men* 
*Some patients had more than one of the above abnormalities. 
One azoospermic and five oligospermic patients did not have 
any abnormalities in the history or examination. 
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31.8 ± 4.1 years. 
Statistical analyses were performed using Student's 
single- tailed t test. 
3.3 Results 
The mean peripheral plasma concentrations of 
oestrone sulphate, oestrone and oestradiol in infertile 
males with elevated FSH were significantly higher than 
that in normal controls. Plasma LH was elevated to a 
lesser extent than FSH, but testosterone remained 
indistinguishable from normal (Fig 3.1). 
In both azoospermic and oligospermic subgroups, the 
oestrogens and gonadotrophins remained significantly 
elevated from normal (Table 3.2). Comparison between 
azoospermic and oligospermic patients showed no 
difference with respect to the three oestrogens and 
testosterone. LH and FSH, however, were higher in the 
azoospermic group. Mean SHBG binding capacity was 
significantly higher in eight oligospermic patients than 
controls but the small number of azoospermic patients did 
not show any difference from either normal or oligospermic 
men (Table 3.2). Combined together as one infertile group, 
SHBG binding capacity was significantly elevated from 
normal (3.35 ± 0.82 vs 2.76 ± 0.89 x 108 M /l, p <0.05, not 
shown in Figure 3.1). 
A significant but weak positive correlation was 
obtained between FSH and oestrone (r = 0.3946), oestrone 
sulphate (r = 0.3457) and oestradiol (r = 0.3221) when the 
patient and control groups were combined. Correlations 
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Comparisons of the mean (± SEM) plasma concentrations of oestrone 
sulphate (p<0.0025), oestrone (P<0.0005), oestradiol (P<0.0025), 
testosterone (N.S.), LH (P <0.005) and FSH (P<0.0005) between 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































between LH and oestrone sulphate (r = 0.3686), LH and FSH 
(r = 0.6278) were also present. 
Although the mean absolute levels of all three 
oestrogens were higher in the infertile group, the ratios 
of oestrone sulphate to oestrone (15.6:1), oestrone 
sulphate to oestradiol (18.1:1) and oestrone to 
oestradiol (1.2:1) have remained similar to that in the 
normal controls - 14.6:1, 17.9:1 and 1.2:1 respectively. 
3.4 Discussion 
This is the first study describing increased 
concentrations of plasma oestrone sulphate, oestrone and 
oestradiol, in infertile men with pathologically raised 
levels of FSH. It contrasts with the studies of Wieland 
et al (1974) and Nankin et al (1977) who found normal 
concentrations of oestradiol in a group of patients with 
similar abnormalities. Purvis et al (1975) demonstrated 
normal plasma oestradiol but low oestrone concentrations 
in ten azoospermic men with elevated FSH levels. 
Nieschlag et al (1978), however, described a tendency 
towards higher plasma oestradiol and lower testosterone 
concentrations with decreasing sperm density in infertile 
men. 
In normal men, oestradiol and oestrone are 
predominantly derived from peripheral conversion of 
androgen precursors (Baird et al, 1969), while testicular 
secretion contributes a small but significant proportion 
of these androgens (Kelch et al, 1972; Baird et al, 1973; 
Weinstein et al, 1974). Based on data from steady state 
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dynamic studies, it has been suggested that oestrone 
sulphate is almost entirely derived from peripheral 
conversion of oestrone and oestradiol (Longcope, 1972; 
Ruder et al, 1972). In the present study, despite 
increased mean plasma levels of all three oestrogens in 
infertile men, the ratios between their concentrations 
were not different from normal. This implies that the 
dynamics of oestrogen production in infertile men may be 
qualitatively similar to normal. Thus the excessive 
oestrogen production in infertile men could have arisen 
from increased testicular secretion of oestradiol and 
oestrone and /or enhanced peripheral conversion of 
androgen precursors. 
In infertile men, basal testosterone and androstene- 
dione concentrations and the response to hCG stimulation 
are either normal or low (de Kretser et al, 1972 & 1975b; 
Purvis et al, 1975; Nieschlag et al, 1978). There is 
therefore no evidence to support an increased production 
of androgen precursors for aromatization in patients with 
oligo or azoospermia. Normal rates of peripheral 
aromatization of testosterone and androstenedione in 
hypergonadotrophic males with or without chromosomal 
abnormalities were reported by Sitteri & MacDonald (1973); 
they suggested that increased testicular secretion of 
oestradiol and oestrone could account for the observed 
oestrogen excess in these patients. This is supported 
by the demonstration of increased testicular aromatase 
activity in patients with Klinefelter's syndrome (Sharma 
et al, 1971). Raised testicular oestradiol concentration 
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(Damber & Bergh, 1980) and oestradiol production in 
response to hCG stimulation (de Kretser et al, 1979) have 
been demonstrated in the experimentally- induced crypt - 
orchid rat testes. Taken together, the available 
evidence suggests that increased testicular secretion is 
the more likely mechanism underlying the excessive 
oestrogen production in infertile men. 
The observation that all three oestrogens were 
positively correlated with FSH suggests that elevated FSH 
may be important in stimulating increased testicular 
oestrogen secretion in infertile men. This is supported 
by the finding that rat Sertoli cells in culture can 
aromatize testosterone and androstenedione to oestradiol 
when incubated with FSH (Dorrington & Armstrong, 1975; 
Rommerts et al, 1978 & 1979). This FSH- stimulated 
aromatase activity is maximal in Sertoli cells from pre- 
pubertal rats and declined as the animals matured 
(Armstrong & Dorrington, 1977). The response to FSH was 
also greater in Sertoli cells after five days compared to 
one day culture. This was associated with a decrease in 
the number of contaminating cells including germ cells 
(Dorrington & Armstrong, 1979). One interpretation of 
these observations is that germ cells may exert an 
inhibitory effect on the ability of Sertoli cells to 
synthesize oestrogens in response to FSH stimulation. 
Thus the present findings of increased oestrogen 
production associated with high FSH and germ cell 
depletion in infertile men are in accordance with the 
data from the in vitro animal experiments. 
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A direct inhibitory action of oestrogens on Leydig 
cell function independent of the systemic suppression of 
gonadotrophins has been demonstrated by a number of 
clinical and experimental studies (Baker et al, 1973; 
Chen et al, 1977; Jones et al, 1978; Hsueh et al, 1978; 
Van Beurden et al, 1978). The direct binding of labelled 
oestradiol to cytoplasmic and nuclear binding sites in 
rat testicular interstitial cells has been demonstrated 
(Brinkman et al, 1972; Mulder et al, 1974). The 
mechanism of the direct inhibitory action is probably via 
suppression of specific enzyme steps (17 -20 lyase and 17a 
hydroxylase) in the testosterone steroidogenic pathway 
(Samuels et al, 1964 & 1969; Hsueh et al, 1978; Kalla et 
al, 1980; Brinkman et al, 1980) although a reduction of 
Leydig cell LH receptor sites may also contribute (Saez 
et al, 1978; Huhtaniemi et al, 1980). Leydig cell 
functions could therefore be impaired subsequent upon a 
primary abnormality of spermatogenesis, increased 
secretion of FSH and testicular overproduction of 
oestrogen. This may account for the presence of Leydig 
cell dysfunction observed in infertile men (Rosen & 
Weintraub, 1971; de Kretser et al, 1972; Aloysio et al, 
1974; Purvis et al, 1975; Oshima et al, 1977; Rodriguez - 
Rigau et al, 1978; Nieschlag et al, 1978) and in animals 
with experimentally induced seminiferous tubular damage 
(Damber et al, 1978; Rich et al, 1979; Kerr et al, 1979; 
de Kretser et al, 1979; Main & Setchell, 1980). If the 
stimulus to excessive oestrogen production is 
sufficiently potent and persistent, testicular oestrogen 
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secretion into the circulation may also be increased. 
The consequent diminished supply of androgens to the 
Sertoli cells may cause a reduction in androgen binding 
protein production and a fall in intratubular androgens 
available for the maintenance of spermatogenesis. This 
hypothetical series of eventsmay form a vicious circle 
which aggravates or perpetuates the initial insult to 
the seminiferous epithelium (de Kretser, 1979). 
It is noteworthy that concurrent with the rise in 
plasma oestrogens in infertile men with elevated FSH, 
SHBG binding capacity was also significantly increased. 
As excessive endogenous or exogenous oestrogen is well - 
known for increasing SHBG concentration (Pearlman et al, 
1967; Migeon et al, 1968; Vermeulen et al, 1969), this 
observation provides further supportive evidence for the 
principle findings in the present study. It is of 
further interest that the total plasma testosterone 
concentration in the infertile men was not significantly 
different from normal in spite of increased circulating 
LH and SHBG binding capacity. This implies that there is 
a significant fall in testosterone secretion and unbound 
testosterone concentration, and confirms the presence of 
Leydig cell dysfunction in infertile men in this study 
despite the normal total plasma testosterone concentrations. 
That both FSH and to a lesser extent LH remain 
elevated in the infertile patients also implies that the 
rise in oestrogen is modest in magnitude or alternatively, 
that oestradiol plays a minor role in the feedback control 
of gonadotrophins. While compelling evidence has been 
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accumulated in recent years supporting the existence of 
inhibin (Baker et al, 1976; Franchimont et al, 1979), its 
physiological role in humans in relation to gonadal 
steroids remains unresolved. Several experimental studies 
had demonstrated that testosterone, with or without 
oestradiol, provides the major negative feedback signal 
for FSH as well as LH secretion (Resko et al, 1977; Plant 
et al, 1978; Morris & Jackson, 1978; Main et al, 1980a). 
There is evidence also that oestrogens alone may prefer- 
entially suppress FSH (Kulin & Reiter, 1972; Sherins & 
Loriaux, 1973; Santen, 1977; Sawin et al, 1978; Lacroix 
et al, 1979) and hence act synergistically with inhibin 
and /or testosterone (Resko et al, 1977). Since inhibin- 
like activity resides in the aqueous extracts of testes 
(McCullagh, 1932), it is interesting to consider the 
possible role of oestrone sulphate, a water -soluble 
oestrogen conjugate, in the negative feedback control of 
FSH. Our results however demonstrated a positive rather 
than a negative correlation between oestrone sulphate 
(and the unconjugated oestrogens) and FSH. It seems 
unlikely therefore that oestrogens have a major physio- 
logical role in the feedback control of FSH secretion in 
man. 
The diagnostic value of oestrogen measurement in the 
assessment of male infertility is probably limited. 
Other hormonal indices of seminiferous tubule damage are 
probably more helpful although it must be emphasized that 
no large scale study has examined the true incidence or 
the relevance of oestrogen abnormalities in male 
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infertility. The need remains however to 
define the exact aetiological role of oestrogens in the 
pathogenesis of seminiferous tubule disorders. Further 
studies with in vitro techniques and the direct 
testicular secretion of these hormones are indicated. 
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CHAPTER 4 
TESTICULAR OESTROGEN SECRETION 
4.1 Introduction 
Testicular secretion of oestrogen into the spermatic 
vein was first demonstrated in the perfused stallion 
testis (Savard & Goldzieher, 1960). The direct secretion 
of oestrone and oestradiol by the human testis was 
inferred from the finding of higher concentrations of 
these oestrogens in spermatic compared to peripheral 
venous blood (Kelch et al, 1972; Baird et al, 1973; 
Weinstein et al, 1974). From these studies, it was 
estimated that testicular secretion contributed 
approximately one quarter of the total blood production 
of oestradiol but a somewhat smaller proportion in the 
case of oestrone. As there is evidence of increased 
oestrogen production in men with elevated FSH (Chapter 3), 
the direct and simultaneous measurement of these steroids 
in spermatic and peripheral venous plasma may clarify the 
extent of the contribution of testicular secretion to the 
circulating oestrogen excess in men with disorders of the 
seminiferous tubules. 
It has been suggested that oestrone sulphate, the 
most abundant oestrogen in the peripheral circulation 
(Brown & Smyth, 1971), may also be secreted from the 
human testis (Hembree et al, 1969; Baird et al, 1968) as 
is the case in the stallion (Raeside, 1969). However, 
isotope dilution studies have indicated that the entire 
blood production of oestrone sulphate can be accounted 
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for by peripheral conversion of unconjugated oestrone and 
oestradiol (Purdy et al, 1971; Ruder et al, 1972; 
Longcope et al, 1972). Because of significant diurnal 
variation in the secretion of androgens, the extent of 
the contribution to oestrogens by the peripheral 
conversion of androstenedione.and testosterone measured 
under steady state conditions may have been overestimated 
(Baird et al, 1969a) . 
In this study, testicular oestrogen secretion was 
studied in men undergoing operative repair of varicocoeles 
by the simultaneous measurement of oestradiol, oestrone 
and oestrone sulphate concentrations in spermatic and 
peripheral veins. 
4.2 Patients and methods 
Seventeen patients (age 18 -39, mean 26.2 ± 4.4 years) 
in good general health and who had received no regular 
medications prior to surgery underwent ligation of the 
left spermatic vein for treatment of varicocoeles. Eight 
of these patients presented with infertility while the 
other nine were treated for other symptoms associated 
with varicocoeles. Semen analyses were carried out only 
in those patients who presented with infertility. At 
least two semen samples from these patients were analysed 
and the average sperm density was used. 
Blood was aspirated during the operation, which was 
performed under general anaesthesia by needle puncture 
simultaneously from the left spermatic vein (2 -10 ml) and 
the antecubital vein (10 -20 ml). The plasma was separated 
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by centrifugation and stored at -20 °C until analysis. 
Blood samples were taken between 0900 and 1400 hours 
whilst the patients were in a horizontal position. 
Oestradiol, oestrone, oestrone sulphate, androstenedione 
and testosterone concentrations were measured in each 
spermatic vein and peripheral vein sample by the methods 
described in Appendix I. 
Statistical analyses were performed using Student's 
one -tailed t -test and Kendall's rank correlation. 
4.3 Results 
The values of the five steroids in the spermatic and 
peripheral venous plasma and the gonadotrophins in 
peripheral venous plasma are shown in Table 4.1. The 
concentrations of testosterone, androstenedione, 
oestradiol and oestrone were significantly higher in the 
spermatic than peripheral veins (paired t -test P <0.001, 
P <0.005, P <0.025, P <0.01 respectively); the ratios of the 
mean steroid concentrations in spermatic to peripheral 
venous plasma were 77.2, 9.1, 28.7 and 1.6 respectively. 
Although the mean spermatic vein concentration of 
oestrone sulphate was significantly higher (paired t -test, 
P<0.05) than that in peripheral vein, the ratio of the 
mean spermatic and peripheral vein concentrations were 
not significantly different from unity. Furthermore, in 
five patients, the spermatic vein concentrations of 
oestrone sulphate were lower than those in the peripheral 
vein. 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































correlation P <0.05 - <0.01) between the testicular 
secretion as represented by the individual spermatic : 
peripheral venous concentrations in each of the 17 
patients of oestrone, oestradiol, androstenedione and 
testosterone, but not of oestrone sulphate. 
The blood production rate (PB), defined as the total 
amount of steroid entering the circulation de novo, and 
testicular secretion rate (S) of the five steroids can be 
estimated from the known metabolic clearance rates (MCRs) 
in previous publications and the testicular blood flow 
(TBF) respectively. Based on the finding that testo- 
sterone enters the circulation entirely from testicular 
secretion (Hudson et al, 1967), it follows that blood 
production rate of this testicular steroid is the same as 
the testicular secretion rate. Consequently, the 
testicular blood flow (two testes combined) can be 
derived from the following formulations (Baird, 1971): 
S = TBF x (iv - iA) = PB = MCR x iA 
TBF = MCR x iA 
iv - iA 
MCR 
r - 1 
where iv is steroid concentration in spermatic vein, iA 
is steroid concentration in spermatic artery or peripheral 
vein and r is the ratio of iv /iA. Applying this formula 
to the mean testosterone concentration in the spermatic 
and peripheral veins in the present study, the mean 












































































































































































































































































































































































































































































































































































































































































































































































































































9.9 ml /min. This enabled the testicular secretion rates 
of the other steroids to be estimated from the spermatic 
and peripheral vein concentration differentials 
(Table 4.2). 
The mean LH and FSH levels in the 17 patients with 
varicocoeles were within the appropriate normal ranges 
for adult males (LH 3.4 -10 u/1 and FSH 1.7 -6.7 u /l). 
However, four patients (Nos. 1, 4, 6 & 10), one of whom 
was severely oligospermic, had raised plasma concen- 
trations of FSH. The mean levels of various steroids 
in spermatic and peripheral venous blood in these four 
patients with elevated FSH were not significantly 
different from those with normal gonadotrophins although 
the mean spermatic vein concentration of oestradiol was 
higher in the former group (2432 ± 1607 vs 996 ± 1643 
pg /ml). 
4.4 Discussion 
The mean peripheral venous concentration of oestrone 
sulphate in seventeen men with varicocoeles was 917 ± 325 
(S.D.) pg /ml. This is comparable to values in previous 
studies in normal adult men, for example Hawkins and 
Oakey (1974): 716 ± 299 pg /ml;Wright et al (1978): 922 ± 
62 pg /ml; Franz et al (1979): 458 ± 25 pg /ml and Towobola 
et al (1980): 1180 ± 225 pg /ml. 
The demonstration of adrenal secretion of dehydro- 
epiandrosterone sulphate (Baulieu et al, 1965) and the 
finding that sulphated steroids can interconvert without 
prior hydrolysis of the sulphate moiety (Lieberman, 1967) 
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prompted studies to investigate whether phenolic steroid 
conjugates are also secreted by steroid- producing glands 
or formed solely as a result of peripheral conversion of 
precursors. The present study demonstrated an 
insignificant testicular -peripheral vein concentration 
gradient for oestrone sulphate indicating, if spermatic 
artery concentration is equated with that in the 
peripheral vessels, that there is no testicular secretion 
of the conjugated oestrogen despite its relative 
abundance in the circulation. The blood production rate 
Pg (metabolic clearance rate x arterial concentration) of 
oestrone sulphate is estimated to be 147 pg /day (Table 4.2). 
This is two to three times higher than that reported by 
Ruder et al (1972) and Longcope (1972) whose calculations 
were based on the rather low mean peripheral plasma 
concentration of oestrone sulphate in the study of 
Loriaux et al (1971). The observation that the combined 
contributions of oestradiol and oestrone as precursors of 
oestrone sulphate (Ruder et al, 1972) considerably 
exceeded the calculated blood production rate of oestrone 
sulphate (Ruder et al, 1972; Longcope, 1972) suggested 
that these earlier estimates of blood production may be 
too low. Using the transfer constants (defined as the 
fraction of precursor which enters the blood de novo as 
the relevant product) from Ruder et al (1972) and 
Longcope (1972), it was possible to estimate, from the 
plasma concentrations in the present study, that the 
contribution of the two precursors to oestrone sulphate 
was 51 pg /day (oestradiol) and 73 pg /day (oestrone). 
382 
This indicates that virtually all of the plasma oestrone 
sulphate is derived from oestrone and oestradiol, 
confirming the insignificant contribution by testicular 
secretion. Since the error in such calculations is 
relatively high, it is possible that the adrenal gland is 
a further source of oestrone sulphate. Bovine adrenal 
tissue can synthesize oestrone sulphate in vitro (Sneddon 
& Marrian, 1963), but whether there is significant 
synthesis in vivo and secretion of oestrone sulphate by 
the human adrenal gland remains to be determined. Thus 
on present evidence, unlike dehydroepiandrosterone 
sulphate, oestrone sulphate is unlikely to be an important 
precursor for unconjugated oestrogens in either normal or 
infertile men (see later). 
The blood production rate of oestrone is estimated 
to be 109 vg/day. This is in good agreement with 
previous studies (Baird et al, 1969a; Longcope, 1972; 
Ruder et al, 1972). The concentration of oestrone in the 
spermatic vein in this study is considerably lower than 
that reported by Baird et al (1973) and Weinstein et al 
(1974), but more comparable to that reported by Longcope 
et al (1972). In this latter study, unexpectedly low 
spermatic vein concentrations of androstenedione, 
testosterone and oestradiol were also found suggesting 
that the retrograde approach via the inferior vena cava 
and renal vein might have introduced a degree of dilution 
in the spermatic vein effluent. This is unlikely to be 
the case in the present study since the spermatic vein 
concentration of testosterone, androstenedione and 
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oestradiol were comparable to other reports_(Laatikainen 
et al, 1971; Weinstein et al, 1974; Fiorelli et al, 1976; 
Hammond et al, 1977; Pirke et al, 1977; de la Torre et al, 
1978). The correlation of spermatic-peripheral vein 
concentration ratios of the four unconjugated steroids 
further substantiates the validity of the present results. 
Thus the testicular secretion of oestrone in this study 
would appear to be smaller than previously found, with a 
contribution of under 1% to the daily blood production 
(Table 4.2). Since the contribution from androstenedione 
accounts for at most 50 -60% of oestrone production rate, 
and the adrenal secretion is small - 10 pg /day (Baird et 
al, 1969b), a substantial proportion of oestrone blood 
production remains unaccounted for. The considerable 
variation in spermatic vein steroid concentration 
(coefficient of variation 33 -134 %) is not unexpected in 
view of the episodic nature of testicular hormone 
secretion (Smith et al, 1974) and the variability 
inherent in the anatomical level of operative approach 
to the spermatic vein, the duration and the negative 
pressure applied in blood sampling. Where the rate of 
testicular hormone secretion is low, as in oestrone, 
these variables may have disproportionate effects leading 
to underestimation. These does not seem to be any 
entirely satisfactory explanation for the discrepant 
results in testicular secretion of oestrone at present. 
The peripheral vein concentration and hence the 
production rate of oestradiol in this study (Table 4.2) is 
higher than previous studies (Kelch et al, 1972; Baird 
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et al, 1973; Weinstein et al, 1974). However, the 
calculated testicular secretion of oestradiol amounted to 
22% of blood production which is in good agreement with 
previous data (Kelch et al, 1972; Weinstein et al, 1974). 
Both the peripheral plasma concentration and the 
calculated blood production rate of androstenedione are 
somewhat higher than values obtained in previous studies 
under basal conditions (Horton & Tait, 1966; Rivarola et 
al, 1966). In patients undergoing surgery this is not 
unexpected in view of the reports of increased plasma 
levels (Rivarola et al, 1966; Beitins et al, 1973; Irvine 
et al, 1974) and adrenal secretion (Baird et al, 1969b; 
Rosenfield, 1969) of androstenedione in response to ACTH 
stimulation or stress. The calculated testicular 
secretion is small (under 10% of 2 mg which is the 
generally accepted daily production rate under basal 
conditions). This contrasts with the female where 
ovarian secretion contributes 20 -50% of the daily blood 
production of androstenedione (Baird, 1971; Baird et al, 
1974). Peripheral conversion of testosterone and 
dehydroepiandrosterone is expected to produce no more 
than 0.9 mg of androstenedione daily (Horton & Tait, 
1967). Thus it would appear that adrenal secretion 
provides the major share of androstenedione blood 
production in man. This conclusion is supported by 
earlier reports (Weinheimer et al, 1965; Wieland et al, 
1965; Baird et al, 1969b; Rosenfield, 1969) confirming 
the substantial adrenal secretion of androstenedione with 
adrenal vein concentrations well in excess of that found 
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in the spermatic and peripheral veins. 
The comparison of spermatic and peripheral venous 
concentrations of the five steroids between the four 
subjects with raised FSH and /or oligospermia and the 
rest of the study group with normal FSH and /or sperm 
densities showed only higher spermatic vein concentrations 
of oestradiol which just failed to reach the 5% level of 
statistical significance. This is compatible with the 
findings in Chapter 3 that men with severe disorders of 
spermatogenesis have increased levels of oestrogens in 
the peripheral circulation. The present findings would 
suggest that increased testicular secretion of oestradiol 
may be one of the mechanisms which contribute to this 
circulating oestrogen excess in men with elevated FSH 
secondary to seminiferous tubular damage. However, no 
difference in peripheral venous concentrations of the 
three oestrogens was demonstrated between men with normal 
or elevated FSH. This may be due to the small number of 
subjects studied, the relatively lower FSH levels in the 
subjects in this compared to the study in Chapter 3 and 
the rather small difference demonstrated in spermatic 
vein concentration of oestradiol. For these reasons, the 
present results must be regarded as preliminary and the 
association between elevated FSH and increased testicular 
oestrogen secretion tentative. 
Although some reports claimed to have demonstrated 
abnormal Leydig cell function in patients with varico- 
coele, this has not been confirmed by others. Raboch and 
Starka (1971) and Comhaire & Vermeulen (1975) found lower 
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peripheral testosterone levels in patients with 
varicocoeles which correlated with increasing age. In 
vitro studies using testicular biopsy specimens showed 
reduced synthesis of 3H- testosterone from 3H- pregnenolone 
in 16 patients with varicocoeles compared with one normal 
control (Weiss et al, 1978). However, normal peripheral 
concentrations of gonadotrophins, testosterone and 
oestradiol were reported by Swerdloff & Walsh (1975), 
Schiff et al (1976) and Rege et al (1979). Baird et al 
(1973) and Swerdloff & Walsh (1975) also found comparable 
levels of testosterone and oestradiol in spermatic veins 
of patients with varicocoeles or inguinal hernias. The 
available evidence suggests that studies on testicular 
steroid secretion based on spermatic vein concentrations 
in patients with varicocoeles should only be extrapolated 
to the physiological state provided that the seminiferous 
tubular function has not been damaged to the extent that 
FSH becomes elevated. Furthermore, other factors which 
have not so far been taken into account are the 
suppressive effects of surgical stress (Eik -Nes, 1970; 
Wang et al, 1978) and anaesthesia (Carstensen et al, 1973) 
on Leydig cell function. 
In summary, the present study showed minimal 
testicular secretion of oestrone sulphate, supporting the 
view derived from isotope dilution studies that almost 
all of this conjugated steroid is derived from peripheral 
conversion of other precursor steroids. There is 
preliminary evidence for increased testicular secretion 
of oestradiol in men with elevated FSH. 
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SECTION D 
CONCLUSION AND OVERVIEW 
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This series of clinical studies in male patients 
with delayed puberty and infertility were conducted 
primarily to gain further insight into the pathophysiology 
of these two entities. The information obtained did 
improve the diagnostic efficiency and rationalized the 
clinical management in these patients. In the assessment 
of patients with delayed puberty, testicular volume was 
confirmed to be the most informative single clinical 
parameter which bore a constant relationship to the 
hormonal changes throughout puberty. Amongst the many 
hormonal measurements, the LH response to a single 10 µg 
bolus of exogenous GnRH provided the most representative 
information on the state of maturity of the HPT axis. 
Since pituitary responsiveness reflects previous exposure 
to GnRH, an immature response does not carry any 
predictive information. Thus hypogonadotrophic patients 
cannot be distinguished from those with constitutional 
delayed puberty on the strength of a single GnRH 
stimulation test. Basal concentrations of gonadotrophins 
including those at night and multiple GnRH stimulation 
did not yield any additional information clinically. In 
adult patients with defective spermatogenesis on the 
other hand, the GnRH response correlated so well with 
basal gonadotrophin concentrations that a single basal 
measurement of FSH, if it was elevated, was able to 
predict the presence of significant and probably 
irreversible germ cell loss /damage in the testis. 
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Routine measurement of LH, testosterone and oestrogen 
added little useful information in these normally 
virilized patients. These findings indicate that it is 
only when hormone deficiency is suspected that dynamic 
stimulatory tests may have advantages over the use of 
basal measurements; the latter usually suffices for the 
diagnosis of hormone excess. 
Although the clinical information is helpful, it is 
the implications of these data to the normal homeostatic 
mechanisms in the hypothalamic -pituitary- testicular axis 
which generated most interest. Puberty should be 
regarded as the second half of a diphasic mechanism with 
the first half being the pre and neonatal sexual 
differentiation. Interposed between the two is a long 
period of physical and mental growth with quiescent 
of the 
sexual function. The reawakening /sexual developmental 
process may be a function of the maturity of the whole 
body and in particular the brain. Although the ontogenic 
function of sexual differentiation and development is 
genetically programmed, the timing and the individual 
components in the system are influenced by epigenetic and 
environmental factors. The triggering mechanism and its 
timing for the initiation of the second phase of sexual 
development is still unclear. This study confirmed that 
the initiation of spontaneous puberty is intimately 
associated with neuronal mechanisms (probably via neuro- 
transmitters and /or neuronal peptides) that also control 
sleep. Thus, the prepubertal 
neuroinhibitory mechanisms acting on the hypothalamic 
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"pulse generator" become suppressed during sleep in early 
puberty, allowing the uninhibited discharge of GnRH- 
secreting neurones in the arcuate nucleus. Accordingly, 
the primary neuronal signal in the afferent neurones 
supplying the arcuate nucleus is frequency -coded and is 
translated into an endocrine signal by the GnRH- secreting 
neurones which discharge intermittently into the 
privileged channels of the hypophysial portal circulation. 
The pituitary gonadotropes are sensitive to the frequency 
changes of the pulsative GnRH stimulation but the 
alterations in amplitude in the hypophysial portal 
circulation seem of less consequence. Thus the change in 
frequency of neuroendocrine discharge of the hypothalamus 
is the principal mechanism by which the neuronal repro- 
ductive signal of the brain is translated into a hormonal 
message of the HPT axis. At the pituitary, the neuro- 
endocrine signal is amplified a few thousand -fold in 
order to preserve its temporal pattern in the systemic 
circulation. Optimal function of the gonads during 
puberty may be dependent both on the amplitude and 
frequency of LH pulsatile stimulation. Testosterone 
levels in the peripheral circulation of man do not show 
distinct episodic fluctuations which are temporally 
synchronized to that of LH. Although the explanation for 
this is unclear, it does imply that physiological 
functions in the androgen -responsive target cells may be 
independent of the pulsatile signal pattern which is 
critical for pituitary regulation. Thus as the 













































































































































































































































































































































































































































































































































centres down the hypothalamic- pituitary- testicular axis 
to the target cells, there is a gradual transformation of 
the pattern of signals from frequency to amplitude mode 
(Table 1). By the time the hormonal signal reaches the 
target cells, these androgen- sensitive tissues are 
exposed to more or less constant levels of sex steroids 
in which the pulse pattern generated by the arcuate 
nucleus is no longer detectable. 
The disruption of normal spermatogenesis in adult 
patients with infertility also provided information 
compatible with the existence of intratesticular 
regulatory mechanisms which so far has only been 
demonstrated in experimental animals. Although the 
information is mainly based on circulating hormone 
concentrations, spermatic vein sampling brought us one 
step nearer towards the study of control mechanisms 
within secretory and target organs in the HPT axis. The 
successful completion of spermatogenesis is dependent on 
the triangular relationship between germ cells, Sertoli 
cells and Leydig cells in the testis. Mediating their 
interactions may be both stimulatory as well as 
inhibitory factors including testosterone, oestradiol, 
GnRH -like testicular peptide and Sertoli cell factor - 
all functioning as local intratesticular hormones. On 
present evidence, it is probable that both circulating or 
local hormones exert their effects on germ cells via the 
Sertoli cells. Thus it is conceivable that the inter- 
action between Leydig and Sertoli cells, via the local 
regulatory factors, can ensure a stable biochemical 
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milieu in the adluminal compartment of the seminiferous 
tubules where meiosis of the spermatocytes can be 
completed and the various steps of spermiogenesis can 
take place. In this way, the primary reproductive signal 
is decoded at the hypothalamus and the effects of the 
fluctuating stimulus is smoothed out by the intra- 
testicular regulatory mechanisms and perhaps androgen 
binding protein in order to effect the continuous 
production of mature spermatozoa. An analagous situation 
where the stable action of steroid is more effective than 
an intermittent one is seen in the negative feedback of 
LH secretion and stimulation of accessory glands by 
testosterone (Damassa et al, 1976; Smith et al, 1977). 
The existence of sex hormone binding globulin may also 
contribute in this respect to the action of testosterone 
on other target organs. 
By virtue of the proximity of the seminiferous 
tubules to the Leydig cells, the former is the only 
androgen target tissue which can directly feed back on 
their source of supply of steroid hormone and modify its 
function. This highlights the crucial role of androgen 
in spermatogenesis and further emphasizes the physiological 
significance of intratesticular regulatory mechanisms. 
Since the first wave of spermatogenesis is established 
very soon after the formation of spermatogonia with 
appearance of spermatozoa in the lumen of seminiferous 
tubules in most species studied, it follows that the 
intratesticular regulatory mechanisms must be established 
together with feedback mechanisms at the pituitary at a 
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very early stage during pubertal development. The 
finding that FSH secretion in the pituitary becomes 
suppressed with the first signs of testicular enlargement 
is compatible with this view. Once the effects of FSH on 
Sertoli and Leydig cell maturation is accomplished in 
early puberty, the imminent suppression of FSH and the 
relative insensitivity of adult Sertoli cells to FSH 
stimulation can be regarded as a double safeguard against 
excessive FSH- induced oestrogen production which may be 
deleterious to both Leydig and germ cells (Libbus & 
Scheutz, 1979 & 1980). These safety mechanisms may be 
overcome under pathological situations as shown here by 
the increased circulating levels of oestrogens in men 
with elevated FSH. Any disturbance of the delicately - 
balanced interrelationship between Sertoli and Leydig 
cells during the establishment of spermatogenesis in the 
peripubertal period may ultimately lead to defective 
spermatogenesis in adult life which may not be associated 
with any structural or circulatory hormonal abnormalities. 
In the last decade, the traditional boundaries of 
endocrinology have been greatly expanded. The concept 
that a hormone is the unique product of a specific cell 
type in an endocrine gland is no longer tenable. The 
discovery of hormone secreting neurones and a wide 
variety of hormonal peptides in the brain and gut tissues 
as well as unicellular organisms has led to a complete 
reshaping of the current concepts of the endocrine system 
(Roth et al, 1982; Kruger & Martin, 1981). The new -found 
knowledge regarding the functions of the brain- 
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hypothalamus -pituitary -gonadal axis has provided 
prominent examples towards the redefining of biochemical 
messengers used in vertebrates as mechanisms of inter- 
cellular communication. Thus the functions of the 
classical endocrine glands of pituitary and testes are 
seen to overlap with those of the central nervous system, 
paracrine agents and exocrine secretions. The GnRH 
secretory neurones in the hypothalamus under the 
controlled neurotransmitter amines play a key role in the 
neuroendocrine control of reproductive function. This is 
probably the best example to date that the central 
nervous system not only functions as part of the endo- 
crine system but is also the means for adapting diverse 
body functions constantly to changes in the environment. 
The brain itself is a target organ for gonadal steroids 
in the organization and activation of sexual behaviour 
and in the negative feedback control of GnRH secretion. 
Paracrine agents or local tissue factors in the form of 
GnRH -like peptides, oestradiol, Sertoli cell factor, 
Mullerian- Inhibiting- Factor show the diversity of intra- 
testicular control mechanisms. Although we are just 
beginning to identify the mechanisms of control and 
action of these paracrine agents, there is little doubt 
that they are important in the physiological regulation 
of normal testicular function. Lastly, the testis has 
long been recognized as an organ which combines endocrine 
and exocrine functions. What was not known until 
recently is the intimate interrelationship between the 
Leydig cells and seminiferous tubular function. In the 
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Sertoli cells reside the principal source of a wide 
variety of exocrine secretory products which may prove to 
execute the hormonal control of spermatogenesis. Viewed 
in this new light, the endocrine system can be regarded 
as a system made up of intercellular biochemical 
messengers relaying metabolic signals and coinuuands 
between secretory and target cells. In the case of the 
male reproductive function, the biological process is 
made up of a hierarchical system of biochemical communic- 
ation and control between the brain and the genome in 
target cells. In between these lies a series of stages 
of information transfer including (1) genome -ribosome 
communications, (2) job control at genome level, (3) 
metabolite flow, (4) second messenger and protein 
phosphorylation, (5) steroid signals, (6) amino acid 
derivative signals, (7) polypeptide signals, (8) glyco- 
protein /glycolipid receptors- receptor interaction at cell 
surfaces, (9) gap junction network convections and (10) 
neural net electrochemical pulsing (Yates, 1981). It is 
clear that many forms of co- operation at multiple levels 
are required to support this life function. The study of 
hormonal signal dynamics in blood is only one aspect of 
the entire system of intercellular communication. There 
are obviously many other equally important facets of male 
reproductive function or dysfunction which await the same 
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APPENDIX I 
METHODOLOGY OF HORMONE ASSAYS 
Gonadotrophins 
Luteinizing hormone and follicle stimulating hormone 
were measured by double antibody radioimmunoassay (Hunter 
& Bennie, 1979). The standard for LH was MRC 68/40 
(designated potency 77 u /ampoule) and FSH, MRC 69/104 . 
(designated potency 10 u /ampoule) from the National 
Institute for Biological Standards and Control, London. 
The highly specific antisera to h -LH (F87) and to h -FSH 
(M93) raised against the human pituitary fraction CPDS /6 
from Professor W.R. Butt were used at a dilution of 1 in 
400,000. 1251 -LH was prepared from h -LH preparation 
IRC -2 from Dr A.S. Hartree; 125I -FSH was prepared from 
highly purified h -FSH supplied by Professor W.R. Butt. 
Separation of bound from free hormone -tracer was achieved 
by filtration automatically in the Kemtech 3000 automated 
system (Bagshawe,l975). The within -assay variation for 
LH was 11.3 %, 6.6% and 8.0% for values under 2.0, between 
2.0 -6.0 and over 6.0 u/1 respectively. The within -assay 
váriation for FSH was 7.1 %, 5.2% and 6.7% for values 
under 2.0, between 2.0 -4.0 and over 4.0 u/1 respectively. 
The mean between -assay variation for LH was 9.74% for 
quality control samples with values between 2 -12 u /l. 
The mean between -assay variation for FSH was 8.30% for 
quality control samples with values between 1.8 -10 u /l. 




Testosterone was measured by radioimmunoassay in 
plasma extracts (hexane -ether 4:1) without chromatography 
(Corker & Davidson, 1978). The antiserum was raised in 
goat against testosterone -3 -(0- carboxymethyl) -oxime 
bovine serum albumin and was kindly donated by Dr S. 
Tillson. The antiserum showed a significant cross - 
reaction with 5 -dihydrotestosterone (23.9 %). [1,2,6,7- 
3H]testosterone (Amersham International Ltd, Amersham) 
with spec. act. 94 Ci /mmol was the tracer and dextran- 
coated charcoal was used to separate the bound from free 
hormone. The within -assay variation was 7.45 %, 4.13% and 
6.36% for samples with mean values of 76.8, 414 and 818 
ng /dl respectively. The mean between -assay variation 
based on the same three quality control pools was 6.55 %. 
The limit of detection of the assay was 8 pg per tube or 
16 ng /dl. 
Oestradiol 
Oestradiol was measured by radioimmunoassay (Van 
Look et al, 1977) in plasma extracts (diethylether) using 
a'highly specific antiserum raised against l7ß- oestradio1- 
6 -(0- carboxymethyl) -oxime- bovine serum albumin kindly 
donated by Dr P. Dean (Dean et al, 1971; Exley et al, 
1971). [2,4,6,7- 3H]oestradiol (Amersham International 
Ltd, Amersham) with spec. act.91 Ci /mmol was used as 
tracer and the separation of bound from free hormone was 
achieved by the addition of dextran- coated charcoal 
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suspension. The mean between -assay variation was 10% in 
six plasma pools with concentrations between 28 -405 pg /ml. 
The within -assay variation was 9.3 %. The limit of 
detection of the assay was 10 pg /ml. 
Oestrone sulphate and oestrone 
The simultaneous measurement for oestrone sulphate 
and oestrone in the same plasma samples were developed by 
the author specifically for the studies described in 
Section C. The methodology and validation are therefore 
described in full. Radioimmunoassay of oestrone sulphate 
is carried out with a specific antiserum directed against 
oestrone released after acid solvolysis of plasma samples. 
This approach was chosen because of the difficulty in 
raising a satisfactory antiserum against oestrone sulphate 
due to the instability of the immunogen. 
Radioactive oestrogens Oestrone -3- sulphate [6,7 -3H) 
potassium salt (specific activity of 39 Ci /mmol or 101 
mCi /mg) and oestrone 2,4,6,7 -3H] (specific activity of 
110 Ci /mmol or 407 mCi /mg) from the Radiochemical Centre, 
Amersham, were used without further purification. 
NOn- radioactive oestrogens Oestrone -3- sulphate 
potassium salt containing 9.6% by weight of potassium 
acetate stabilizer was obtained from Sigma (London) Ltd, 
Poole. The purity was confirmed by thin -layer chromato- 
graphy before use. Solutions were made up in phosphate - 
gelatin buffer and used within one week. Solutions of 
oestrone (Calbiochem C.P. Laboratories Ltd, Bishop 
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Stortford) were made up in absolute ethanol and stored 
at 4 °C. 
Solvents and reagents Organic solvents were AR grade 
(BDH Ltd, Poole). Diethyl ether was washed with acidified 
ferrous sulphate solution (50 G ferrous sulphate in 100 ml 
5% w/v sulphuric acid) and redistilled before use. 
Sterile distilled water was purchased from Antigen Ltd, 
Rosecrea, Ireland. Steroid -free plasma was prepared by 
Charcoal Norit A (Sigma) adsorption of plasma obtained 
from female blood- donors. 
Phosphate gelatin buffer (pH7) was prepared by 
dissolving NaN3 (5 G) , NaCl (45 G) , Na2HPO4 (43 G) , 
NaH2PO4H2O (27 G) and gelatin (5 g) in deionized 
distilled water (5 1). Dextran coated charcoal suspension 
contained 250 mg charcoal Norit A (Sigma) and 25 mg 
dextran T70 (Pharmacia G.B. Ltd, Hounslow) in 100 ml 
phosphate gelatin buffer. 
Internal standards for estimation of procedural loss 
[3 H]oestrone sulphate (1000 CPM, 8 pg) was added to each 
plasma sample for assessment of procedural loss. For the 
oestrone estimations, three to four samples containing 
1 m of male plasma and [3H]oestrone (5000 counts /min, 
10 pg) were processed in each assay for estimation of 
group recovery. The mean recovery in oestrone sulphate 
samples (n = 173) was 63.4 ± 8.8% and oestrone (8 assays, 
n = 30) 84.3 ± 5.6 %. After the addition of these internal 
standards, the samples were left at room temperature for 
1 h to equilibrate. 
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Extraction of unconjugated oestrone prior to acid 
solvolysis One ml of plasma was shaken twice with 5 ml 
of freshly distilled peroxide -free diethyl ether. The 
organic phases were combined and dried under N2 at 40 °C. 
The residue was dissolved in 100 µl of phosphate gelatin 
buffer and kept at -20 °C until assay. 
Acid solvolysis This procedure was based on the method 
of Hawkins & Oak ey (1973) with minor modifications. 
After extraction of unconjugated oestrone, oestrone 
sulphate in each plasma sample was solvolysed by adding 
crystalline (NH4)2 SO4 1 G, 66% aqueous (v /v) sulphuric 
acid 25 µl and ethyl acetate 5 ml. The reaction mixture 
was left overnight or for a minimum of 16 h in a water 
bath at 43 °C. The unconjugated oestrone released by 
solvolysis was extracted into diethyl ether as above. 
The ether was washed with 1 ml of 8% (w /v) NaHCO3, with 
1 ml of sterile distilled water and evaporated to dryness. 
The residue was redissolved in 500 µl of phosphate 
gelatin buffer and kept at -20 °C until assay. Two 100 µl 
aliquots from each sample were assayed and 200 pl counted 
for estimation of recovery. 
Further purification of solvolysed extract by celite 
column chromatography Oestrone sulphate in plasma from 
post menopausal females and normal males were processed 
as described above and the oestrone obtained was assayed 
with and without purification with celite column chromato- 
graphy (Thorneycroft, Ribiero, Stone & Tillson, 1973). 
Celite 545 (Johns -Manville Products Corporation, Richmond) 
was heated to 600 °C for 18 hours to remove contaminants 
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and cooled in a dessicator. It was mixed thoroughly with 
ethylene glycol (2:1 W /V) and the columns packed dry in 5 
ml graduated disposable pipettes to a height of 6 cm. 
After washing twice with 5 ml of iso- octane, the residues 
were applied to the columns in 0.5 ml iso- octane and then 
again washed with 2 ml and then 3.5 ml of iso- octane. 
The oestrone fraction was eluted with 4 ml of 15% ethyl - 
acetate in iso- octane which was evaporated under N2. The 
residues were redissolved in 200 µl of buffer of which 
100 µl was assayed and 50 µl counted for recovery. 
Radioimmunoassay The antiserum was raised in ewes 
against oestone -6 -(0- Carboxymethyl) oxime- bovine serum 
albumin (Martensz, Scaramuzzi & Van Look, 1979). 
Oestrone extracted before solvolysis and unconjugated 
oestrone liberated by solvolysis of the same samples were 
analysed together in one assay. To each sample antiserum 
(100 µl, 1:10,000 dilution in buffer) was added and the 
contents of the tubes mixed and equilibrated at room 
temperature for 1 h. [3 H]oestrone (5000 counts /min in 
0.1 ml buffer) was added, mixed and the samples left over- 
night at 4 °C. Unbound oestrogen was removed by adding 
1;ml dextran coated charcoal suspension; the mixture was 
kept at 0 °C for 15 min in an ice bath. The charcoal was 
separated by centrifugation at 1000 g for 10 min at 4 °C 
and the supernatant fraction decanted into counting vials. 
Standard curves were obtained from samples 
containing known quantities of oestrone (0 -500 pg) 
processed by the same procedure as the unknown samples. 
The mass of oestrone in the latter was extrapolated 
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directly from the standard curves and corrected for 
procedural losses. 
Liquid scintillation counting All samples were counted 
in 10 ml of scintillation fluid containing 2,5- Diphenyl- 
oxazole (10 G) and 1,4- di- 2,5- phenylozazolyl- benzene 
(750 ng) in 2.5 litres sulphur -free toluene and 1.25 
litres Triton X -100 (all from Koch -Light Laboratories Ltd, 
Colnbrook). Tritium was measured in a Packard Tri -Carb 
Liquid Scintillation spectrometer Model 3320 with a 
counting efficiency for tritium of 54 %. Sufficient counts 
were recorded to give a counting error of less than 5 %. 
Specificity The specificity of the assay of oestrone 
sulphate was dependent on the solvolysis step and the 
specificity of the antiserum. Cross reactions with other 
steroids, expressed relative to oestrone (100 %) at 50% 
tracer binding in the displacement of the dose -response 
curve (Abraham, 1969), was as follows: oestrone sulphate, 
30.5% equilenin, 15.0% oestradiol -l78, oestradiol -17a, 
oestriol, dehydroepiandrosterone, testosterone, andro- 
sterone, 17a- hydroxyprogesterone, progesterone, cortisol 
and aldosterone, all less than 0.02 %. 
There was no significant difference in concentration 
of oestrone sulphate measured with and without celite 
column chromatography in replicate estimates of plasma 
from post -menopausal women (262 ± 43 vs 234 ± 33 pg /ml, 
n = 8, p >0.1) and normal men (722 ± 108 vs 674 ± 13 pg /ml, 
n = 8, p >0.1) . 
Accuracy Known amounts of oestrone sulphate (potassium 
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salt) and oestrone were added to water and samples of 
human plasma. The slopes of the regression equations 
were not significantly different from unity indicating 
that there were no systematic errors in the method. For 
oestrone sulphate added to water, amount found = 0.9946 
(amount added) + 46.5 pg /ml; for oestrone sulphate added 
to plasma from post- menopausal women, amount found = 
0.9631 (amount added) + 73.1 pg /ml. The y intercept for 
oestrone sulphate added to water was not significantly 
higher than the average water blank in subsequent assays 
(20 pg /ml). 
Precision The within -assay precision for the oestrone 
sulphate assay was estimated from assay of 25 duplicate 
samples (range of concentration 31 -1588 pg /ml) in four 
assays was 6.7 %. For the oestrone assay, the within - 
assay precision was determined in replicate samples at 
four different concentrations, 34 ± 2.4, 68 ± 4.7, 128 ± 
11.9 and 264 ± 15.3 pg /ml, giving the coefficients of 
variations of 6.9, 6.9, 9.3 and 5.8% respectively with a 
mean of 7.2 %. 
Interassay precision was assessed by repeated 
analyses of three plasma samples with mean concentration 
(± SD) of 468 ± 44, 909 ± 105 and 2095 ± 502 pg /ml for 
oestrone sulphate and 33.3 ± 1.6, 43.3 ± 3.3 and 71.2 ± 
17.9 pg /ml for oestrone in 3 -5 consecutive assays. The 
average interassay coefficients of variation for the 
oestrone sulphate and the oestrone assays were 15% and 
12.5% respectively. 
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Sensitivity The average binding in the zero standard 
tubes was 60 ± 3.9% of total oestrone tracer added (5000 
CPM = 10.2 pg /tube) in eight consecutive assays. The 
sensitivity of the standard curve (3.4 pg /ml) defined as 
the smallest amount of steroid significantly different 
from zero was derived from the standard deviation of 
zero points of standard curves. Taking into account the 
procedural losses (mean recoveries for oestrone sulphate 
63.4% and oestrone 84.3 %) and the volume of plasma 
extract used for assay, the sensitivities of the assays 
were: oestrone sulphate 26.8 pg /ml; oestrone 4 pg /ml. 
In the oestrone sulphate assay, the mean ± SD value 
for the water blank was 19.9 ± 4.16 pg /ml (n = 4) and 
average plasma blank, 39.8 ± 1.65 pg /ml (n = 3). The 
lower limit of detection of the method was arbitrarily 
set at 50 pg /mi, equivalent to 80% inhibition of the 
binding found at zero mass. The plasma and water blank 
values were consistently less than the detection limit 
and were not subtracted from the results. 
In the oestrone assay, the mean (± SD) blank value 
for water was 8.3 ± 2.0 pg /ml (n = 5) and of oestrone 
free plasma was 30 -206 pg /ml (n = 3). The lower limit 
of detection of the method was set at 15 pg /ml, 
equivalent to 70% inhibition of the binding at zero mass. 
Blank values were not subtracted from the results. 
The specificity of the oestrone sulphate assay was 
achieved by the solvolysis procedure and the lack of 
cross reaction of the antiserum with possible interfering 
steroids. This was further substantiated by the 
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similarity of results obtained with or without celite 
column chromatography. The accuracy and precision were 
within the acceptable limits for steroid radioimmuno- 
assays. The sensitivity was adequate for the range of 
values expected in the present studies and the values for 
water and steroid -free plasma were below the limits of 
detection of the method. 
Androstenedione 
Plasma androstenedione was measured by the radio - 
immunoassay method described by Baird et al (1974). The 
samples were purified by alumina column chromatography 
(McNatty et al, 1976). Intra- and inter -assay variations 
were 5.7% and 5.2% respectively and the limit of 
detection 145 pg /ml. 
Prolactin 
Prolactin was measured by double -antibody homologous 
radioimmunoassay (McNeilly & Hagen, 1974). Highly 
purified human prolactin (Dr H. Friesen) was used as 
standards and preparation of iodinated tracer. The anti- 
body was raised in rabbits against an impure preparation 
of human prolactin. Due to the scarcity of pure 
preparations of human prolactin, standards for assay were 
prepared from doubling dilutions of pools of human serum 
containing high concentrations of prolactin standardized 
against Friesen's prolactin or MRC 71/222 (designated 
potency 10 mu /ampoule). Separation of bound from free 
hormone was accomplished by the addition of a 
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precipitating antirabbit gamma -globulin and the 
resulting precipitate separated by centrifugation. The 
within -assay variation based on ten replicates at three 
concentrations was 6.0 %. The between -assay variation 
was 8.0 %. 
All hormone samples were assayed in duplicate and 




Plasma LH, FSH and testosterone concentrations at 20 
minute intervals from 20.00 -09.00 h and the response of 
these hormones to four 10 µg intravenous boluses of GnRH 
at two -hourly intervals in 33 studies from 16 adolescent 
subjects in order of increasing maturity. Two subjects 
(5 & 12) were studied on four occasions, three subjects 
(13, 14, 16) on three occasions and five subjects (4, 6, 
8, 9, 11) on two occasions at approximately six -monthly 
intervals. All subjects slept during the dark period 
between 23.00 -07.00 h undisturbed by blood sampling via 
an indwelling intravenous cannula with an extension into 
an adjacent room. Electroencephalographic monitoring of 
sleep onset and sleep stages was performed in 19 studies - 
see table 2.2. Puberty rating was determined according 
to Tanner (1962). Testicular volume in mis was measured 
by comparison with Prader's orchidometer. Subject 5 ST 
underwent left orchidopexy immediately prior to entering 
the study. He subsequently matured sexually and was 
studied on four occasions over a period of 26 months. 
However, since he received a twelve -week course of HCG 
(Pregnyl, Organon) after the first study, the hormonal 
data from the subsequent three studies had not been 
included in the group analyses. It is also noteworthy 
that the FSH concentrations in this patient were elevated 
only in late puberty in study IV. The left testis 
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ENDOCRINE ASSESSMENT OF THE SUBFERTILE MALE 
F. C. W. WU, P. EDMOND, G. RAAB AND W. M. HUNTER 
Departments of Obstetrics and Gynaecology, and Urology, University of Edinburgh, 
Medical Computing and Statistics Group, University of Edinburgh, MRC Immunoassay 
Team, Edinburgh 
(Receieved 13 June 1980; revised 20 October 1980; accepted 29 November 1980) 
SUMMARY 
Sixty -three male (XY) patients attending a subfertility clinic with average sperm 
density under 40 million /ml were studied by testicular biopsy and multiple basal 
estimations of plasma LH, FSH, testosterone as well as LHRH (50 ug i.v.) 
stimulation. A further forty patients with similar sperm densities also had 
testicular biopsy but only single estimations of the three hormones. A single 
basal FSH was found to be the best discriminator of testicular histologies. 
Patients with testicular biopsies showing germ cell aplasia in some or all 
seminiferous tubules (grades 3 and 4) had significantly higher basal FSH than 
those with hypospermatogenesis, germ cell arrest or normal appearance (grades 
1 and 2). Basal FSH also showed a linear trend rising with decreasing sperm 
density but only rose above the normal range when sperm densities fell below 1 
million /ml. When basal FSH, testicular histology and sperm density were 
considered together in the whole group (n= 100), high levels of FSH accurately 
indicated the presence of germ cell aplasia in some or all seminiferous tubules in 
azoo- and oligospermic men with sperm density under 5 million /ml. Normal 
FSH and azoospermia is diagnostic of obstruction in the excurrent ducts, and 
further investigation is undertaken if surgical correction of the obstruction is 
contemplated. Hormone estimations are not helpful in oligospermic patients 
with average sperm density over 5 million /ml. On the basis of these findings it is 
suggested that there is little place for the LHRH test in the routine assessment of 
male subfertility. Testicular biopsy is indicated only in oligospermic patients 
with average sperm density under 5 million /ml and normal basal FSH. 
Hormonal measurement, especially that of FSH,has recently added a new demension to 
the investigation of male infertility which has traditionally relied on semen analysis 
(Eliasson, 1975) and testicular biopsy (Charny, 1940). The finding of a reciprocal 
relationship between urinary or plasma FSH and the number of germ cells in seminiferous 
tubule cross -sections (Johnsen, 1970; Franchimont et al., 1972; de Kretser et al., 1974) has 
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provided a convenient quantitative measurement of spermatogenesis which could replace 
the invasive procedure of testicular biopsy. Sperm density has also been shown to have an 
inverse relationship to FSH (Rosen & Weintraub, 1971; Mauss & Börsch 1973; Kjessler & 
Wide, 1973; Hunter et al., 1974; Christiansen, 1975; Aafjes et al., 1977) although this was 
not confirmed by others (Franchimont et al., 1972; de Kretser et al., 1972; Leonard et al., 
1972). We therefore decided to evaluate further the efficacy of plasma FSH in assessiing 
the degree of seminiferous tubular damage at different levels of sperm density in men 
presenting with infertility. 
Exaggerated FSH response to LHRH proportional to basal levels has been reported in 
patients with oligospermia and azoospermia (Isurgi et al., 1973; Mecklenberg & Sherins, 
1974; Franchimont et al., 1975; Roulier et al., 1976; Guay et al., 1977). However, 
Lipschultz et al. (1977) found exaggerated FSH response to LHRH in oligospermic 
patients with normal basal FSH levels, implying that the LHRH response (rather than 
basal FSH) may be a more sensitive index of seminiferous tubular function. The clinical 
value of the LHRH test, in comparison with basal FSH measurements in male 
subfertility, therefore needs further evaluation. 
The presence of abnormal Leydig cell function in subfertile males with more severe 
forms of seminiferous tubular damage was indicated by elevated basal LH (Kjessler & 
Wider, 1973; Mauss & Börsch 1973; Christiansen, 1975; Hunter et al., 1974), exaggerated 
LH response to LHRH stimulation (Isurgi et al., 1973; Mecklenberg & Sherins, 1974; de 
Kretser et al., I975a; Roulier et al., 1976; Guay et al., 1977) and more directly by 
statistically lower testosterone levels and impaired response to hCG stimulation (de 
Kretser et al., 1972; 1975b). Study of the LH- testosterone axis may therefore also furnish 
diagnostically useful information in addition to FSH measurements in the investigation 
of male fertility status. 
Since LH and testosterone, and to a lesser extent FSH, are secreted episodically 
(Nankin & Troen, 1971; Naftolin et al., 1972; Santen & Bardin, 1973; Alford et al., 1973; 
Smith et al., 1974) multiple measurements of these hormones may provide more accurate 
information than single estimations. 
The aims of the present study were to evaluate and compare the clinical application of: 
(1) single basal measurements of FSH, LH and testosterone; (2) multiple measurements of 
FSH, LH and testosterone and (3) the LHRH response, in the assessment of subfertile 
males in terms of their relationship with testicular histology and sperm production. 
Having established the best hormone parameter(s) and their limitations the indications 
for testicular biopsy can then be rationalized. 
PATIENTS AND METHODS 
Patients 
A total of 103 consecutive patients referred to the Male Subfertility Clinic, Royal 
Infirmary, Edinburgh with average sperm density under 40 million /ml were studied. All 
patients were normally virilized and had normal male chromosome karyotype (46XY). 
The median age was 34 years and range 24-45 years. The clinical histories, summarized in 
Table 1, revealed no abnormalities in three -quarters of the group. A history of unilateral 
or bilateral cryptorchidism could be elicited in eleven patients while six had infections in 
the genital tract. One patients received radiotherapy to the spine for ankylosing 
spondylitis while another underwent unilateral orchidectomy following a road accident. 
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Table 1. Summary of clinical findings in 103 patients attending a 
subfertility clinic with average sperm density under 40 million /ml 
History Physical findings 
Nil of note 82 Normal external genitalia 51 
Unilateral undescended or 
retractile testis 6 Bilateral small testes 27 
Bilateral undescended or 
retractile testes 5 Unilateral small testis 7 
Genital infections 6 Varicocoele 12 
Irradiation 1 Epididymal or vas abnormalities 4 
Trauma I Phimosis 1 
Sexual difficulties 2 Hydrocoele 1 
Two patients reported psychosexual difficulties. No abnormalities were found on physical 
examination in half of the patients (Table 1). Bilateral (twenty- seven) and unilateral 
(seven) small testes -under 15 ml volume as measured by Prader's orchidometer, were 
found in thirty -four patients. Twelve patients had clinically detectable varicocoeles and 
four had palpable abnormalities of the epididymis or vas deferens. Phimosis and 
hydrocoele were each present in one patient. 
Thirteen healthy normal subjects who had fathered one or more children within the 
past 5 years were also investigated hormonally as controls. Their median age was 31 years 
and range 24-37 years. 
Endocrine investigations 
In the first sixty -three patients and the thirteen controls, basal samples of LH, FSH and 
testosterone were obtained at 30 min intervals for 14 h. This was followed by an i.v. bolus 
injection of 50 pg LHRH (Gonadorelin, Ayerst) and samples for LH and FSH collected at 
30, 60 and 90 min afterwards. In the subsequent forty patients, only single samples of 
basal LH, FSH and testosterone were obtained. 
Hormone assays 
Gonadotrophins were measured by a double- antibody radioimmunoassay employing 
the LH standard 68/40 (77 u /ampoule) and FSH standard 69/104 (10 u /ampoule) from 
the National Institute of Biological Standards and control, London (Hunter & Bennie, 
1978). Within assay coefficients of variation for LH and FSH were 8.0 and 7.0% 
respectively. Interassay and intra -assay coefficients of variation were 8.6 and 7.4% for LH 
and FSH respectvely. The limit of detection, arbitrarily set at 15% inhibition of Bo 
(corresponding to 6 x SD of Bo), was 0.56 u/1 for LH and 0.74 u/1 for FSH. The normal 
range was determined in 100 healthy adult male blood donors aged 18-49 and the normal 
limits set at the fifth to ninety -fifth percentile for LH (3.3 -10.0 u /1) and FSH (1.7 -6.7 u /l). 
Plasma testosterone was measured by radioimmunoassay without chromatography 
(Corker & Davidson, 1978). The anti -testosterone -3- carboxymethyloxime -ovalbumen 
antiserum (HP /S55 -IIA Guilhday) had 32% cross reaction with 5a- dihydrotestosterone 
and 21% with 4- androstenediol. Separation of bound from unbound tracer was effected 
by dextran -charcoal suspension. The intra -assay and interassay coefficients of variation 
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Fig. 1. Profiles of mean basal gonadotrophins (aLH bFSH) and response to 50 µg of LHRH i.v. in 
the four grades of testicular histology (see text) in sixty -one patients and thirteen normal controls. 








were 6.7 and 10.8% respectively. Pooled equal aliquots from the four testosterone samples 
from each patient were assayed. The normal range for adult males (10-35 nmol /1) was 
determined in fifty -six fertile men aged 24-50 years with at least one child under the age of 
two, who requested vasectomy. 
Analysis of LHRH response 
Examination of the LH and FSH profiles after LHRH stimulation (Fig. 1) suggested 
that a model of exponential decline might be appropriate, with a relatively slower decline 
in FSH which might effectively be zero for the duration of the test (i.e. constant stimulated 
level). All gonadotrophin values were log transformed since both LH and FSH in the 100 
blood donors had log normal distributions. For each individual, a straight line fit to log 
(stimulated -mean basal) LH and FSH values with time was obtained by least squares. 
Pooled estimates of the slopes of these straight lines for the whole group were obtained for 
each gonadotrophin. This assumed that the half -life for the hormones were the same for 
all subjects studied. This assumption was tested by analysis of variance between 
individual and common slope models, and confirmed the linear decrease in log 
(peak -mean basal) LH with a common slope for all subjects which corresponded to a 
common half -life of 1.36 h (1.20- 1.56 -95% confidence interval) after LHRH stimula- 
tion. It also confirmed a constant stimulated level of FSH for each individual, with no 
increase or decrease between 30 and 90 min after LHRH stimulation. In the following 
analyses, the gonadotrophin measures for each individual were designated as follows: 
1 Basal LH (LB): the geometrical mean of four basal LH values before LHRH 
stimulation. 
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2 Basal FSH (FB): the geometrical mean of four basal FSH values before LHRH 
stimulation. 
3 Peak LH (LP): estimated 30 min value (minus LB) obtained by fitting a straight line 
with the common slope to the set of log (peak -basal) LH readings for each individual. 
4 Peak FSH (FP): the geometrical mean of the three stimulated FSH values minus FB. 
Semen analysis 
At least two semen samples obtained by masturbation after a period of ejaculatory 
abstinence of 72 h or more were analysed in each patient in the 3 months prior to the 
endocrine investigations and biopsy. The method of analysis has been described in a 
previous publication (Chandley et al., 1976). In one patient, the semen data was 
inadequate according to the above criteria and was excluded from analysis. 
Testicular biopsy and histology 
Under general anaesthesia, unilateral testicular biopsies were performed in ninety 
patients and bilateral biopsies in twelve. One of the latter group had very different 
histological appearances in the two testes and one patient refused to undergo the 
procedure after his endocrine investigations. These two patients were excluded from 
subsequent analyses involving testicular histology. The biopsies were fixed in Bouin's 
solution and embedded in paraffin. The sections (5y thick) were stained with haematoxy- 
lin and eosin. Testicular histology was graded according to the proportion of 
seminiferous tubules showing spermatogenic activity and the degree of such activity 
within tubules (McIlree et al., 1966; Chandley et al., 1976). Definition of the gradings were 
as follows: 
Grade 1. All tubules show active spermatogenesis with production of mature sperms. 
Grade 2. Some or all tubules show depression or arrest of spermatogenesis at various 
stages or a diminished number of germ cells. No tubules show a complete absence of 
germ cells. 
Grade 3. Some but not all tubules show a complete absence of germ cells and contain only 
Sertoli cells. 
Grade 4. Germ cells are absent from all tubules examined, their only content being Sertoli 
cells. 
Thickening of the tunica propria, hyalinization of the tubules, or increase in Leydig cell 
numbers may occur in grades 3 and 4. 
RESULTS 
The distribution of testicular histology and sperm density in the 100 patients is presented 
in Table 2. Of the twenty -four patients with grade 3 and 4 histology only one had an 
average sperm density over 5 million /ml. In contrast, the full range of sperm density from 
azoospermia to 40 million/ml was encountered in the seventy -six patients with grade 1 
and 2 histology. In patients with sperm density over 5 million /ml, all except one had grade 
1 or 2 histology. In those with sperm density under 5 million /ml, any histólogical grade 
could be present. It is in this last group that hormone studies may prove to be most 
helpful. 
The relationship between testicular histology and the gonadotrophin and testosterone 
levels in the first sixty -three patients who underwent LHRH testing is shown in Table 3. 
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Table 2. The distribution of sperm density and testicular histology in 100 patients. Three 
patients had been excluded due to inadequate information in semen analyses (1) and 














Grade 1 11 2 11 8 15 7 54 
Grade 2 2 2 6 4 4 4 22 
Grade 3 1 11 2 0 1 0 15 
Grade 4 5 3 1 0 0 0 9 
Total 19 18 20 12 20 11 100 
Although there was no significant difference in testosterone between any of the patient or 
control groups, the four gonadotrophin measures (FB, FP, LB & LP) separated the 
patients into broad histological groups: grade 1 with 2 and grade 3 with 4. This pooling of 
gonadotrophin measures in terms of similar means and standard deviations is also 
illustrated by the profiles of responses to LHRH in Fig. 1. 
To determine the best gonadotrophin measure(s) to distinguish between the two 
histological groupings (grades 1 and 2 from grades 3 and 4), multivariate discriminant 
analysis (Marriot, 1974) was used. This calculates the generalized distances (Mahala- 
nobis's D) which give the differences between the two patient groups and controls in 
standard deviation units allowing for the correlation between the variables (Table 4). 
Either basal FSH or peak FSH alone could provide the best separation between the two 
histological groupings and no increase in discrimination was obtained by including 
further hormonal parameters. The difference in LH between the histological groups could 
entirely be explained by the correlation between LH and FSH measures. Basal and peak 
FSH were highly correlated (r = 0.75, P < 0.0001) in the various patient and control 
groups (Fig. 2), so that either one of these measures would not improve the discriminant 
function of the other. Using basal FSH alone with the upper limit of the normal range at 
6.7 u /l, elevated values in 81% (thirteen of sixteen ) of grade 3 and 4 biopsies and normal 
values in 91% (forty -one of forty -five) of grade 1 and 2 biopsies were found. 
The best discrimination between normal controls and the two subfertile patient groups 
was provided by the LH measures (Table 4). Peak LH was the best single parameter 
distinguishing controls from patients with grade 1 or 2 histology. The addition of other 
measures did not significantly improve the discrimination. Although either peak FSH or 
peak LH alone provided a very clear cut separation between controls and patients with 
grade 3 or 4 histology, the best discrimination was given by the combination of basal and 
peak LH. 
The relationship between sperm density and the five hormonal parameters is shown in 
Table 5. Five azoospermic patients with normal FSH and grade 1 or 2 testicular histologies 
were considered to have obstructions in the excurrent ducts and were excluded from this 
analysis. Both basal and peak FSH showed a significant linear rising trend (P < 0.0001) 
with decreasing sperm density (Fig. 3). Mean basal FSH remained fairly constant until 
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Table 4. Discriminant functions of the hormone (see text) basal LH (LB), basal FSH (FB), 
peak LH (LP) and peak FSH (FP) in differentiating testicular histological groups and 
controls as represented by the generalized distance (D) between them 
Hormone 
measure 
Generalized distance (D) 
Testicular histology 
grades 1 & 2 v. 3 and 4 
Testicular histology 
grades 1 and 2 v. controls 
Testicular histology 
grades 3 and 4 v. controls 
LB alone 1.07 0.22 1.88 
FB alone 2.00 0.50 3.31 
LP alone 0-97 1.46 3.89 
FP alone 1-71 1.34 4.31 
Best FB LP LB 
pair + 2.18 + 1.58 + 5.36 
FP FP LP 
All four 
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Peak FSH (u /I) 
Fig. 2. Basal and peak FSH (response to 50 pg LHRH i.v.) were highly correlated in the sixty -one 
patients and thirteen controls. Coefficient of correlation r =0.749 and P<0.00001. Biopsy 1 & 2 
(n = 45) ; biopsy 3 & 4 (n = 16) o; normal x. 
FSH range (6.7 u /1) with sperm densities under 1 million /ml. Peak FSH showed a linear 
rising trend over the whole range of sperm densities from 40 million /ml to azoospermia, 
but the increase at each level was smaller than basal FSH. Neither testosterone basal LH 
or peak LH differed significantly with changes in sperm density, but the latter did show a 
weak degree of linearity. 
Thus in the analysis of the first sixty -three patients, basal FSH was the best single 
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Table 5. Mean levels and 95% confidence limit in parenthesis of basal and peak (response to 50µg 
LHRH i.v.) gonadotrophins and basal testosterone at different sperm densities. Patients with 





















Non -obstructive 3 17.82 7.39 10.63 22.12 22.86 
azoospermia (6.38 -49.83) (2.45- 22.08) (10.11 -11.18) (9.67- 50.61) (17.55- 28.17) 
S 1.0 M /ml 13 8-80 9.96 5.68 32.11 19-61 
(6.07- 12.76) (6-73-14-73) 4.50 -7.17) (2488 -41.43) (16.83- 22.39) 
1.1 -5.0 M /ml 11 4.32 3-57 4.24 22.97 21-99 
(3.44 -5.41) (2.00 -6.38) (3.11 -5.76) (14.90- 35.41) (19.37- 24.61) 
5.1 -10.0 M /mi 6 2-69 2-83 4.93 20.81 20.53 
(1.40 -5.17) (0-90-8-85) (1.25 -6.98) (14.06- 30.79) (15.13- 25.93) 
10.1 -20.0 M/1 16 3.18 2.33 4-56 19.69 22.81 
(2.45 -4.12) (1.66 -327) (4.18 -4.97) (14.53- 26.68) (20.03- 25.39) 
20.1-40.0 M/1 8 3.40 122 4.65 13.46 1° i i 
(2.02 -5.73) (0.64 -2.31) (3.07 -7.04) (9.56- 18.94) (1F 34- 21.88) 
Obstructive 5 2.62 1.22 4.16 16.18 21-98 
azoospermia (1-50-4.60) (0.59 -2.49) (2-45-7-05) (11.67- 22.43) (14'9- 29.17) 
Normal 13 1-86 0.61 3.53 9-78 20.20 
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Sperm density (millions /ml) 
Fig. 3. Mean ( ±SEM) levels of (a) basal and (b) peak FSH (response to 50 µg LHRH i.v.) at 
different sperm densities. Patients with obstructive azoospermia had grade 1 or 2 histologies and 
major abnormalities of the efferent ducts. 
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hormonal parameter in terms of its relationship to testicular histology and sperm density. 
The LHRH response did not contribute any additional useful information in these 
respects. The within -patient coefficient of variation for four basal samples of FSH at 30 
min intervals was so small (10 %) that using a single measurement instead of the mean of 
four would not alter the above analyses significantly. 
In the other forty patients, only single samples of basal FSH, basal LH, testosterone, 
and testicular histology were analysed. Discriminant analysis again confirmed basal FSH 
to be the best parameters in distinguishing the two histological categories. The addition of 
basal LH and testosterone did not improve the discriminant function. Elevated basal 
FSH was found in 75% (four of six) of grade 3 and 4 histologies and normal FSH in 97% 
(thirty of thirty -one) of grade 1 and 2 histologies. This was similar to the findings in the 
first sixty -three patients. The linear rising trend in basal FSH with decreasing sperm 
density was also confirmed. Thus the relationship between a single basal FSH and 
testicular histology and sperm density in the additional forty patients followed the same 
pattern in the first sixty- three. 
The findings in 100 patients (three patients excluded from analysis due to insufficient 
data) are summarized in Fig. 4 and demonstrate the interrelationship between basal FSH, 
testicular histology and sperm density. In the nineteen azoospermic patients, basal FSH 
clearly differentiated the six with severe germ cell damage (grade 3 and 4 histologies) from 
the thirteen with grade 1 and 2 histologies. Of the latter thirteen patients, one had 
maturation arrest at the primary spermatocyte stage and five were confirmed to have 
bilateral agenesis of the vasa deferentia on scrotal exploration. One had patent vasa 
bilaterally on vasography and the obstruction was presumed to be in the epididymis. Six 
patients were not submitted to either scrotal exploration or vasography as they were 
reluctant to pursue further investigation or treatment. These thirteen patients form a 
separate aetiological group and were excluded from subsequent analyses. In the other 
eighty -one patients (oligospermic) normal FSH and grade 1 and 2 histologies were found 
in all those with sperm densities over 5 million /ml with the exception of three patients. On 
the other hand, the majority of patients with sperm density under 1 million /ml had 
elevated FSH and grade 3 and 4 histologies. Between these two extremes, there was an 
intermediate group with sperm densities of 1 -5 million /ml. 
The diagnostic value of FSH can be estimated from the following analyses. In patients 
with sperm densities over 5 million /ml (Fig. 4) forty -two out of forty -three (97.7 %) had 
grade 1 or 2 testicular histology. With the use of FSH, all patients with normal levels 
(< 6.7 u /l) had grade 1 or 2 histology. Of the three patients with elevated (> 6.7 u /1) FSH, 
only one had grade 3 testicular histology. Thus the contribution of FSH is limited in 
patients with sperm densities over 5 million /ml who, with very few exceptions, are likely to 
have grade 1 or 2 histology. In patients with sperm density under 5 million /ml, 48% had 
grade 1 or 2 and 52% grade 3 or 4 histologies. With the use of FSH, 78% (eighteen of 
twenty- three) with normal values had grade 1 or 2 and 83% (eighteen of twenty -one) with 
elevated values had grade 3 or 4 histologies. In patients with sperm densities under 1 
million /ml, 83% had grade 3 or 4 histology and only 17% had grade 1 or 2 histology. All 
patients with elevated FSH had grade 3 or 4 histology, but in those with normal FSH both 
histological groups occurred with similar frequencies -57% grades 3 and 4 and 42% 
grades 1 and 2. Thus if sperm density is under 5 or 1 million /ml, the finding of elevated 











































Sperm density (millions /ml) 
Fig. 4. Basal FSH, sperm density and testicular histology (grades 1 -4-see text) in 100 subfertile 
patients. Horizontal line represents the upper limit of the normal range (6.7 u /l) for basal FSH in 
100 healthy male blood donors. Markers indicate patients who subsequently impregnated their 
wives with or without treatment. Biopsy 1 ; biopsy 2 .; biopsy 3 o; biopsy 4 G. 
DISCUSSION 
Our findings showed that in terms of the inverse relationships with sperm density and the 
degree of germ cell loss demonstrated by testicular histology, basal FSH, amongst the 
various combinations of hormonal parameters, gave the greatest discriminant value. This 
confirmed the findings in previous studies (Johnsen, 1970; Rosen & Weintraub, 1972; 
Kjessler & Wide, 1973; Mauss & Börsch, 1973; de Kretser et al., 1974; Hunter et al., 1974; 
Christiansen, 1975; Aafjes et al., 1977). The variation of basal FSH at intervals of 30 min 
504 F. C. W. Wu et al. 
was small and single estimations were representative. The additional measurements of 
basal LH, testosterone and the LHRH response did not contribute further to the 
discriminant function of basal FSH alone. 
The finding that the FSH response to LHRH stimulation was highly correlated with 
basal FSH confirms the previous studies (Isurgi et al., 1973; Mecklenberg & Sherins, 1974; 
Franchimont et al., 1975; Roulier et al., 1976). Lipschulz et al. (1977) however, 
demonstrated an exaggerated FSH response to 250 pg of LHRH in spite of normal basal 
levels in oligospermic patients with sperm density under 10 million /ml. This discrepancy 
may be due to the difference in LHRH dose employed and the different criteria for 
selection of oligospermic patients (under 40 million /ml in the present study). A further 
explanation lay in the different relationship of sperm density to basal and peak FSH. 
Basal FSH remained fairly constant and only increased outwith the normal range when 
sperm density fell below 5 million /ml. A similar finding has been reported by Mauss & 
Börsch (1973) although the critical level of sperm density was 10 million /ml. The FSH 
response to LHRH (peak FSH) however showed a linear trend rising over the entire range 
of sperm density from 40 million to azoospermia. Thus patients with sperm density 
around 5-10 million /ml may have basal FSH within the normal range but exaggerated 
FSH response to LHRH -the group of patients that Lipschultz et al. (1977) selected for 
investigation. However, even in that study, basal FSH in the oligospermic patients was 
significantly elevated compared with controls, though the individual levels remained 
within the normal range. Furthermore, the magnitude of the LHRH response was 
proportional to basal FSH in all patient groups and controls. Their findings were 
therefore entirely compatible with those of the present study. 
The elevated basal and peak LH found in patients with grade 3 and 4 histology 
confirmed the reports of de Kretser et al. (1972), Hunter et al. (1974) and Christiansen 
(1975). However, the testosterone levels in our patients were normal and a tendency for 
lower testosterone in patients with severe germ cell damage (de Kretser et al., 1972) was 
not demonstrated. This apparent discrepancy is due to the exclusion of patients with 
chromosomal abnormalities (Klinefelter's and variants) and the smaller proportion of 
patients with more severe seminifereous tubular damage in the present study. The 
elevated LH with or without low testosterone may be the result of compensated Leydig 
cell failure, presumably caused by the same aetiological factors which affected the 
seminiferous tubular compartment. Recent evidence from in vitro studies (Rodriquez - 
Riqau et al., 1978; Weiss et al., 1978) confirmed abnormalities in Leydig cell functions in 
infertile men but the possibility that Leydig cell failure being a consequence of germ cell 
damage cannot be excluded. 
Summarizing the clinical implications of the foregoing considerations: the most 
informative endocrine investigation in severly oligospermic (< 5 million /ml) and 
azoospermic patients is a single estimation of basal FSH, raised levels of which are 
indicative of severe and probably irreversible germ cell damage. The response to LHRH 
stimulation confers very little additional information and is not indicated in routine 
management of male infertility. Measurement of LH and testosterone has limited value in 
patients without clinical evidence of androgen deficiency. 
Having established the role of endocrine investigations it will be necessary to reconsider 
the indications for testicular biopsy in the assessment of male infertility. From the results 
of this study and that of Pryor et al. (1978), it is clear that in azoospermic patients, FSH 
can differentiate those with efferent duct obstruction from those with germ cell depletion 
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(Fig. 4). The latter group, with elevated FSH, will not require further investigation and 
can be advised to consider the alternatives of adoption or artificial insemination by donor 
at an early stage. For the azoospermic patients with normal FSH, scrotal exploration, 
vasogram and testicular biopsy should be performed to demonstrate the obstruction 
prior to epididymo -vasostomy. The importance of testicular biopsy, especially when the 
epididymides appear normal on exploration should be emphasized. This enable germ cell 
maturation arrest to be recognized as these patients are not suitable for epididymo- vasos- 
tomy. Baker et al. (1976) found that 52% of patients with germ cell arrest had elevated 
FSH levels. The classification of testicular histology in our study does not distinguish 
germ cell arrest as a separate category so that this finding could not be confirmed. For 
oligospermic patients with sperm density under 5 million /ml, elevated FSH has virtually 
the same implications as in azoospermic patients. If FSH is normal, testicular histology 
cannot be reliably predicted and biopsy is required if clinical decisions are made on the 
basis of histological changes in the semeniferous epithelium. For oligospermic patients 
with sperm density over 5 million /ml, neither testicular biopsy nor FSH estimation is 
required since the vast majority have normal levels of FSH and grade 1 or 2 histology (Fig. 4). 
There were a number of patients that did not conform with predictions in this 
diagnostic scheme: five patients with elevated FSH but grade 1 and 2 histologies and five 
with normal FSH but grade 3 and 4 histologies. Valid explanations may be present for 
these apparent anomalies. Unilateral biopsies were performed in all except twelve cases. 
Where the two testes in a patient were of dissimilar size of consistency, the one considered 
more normal clinically was biopsied. Although it is generally held that testicular size is a 
good index of spermatogenesis in adults (Rifka & Sherins, 1978) several studies have 
emphasized that this may not be entirely reliable (Meinhard et al., 1973; Pryor et al., 1976 
Guay et al., 1977). In the present context, the five patients with normal FSH and grade 3 
or 4 histologies may have more active spermatogenesis in the unbiopsied contralateral 
testis providing an adequate feedback to suppress FSH. The finding that all five patients 
had normal LH and testosterone and a normal or exaggerated response to LHRH makes 
the possibility of pituitary failure very unlikely. 
One interesting finding in this study is that amongst the six patients with unilateral 
atrophic or absent testes, three had elevated basal FSH levels in spite of relatively good 
sperm production of over 15 million /ml. In a further two patients in this group the FSH 
response to LHRH was greatly exaggerated even though basal FSH was normal. This 
may be interpreted as a state of compensated spermatogenetic failure with the 
hypothalamic- pituitary unit being readjusted to a higher set point in response to the 
lower level of testicular feedback due to unilateral testicular atrophy. Whether 
compensatory hypertrophy occurs in the contralateral testis in these patients could not be 
assessed from the present study. Laron et al. (1975) postulated that compensatory 
hypertrophy occurs in the normal contralateral testis in patients with unilateral 
cryptorchidism, although the seminiferous tubular diameter remains unchanged. They 
also found FSH to be elevated in these patients with unilateral cryptorchidism. This was 
subsequently confirmed by Werder et al. (1976) and Lipschultz et al. (1976). In our 
patients however, unilateral testicular atrophy resulted not only from cryptochidism but 
also from variocoele, mumps orchitis, orchidectomy after a road traffic accident and 
radiation to the spine for ankylosing spondylitis. The clinical significance of our finding is 
that in the presence of obvious unilateral atrophic or absent testes from whatever 
506 F. C. W. Wu et al. 
aetiology, elevated FSH levels are compatible with relatively good sperm production or 
even fertility and do not necessarily indicate severe germ cell failure. 
Having considered these anomalous situations, there still remain a very small number 
of patients who did not fit into this diagnostic scheme. For these patients at least, one may 
have to postulate that the feedback signal for FSH (inhibin) is produced in some 
independent station within the seminiferous tubules whose functional integrity is 
dissociated from that of the germ cells (Leonard et al. 1972). This concept is compatible 
with the finding (Steinberger & Steinberger, 1976) that media from Sertoli cell culture can 
inhibit FSH secretion selectively in cultured pituitary cells. 
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SUMMARY 
In twenty oligospermic or azoospermic patients with elevated plasma FSH, the 
mean concentrations of plasma oestrone sulphate (843 ± 233 pg /ml), oestrone 
(54± 10.4 pg /ml) and oestradiol (46.6± 12.6 pg /ml) were found to be signifi- 
cantly higher than in twenty -one normal fertile men of comparable age 
(593 ±220 pg /ml, 40.6 ±8.8 pg /ml and 33.1 ±10.9 pg /ml respectively). SHBG 
binding capacity was elevated in the infertile group (infertile 3.35 ±0.82 x 10_8 
M/I v. normal 2.76 ±0.89 x 10 -8 M /l) but the total plasma testosterone 
concentrations were comparable (infertile 5435 ±1578 pg /ml v. normal 
5046 ± 1102 pg /ml). Evidence was cited to support the view that Sertoli cells, in 
response to an unphysiological FSH stimulation, are a likely source of excessive 
oestrogen production. The possible significance of increased intra- testicular and 
circulating oestrogen in the altered state of testicular steroidogenic function in 
men with primary seminiferous tubular defects was discussed. 
Although raised FSH has proved a useful diagnostic index of the state of the seminiferous 
epithelium (Hunter et al., 1976; Wu et al., 1981), in the majority of cases of male inferti- 
lity, the underlying pathogenesis in the impairment of spermatogenesis remains un- 
known. With the realization that androgens are essential for spermatogenesis (Stein - 
berger, 1971; Steinberger et al., 1978) more attention has been focused on Leydig cell 
function in infertile males. Mean concentration of testosterone in infertile men has been 
found to be lower than normal (Rosen & Weinstraub, 1971; de Kretser et al., 1972; Aloy- 
sio et al., 1974; Purvis et al., 1975; Nieschlag et al., 1978) although this was not found by 
others (Ruder et al., 1974; Lawrence & Swyer, 1974; Nankin et al., 1977; Wu et al., 1981). 
Some in vitro studies of testicular biopsy tissue from oligospermic men showed abnor- 
malities in testicular steroidogenesis (Rodriguez -Rigau et al., 1978; Oshima et al., 1977) 
but, again, this was not confirmed (Nieschlag et al., 1979). There was more general agree- 
ment in the finding of elevated LH levels which may be compatible with primary Leydig 
cell failure. Furthermore, the hCG response was subnormal in some severely oligospermic 
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Details of the radioimmunoassay method for plasma oestrone and oestrone sulphate 
have already been described in full in a previous publication (Wu et al., 1982). Plasma 
oestradiol, testosterone, LH and FSH concentrations were determined by radioim- 
munoassay according to the methods of Van Look et al. (1977), Corker & Davidson 
(1978) and Hunter & Bennie (1979) respectively. The sex -hormone binding capacity was 
measured by the method of Rosner modified by Anderson et al. (1976). 
Statistical analyses were performed using Student's single -tailed t test. 
RESULTS 
The mean peripheral plasma concentrations of oestrone sulphate, oestrone and oestradiol 
in infertile males with elevated FSH were significantly higher than that in normal controls 
(Fig. 1). Plasma LH was elevated to a lesser extent than FSH, but testosterone remained 
indistinguishable from normal (Fig. 1). 
In both azoospermic and oligospermic subgroups, the oestrogens and gonadotrophins 
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Fig. 1. Comparisons of the mean ± SEM plasma concentrations of oestrone sulphate 
(P <0.0025), oestrone (P <0.0005), oestradiol (P<0.0025), testosterone (P >0.05 NS), LH 
(P <0.005) and FSH (P < 0.0005) between normal (D) and infertile ( ) men. 
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plasma oestradiol but low oestrone concentrations in ten azoospermic men with elevated 
FSH levels. Nieschlag et al. (1978) however described a trend towards higher plasma oes- 
tradiol and lower testosterone concentrations with decreasing sperm density in infertile 
men. 
In normal men, oestradiol and oestrone are predominantly derived from peripheral 
conversion of androgens (Baird et al., 1969), while testicular secretion contributes a small 
but significant proportion of these oestrogens (Kelch et al., 1972; Baird et al., 1973; 
Weinstein et al., 1974). Oestrone sulphate is almost entirely derived from peripheral 
conversion of oestrone and oestradiol (Longcope, 1972; Ruder et al., 1972) with 
insignificant testicular secretion (Wu et al. 1982). In the present study, despite increased 
mean plasma levels of all three oestrogens in infertile men, the ratios between their 
concentrations were not different from normal. This implies that the dynamics of 
oestrogen production is qualitatively similar to normal men. Thus the excessive oestrogen 
production in infertile men could arise from either increased testicular secretion of 
oestradiol and oestrone and /or enhanced peripheral conversion of androgen precursors. 
Low plasma testosterone (de Kretser et al., 1972; Nieschlag et al., 1978), normal 
androstenedione (Purvis et al., 1975) and subnormal response to hCG stimulation (de 
Kretser et al., 1975) are commonly found in infertile men. Sitterii & MacDonald (1973) 
suggested that increased testicular secretion accounted for the excessive oestrogen pro- 
duction in hypergonadotrophic patients since the rate of peripheral aromatization of 
androgens was normal. Recently, we found increased oestradiol concentrations in sper- 
matic vein in patients with varicocoeles and elevated FSH (Wu et al., 1982). Raised 
testicular oestradiol concentration (Damber & Bergh, 1980) and oestradiol production in 
response to hCG stimulation (de Kretser et al., 1979) have been demonstrated in the 
experimentally- induced cryptorchid rat testis. Taken together, the evidence is compatible 
with increased testicular secretion of oestradiol (and oestrone) as a probable mechanism 
underlying the excessive oestrogen production in infertile men. 
The observation that all three oestrogens were positively correlated with FSH suggests 
that elevation of this gonadotrophin may be important in enhancing testicular oestrogen 
secretion. This is supported by the finding that FSH -stimulated rat Sertoli cells in culture 
can aromatize testosterone and androstenedione to oestradiol (Dorrington & Armstrong, 
1975; Rommerts et al., 1978; 1979). However, the relative contribution of oestrogen syn- 
thesis by Leydig cells (Payne et al., 1976; Valladares & Payne 1979a; 1979b; Canick et al., 
1979) compared to Sertoli cells remains to be defined. 
A direct inhibitory action of oestrogens on Leydig cell function independent of the sys- 
temic suppression of LH has been demonstrated by a number of clinical and experimental 
studies (Baker et al., 1973; Chen et al., 1977; Jones et al., 1978; Hseuh et al., 1978; Van 
Buerden et al., 1978). Thus Leydig cell function could be impaired subsequent upon a pri- 
mary abnormality of spermatogenesis, increased pituitary FSH secretion and testicular 
over -production of oestrogens. This may explain the presence of Leydig cell dysfunction 
in infertile men (Rosen & Weintraub, 1971; de Kretser et al., 1972; Aloysio et al., 1974; 
Purvis et al., 1975; Oshima et al., 1977; Rodriquez -Rigau et al., 1978; Nieschlag et al., 
1978) and in animals with experimentally- induced seminiferous tubular damage (Damber 
et al., 1978; Rich et al., 1979; Kerr et al., 1979; de Kretser et al., 1979; Main & Setchell, 
1980). Furthermore, the consequent diminished supply of androgens to the Sertoli cells 
may cause a reduction in androgen binding protein production and a fall in intratubular 
androgens available for maintenance of spermatogenesis. This hypothetical series of 
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HUMAN TESTIS DOES NOT SECRETE OESTRONE SULPHATE 
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SUMMARY 
The concentrations of five steroids in samples of spermatic venous blood collected from 17 
men undergoing ligation of varicocoeles were compared with those in samples from the 
antecubital vein. There was evidence of testicular secretion of testosterone, androste- 
nedione, oestradiol -17f3 and oestrone, since the ratios of the mean concentrations in 
spermatic venous plasma to those in peripheral venous plasma were 77.2, 9.1, 28.7 and 1.6 
respectively. The testicular secretion of oestrone sulphate was minimal; the ratio of the 
mean concentrations in spermatic and peripheral plasma was 1.07. These results support 
the view derived from isotope dilution studies that almost all oestrone and oestrone 
sulphate in the circulation is derived from peripheral conversion of other precursor 
steroids. 
INTRODUCTION 
Direct testicular secretion of oestrone and oestradiol in man has been inferred from the fact 
that the concentrations of these oestrogens in plasma from the spermatic vein are higher 
than in the peripheral vein (Kelch, Jenner, Weinstein, Kaplan & Grumbach, 1972; Baird, 
Galbraith, Fraser & Newsam, 1973). It has been suggested that oestrone sulphate,---the most 
abundant oestrogen in peripheral plasma (Brown & Smyth, 1971), may also be secreted 
from the human testis (Baird, Horton, Longcope & Tait 1968; Hembree, Bardin & Lipsett, 
1969) as in the stallion (Raeside, 1969). However, isotope dilution studies have indicated 
that the entire blood production of oestrone sulphate can be accounted for by peripheral 
conversion of unconjugated oestrone and oestradiol (Purdy, Engel & Oncley, 1961; 
Longcope, 1972; Ruder, Loriaux & Lipsett, 1972). Because of significant diurnal variation 
in the secretion of androgens, the contribution to oestrogens by the peripheral conversion 
of androstenedione and testosterone measured under steady state conditions may have 
been overestimated (Baird, Horton, Longcope & Tait, 1969). 
In this study we have attempted to determine directly the testicular secretion of 
oestrogens by measurement of the concentrations of oestrone, oestradiol -173 and oestrone 
sulphate in spermatic venous blood of men undergoing surgery for operative repair of 
varicocoeles. 
PATIENTS, MATERIALS AND METHODS 
Patients 
Seventeen patients (age 18 -34 years, mean 26.2 ±4.4 (s.D.) years) in good general health 
who had received no regular medications before surgery underwent ligation of the left 
spermatic vein for treatment of varicocoeles. During the operation, which was performed 
*Present address: Royal Infirmary, Edinburgh, EH3 9YW. 
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NaHCO3 and with 1 ml sterile distilled water and evaporated to dryness. The residue was 
redissolved in 500 µl phosphate -gelatin buffer and kept at -20 °C until assay. Two 100 -µl 
portions from each sample were assayed and 20011l counted for estimation of recovery. 
Further purification of solvolysed extract by celite column chromatography 
Oestrone sulphate in plasma from postmenopausal females and normal males was 
processed as described above and the oestrone obtained was assayed with and without 
purification with celite column chromatography (Thorneycroft, Ribiero, Stone & Tillson, 
1973). Celite 545 (Johns -Manville Products Corporation, Richmond) was heated to 600 °C 
for 18 h to remove contaminants and was cooled in a desiccator. It was mixed thoroughly 
with ethylene glycol (2: 1, w /v) and the columns were packed dry in 5 -ml graduated 
disposable pipettes to a height of 6 cm. After washing the columns twice with 5 ml iso- 
octane, the residues were applied in 0.5 ml iso- octane and then again washed with 2 ml and 
then 3.5 ml iso- octane. The oestrone fraction was eluted with 4 ml 15% ethyl acetate in iso- 
octane which was evaporated under N2. The residues were redissolved in 200 tl buffer of 
which 100 gl was assayed and 50 p.1 counted for recovery. 
Radioimmunoassay 
The antiserum was raised in ewes against oestrone- 6- (O- carboxymethyl)oxime- bovine 
serum albumin (Martensz, Scaramuzzi & Van Look, 1979). Oestrone extracted before 
solvolysis and unconjugated oestrone liberated by solvolysis of the same samples were 
analysed together in one assay. To each sample antiserum (100 µl, 1: 10 000 dilution in 
buffer) was added and the contents of the tubes were mixed and equilibrated at room 
temperature for 1 h. [3H]Oestrone (5000 counts /min in 0.1 ml buffer) was added, mixed and 
the samples left overnight at 4 °C. Unbound oestrogen was removed by adding 1 ml 
dextran- coated charcoal suspension; the mixture was kept at 0 °C for 15 min in an ice bath. 
The charcoal was separated by centrifugation at 1000g for 10 min at 4 °C and the 
supernatant fraction decanted into counting vials. 
Standard curves were obtained from samples containing known quantities of oestrone 
(0 -1.85 pmol) processed by the same procedure as the unknown samples. The mass of 
oestrone in the latter was extrapolated directly from the standard curves and corrected for 
procedural losses. 
Liquid scintillation counting 
All samples were counted in 10ml scintillation fluid containing 2,5- diphenyloxazole 
(45 mmol) and 1,4- di- 2,5- phenylozazolyl- benzene (2 mmol) in 2.5 litres sulphur -free toluene 
and 1.25 litres Triton X -100 (all from Koch -Light Laboratories Ltd, Colnbrook). Tritium 
was measured in a Packard Tri -Carb Liquid Scintillation spectrometer (model 3320) with a 
counting efficiency for tritium of 54 %. Sufficient counts were recorded to give a counting 
error of less than 5 %. 
Radioimmunoassay of other hormones 
Oestradiol -l7ß was measured by the method of Van Look, Hunter, Corker & Baird (1977). 
The intra- and interassay variations were 9.3 and 10% respectively and the limit of detection 
was 37 pmol /1. 
Androstenedione was measured by the method of Baird, Burger, Heavon -Jones & 
Scaramuzzi (1974) after purification by alumina column chromatography (McNatty, Baird, 
Bolton, Chambers, Corker & McLean, 1976). The intra- and interassay variations were 5.7 
and 5.2% respectively and the limit of detection was 0.52 nmol /1. 
Testosterone was measured by the method of Corker & Davidson (1978) without 
chromatography. The intra- and interassay variations were 7.6 and 11.5% respectively and 
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the assay was achieved by the solvolysis procedure and the low cross -reaction of the 
antiserum with possible interfering steroids. This is further substantiated by the similarity 
of results obtained with or without celite column chromatography. The accuracy and 
precision were within the acceptable limits for radioimmunoassays. The sensitivity was 
adequate for the range of values studied in the present investigation and values for water 
and steroid -free plasma were below the limits of detection of the method. The mean 
peripheral venous concentration of oestrone sulphate in 17 men undergoing varicocoele 
repair was 2.48 ±0.88 (s.D.) nmol /1. This is comparable to values given in previous reports, 
for example, Hawkins & Oakey (1974): 1.95 ±0.80nmo1 /l; Wright, Collins, Musey & 
Preedy (1978): 2.50 ±0.17nmol /1; Franz, Watson & Longcope (1979): 1.24 ±0.07nmo1 /1; 
and Towobola, Crilly & Oakey (1980): 3.20 ±0.61 nmol /1. 
The demonstration of adrenal secretion of dehydroepiandrosterone sulphate (Baulieu, 
Corpechot, Dray, Emiliozzi, Lebeau, Mauvais- Jarvis & Robel, 1965) and the finding that 
sulphated steroids can be metabolized without prior hydrolysis of the sulphate moeity 
(Lieberman, 1967) stimulated interest in investigating whether phenolic steroid conjugates 
are also secreted by steroid -producing glands or formed solely as a result of peripheral 
conversion of precursors. The present study demonstrated an insignificant testicular 
vein -peripheral vein concentration gradient for oestrone sulphate indicating, if concen- 
tration in the spermatic artery is equated with that in the peripheral vessels, that there is no 
testicular secretion of this conjugated oestrogen despite its relative abundance in the 
circulation. Using the transfer constants (defined as the fraction of precursor which enters 
the blood de novo as the relevant product) from Ruder et al. (1972) and Longcope (1972) it 
was possible to estimate, from the plasma concentrations in the present studies, that nearly 
all of the plasma oestrone sulphate is derived from oestrone and oestradiol. Since the error 
in such calculations is high, it is possible that the adrenal gland is a further source of 
oestrone sulphate. Sneddon & Marrian (1963) showed that bovine adrenal tissue can 
synthesize oestrone sulphate in vitro, but whether there is significant synthesis in vivo and 
secretion of oestrone sulphate by human adrenals remain to be determined. Thus on 
present evidence, unlike dehydroepiandrosterone sulphate, oestrone sulphate is not an 
important precursor for unconjugated oestrogens under physiological conditions in man. 
Testicular secretion of testosterone, androstenedione, oestradiol and oestrone was 
confirmed by the spermatic - peripheral vein concentration differentials found in the present 
study. The spermatic vein concentrations of testosterone, androstenedione and oestradiol 
are comparable to those given in previous reports (Laatikainen, Laitinen & Vihko, 1971; 
Weinstein, Kelch, Jenner, Kaplan & Grumbach, 1974; Fiorelli, Borrelli, Forti, Gonnelli, 
Pazzagli & Serio, 1976; Hammond, Ruokonen, Kontturi, Kosbela & Vihko, 1977; Pirke, 
Sintermann & Doerr, 1977; de la Torre, Noren, Hedman & Diczfalusy, 1978). The 
spermatic vein concentration of oestrone, however, is considerably lower than that 
reported by Baird et al. (1973) and Weinstein et al. (1974) but more comparable to that 
found by Longcope, Widrich & Swain (1972). In this latter study, unexpectedly low 
spermatic vein concentrations of androstenedione, testosterone and oestradiol were also 
found, suggesting that the retrograde approach via the inferior vena cava and renal vein 
might have introduced a degree of dilution in the spermatic vein effluent. This is unlikely to 
be the case in the present study since the approach to the spermatic vein was direct and the 
spermatic vein concentrations of other steroids are comparable to those given in other 
published reports. The correlation of spermatic- peripheral vein concentration ratios of the 
four unconjugated steroids further substantiates the validity of the present results. The 
considerable variations in the concentrations of the steroids measured in spermatic venous 
plasma (coefficient of variation 33 -134 %) are not unexpected in view of the episodic nature 
of testicular hormone secretion (Smith, Tcholakian, Chowdhury & Steinberger, 1974) and 
the variability inherent in the anatomical level of operative approach to the spermatic vein, 
the duration of, and the negative pressure applied in, blood sampling. Where the rate of 
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men (de Kretser et al., 1975). The weight of available evidence would support the presence 
of Leydig cell dysfunction in men with primary defects of spermatogenesis. The 
mechanism underlying this observation is at present unknown. 
In man, the normal testis secretes oestrogens (Kelch et al., 1972; Baird et al., 1973; 
Weinstein et al., 1974), although their physiological function is unclear. Dufau et al. 
(1978) suggested that oestrogens may have an intra- testicular role in the local control of 
Leydig cell function. Dorrington & Armstrong (1975) demonstrated the ability of FSH - 
stimulated rat Sertoli cells to form oestradiol from testosterone and androstenedione in 
vitro. Oestrogens may therefore be important in the pathogenesis of Leydig cell dysfunc- 
tion in infertile men. 
We report here in an investigation of the levels of circulating oestrogens in infertile men 
with pathologically- elevated FSH. Oestrone sulphate, oestrone and oestradiol were mea- 
sured in plasma to provide comprehensive indices of oestrogenic function in men with pri- 
mary disorders of seminiferous tubules. 
PATIENTS AND METHODS 
Peripheral venous blood samples were obtained from twenty patients attending the Male 
Subfertility Clinic, Royal Infirmary, Edinburgh. These patients were selected by the find- 
ing of one or more elevated plasma FSH level (normal male range 1.6 -6.7 u /1) in 
association with repeated azoospermia or oligospermia (sperm density under 10 
million /ml). Thirteen patients were oligospermic with mean sperm density of 3.1 ±2.3, 
range 0.25 -8.5 million /ml. Seven patients were azoospermic. The mean age of this infertile 
group (n =20) was 28.9 ±4.3 years. All patients had a normal 46 XY karyotype and 
normally developed secondary sexual characteristics. Details of the clinical findings are 
summarized in Table 1. 
The control group was represented by thirteen men whose wives had delivered normal 
infants within the previous 4.6 ±4 months in the Simpson's Memorial Maternity Pavilion, 
Edinburgh. No semen analysis was performed in this group. Blood samples were also 
obtained from eight male partners of infertile couples attending the Gynaecological Infer- 
tility Clinic, Royal Infirmary, Edinburgh; they were considered fertile by virtue of repeat- 
edly normal semen analyses (mean sperm density =181.5 ± 84.2, range 86-327 mil - 
lion/ml) and the absence of any abnormalities in the history or examination. The mean 
age of the normal fertile control groups (n = 21) was 31.8 ± 4.1 years. 
Table 1. Clinical findings in twenty infertile men* 
History Examination 
Mumps orchitis I L. varicocoele 2 
R. inguinal herniorrhaphy 1 R. undescended testis 1 
Bilateral orchidopexy 3 Small atrophic testes 
Unilateral testicular torsion 1 Unilateral I 
Bilateral 7 
* Some patients had more than one of the above abnormalities. 
One azoospermic and five oligospermic patients did not have any 
abnormalities in both history or examination. 
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Table 2. Comparisons of mean plasma levels of oestrone sulphate, oestrone, oestradiol, SHBG, LH and FSH in 






Oestrone Oestradiol Testosterone 
(pg /ml) (pg /ml) (pg /m1) 
SHBG 





Azoospermic Mean 829 52.6 50.3 5328 2-96 14.4 27-2 
(A) SD 225 8-6 12.1 1298 0.63 1-4 10.4 
Range 539 -1225 36-64 40-76 3974 -8024 2.37 -4.0 4.4 -46.4 12-7-42.7 
N 7 7 6 7 4 7 7 
Oligospermic Mean 851 54.8 44-8 5492 3-60 7.4 12.0 
(0) SD 237 11-2 12-5 1707 0.88 1.5 33 
Range 422 -1423 31 -77 21-67 2765 -8025 2-7-5-0 5.3 -11.1 7.2 -20.7 
N 13 13 13 13 8 13 13 
Normal Mean 593 40.6 33-1 5046 2.76 4.2 2-6 
(N) SD 220 8-8 10-9 1102 0.89 1.6 l4 
Range 369 -1230 22 -58 17 -59 3457 -7160 1.20 -4.74 1.9 -8.3 1.0 -5.5 
N 21 20 21 21 16 21 20 
Statistical A v O NS NS NS NS NS <0.05 <0.0005 
difference A v N <0.025 <0.005 <0.005 NS NS <0.0025 <0.0005 
P O v N <0.0025 <0.0005 <0.005 NS <0.05 <0.0005 <0.0005 
NS =not significant when P 0.05. 
and oligospermic patients showed no difference with respect to the three oestrogens and 
testosterone. LH and FSH, however, were higher in the azoospermic group. Mean 
SHBG- binding capacity was significantly higher in eight oligospermic patients than con- 
trols but the small number of azoospermic patients did not show any difference from 
either normal or oligospermic men (Table 2). Combined together as one infertile group, 
SHBG binding capacity was significantly elevated from normal (3.35 ±0.82 v. 
2.76 ±0.89 x 108 M, P <0.05, not shown in Fig. 1). 
A significant but weak positive correlation was obtained between FSH and oestrone 
(r = 0.3946), oestrone sulphate (r = 0.3457) and oestradiol (r = 0.3221) when the patient 
and control groups were combined. Correlations between LH and oestrone sulphate 
(r = 0.3686), LH and FSH (r = 0.6278) were also present. 
Although the mean absolute levels of all three oestrogens were higher in the infertile 
group, the ratios of oestrone sulphate to oestrone (15-6: 1) oestrone sulphate to oestradiol 
(18.1:1) and oestrone to oestradiol (12:1) have remained similar to that in the normal 
controls -14.6:1, 17.9:1 and 1.2:1 respectively. 
DISCUSSION 
This is the first report of increased concentrations of plasma oestrone sulphate, oestrone 
and oestradiol in infertile men with pathologically raised levels of FSH. It contrasts with 
the studies of Wieland et al. (1974) and Nankin et al. (1977) who found normal concentra- 
tion of oestradiol in a similar group of patients. Purvis et al. (1975) demonstrated normal 
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events may form a vicious circle which aggravates or perpetuates the initial insult to the 
seminiferous epithelium (de Kretser, 1979). 
It is noteworthy that concurrent with the rise in plasma oestrogens in infertile men with 
elevated FSH, SHBG- binding capacity was also significantly increased. As excessive 
endogenous on exogenous oestrogen is well -known to increase SHBG concentration 
(Pearlman et al., 1967; Migeon et al., 1968; Vermeulen et al., 1969), this observation pro- 
vides further supportive evidence for the principle findings in the present study. More- 
over, the total plasma testosterone concentration in infertile men was not significantly dif- 
ferent from normal in spite of increased LH and SHBG binding capacity. This implies 
that there is a significant fall in testosterone secretion rate and unbound testosterone con- 
centration, confirming the presence of Leydig cell dysfunction in infertile men despite nor- 
mal total plasma testosterone levels. 
That both FSH, and to a lesser extent LH, remain elevated in the infertile patients also 
implies that the rise in oestrogen is modest in magnitude or alternatively, that oestradiol 
plays a minor role in the feedback control of gonadotrophins. While compelling evidence 
has been accumulated in recent years supporting the existence of inhibin (Baker et al., 
1976; Franchimont et al., 1979) its physiological role in humans in relation to gonadal 
steroids remains unresolved. Several experimental studies had demonstrated that testos- 
terone, with or without oestradiol, provides the major negative feedback signal for FSH 
as well as LH secretion (Resko et al., 1977; Plant et al., 1978; Morris & Jackson, 1978; 
Main et al., 1980). There is evidence also that oestrogens alone may preferentially sup- 
press FSH (Kulin & Reiter, 1972; Sherins & Loriaux, 1973; Santen 1977; Sawin et al., 
1978; Lacroix et al., 1979) and hence act synergistically with inhibin and /or testosterone 
(Resko et al., 1977). Since inhibin -like activity resides in the aqueous extracts of testes 
(McCullagh, 1932), it is interesting to consider the possible role of oestrone sulphate, a 
water -soluble oestrogen conjugate, in the negative feedback control of FSH. Our results 
however demonstrated a positive rather than negative correlation between oestrone sul- 
phate (and the unconjugated oestrogens) and FSH. It seems unlikely therefore that oes- 
trogens have a major physiological role in the feedback control of FSH secretion in man. 
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under general anaesthesia, blood was aspirated by needle puncture simultaneously from the 
left spermatic vein (2 -10 ml) and the antecubital vein (10-20 ml). The plasma was separated 
by centrifugation and stored at -20 °C until analysis. Blood samples were taken between 
09.00 and 14.00 h whilst patients were in a horizontal position. 
Radioimmunoassay for oestrone sulphate and oestrone 
Radioactive oestrogens 
[6,7- 3H]Oestrone -3- sulphate potassium salt (sp. act. 39 Ci /mmol) and [2,4,6,7- 3H]oestrone 
(sp. act. 110 Ci /mmol) from The Radiochemical Centre, Amersham were used without 
further purification. 
Non -radioactive oestrogens 
Oestrone -3- sulphate potassium salt containing 9.6% by weight of potassium acetate 
stabilizer was obtained from Sigma (London) Ltd, Poole. The purity was confirmed by 
thin -layer chromatography before use. Solutions were made up in phosphate -gelatin buffer 
and used within 1 week. Solutions of oestrone (Calbiochem C.P. Laboratories Ltd, Bishop 
Stortford) were made up in absolute ethanol and stored at 4 °C. 
Solvents and reagents 
Organic solvents were AR grade (BDH Ltd, Poole). Diethyl ether was washed with 
acidified ferrous sulphate solution (180 mmol ferrous sulphate in 100 ml 5% (w /v) sulphuric 
acid) and redistilled before use. Sterile distilled water was purchased from Antigen Ltd, 
Rosecrea, Ireland. Steroid -free plasma was prepared by treatment with charcoal (Norit A; 
Sigma) of plasma obtained from female blood- donors. 
Phosphate -gelatin buffer (pH 7) was prepared by dissolving NaN3 (77 mmol), NaC1 
(770 mmol), Na2HPO4 (305 mmol), NaH2PO4.H20 (173 mmol) and gelatin (5 g) in 
deionized distilled water (5 litres). Dextran- coated charcoal suspension contained 250 mg 
charcoal (Norit A; Sigma) and 25 mg dextran T70 (Pharmacia G.B. Ltd, Hounslow) in 
100 ml phosphate -gelatin buffer. 
Internal standards for estimation of procedural loss 
[3H]Oestrone sulphate was added to each plasma sample for assessment of procedural loss. 
For the oestrone estimations, three to four samples containing 1 ml male plasma and 
[3H]oestrone (5000 counts /min, 37 fmol) were processed in each assay for estimation of 
group recovery. The mean recovery in oestrone sulphate samples (n = 173) was 63.4 ±8.8 
and in oestrone samples (eight assays, n = 30) was 84.3 ± 5.6 %. After the addition of these 
internal standards, the samples were left at room temperature for 1 h to equilibrate. 
Extraction of unconjugated oestrone before acid solvolysis 
One millilitre of plasma was shaken twice with 5 ml freshly distilled peroxide -free diethyl 
ether. The organic phases were combined and dried under N2 at 40 °C. The residue was 
dissolved in 100111 phosphate -gelatin buffer and kept at -20 °C until assay. 
Acid solvolysis 
This procedure was based on the method of Hawkins & Oakey (1974) with minor 
modifications. After extraction of unconjugated oestrone, oestrone sulphate in each plasma 
sample was solvolysed by adding 7.6 mmol crystalline (NH4)2SO4, 2512l 66% aqueous (v /v) 
sulphuric acid and 5 ml ethyl acetate. The reaction mixture was left overnight or for a 
minimum of 16 h in a water bath at 43 °C. The unconjugated oestrone released by solvolysis 
was extracted into diethyl ether as above. The ether was washed with 1 ml 8% (w /v) 
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The gonadotrophins, luteinizing hormone (LH) and follicle -stimulating hormone (FSH), 
were measured by the method of Hunter & Bennie (1979). The LH standard 68/40 (77 
units /ampoule) and FSH standard 69/104 (10 units /ampoule) from the National Institute 
of Biological Standards and Control, London were used. Within -assay variations for LH 
and FSH were 8.0 and 7.0% respectively. Interassay variations were 8.6 and 7.4% for LH 
and FSH respectively. The limit of detection was 0.65 units /1 for LH and 0.74 units /I for 
FSH. 
Semen analysis 
Semen analysis was carried out in the eight patients who presented with infertility. The 
method of analysis was as described in Chandley, Edmond, Christie, Gowans, Fletcher, 
Frackiewicz & Newton (1975). At least two semen samples from each of these patients 
were analysed and the average sperm density was used. 
Statistical analyses 
Statistical analyses were performed using Student's one -tailed t -test and Kendall's rank 
correlation. 
RESULTS 
Validation of assays for oestrone sulphate and oestrone 
Specificity 
The specificity of the assay of oestrone sulphate was dependent on the solvolysis step and 
the specificity of the antiserum. Cross -reactions with other steroids, expressed relative to 
oestrone (100 %) at 50% tracer binding in the displacement of the dose -response curve 
(Abraham, 1969), were as follows: oestrone sulphate, 30.5 %; equilenin, 15.0 %; oestradiol- 
1713, oestradiol-17a, oestriol, dehydroepiandrosterone, testosterone, androsterone, 17a- 
hydroxyprogesterone, progesterone, cortisol and aldosterone, all less than 0.02 %. 
There was no significant difference in the mean concentrations of oestrone sulphate 
measured with and without celite column chromatography in replicate estimates of plasma 
from postmenopausal women (0.71 ±0.10 v. 0.63 + 0.10 nmo1/1, n = 8, P >0.1) and normal 
men (1.96 ±6.29 v. 1.82 + 0.04 nmo1/1, n = 8, P >0.1). 
Accuracy 
Known amounts of oestrone sulphate (potassium salt) and oestrone were added to water 
and samples of human plasma. The slopes of the regression equations were not significantly 
different from unity indicating that there were no systematic errors in the method. For 
oestrone sulphate added to water: amount found = 0.99(amount added) + 0.13 nmo1/1; for 
oestrone sulphate added to plasma from postmenopausal women: amount 
found = 0.97(amount added) + 1.25 nmol /1; for oestrone added to plasma from pre- 
menopausal women: amount found = 0.96(amount added) +0.27nmo1 /1. The y intercept 
for oestrone sulphate added to water was not significantly higher than that for the average 
water blank in subsequent assays (0.05 nmol /1). 
Precision 
The within -assay precision for the oestrone sulphate assay estimated from assay of 25 
duplicate samples (range of concentration 0.08 -4.30 nmol /1) in four assays was 6.7 %. For 
the oestrone assay, the within -assay precision was determined in replicate samples at four 
different concentrations, 126 ±9, 252± 17, 474 ±44 and 978 ±57 pmol /1, giving coefficients 
of variation of 6.9, 6.9, 9.3 and 5.8% respectively, with a mean of 7.2 %. 
Interassay precision was assessed by repeated analyses of three plasma samples with 
mean concentrations ( ±s.D.) of 1.27 +0.10, 2.46 ±0.28 and 5.68 + 1.36 nmo1/1 for oestrone 
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sulphate and 123 ± 6, 160 ± 12 and 264 ± 66 pmol /1 for oestrone in three to five consecutive 
assays. The average interassay coefficients of variation for the oestrone sulphate and the 
oestrone assays were 15 and 12.5% respectively. 
Sensitivity 
The average binding in the zero standard tubes was 60.0 ± 3.9% of total oestrone tracer 
added (5000 counts /min = 38 fmol /tube) in eight consecutive assays. The sensitivity of the 
standard curve (12.6 fmol), defined as the smallest amount of steroid significantly different 
from zero, was derived from the standard deviation of zero points of standard curves. 
Taking into account the procedural losses (mean recoveries for oestrone sulphate 63.4% 
and oestrone 84.3 %) and the volume of plasma extract used for assay, the sensitivities of the 
assays were 0.1 nmol /1 for oestrone sulphate and 15 pmol /1 for oestrone. 
In the oestrone sulphate assay, the mean ( ±S.D.) value for the water blank was 
0.05 ±0.01 nmol /1 (n = 4) and for the average plasma blank, 0.11 ±0.01 nmol (n = 3). The 
range of values obtained for experimental samples was 0.48 -5.42 nmol/1. The lower limit of 
detection of the method was arbitrarily set at 0.14 nmol /1, equivalent to 80% inhibition of 
the binding found at zero mass. The plasma and water blank values were consistently less 
than the detection limit and were not subtracted from the results. 
In the oestrone assay, the mean ( ±s.D.) blank value for water was 30.7 ±7.4pmo1 /1 
(n = 5) and for steroid -free plasma was 50.7 ± 44 pmol/1(n = 3). The working range in this 
study for oestrone was 111 -760 pmol /1. The lower limit of detection of the method was set 
at 55 pmol /1, equivalent to 70% inhibition of the binding at zero mass. Blank values were 
not subtracted from the results. 
Concentration of steroids in spermatic venous plasma 
The concentrations of the five steroids in the spermatic and peripheral venous plasma 
from individual subjects are listed in Table 1. The concentrations of testosterone, andro- 
stenedione, oestradiol and oestrone were significantly higher in plasma from the spermatic 
vein than from the peripheral vein (P < 0.001, P < 0.005, P <0.025, P < 0.01 respectively, 
paired t- test). The ratios of the mean concentrations in spermatic venous plasma to those in 
peripheral venous plasma were 77.2, 9.1, 28.7 and 1.6 respectively. Although the mean 
concentration of oestrone sulphate in the spermatic vein was significantly higher (P <0.05, 
paired t -test) than that in peripheral vein, the ratio of the mean spermatic and peripheral 
concentrations was not significantly different from unity. Furthermore, in five patients the 
spermatic vein concentrations were lower than those in the peripheral vein. 
There were significant correlations (P <0.05 to <0.01, Kendall's rank correlation) 
between the testicular secretion, as represented by the individual spermatic : peripheral 
venous concentrations in each of the 17 patients, of oestrone, oestradiol, androstenedione 
and testosterone but not of oestrone sulphate. 
Although the mean LH and FSH levels in the 17 patients with varicocoeles were within 
the appropriate normal ranges (LH 3.4 -10.0 units /1 and FSH 1.7 -6.7 units/1), four patients 
(nos 1, 4, 6 and 10), one of whom was severely oligospermic, had raised concentrations of 
FSH. The mean levels of various steroids in spermatic and peripheral venous blood in these 
four patients with raised FSH were not significantly different from those with normal 
gonadotrophins although the mean spermatic vein concentration of oestradiol was higher 
in the former group (8.9 ± 6.0 v. 3.7 ± 6.0 nmol /1). 
DISCUSSION 
The estimation of oestrone sulphate was carried out with an antiserum directed against 
oestrone and applied to the assay of oestrone released after acid solvolysis of plasma 
samples. This approach was selected because of the difficulty in raising an effective 
antiserum against oestrone sulphate due to the instability of the immunogen. Specificity of 
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testicular hormone secretion is low, as for oestrone, these variables may have dispro- 
portionate effects leading to underestimation. There does not seem to be any entirely 
satisfactory explanation for the discrepant results in testicular secretion of oestrone at 
present. 
Although some studies claimed to have demonstrated abnormal Leydig cell function in 
patients with varicocoeles, this has not been confirmed by others. Raboch & Starka (1971) 
and Comhaire & Vermeulen (1975) found lower peripheral testosterone levels in patients 
with varicocoeles which correlated with increasing age. In -vitro studies using testicular 
biopsy specimens showed reduced synthesis of [3H]testosterone from [3H]pregnenolone in 
16 patients with varicocoeles compared with one normal control (Weiss, Rodriguez -Rigau, 
Smith & Steinberger, 1978). However, normal concentrations of gonadotrophins, testo- 
sterone and oestradiol were reported by Swerdloff & Walsh (1975), Schiff, Wilson, Newton, 
Shane, Kates, Ryan & Naftolin (1976) and Rege, Phadke, Bhatt, Khatri, Sheth, Joski & 
Vaidya (1979). Baird et al. (1973) and Swerdloff & Walsh (1975) also found comparable 
levels of testosterone and oestradiol in spermatic veins of patients with varicocoeles or 
inguinal hernias. In the present study, comparison of spermatic and peripheral vein 
concentrations of all five steroids between the four patients with raised FSH and /or 
oligospermia and the rest of the study group with normal FSH and /or sperm densities 
showed only higher spermatic vein concentrations of oestradiol which did not reach the 5% 
level of statistical significance. The balance of available evidence would suggest that studies 
on testicular steroid secretion based on spermatic vein concentrations in patients with 
varicocoeles may justifiably be extrapolated to the normal physiological situation. 
However, other factors which have not so far been taken into account are the suppressive 
effects of surgical stress (Eik -Nes, 1970; Wang, Chan & Yeung, 1978) and anaesthesia 
(Carstensen, Amen, Wide & Amen, 1973) on Leydig cell function. 
This study was carried out while F. C. W. W. was an MRC Clinical Training Fellow at 
the Department of Obstetrics and Gynaecology, University of Edinburgh. We wish to 
thank Mr J. W. Fowler, Department of Urology, Royal Infirmary, Edinburgh, for his co- 
operation in obtaining some of the spermatic venous samples and Dr R. A. Hawkins, 
Department of Clinical Surgery, University of Edinburgh for his encouragement and 
advice. 
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